WorldWideScience

Sample records for surgery radioactive iodine

  1. Radioactive Iodine Treatment for Hyperthyroidism

    Science.gov (United States)

    ... Balance › Radioactive Iodine for Hyperthyroidism Fact Sheet Radioactive Iodine for Hyperthyroidism April, 2012 Download PDFs English Zulu ... prepare for RAI or surgery. How does radioactive iodine treatment work? Iodine is important for making thyroid ...

  2. Low-Dose Radioactive Iodine Destroys Thyroid Tissue Left after Surgery

    Science.gov (United States)

    A low dose of radioactive iodine given after surgery for thyroid cancer destroyed (ablated) residual thyroid tissue as effectively as a higher dose, with fewer side effects and less exposure to radiation, according to two randomized controlled trials.

  3. Treatment of hyperthyroidism with radioactive iodine

    International Nuclear Information System (INIS)

    Bell, R.L.

    1974-01-01

    While radioactive iodine is clearly the therapy of choice for Graves' disease (even in younger patients) the use of radioactive iodine for therapy of the toxic multinodular or uninodular goiter presents an entirely different problem. Although these two entities can be treated with radioactive iodine provided there is some suppression of the tissue that is not autonomous, transient release of thyroid hormone may induce symptoms of thyroid storm in the very large multinodular toxic goiter treated with radioiodine therapy. These toxic nodules generally require much larger doses of radioiodine than is commonly used for classical Graves' disease and may either require fractional administration of radioisotopes or concomitant use of antithyroid drugs and iodides. In general, surgery remains the treatment of choice for large toxic multinodular goiters, after proper preparation by medical means including radioactive iodine. Radioactive iodine therapy for hyperthyroidism is contraindicated in pregnancy and generally is not used in children below five years of age. (U.S.)

  4. Hyperthyroidism and radioactive iodine

    International Nuclear Information System (INIS)

    Corstens, F.H.M.

    1980-01-01

    The study details the results of treatment of patients with hyperthyroidism using a combination of fractionated low doses radioactive iodine and anthithyroid drug therapy. The patients studied were treated according to this regimen after August 1968 and all reached euthyroidism before March 1979. None of the patients had been treated with radioactive iodine prior to the start of the protocol. A subgroup of the patients had received an unsuccessfull course with antithyroid drug therapy and, or, surgical therapy before the start of the protocol. Patients who had never been treated for hyperthyroidism were given antithyroid drug therapy for at least 6 months in an attempt to reach euthryroidism without the use of 131 I therapy. Therefore, all patients had experienced a course of unsuccessfull therapy prior to the start of the treatment protocol using combined fractionated low doses of 131 I and antithyroid drug therapy. (Auth.)

  5. Radioactive iodine intake through foodstuff

    International Nuclear Information System (INIS)

    Omomo, Yoichiro

    1974-01-01

    The transition of radioactive iodine to human bodies is affected by the amount of coexisting stable iodine. The intake of stable iodine through foodstuffs was studied from the stand point of I) discussion of the literature which states the approximate amounts of stable iodine contained in environmental materials, and II) the authors' research on the consumption of foodstuffs. For example, the amounts of iodine intake of fishermen living in Kuji-cho (Ibaragi Prefecture) was estimated from I and II, and was revealed as 2704p. The national average iodine intake was about 800p indicating that the former estimated value was remarkably high. Eighty Four per cent of the 2.7 mg iodine intake was taken from marine products, indicating that marine products are important sources of iodine supply. (Tsukamoto, Y.)

  6. Radioactive Iodine (I-131) Therapy for Hyperthyroidism

    Science.gov (United States)

    ... Physician Resources Professions Site Index A-Z Radioactive Iodine (I-131) Therapy Radioiodine therapy is a nuclear ... thyroid cancer. When a small dose of radioactive iodine I-131 (an isotope of iodine that emits ...

  7. Treatment of hyperthyroidism: who's afraid of radioactive iodine?

    International Nuclear Information System (INIS)

    Doorenbos, H.

    1986-01-01

    Discussed is the fact that treatment of hyperthyroidism with radioactive iodine is not often used although comparative studies show that radioactive iodine gives the best results compared with drugs or surgery. Argued is that the government besides legal radiation safety regulations, hospital planning and cost control, should reconsider the interest of the individual patient. (Auth.)

  8. Hyperparathyroidism after radioactive iodine therapy for Graves disease

    International Nuclear Information System (INIS)

    Esselstyn, C.B. Jr.; Schumacher, O.P.; Eversman, J.; Sheeler, L.; Levy, W.J.

    1982-01-01

    The association of external ionizing radiation to the head and neck and the subsequent development of hyperfunctioning parathyroid glands has been documented in recent years. This also has been demonstrated experimentally in animals. Despite the numbers of patients with Graves disease who have been treated with radioactive iodine, there are no reports in the literature of parathyroid surgery for hyperparathyroidism secondary to earlier treatment with radioactive iodine for Graves disease. This report describes the operative and pathologic findings in four patients with hyperparathyroidism. These patients had previously been treated with radioactive iodine for Graves disease. The pathologic findings at surgery included in three cases a single enlarged hyperplastic gland consistent with a parathyroid adenoma. One patient had hyperplasia of all four glands. The two largest glands and halves of the two remaining glands were removed. In a long-term follow-up of children and adolescents treated with radioactive iodine for Graves disease, Levy and Schumacher found calcium elevations in 10 of 159 patients. The increased incidence of hyperparathyroidism following radioactive iodine treatment for Graves disease in children and adolescents would seem several times higher than normal. Whether adults who have radioactive iodine treatment for Graves disease have a similar increase incidence is not known. Meanwhile it would seem reasonable to suggest that patients whose hyperthyroidism is treated with radioactive iodine should have their serum calcium levels determined at 5-year intervals

  9. The place of radioactive iodine in the treatment of hyperthyroidism

    International Nuclear Information System (INIS)

    Hennemann, G.; Krenning, E.P.; Erasmus Univ., Rotterdam; Sankaranaranayan, K.

    1986-01-01

    The effect of treatment of thyrotoxicosis with drugs, radioactive iodine, or surgery in different age groups is reviewed. In Graves' disease and toxic multinodular goitre the remission rate is about 40-50% after antithyroid drugs, but these drugs have little effect in toxic adenoma. Hypothyroidism developed in 35-49% of patients who had had thyroidectomy, and the risks of operation are high. The risk of malignant disease and genetic abnormalities was statistically not significantly greater after treatment with radioactive iodine in any age group. In general, treatment with radioactive iodine should have priority over thyroidectomy at all ages. (Auth.)

  10. Hygienic assessment of radioactive iodine isotopes

    International Nuclear Information System (INIS)

    Vasilenko, I.Ya.

    1987-01-01

    Sources of radioactive iodine isotopes and their biological significance depending on the way of intake are discussed. The degree of food contamination by radioactive iodine as well as products, which serve as the source of its intake into the human body, and results of their processing are considered. The danger of radioactive iodine intake by different groups of population as well as thyroid irradiation effects are discussed. Description of activities, directed to the human body protection against radioactive iodine and assessment of these protection measures efficiency is presented

  11. Method for immobilizing radioactive iodine

    International Nuclear Information System (INIS)

    Babad, H.; Strachan, D. M.

    1980-01-01

    Radioactive iodine, present as alkali metal iodides or iodates in an aqueous solution, is incorporated into an inert solid material for long-term storage by adding to the solution a stoichiometric amount with respect to the formation of a sodalite (3M2O.3Al2O3. 6SiO2.2MX, where M alkali metal; X I - or IO 3- ) of an alkali metal, alumina and silica, stirring the solution to form a homogeneous mixture, drying the mixture to form a powder, compacting and sintering the compacted powder at 1073 to 1373 K (800 0 to 1100 0 C.) for a time sufficient to form sodalite

  12. Salivary gland dysfunction following radioactive iodine therapy

    International Nuclear Information System (INIS)

    Wiesenfeld, D.; Webster, G.; Cameron, F.; Ferguson, M.M.; MacFadyen, E.E.; MacFarlane, T.W.

    1983-01-01

    Radioactive iodine is used extensively for the treatment of thyrotoxicosis and thyroid carcinoma. Iodine is actively taken up by the salivary glands and, following its use, salivary dysfunction may result as a consequence of radiation damage. The literature is reviewed and a case is reported in which a patient presented with a significant increase in caries rate attributed to salivary dysfunction following radioactive iodine therapy for a thyroid carcinoma

  13. Radioactive iodine absorbing properties of tetrathiafulvalene

    Energy Technology Data Exchange (ETDEWEB)

    Ito, Tomiyasu; Nakamura, Asao (Ajinomoto Co. Inc., Kawasaki, Kanagawa (Japan). Central Research Labs.); Nogawa, Norio; Oohashi, Kunio; Morikawa, Naotake

    1989-05-01

    For the purpose of searching some effective absorbents of gaseous radioactive iodine, 16 substances considered as having an affinity for iodine were investigated with regular iodine and /sup 125/I. In a preliminary survey, only tetrathiafulvalene (TTF) was found to have satisfactory absorbing properties comparable to activated charcoal. A further detailed comparison of the properties between TTF and activated charcoal led us to the conclusion that the former has more preferable properties as absorbent of radioactive iodine than the latter in all points studied. The results are summarized as follows: (1) The absorption of iodine on TTF in atmosphere was about twice as much as that on activated charcoal. Desorption of iodine from saturatedly absorbed iodine on TTF was practically negligible except trace amount of initial desorption, while that on activated charcoal was considerable (3%/50h) even in the air at room temperature. (2) Absorbed amount of iodine on activated charcoal decreased with increasing gaseous iodine concentration, air flow rate, on humidity of flowing-air. On the other hand, those factors scarcely affected that on TTF. Under an air flow rate of 1m/s, activated charcoal absorbs only 80% of iodine, while TTF absorbs more than 99%. (3) In flowing-air saturated with water vapor, iodine absorbed on activated charcoal was gradually liberated although by small amount (0.08%/100h), while that on TTF was much more stable for a long period (0.004%/100h). As a conclusion, TTF is considered to be useful as a quite effective radioactive iodine absorbent, especially in the case where protection from radioactive iodine should be serious, though it is expensive now. (author).

  14. Radioactive iodine absorbing properties of tetrathiafulvalene

    International Nuclear Information System (INIS)

    Ito, Tomiyasu; Nakamura, Asao; Nogawa, Norio; Oohashi, Kunio; Morikawa, Naotake.

    1989-01-01

    For the purpose of searching some effective absorbents of gaseous radioactive iodine, 16 substances considered as having an affinity for iodine were investigated with regular iodine and 125 I. In a preliminary survey, only tetrathiafulvalene (TTF) was found to have satisfactory absorbing properties comparable to activated charcoal. A further detailed comparison of the properties between TTF and activated charcoal led us to the conclusion that the former has more preferable properties as absorbent of radioactive iodine than the latter in all points studied. The results are summarized as follows: (1) The absorption of iodine on TTF in atmosphere was about twice as much as that on activated charcoal. Desorption of iodine from saturatedly absorbed iodine on TTF was practically negligible except trace amount of initial desorption, while that on activated charcoal was considerable (3%/50h) even in the air at room temperature. (2) Absorbed amount of iodine on activated charcoal decreased with increasing gaseous iodine concentration, air flow rate, on humidity of flowing-air. On the other hand, those factors scarcely affected that on TTF. Under an air flow rate of 1m/s, activated charcoal absorbs only 80% of iodine, while TTF absorbs more than 99%. (3) In flowing-air saturated with water vapor, iodine absorbed on activated charcoal was gradually liberated although by small amount (0.08%/100h), while that on TTF was much more stable for a long period (0.004%/100h). As a conclusion, TTF is considered to be useful as a quite effective radioactive iodine absorbent, especially in the case where protection from radioactive iodine should be serious, though it is expensive now. (author)

  15. Hyperparathyroidism after radioactive iodine therapy for Graves' disease

    International Nuclear Information System (INIS)

    Kawamura, Juichi; Tobisu, Kenichi; Sanada, Shingo

    1983-01-01

    Herein we report a 36-year-old man with hyperparathyroidism and a past history of internal irradiation to the thyroid. Twelve years previously at age 24 years he had received 8 mCi of radioactive iodine for Graves' disease. An additional dose of 4 mCi was required 3 years later. A right lower parathyroid adenoma (28 x 23 x 20 mm, 5.7 g) was found at neck exploration. Although the association of external ionizing radiation to the head and neck and the subsequent development of hyperfunctioning parathyroid glands has been described in recent years, there are only 4 cases in the literature of parathyroid surgery for hyperparathyroidism secondary to earlier treatment with radioactive iodine for Graves' disease. In a long-term follow-up of 180 patients treated with radioactive iodine for Graves' disease, neither hypercalcemia nor hypophosphatemia was found. Whether internal radiation therapy can be a causative factor in the development of hyperparathyroidism should be elucidated in future. However, it seems reasonable to suggest that patients whose hyper-thyroidism has been treated with radioactive iodine should have their scrum calcium levels examined at 5-year intervals. (author)

  16. Labelling of olive oil with radioactive iodine and radioactive technetium

    International Nuclear Information System (INIS)

    Al-Dayel, O.A.F.

    1988-03-01

    Investigates labelling of olive oil with 125 iodine and with the radioactive 99mTC. A radio analytical study for 99Mo-99mTC generator is also presented. Iodine monochloride and chlormine-T methods are used for labelling olive oil and oleic acid with radioactive iodine. Diethyl ether, benzene and n-heptane have been used as solvents, with diethyl ether giving best results using iodine monochloride method. Infrared spectroscopic studies show that labelling took place at the double bond. Use of milked 99mTc gave very low yield only. A fairly higher labelling yield was achieved when 20 mg of tin chloride has been added in acetone medium than diethyl ether medium. Thin layer chromatography and paper chromatography technique were used as quality control systems. The labelled oil can be used for diagnostic and study purposes. 140 Ref

  17. Radio-active iodine uptake in vitiligo

    Energy Technology Data Exchange (ETDEWEB)

    Kumar, V.; Shankar, V.; Chaudhary, S.; Bhatia, K.K.; Mehta, L.K.; Arora, D.R. (Medical College and Hospital, Rohtak-124001 (India))

    1990-01-01

    Vitiligo and thyroid disease are commonly associated disorders. Twenty-two clinically euthyroid vitiligo patients were studied for functional assessment of thyroid by radioactive iodine uptake assay. Half of them showed abnormal uptake values at 24 hours. Of these patients, 90% had lower values indicating a tendency towards developing hypothyroid state. Subclinical thyroid dysfunction in vitiligo appears to be an adaptive change. (author).

  18. Radio-active iodine uptake in vitiligo

    International Nuclear Information System (INIS)

    Kumar, V.; Shankar, V.; Chaudhary, S.; Bhatia, K.K.; Mehta, L.K.; Arora, D.R.

    1990-01-01

    Vitiligo and thyroid disease are commonly associated disorders. Twenty-two clinically euthyroid vitiligo patients were studied for functional assessment of thyroid by radioactive iodine uptake assay. Half of them showed abnormal uptake values at 24 hours. Of these patients, 90% had lower values indicating a tendency towards developing hypothyroid state. Subclinical thyroid dysfunction in vitiligo appears to be an adaptive change. (author)

  19. Novel method of producing radioactive iodine

    International Nuclear Information System (INIS)

    Shikata, E.; Amano, H.

    1976-01-01

    Radioactive iodine(I-131) is easily obtained by heating, at a temperature ranging from 600 0 C to 650 0 C, a tellurium oxide intermediate which was obtained by heating telluric acid or tellurium trioxide at a temperature from about 400 0 C to 560 0 C and was irradited with a neutron flux. Thus, pure I-131 is obtained without the complicated operations required in a conventional process for separation and/or purification of the product. 4 claims

  20. Outcome of hyperthyroidism treated by radioactive iodine

    International Nuclear Information System (INIS)

    Al-Shaikh, A.A.

    2009-01-01

    To study the outcome of Radioactive Iodine (RAI) in treatment of hyperthyroidism. It is a retrospective study of all patients of hyperthyroidism treated by Radioactive Iodine (RAI) seen in endocrinology clinic at King Abdulaziz University Hospital and Dr. Soliman Fageeh Hospital in Jeddah, Saudia Arabia. Two hundred and sixteen (216) patients were treated by RAI. They proved to have hyperthyroidism by thyroid function test (TSH, FT4 and T3) and isotopes scanning of the thyroid gland. All received 10 mci of RAI and were then followed up after one month and every two months thereafter for at least one year. The efficacy of the therapy was assessed by the improvement of the clinical features and by the thyroid function tests. A total of 216 patients were seen, the mean age was 36.5+- 10.64 years. One hundred fifty three were female and sixty three were male. Graves disease was the underlying cause in 163 patients [65.55%], toxic multi nodular goiter in 37 patients [25.1%] and toxic adenoma in 16 patients [9.3%]. The symptoms improved after one month only in 11 patients but others required antithyroid treatment for two months. Only 17 patients remained hyperthyroid after six months of treatment. Radioactive iodine is very effective in treatment of hyperthyroidism with minor side effects such as weight gain, fatigability and hypothyroidism. (author)

  1. Radioactive iodine therapy in cats with hyperthyroidism

    International Nuclear Information System (INIS)

    Turrel, J.M.; Feldman, E.C.; Hays, M.; Hornof, W.J.

    1984-01-01

    Eleven cats with hyperthyroidism were treated with radioactive iodine ( 131 I). Previous unsuccessful treatments for hyperthyroidism included hemithyroidectomy (2 cats) and an antithyroid drug (7 cats). Two cats had no prior treatment. Thyroid scans, using technetium 99m, showed enlargement and increased radionuclide accumulation in 1 thyroid lobe in 5 cats and in both lobes in 6 cats. Serum thyroxine concentrations were high and ranged from 4.7 to 18 micrograms/dl. Radioactive iodine tracer studies were used to determine peak radioactive iodine uptake (RAIU) and effective and biological half-lives. Activity of 131 I administered was calculated from peak RAIU, effective half-life, and estimated thyroid gland weight. Activity of 131 I administered ranged from 1.0 to 5.9 mCi. The treatment goal was to deliver 20,000 rad to hyperactive thyroid tissue. However, retrospective calculations based on peak RAIU and effective half-life obtained during the treatment period showed that radiation doses actually ranged from 7,100 to 64,900 rad. Complete ablation of the hyperfunctioning thyroid tissue and a return to euthyroidism were seen in 7 cats. Partial responses were seen in 2 cats, and 2 cats became hypothyroid. It was concluded that 131 I ablation of thyroid tumors was a reasonable alternative in the treatment of hyperthyroidism in cats. The optimal method of dosimetry remains to be determined

  2. Volatile suppressing method for radioactive iodine

    International Nuclear Information System (INIS)

    Ohara, Atsushi; Haruguchi, Keiko.

    1997-01-01

    In the present invention, a metal plate is disposed above the pool water surface of a suppression chamber disposed to a reactor container in order to reduce evaporation of radioactive iodine released from a suppression pool. A metal plate is disposed above the pool water surface of the suppression chamber disposed to the reactor container. In addition, a metal plate is disposed around the space connecting a bent tube extending from a dry well to underwater of suppression pool water and a gas bent tube extending from the suppression chamber to an emergency gas processing system. Spray water is supplied for cooling the suppression chamber d as a means for cooling the metal plate. Then, among iodine released to the suppression chamber, elemental iodine liberated from the pool water is deposited on the surface of the metal plate, and the amount of iodine to be flown into and processed by an emergency gas processing system or a filter bent system can be reduced. (T.M.)

  3. Incidence of symptomatic salivary disease in patients with differentiated thyroid cancer treated with radioactive iodine

    International Nuclear Information System (INIS)

    Goni E, Ignacio; Selt A, Guillermo Vander; Ruiz A, Catalina; Leon R, Augusto; Solar G, Antonieta; Orellana B, Catalina

    2015-01-01

    Background: The radioactive iodine therapy for differentiated thyroid cancer can produce severe and frequent salivary symptoms, during the treatment or later. Aim: To analyze the incidence, severity and characteristics of the salivary signs and symptoms in these patients. Patients and Method: Retrospective and descriptive anal isis of 106 patients with confirmed diagnosis of differentiated thyroid cancer, treated with surgery and radioactive iodine, that completed a telephonic survey for the evaluation of salivary symptoms. Results: 26 (24.52%) patients presented with salivary symptoms or signs after the radioactive iodine therapy (mean 5 months). The average doses of I 131 was 128,5 mCi. Xerostomy, pain, xeroftalmy, inflammation, sialoadenitis and dysgeusia, were the most frequent clinical symptoms. Conclusions: After radioactive iodine therapy the salivary symptoms and signs incidence is high. We conclude that the indication for this treatment must be selective, but in accordance with the oncological risk of each patient

  4. Thyroid storm precipitated by radioactive iodine therapy

    International Nuclear Information System (INIS)

    Redkar, Neelam N.; Rawat, Kavita J.; Yelale, Abhijit; Shivchand, Akshay

    2015-01-01

    Thyroid storm or thyrotoxic crisis is a rare but life-threatening condition requiring immediate treatment, preferably in an intensive care unit. Its incidence is about 1-2% among patients with overt hyperthyroidism. A thyrotoxic crisis occurs predominantly in the elderly and is three to five times more common in women than in men. The overall mortality is 10-20%. Even though the pathogenesis is still not fully understood, an increased sensitivity to catecholamines appears to be an important mechanism, and a number of endogenous and exogenous stress factors that can provoke the onset of a thyrotoxic storm have been identified. Authors presented a case where the cause of precipitation of thyroid storm was improper preparation of patient for Radioactive iodine treatment

  5. Radioactive iodine releases from nuclear power plant, (2)

    International Nuclear Information System (INIS)

    Naritomi, Mitsuo

    1974-01-01

    Internal radiation dose through the respiratory intake of fission products is predominantly due to radioactive iodine not only at the time of reactor accidents but also in normal operation of nuclear facilities. Technological studies in this field have thus been quite active to this day. With the rapid advance of nuclear power generation in recent years, the efforts to reduce environmental release of radioactive iodine and to enhance environmental safety are all the more emphasized. Experiences in the Japan Atomic Energy Research Institute during past about six years are described concerning the radioactive iodine release to the atmosphere in 131 I production and the measures taken to reduce the release. Then, problems are expounded regarding the radioactive iodine release at the time of reactor accidents and in spent fuel reprocessing. (Mori, K.)

  6. Chylothorax Associated with Substernal Goiter in Graves' Disease Treated with Radioactive Iodine.

    Science.gov (United States)

    Young Oh, Seo; Hyun Kim, Bo; Young Kim, Do; Min Lee, Kyu; Jin Lee, Min; Su Kim, Sung; Ho Kim, Jong; Kyung Jeon, Yun; Soo Kim, Sang; Ki Kim, Yong; Joo Kim, In

    2017-04-01

    We present a rare case of chylothorax associated with an intrathoracic goiter in Graves' disease that was treated with radioactive iodine. A 23-year-old woman with Graves' disease was referred to our clinic with a pleural effusion, dyspnea, characteristic bilateral proptosis, and a diffuse goiter. The pleural fluid biochemistry was consistent with chylothorax. However, the chylothorax did not decrease with conservative therapy. Therefore, RAI was administered. Subsequently, the chylothorax and goiter improved more quickly than expected. This case illustrates that chylothorax associated with a substernal goiter in Graves' disease can be treated successfully with radioactive iodine instead of surgery.

  7. Two-layer type filter for removal of radioactive iodine

    Energy Technology Data Exchange (ETDEWEB)

    Taoki, M

    1976-04-16

    The object is to provide a filter for removing radioactive iodine, which is used for disposal of gaseous waste in an atomic power plant, to particularly hold a pressure loss lower. The filter according to the present invention comprises two layers, which are filled at a front stage with active carbon, which is small in pressure loss and has a good collective efficiency relative to iodine, and at a rear stage with silver zeolite, which has a good collective efficiency relative to both iodine and methyl iodine, whereby respective adsorbent are effectively utilized to minimize pressure loss even if a large quantity of air.

  8. Two-layer type filter for removal of radioactive iodine

    International Nuclear Information System (INIS)

    Taoki, Masafumi.

    1976-01-01

    Object: To provide a filter for removing radioactive iodine, which is used for disposal of gaseous waste in an atomic power plant, to particularly hold a pressure loss lower. Structure: The filter according to the present invention comprises two layers, which are filled at a front stage with active carbon, which is small in pressure loss and has a good collective efficiency relative to iodine, and at a rear stage with silver zeolite, which has a good collective efficiency relative to both iodine and methyl iodine, whereby respective adsorbent are effectively utilized to minimize pressure loss even if a large quantity of air. (Kamimura, M.)

  9. Method for solidification of radioactive iodine-containing solid wastes

    International Nuclear Information System (INIS)

    Ozawa, Yoshihiro; Funabashi, Kiyomi; Uetake, Naoto.

    1987-01-01

    Purpose: To process radioactive iodine containing solid wastes as non-leaching solidified wastes with no risk of iodine release. Method: It has been known for the thermal stability of CuI, PbI 2 or adsorbents containing the same that they do not release iodine in an inert gas atmosphere or in a reducing atmosphere at a temperature lower than 480 deg C. In view of the above, adsorbents containing iodine in the chemical form of CuI or PbI 2 , or CuI or powdery PbI 2 per se are sealed and solidified into low melting glass at a temperature of lower than 480 deg C at which no iodine release occurs in a non-oxidative atmosphere. Since the products are vitrified wastes, they scarcely show leaching property and are excellent in durability and stability. (Takahashi, M.)

  10. Mixed-layered bismuth--oxygen--iodine materials for capture and waste disposal of radioactive iodine

    Science.gov (United States)

    Krumhansl, James L; Nenoff, Tina M

    2015-01-06

    Materials and methods of synthesizing mixed-layered bismuth oxy-iodine materials, which can be synthesized in the presence of aqueous radioactive iodine species found in caustic solutions (e.g. NaOH or KOH). This technology provides a one-step process for both iodine sequestration and storage from nuclear fuel cycles. It results in materials that will be durable for repository conditions much like those found in Waste Isolation Pilot Plant (WIPP) and estimated for Yucca Mountain (YMP). By controlled reactant concentrations, optimized compositions of these mixed-layered bismuth oxy-iodine inorganic materials are produced that have both a high iodine weight percentage and a low solubility in groundwater environments.

  11. Mixed-layered bismuth-oxygen-iodine materials for capture and waste disposal of radioactive iodine

    Science.gov (United States)

    Krumhansl, James L; Nenoff, Tina M

    2013-02-26

    Materials and methods of synthesizing mixed-layered bismuth oxy-iodine materials, which can be synthesized in the presence of aqueous radioactive iodine species found in caustic solutions (e.g. NaOH or KOH). This technology provides a one-step process for both iodine sequestration and storage from nuclear fuel cycles. It results in materials that will be durable for repository conditions much like those found in Waste Isolation Pilot Plant (WIPP) and estimated for Yucca Mountain (YMP). By controlled reactant concentrations, optimized compositions of these mixed-layered bismuth oxy-iodine inorganic materials are produced that have both a high iodine weight percentage and a low solubility in groundwater environments.

  12. FAILURE OF RADIOACTIVE IODINE IN TREATMENT OF HYPERTHYROIDISM

    Science.gov (United States)

    Schneider, David F.; Sonderman, Philip E.; Jones, Michaela F.; Ojomo, Kristin A.; Chen, Herbert; Jaume, Juan C.; Elson, Diane F.; Perlman, Scott B.; Sippel, Rebecca S.

    2015-01-01

    Introduction Persistent or recurrent hyperthyroidism after treatment with radioactive iodine (RAI) is common, and many patients require either additional doses or surgery before they are cured. The purpose of this study was to identify patterns and predictors of failure of RAI in patients with hyperthyroidism. Methods We conducted a retrospective review of patients treated with RAI from 2007–2010. Failure of RAI was defined as receipt of additional dose(s) and/or total thyroidectomy. Using a Cox proportional hazards model, we conducted univariate analysis to identify factors associated with failure of RAI. A final multivariate model was then constructed with significant (p treatment. 53 (71.6%) received additional RAI, 13 (17.6%) received additional RAI followed by surgery, and the remaining 8 (10.8%) were cured after thyroidectomy. The percentage of patients who failed decreased in a step-wise fashion as RAI dose increased. Similarly, the incidence of failure increased as the presenting T3 level increased. Sensitivity analysis revealed that RAI doses treatment (HR 2.55, 95% CI 1.22–5.33, p=0.01) were associated with failure. Conclusions Laboratory values at presentation can predict which patients with hyperthyroidism are at risk for failing RAI treatment. Higher doses of RAI or surgical referral may prevent the need for repeat RAI in selected patients. PMID:25001092

  13. Failure of radioactive iodine in the treatment of hyperthyroidism.

    Science.gov (United States)

    Schneider, David F; Sonderman, Philip E; Jones, Michaela F; Ojomo, Kristin A; Chen, Herbert; Jaume, Juan C; Elson, Diane F; Perlman, Scott B; Sippel, Rebecca S

    2014-12-01

    Persistent or recurrent hyperthyroidism after treatment with radioactive iodine (RAI) is common and many patients require either additional doses or surgery before they are cured. The purpose of this study was to identify patterns and predictors of failure of RAI in patients with hyperthyroidism. We conducted a retrospective review of patients treated with RAI from 2007 to 2010. Failure of RAI was defined as receipt of additional dose(s) and/or total thyroidectomy. Using a Cox proportional hazards model, we conducted univariate analysis to identify factors associated with failure of RAI. A final multivariate model was then constructed with significant (p treatment, 53 (71.6 %) received additional RAI, 13 (17.6 %) received additional RAI followed by surgery, and the remaining 8 (10.8 %) were cured after thyroidectomy. The percentage of patients who failed decreased in a stepwise fashion as RAI dose increased. Similarly, the incidence of failure increased as the presenting T3 level increased. Sensitivity analysis revealed that RAI doses treatment (HR 2.55; 95 % CI 1.22-5.33; p = 0.01) were associated with failure. Laboratory values at presentation can predict which patients with hyperthyroidism are at risk for failing RAI treatment. Higher doses of RAI or surgical referral may prevent the need for repeat RAI in selected patients.

  14. Labelling aflatoxine-B1 by radioactive iodine

    International Nuclear Information System (INIS)

    Kim, Y.S.; Park, K.B.; Sung, H.K.; Ryu, Y.W.

    1977-01-01

    Labelling aflatoxines, the potential carcinogenic compounds, by radioactive iodine has been studied. The auflatoxine-B 1 , which is known to be the most abundant components of auflatoxines in the nature, was labelled by radioactive iodine-125 through an acid catalyst chloroamine-T procedure. The radiochemical yield was amounted to 63.6%. The chemical structure of the labelled product was proved to be 6-iodo 5-methoxy coumarine structure of auflatoxine-B 1 molecule by means of I.R. and N.M.R. spectroscopy. The labelled product was orally administered in a test animal (rat) and examined the accumulation of radioactivity in the body at the definite time interval. The accumulation of the radioactivity was pronounced at the blood and the liver. There was no indication of the decomposition of auflatoxine-B 1 - 125 I in the organs of the test animal. (author)

  15. Study on adsorption performance of coal based activated carbon to radioactive iodine and stable iodine

    International Nuclear Information System (INIS)

    Zhou, Junbo; Hao, Shan; Gao, Liping; Zhang, Youchen

    2014-01-01

    Highlights: • The impregnated coal-based activated carbons as adsorbent for removing methyl iodide. • The coal-based activated carbons to remove stable iodine. • Iodine residues are under 0.5 μg/ml after adsorption treatment. • The decontamination factor is much higher than 1000. - Abstract: Nuclear power plant, nuclear reactors and nuclear powered ship exhaust contains a large amount of gaseous radioactive iodine, and can damage to the workplace and the surrounding environment. The quantitative test to remove methyl iodide and the qualitative test for removing stable iodine were investigated using the impregnated coal-based activated carbons and coal-based activated carbons as adsorbents. The research conducted in this work shows that iodine residues were under 0.5 μg/ml after adsorption treatment and the decontamination factor of the coal-based activated carbon for removing the stable iodine was more than 1000, which can achieve the purpose of removing harmful iodine, and satisfy the requirement of gaseous waste treatment of nuclear powered vessel and other nuclear plants

  16. Management of radioactive wastes of iodine therapy

    International Nuclear Information System (INIS)

    Silva, Andre R.M.; Santos, Helena C.

    2015-01-01

    The main objective of waste radioactive management is to ensure the protection of man and the preservation of the environment. The regulation that established the basis for the good radioactive waste management was elaborated by the Comissao Nacional de Energia Nuclear (CNEN), in 1985. It is the CNEN-NE-6:05: 'Management radioactive waste in radioactive facilities', which although it an important standard related to radioactive waste management and help largely in the design of a management system in radioactive facilities of radioisotope users, covers the topics in a general way and does not consider individuals aspects of the different plants, as is the case of nuclear medicine units. The main objective of this study is to show the segregation and safe packaging, avoiding unnecessary exposure of professionals involved and public individuals in general

  17. POSTOPERATIVE TREATMENT OF THYROID CANCER WITH RADIOACTIVE IODINE

    Energy Technology Data Exchange (ETDEWEB)

    Blahd, William H.; Koplowitz, Jerry M.

    1963-06-15

    Experiences in the postoperative treatment of thyroid cancer with radioactive iodine since 1949 are reviewed. Forty-five patients received therapeutic amounts of I/sup 131/ and were followed for more than one year. Cancer metastases were localized by means of the mechanical scintiscanner after patients had received large tracer doses of I/sup 131/ preceded by injections of thyrotropic hormone. A consistent therapeutic regimen was followed involving four basic modalities of therapy: surgical thyroidectomy, thyrotropic hormone stimulation, cancerocidal doses of I/sup 131/ and thyroid extract administration. Twenty-nine patients in the series had proved metastatic lesions; 11 died, 18 are living, and 41% have lived 5 or more years. All patients who were free of metastases after initial thyroid surgery are alive. No complications from I/sup 131/ therapy were observed. This is attributed to the conservative dosage regimen employed. The results of the use of I/sup 131/ in the postoperative treatment of thyroid cancer in other reported series are also reviewed. (P.C.H.)

  18. Treatment of Thyrotoxicosis Using Radioactive Iodine 131

    International Nuclear Information System (INIS)

    JAJA, Salvador Bessarione

    1998-01-01

    Throtoxicosis is common in the Sudan, and its management constitute a significant health problem in terms of expenses, in addition to dilemma of best therapy between the physician's choice and the patients' reference. As the role of Radioactive lodine is becoming more acceptable. It is wise to evaluate our experience and compare it to the current literature, aiming to use the treatment more effectively in our setting. The objective is to evaluate the effectively of radioiodine and factors affecting them, and to find out the possible complications, and compare the cost of treatment to that of surgery and antithyroid drugs, as well as to find out the patient attitude and knowledge towards the treatment. 103 thyrotoxic patients referred to Radioisotope center and received Radioiodine therapy in the period between 1986-1997 were considered in the study. Those who received the treatment in 1997 were followed up prospectively for minimum of 12 months. Clinical feature, severity of the disease, size and type of goitre and complications were considered. Patients were treated as out patients and followed up in the referred clinic. 115 patients (88.5%) were female and 15(11.5%) were male. The mean age was (49±)10.7), the majority (43.9%) were fluocortolonum state and the least (1.5%) from Southern states. Most of the patients (58%) were referred from medical units in the hospitals, their mean thyroxine level (212.285±36.753) and mean weight (58.031±8.724)kg. (54.6%) had diffused goitre and 36% multinodular goitre and 9.2% had solitary nodule. 48.5% of the patients had moderate size goitre, 32.3% large size and 19.2% small size goitre. The main indication was replace after medical treatment (40%). Out of the 59 patients interviewed (77.9%) have no knowledge about the therapy, and (48.4%) accepted the treatment without difficulty. 22 patients presented with complications, and most of the complications were cardiac, heart failure with arrhythmia (50%) 15 patients had

  19. Changes is radioactive iodine metabolism in acute chemical intoxications

    International Nuclear Information System (INIS)

    Selyutitskij, G.V.; Likhtarev, I.A.; Volkova, N.V.; Zvonova, I.A.; Ostryakova, N.I.

    1978-01-01

    It is shown that the response of the endocrine system (iodine-absorbing and hormone-secreting fUnctions of the thyroid) as studied by the radioactive iodine test may be a reasonably versatile indicator of the response of the thyroid component of the endocrine system to acute intoxication of the organism. Trials of this test using seven chemical substances have confirmed that the radioiodine test is a sufficienty universal method to be used in setting sanitary and hygienic standards for permissible levels of chemical substances

  20. Recovery and storage method for radioactive iodine by vacuum freeze-drying

    International Nuclear Information System (INIS)

    Otsuka, Katsuyuki; Ouchi, Hitoshi; Suzuki, Toru.

    1990-01-01

    After scrubbing off-gas formed in a re-processing process for spent nuclear fuels, scrubbing liquids after use are subjected, as they are or with addition of additives, to a precipitating treatment. Then, liquid wastes containing radioactive iodine was subjected to freeze-drying treatment by freeze-drying under vacuum to recover radioactive iodine as iodine compounds. Off-gas scrubbing is conducted by using a sodium hydroxide solution and copper or silver ions may be added as additives in the precipitating treatment. Recovered iodine compounds containing radioactive iodine are solidified, either directly or after formulating into a composition of naturally existing iodine-containing ores by means of high pressure pressing into ores. This can prevent radioactive iodine 1 29I of long half-decay time from diffusing into the circumference and store the radioactive iodine stably for a long period of time. (T.M.)

  1. Behavior of highly radioactive iodine on charcoal in moist air

    International Nuclear Information System (INIS)

    Lorenz, R.A.; Manning, S.R.; Martin, W.J.

    1976-01-01

    The behavior of highly radioactive iodine adsorbed on charcoal exposed to moist air (110 torr water vapor partial pressure) was investigated in a series of six experiments. The amount of radioactive 130 I on the well-insulated 28-cm 3 bed ranged from 50 to 570 Ci, and the relative humidity was 47 percent at the bed inlet temperature of 70 0 C. Radioactive iodine was released from the test beds at a continuous fractional release rate of approximately 7 x 10 -6 /hr for all types of charcoal tested. The chemical form of the released iodine was such that it was very highly penetrating with respect to the nine different types of commercial impregnated charcoals tested in backup collection beds. Two types of silver-nitrate-coated adsorption materials behaved similarly to the charcoals. Silver-exchanged type 13-X molecular sieve adsorbers were 20 to 50 times more efficient for adsorbing the highly penetrating iodine, but not as efficient as normally found for collecting methyl iodide. The chemical form of the highly penetrating iodine was not determined. When the moist air velocity was decreased from 28.5 fpm (25 0 C) to as low as 0.71 fpm (25 0 C), the charcoal bed temperature rose slowly and reached the ignition temperature in three of the experiments. At 0.71 fpm (25 0 C) the ignited charcoal beds reached maximum temperatures of 430 to 470 0 C because of the limited oxygen supply. The charcoal exposed for four years at Oak Ridge ignited at 283 0 C compared with 368 0 C for unused charcoal from the same batch. Two of the experiments used charcoal containing 1 or 2 percent TEDA (triethylene-diamine) and a proprietary flame retardant. The oxidation and ignition behavior of these charcoals did not appear to be affected adversely by the presence of the TEDA

  2. Low sintering temperature glass waste forms for sequestering radioactive iodine

    Science.gov (United States)

    Nenoff, Tina M.; Krumhansl, James L.; Garino, Terry J.; Ockwig, Nathan W.

    2012-09-11

    Materials and methods of making low-sintering-temperature glass waste forms that sequester radioactive iodine in a strong and durable structure. First, the iodine is captured by an adsorbant, which forms an iodine-loaded material, e.g., AgI, AgI-zeolite, AgI-mordenite, Ag-silica aerogel, ZnI.sub.2, CuI, or Bi.sub.5O.sub.7I. Next, particles of the iodine-loaded material are mixed with powdered frits of low-sintering-temperature glasses (comprising various oxides of Si, B, Bi, Pb, and Zn), and then sintered at a relatively low temperature, ranging from 425.degree. C. to 550.degree. C. The sintering converts the mixed powders into a solid block of a glassy waste form, having low iodine leaching rates. The vitrified glassy waste form can contain as much as 60 wt % AgI. A preferred glass, having a sintering temperature of 500.degree. C. (below the silver iodide sublimation temperature of 500.degree. C.) was identified that contains oxides of boron, bismuth, and zinc, while containing essentially no lead or silicon.

  3. Radioactive iodine releases from nuclear power plant, (1)

    International Nuclear Information System (INIS)

    Hashimoto, Tatsuya

    1974-01-01

    Concerning the release of radioactive iodine from nuclear power plants, the guidelines and data both in Japan and abroad are briefed, including those in the United States, Tsuruga nuclear power station and working Group of the Environmental Radiation Study Committee. In case of the Tsuruga nuclear power station, the radiation dose and other data for a few years are presented. Parameters and factors proposed by the working group cover such as the dose through food intake and respiration, concentration factor, etc. (Mori, K.)

  4. Comparison between methods for fixing radioactive iodine in silver substrate for manufacturing brachytherapy sources

    Energy Technology Data Exchange (ETDEWEB)

    Peleias Junior, Fernando S.; Zeituni, Carlos A.; Rostelato, Maria Elisa C.M., E-mail: fernandopeleias@gmail.com, E-mail: czeituni@ipen.br, E-mail: elisaros@ipen.br; and others

    2013-07-01

    Cancer is a term used generically to represent a group of more than 100 illnesses, including malignant tumors from different locations. According to World Health Organization (WHO), is a leading cause of death worldwide, accounted for 7.6 million deaths. Prostate cancer is the sixth most common type in the world, representing about 10% of all cases of cancer and its treatment may be by surgery, radiotherapy or even vigilant observation. A method of radiotherapy which has been extensively used in the early and intermediate stages of the illness is brachytherapy, where radioactive seeds are placed inside or next to the area requiring treatment, which reduces the probability of unnecessary damage to surrounding healthy tissues. Currently, the radioactive isotope Iodine-125, adsorbed on silver substrate, is one of the most used in prostate brachytherapy. The present study compares several deposition methods of radioactive Iodine on silver substrate, in order to choose the most suitable one to be implemented at the laboratory of radioactive sources production of IPEN. The methodology used was chosen based on the available infrastructure and experience of the researchers of the institute. Therefore, Iodine-131 was used for testing (same chemical behavior of Iodine -125). Three methods were selected: method 1 (test based on electrodeposition method, developed by David Kubiatowicz) which presented efficiency of 65.16% ; method 2 (chemical reaction based on the method developed by David Kubiatowicz -HCl) which presented efficiency of 70.80%; method 3 (chemical reaction based on the method developed by Dr. Maria Elisa Rostelato) which presented efficiency of 55.80% . Based on the results, the second method is the suggested one to be implemented at the laboratory of radioactive sources production of IPEN. (author)

  5. Comparison between methods for fixing radioactive iodine in silver substrate for manufacturing brachytherapy sources

    International Nuclear Information System (INIS)

    Peleias Junior, Fernando S.; Zeituni, Carlos A.; Rostelato, Maria Elisa C.M.

    2013-01-01

    Cancer is a term used generically to represent a group of more than 100 illnesses, including malignant tumors from different locations. According to World Health Organization (WHO), is a leading cause of death worldwide, accounted for 7.6 million deaths. Prostate cancer is the sixth most common type in the world, representing about 10% of all cases of cancer and its treatment may be by surgery, radiotherapy or even vigilant observation. A method of radiotherapy which has been extensively used in the early and intermediate stages of the illness is brachytherapy, where radioactive seeds are placed inside or next to the area requiring treatment, which reduces the probability of unnecessary damage to surrounding healthy tissues. Currently, the radioactive isotope Iodine-125, adsorbed on silver substrate, is one of the most used in prostate brachytherapy. The present study compares several deposition methods of radioactive Iodine on silver substrate, in order to choose the most suitable one to be implemented at the laboratory of radioactive sources production of IPEN. The methodology used was chosen based on the available infrastructure and experience of the researchers of the institute. Therefore, Iodine-131 was used for testing (same chemical behavior of Iodine -125). Three methods were selected: method 1 (test based on electrodeposition method, developed by David Kubiatowicz) which presented efficiency of 65.16% ; method 2 (chemical reaction based on the method developed by David Kubiatowicz -HCl) which presented efficiency of 70.80%; method 3 (chemical reaction based on the method developed by Dr. Maria Elisa Rostelato) which presented efficiency of 55.80% . Based on the results, the second method is the suggested one to be implemented at the laboratory of radioactive sources production of IPEN. (author)

  6. Ophthalmological evolution in hyperthyroid patients treated with radioactive iodine

    International Nuclear Information System (INIS)

    Marrero Rodriguez, Maria Teresa; Rodriguez Gonzalez, Julio Cesar; Alavez Martin, Ernesto

    2005-01-01

    This study was aimed at analyzing the ophthalmological evolution in hyperthyroid patients treated with radioactive iodine. 100 patients (88 females and 12 males) from the thyroid department of the National Institute of Endocrinology with clinical and biochemical diagnosis of hyperthyroidism and with a mean age of 40 + - 10 years old, were studied. These patients underwent a treatment with radioactive iodine at a dose of 80 m Ci/g of thyroid tissue. A bilateral ophthalmometry was performed to each patient before the treatment and 12 months after it. Mean ophthalmometry of the right eye was 14.51 + - 2.86 mm before the treatment and 13.92 + - 2.83 mm after the treatment, whereas for the left eye it was 14.98 + - 2.91 mm and 14.27 + - 2.83 mm , respectively. Taking into account the results of the ophthalmometry, we concluded that the use of radioactive iodine in the treatment of hyperthyroid patients had no negative results on the ophthalmological evolution of the studied patients

  7. Patient and family members perspectives on radioactive iodine treatment

    Energy Technology Data Exchange (ETDEWEB)

    McGrath, P.; Fitch, M.I. [Toronto-Sunnybrook Regional Cancer Centre, Toronto, Ontario (Canada)

    1999-08-01

    This report documents the findings of a survey of patients who received radioactive iodine therapy and their family members. The main objective of the survey was to gain an understanding of the experience of receiving radioactive iodine from the patient and family's perspective. The data from this study helped to inform the ARCP and GMA as they developed AC-9 - Principles of the management of radionuclide therapies. A survey was distributed to 700 patients and family members through physicians at 8 sites across Canada. Locations included: Newfoundland, Nova Scotia, Ontario (2 sites), Quebec (2 sites), Manitoba and British Columbia. A total of 190 patients and 140 family members returned completed surveys. Data was analyzed separately for individuals treated as inpatients and those treated as outpatients. The results of the survey provided a perspective from patients and families about their experiences regarding radioactive iodine therapy. The data indicate variation in patients' and family members' perspectives about how precautions are to be implemented. Both patients and family members expressed the desire for more information regarding many aspects of the treatment experience. The results have implications for the development of patient information, continuing education (in particular in the areas of precaution), the provision of access to supportive and counselling services, and the importance of looking at the individual situations of patients and their families. (author)

  8. Patient and family members perspectives on radioactive iodine treatment

    International Nuclear Information System (INIS)

    McGrath, P.; Fitch, M.I.

    1999-08-01

    This report documents the findings of a survey of patients who received radioactive iodine therapy and their family members. The main objective of the survey was to gain an understanding of the experience of receiving radioactive iodine from the patient and family's perspective. The data from this study helped to inform the ARCP and GMA as they developed AC-9 - Principles of the management of radionuclide therapies. A survey was distributed to 700 patients and family members through physicians at 8 sites across Canada. Locations included: Newfoundland, Nova Scotia, Ontario (2 sites), Quebec (2 sites), Manitoba and British Columbia. A total of 190 patients and 140 family members returned completed surveys. Data was analyzed separately for individuals treated as inpatients and those treated as outpatients. The results of the survey provided a perspective from patients and families about their experiences regarding radioactive iodine therapy. The data indicate variation in patients' and family members' perspectives about how precautions are to be implemented. Both patients and family members expressed the desire for more information regarding many aspects of the treatment experience. The results have implications for the development of patient information, continuing education (in particular in the areas of precaution), the provision of access to supportive and counselling services, and the importance of looking at the individual situations of patients and their families. (author)

  9. Apparatus for eliminating radioactive iodine from off-gases in a nuclear fuel reprocessing plant

    International Nuclear Information System (INIS)

    Kondo, Yoshikazu; Kurihara, Koichi.

    1983-01-01

    Purpose: To improve the eliminating efficiency of an iodine eliminating apparatus using a dry process. Constitution: A hydrogen iodide conversion device and an organic iodine decomposing device are disposed prior to and subsequent to an adsorption tower using adsorbents for the removal of the iodine in a processing gas line through which radioactive iodine containing gases are passed. Elementary iodine and organic iodine can be eliminated by such simple devices. In the case of the dry processing by using the adsorbents, those adsorbents incorporated with inexpensive metal such as lead and copper can be used for the removal of the organic iodine and the radioactive iodine-adsorbing material can be processed as wastes, whereby iodine can effectively be eliminated at a reduced cost. (Moriyama, K.)

  10. Thyroid cancer following exposure to radioactive iodine.

    Science.gov (United States)

    Robbins, J; Schneider, A B

    2000-04-01

    The thyroid gland is one of the most sensitive organs for radiation-induced oncogenesis and the magnitude of the risk from external radiation is well understood. This is not the case for internal radiation derived from the radioiodines, a matter of practical importance because of medical use and potential accidental exposure. This article reviews current knowledge derived from the follow-up of patients receiving diagnostic or therapeutic 131I and populations exposed to radioactive fallout. The latter includes the nuclear power station accident at Chernobyl and the results of atomic bomb development and testing at Hanford, the Nevada Test Site and the Marshall Islands. The most cogent information comes from Chernobyl where an epidemic of childhood thyroid cancer has followed exposure to radioiodine that was mainly 131I. Although much has been learned from this experience about the nature of radioiodine induced thyroid cancer in young children, the reconstruction of thyroid radiation doses is too preliminary to provide accurate knowledge of the risk in comparison to that from external radiation. In the Marshall Islands, much of the exposure was from short-lived radioiodines as well as external radiation, obviating the possibility to determine the risk from 131I. Exposure to 131I in the continental United States from atomic bomb testing is expected to have caused some thyroid cancers, but only in the immediate vicinity of the Nevada Test Site has any evidence of radiation-induced thyroid neoplasms been adduced. This evidence is minimally significant statistically, and not significant for thyroid cancer per se. Medical use of radioiodine has not been observed to cause thyroid cancer but very few of the patients studied were young children, the group most sensitive to thyroid radiation. Despite these limitations, this information is sufficient to make some suggestions concerning protective measures in the case of nuclear accidents and the follow up of individuals who

  11. A contribution to radioactive iodine therapy of the euthyroid goitre

    International Nuclear Information System (INIS)

    Langenbruch, K.; Rische, D.

    1982-01-01

    It is shown that radioactive iodine therapy is an alternative method in the treatment even of large goitres provided this method of treatment is confined to patients beyond the age of 40. If the patient is generally inoperable, this is in fact the method of choice. The success rate can be compared with that of other methods of treatment. In this connection, special attention is drawn to the high rate of alleviation of complaints. No significant sinde effects are seen; in a few cases only, treatment will have to be repeated. (orig.) [de

  12. Facts and fallacies about radioactive iodine therapy for Graves' disease

    International Nuclear Information System (INIS)

    Miller, J.L.

    1982-01-01

    The therapeutic options available in the hyerthyroidism of Graves' disease are two basic treatments. Firstly antithyroid drugs and secondly one can 'ablate' the thyroid gland by means of thyroidectomy or radioactive iodine ( 131 I). At present 131 I is the current treatment of chioce for Graves' disease. In a follow-up study of 21 714 patients who were treated with 131 I and observed for a period of 8 years, there was no increase in the incidence of thyriod carcinoma. A possible explanation for this is that the dose of 131 I used destroys the ability of the thyroid cells to replicate and thus transmit genetically damaged material

  13. Povidone-Iodine Concentration and Dosing in Cataract Surgery.

    Science.gov (United States)

    Koerner, Jagger C; George, Mary J; Meyer, Dale R; Rosco, Michael G; Habib, Matthew M

    2018-05-17

    Iodine has been recognized as an effective bactericide since the 1800's, and povidone-iodine (PI) solution has been applied to the ocular surface and periocular skin since the 1980's to prevent endophthalmitis in cataract surgery. In vitro, PI solution kills bacteria very quickly at dilute concentrations (0.05-1.0%). In many instances, PI kills bacteria more quickly at these dilute concentrations than more conventional (5%-10%) concentrations. This is due to greater availability of diatomic free iodine in dilute solution, the bactericidal component of PI. The toxicity of PI, both in vitro and clinically has been shown to be related to concentration. Current American Academy of Ophthalmology (AAO) and the European Society of Cataract and Refractive Surgeons (ESCRS) recommendations regarding PI use suggest using 5% PI prior to surgery. An alternative dosing strategy uses dilute PI repetitively throughout cataract surgery (0.25% every thirty seconds). We review the povidone-iodine literature with attention to basic science and use of dilute PI. Copyright © 2018 Elsevier Inc. All rights reserved.

  14. Quantification of iodine in porous hydroxyapatite matrices for application as radioactive sources in brachytherapy

    OpenAIRE

    Lacerda, Kássio André; Lameiras, Fernando Soares; Silva, Viviane Viana

    2007-01-01

    In this study, non-radioactive iodine was incorporated in two types of biodegradable hydroxyapatite-based porous matrices (HA and HACL) through impregnation process from sodium iodine aqueous solutions with varying concentrations (0.5 and 1.0 mol/L) . The results revealed that both systems presented a high capacity of incorporating iodine into their matrices. The quantity of incorporated iodine was measured through Neutron Activation Analysis (NAA). The porous ceramic matrices based on hydrox...

  15. Prospective study of the changes in thyrotropin binding inhibitory immunoglobulins in Graves' disease treated by subtotal thyroidectomy or radioactive iodine

    International Nuclear Information System (INIS)

    Teng, C.S.; Yeung, R.T.T.; Khoo, R.K.K.; Alagaratnam, T.T.

    1980-01-01

    The effects of subtotal thyroidectomy and radioactive iodine on thyroid-stimulating immunoglobulins, as measured by a receptor assay, more appropriately termed TSH binding inhibitory immunoglobulins (TBII), were studied in 74 patients with Graves' disease. Fourty-four patients received radioactive iodine therapy, while 30 were subjected to subtotal thyroidectomy. After radioactive iodine, more patients were TBII-positive (90.5% vs 81.8%) than before treatment, and the mean TBII index decreased dramatically, the maximum decrease being 3 months. The mean TBI index subsequently returned gradually to the pretreatment level. Subtotal thyroidectomy had a different effect on TBII activity. TBII indices were positive in 89.3% of these patients before any treatment but were positive in only 40% (12 patients) after antithyroid drugs had been given before surgery. After surgery, TBII indices remained positive in 7 patients, while the remaining 5 patients became TBII negative. Seventeen patients (56.7%) were TBII negative before operation and remained so after surgery. One patient who was TBII negative before operation became TBII positive 2 months after operation. Interestingly, postoperative relapse of hyperthyroidism occurred in 3 patients who were TIBII positive, while hypothyroidism occurred in patients who were TBII negative. Thus, the TBII activity after subtotal thyroidectomy might be an important factor in determining the outcome of surgery

  16. Radiation Sialadenitis Induced by High-dose Radioactive Iodine Therapy

    International Nuclear Information System (INIS)

    Jeong, Shin Young; Lee, Jaetae

    2010-01-01

    Radioactive iodine ( 131 I) is accumulated in the thyroid tissue and plays an important role in the treatment of differentiated papillary and follicular cancers after thyroidectomy. Simultaneously, 131 I is concentrated in the salivary glands and secreted into the saliva. Dose-related damage to the salivary parenchyma results from the 131 I irradiation. Salivary gland swelling and pain, usually involving the parotid, can be seen. The symptoms may develop immediately after a therapeutic dose of 131 I and/or months later and progress in intensity with time. In conjunction with the radiation sialadenitis, secondary complications reported include xerostomia, taste alterations, infection, increases in caries, facial nerve involvement, candidiasis, and neoplasia. Prevention of 131 I sialadenitis may involve the use of sialogogic agents to hasten the transit time of the radioactive iodine through the salivary glands. However, studies are not available to delineate the efficacy of this approach. Treatment of the varied complications that may develop encompass numerous approaches and include gland massage, sialogogic agents, duct probing, antibiotics, mouthwashes, good oral hygiene, and adequate hydration. Recently interventional sialoendoscopy has been introduced an effective tool for the management of patients with 131 I-induced sialadenitis that is unresponsive to medical treatment.

  17. Radiation Sialadenitis Induced by High-dose Radioactive Iodine Therapy

    Energy Technology Data Exchange (ETDEWEB)

    Jeong, Shin Young; Lee, Jaetae [Kyungpook National University Hospital, Daegu (Korea, Republic of)

    2010-06-15

    Radioactive iodine ({sup 131}I) is accumulated in the thyroid tissue and plays an important role in the treatment of differentiated papillary and follicular cancers after thyroidectomy. Simultaneously, {sup 131}I is concentrated in the salivary glands and secreted into the saliva. Dose-related damage to the salivary parenchyma results from the {sup 131}I irradiation. Salivary gland swelling and pain, usually involving the parotid, can be seen. The symptoms may develop immediately after a therapeutic dose of {sup 131}I and/or months later and progress in intensity with time. In conjunction with the radiation sialadenitis, secondary complications reported include xerostomia, taste alterations, infection, increases in caries, facial nerve involvement, candidiasis, and neoplasia. Prevention of {sup 131}I sialadenitis may involve the use of sialogogic agents to hasten the transit time of the radioactive iodine through the salivary glands. However, studies are not available to delineate the efficacy of this approach. Treatment of the varied complications that may develop encompass numerous approaches and include gland massage, sialogogic agents, duct probing, antibiotics, mouthwashes, good oral hygiene, and adequate hydration. Recently interventional sialoendoscopy has been introduced an effective tool for the management of patients with {sup 131}I-induced sialadenitis that is unresponsive to medical treatment.

  18. Radioactive iodine ablation of Grave disease; Traitement ablatif par iode

    Energy Technology Data Exchange (ETDEWEB)

    Taieb, D.; Tessonnier, L.; Nwatsock, F.J.; Mundler, O. [Service central de biophysique et de medecine nucleaire, centre hospitalo-universitaire de la Timone, 264, rue Saint-Pierre, 13385 Marseille cedex 5, (France)

    2009-05-15

    The isotopic destruction by iodine of the thyroid body is an alternative to the surgery in the radical treatment of the Basedow disease, particularly for recurrent forms. Several strategies are possible in the use of iodine 131. between 2004 and 2008, 240 patients with a Basedow disease were treated in our service by an ablative activity of iodine 131 (555 MBq on average). the results are rather reproducible, that is to say a quasi constant hypothyroidism in the first three months. It appears important to underline that the ambulatory management of induced hypothyroidism is often unappropriated with too progressive introductions of LT4, leaving the patient in deep hypothyroidism during several weeks. The recurrences at short and middle term are very rare ( under 4%). A case of severe exophthalmos was observed. The other patients did not progressed with corticosteroids. The evolution of anti receptors autoantibodies of the TSH have been studying. to conclude, this kind of strategy is very efficient and reproducible, but needs an appropriate management of post therapy hypothyroidism, source of discomfort and potential morbidity. (N.C.)

  19. Pollution by radioactive iodine and radioactive cesium in fruit fields

    International Nuclear Information System (INIS)

    Ohtsuki, Tsutomu; Kikunaga, Hidetoshi; Izumi, Yuichi

    2011-01-01

    A lot of radioactive materials were spread out by the accident of the Fukushima Daiichi nuclear power station caused by the tsunami accompanying earthquake in the area of Tohoku district-Pacific Ocean, in 2011/3/11. In early stage, short half-life nuclides, such as "1"3"2Te, "1"3"1I, "1"3"6Cs, as well as "1"3"4Cs, "1"3"7Cs were observed in fields. Now "1"3"4Cs and "1"3"7Cs which are comparatively long half-life became dominant observing nuclides. The nuclear power plant accident brought serious damages in many directions, especially, the influence of the field pollution by these nuclides is great in the agriculture, and the quick actions and the measures are needed. The influence of "1"3"4Cs and "1"3"7Cs to the fruit tree were investigated in cooperation with Fukushima agricultural center, Institute of Fruit Tree Science. We report several facts of the transfer and translocation mechanism of "1"3"4Cs and "1"3"7Cs in fruit trees. (author)

  20. Chemisorption of organic iodine compounds forming from fission isotopes of radioactive iodine

    International Nuclear Information System (INIS)

    Tot, G.; Galina, F.; Zel'd, E.

    1977-01-01

    Studied is ethyl iodine adsorption, labelled by iodine 131, on palladium black and on aluminium oxide activized by palladium. The desorption of adsorbed iodine in the temperature range of 20-600 deg C by the mass spectroscopy and thermal gravimetric methods was investigated. At the ethyl iodine and palladium interaction the bond between carbon and iodine in the ethyl iodine molecule breaks down and extracting iodine reacts with palladium, forming a stable compound at high temperatures. Desorption of adsorbed iodine is insignificant up to the temperatures of 250-300 deg C. Thus, sorbents, containing palladium, may be successfully applied for iodine absorption from the organic iodine compounds. These compounds spontaneously appear from the iodine fragment ratio isotopes during their interaction with some environmental organic impurities

  1. Evaluation of povidone-iodine applications in cataract surgery

    Directory of Open Access Journals (Sweden)

    Xi Zhang

    2013-09-01

    Full Text Available As a routine measure to prevent intraocular inflammation, rinsing conjunctival sac with povidone-iodine(PVP-Ihas been increasingly adopted in cataract surgery. It can effectively reduce the complications of cataract surgery, including endophthalmitis and corneal complications. However, PVP-I itself has certain side effects. Therefore, to achieve the best bactericidal effect and to avoid eye injury, it is necessary to find out the optimal treatment duration and concentration. This article offers a review on the latest researches worldwide in this field.

  2. Alteration of radioactive iodine uptake after treatment of hyperthyroidism with iodine 131

    International Nuclear Information System (INIS)

    Heath, R.C.; Gossain, V.V.; Rovner, D.R.

    1988-01-01

    To determine whether a therapeutic dose of iodine 131 affects the results of 24-hour radioactive iodine uptake (RAIU) testing, we reviewed records of hyperthyroid patients previously treated with 131 I at Michigan State University and its affiliated hospitals. We identified 26 patients who had had clinical evaluation and determination of the serum thyroxine (T4) level, triiodothyronine resin uptake (T3RU), and RAIU (using 131 I) within two weeks before and several months after the therapeutic dose of 131 I. Before treatment, all patients had clinical hyperthyroidism, with an elevated T4 level and increased T3RU and RAIU. After treatment with 131 I, eight patients (31%) had an RAIU that was discordant with their clinical and biochemical (T4 and T3RU) assessment. In six patients (23%) of the RAIU was inappropriately high, and in two patients (8%) it was inappropriately low. Since we did not identify any other factors known to interfere with the results of RAIU testing, we conclude that a therapeutic dose of 131 I, may by itself increase or decrease a subsequent RAIU determination; therefore, after treatment with 131 I, RAIU is not a good diagnostic index of thyroid activity

  3. Thyroid gland protection against radioactive iodine. Fetus and preschool children are more sensitive

    International Nuclear Information System (INIS)

    Noteboom, J.L.

    1995-01-01

    The intake of iodine tablets can prevent the irradiation and accumulation of iodine in the thyroid of humans. The summary of the author's thesis 'Protection of the thyroid against radioactive iodine during fetal life and infancy. An experimental approach in chimpanzees' is presented in an edited form. The research was carried out on pregnant and very young chimpanzees. Based on the experimental results recommendations are made for radiation protection for pre-school children and pregnant women. 3 figs., 1 refs

  4. Method for determination of radioactive iodine isotopes in environmental objects and biologic materials

    International Nuclear Information System (INIS)

    Dubynin, O.D.; Pogodin, R.I.

    1981-01-01

    The method proposed for determination of radioactive iodine isotopes content in environmental objects and biologic materials is based on the extraction of iodine with carbon tetrachloride and subsequent precipitation of bismuthyl iodine (BiOI) in perchloric medium. Sample preparation for analysis is carried out using conventional alkaline ashing methods. Quantitative iodine separation is hampered if macroquantities of Cl - , Br - , SO 4 2 - , SO 8 2 - , Cr 2 O 7 2 - and other ions are present in the solution. Iodine extraction is carried out before its precipitation. Separated iodine preparation activity is measured using scintillation (NaI) Tl gamma spectrometer. The method's sensitivity when measuring iodine-131 preparations makes up 0.07 Bq per 1 sample with the error +-25 %

  5. Significance of iodine radioactive isotopes in the problem of radiation safety of nuclear fuel cycle

    International Nuclear Information System (INIS)

    Malenchenko, A.F.; Mironov, V.P.

    1979-01-01

    The data on actual wastes of nuclear-power plants, environmental distribution and biological effects of iodine radioactive isotopes have been analyzed. Dose-response relationship is estimated as well as its significance for struma maligna development under ionizing radiation and the contribution of iodine radionuclides resulted from nuclear power engineering to this process

  6. Experimental study of contamination by inhalation of radioactive iodine aerosols. Biological balance

    International Nuclear Information System (INIS)

    Marble, G.

    1968-01-01

    Several articles have been published concerning research into contamination produced by inhalation of radioactive iodine aerosols in monkeys. Results dealing with the biological balance of this contamination are presented and discussed in this report. (author) [fr

  7. Value of radioactive iodine uptake and thyroid imaging in diagnosis of painless thyroiditis

    International Nuclear Information System (INIS)

    Zhang Rusen; Feng Yong; Hu Yingjian; He Hongyuan

    2010-01-01

    Objective: To evaluate clinical value of radioactive iodine uptake and thyroid imaging in diagnosis of painless thyroiditis (PT). Methods: Seventy cases of PT patients, 50 cases of GD patients and 50 cases of healthy persons were retrospectively analyzed by using radioactive iodine uptake, thyroid imaging and serological examination. Results: PT group radioactive iodine uptake rate was significantly lower than the control group, GD group was significantly higher than the control group, PT group and the GD group difference was significant (F=64.88, P<0.01). Thyroid image of PT group is not clear, or no to be seen, thyroid image of GD group can be clearly visible. Conclusion: Radioactive iodine uptake and thyroid imaging play an irreplaceable role in the identification of PT and GD, and the method is simple and effective too. (authors)

  8. Effect of Hashimoto thyroiditis on low-dose radioactive-iodine remnant ablation.

    Science.gov (United States)

    Kwon, Hyungju; Choi, June Young; Moon, Jae Hoon; Park, Hyo Jin; Lee, Won Woo; Lee, Kyu Eun

    2016-04-01

    Radioactive-iodine remnant ablation is an integral part of the papillary thyroid carcinoma (PTC) treatment. Although a minimum dose is usually recommended, there is controversy as to whether the low-dose (1100 MBq) radioactive-iodine remnant ablation is adequate for selected patients. A retrospective cohort study was conducted on 691 patients. Patients with no remnant thyroid on the follow-up whole body scan and low stimulated thyroglobulin (sTg) level (Hashimoto thyroiditis based on histopathology diagnosis (odds ratio [OR] = 3.23; p Hashimoto thyroiditis and elevated sTg are negative predictive factors for successful low-dose radioactive-iodine remnant ablation treatment. An appropriate risk-adjusted approach may improve the efficacy of radioactive-iodine remnant ablation treatment. © 2015 Wiley Periodicals, Inc. Head Neck 38: E730-E735, 2016. © 2015 Wiley Periodicals, Inc.

  9. Salts of the iodine oxyacids in the impregnation of adsorbent charcoal for trapping radioactive methyliodide

    International Nuclear Information System (INIS)

    Deitz, V.R.; Blachly, C.H.

    1977-01-01

    Radioactive iodine and radioactive methyliodide can be more than 99.7 percent removed from the air stream of a nuclear reactor by passing the air stream through a 2-inch thick filter which is made up of impregnated charcoal prepared by contacting the charcoal with a solution containing KOH, iodine or an iodide, and an oxyacid, followed by contacting with a solution containing a tertiary amine. 3 claims

  10. Method for removing radioactive iodine and radioactive organic iodides from effluent gases

    International Nuclear Information System (INIS)

    1975-01-01

    A method and composition for removing radioactive and organic iodides from an 131 I-containing off-gas stream is provided. The composition for removal by adsorption is a ceramic material with a surface area of from about 5 m 2 /g to about 250 m 2 /g impregnated with a metallic salt. The method for removing the iodine or iodide is accomplished by passing the off-gas stream over the ceramic material impregnated with the metallic salt. It finds special application in air filters for nuclear power plants

  11. Quantification of iodine in porous hydroxyapatite matrices for application as radioactive sources in brachytherapy

    Energy Technology Data Exchange (ETDEWEB)

    Lacerda, Kassio Andre; Lameiras, Fernando Soares [Centro de Desenvolvimento da Tecnologia Nuclear, (CDTN/CNEN-MG), Belo Horizonte, MG (Brazil); Silva, Viviane Viana [Centro de Desenvolvimento da Tecnologia Nuclear, (CDTN/CNEN-MG), Belo Horizonte, MG (Brazil); Universidade Vale do Rio Verde de Tres Coracoes, MG (Brazil)

    2007-07-15

    In this study, non-radioactive iodine was incorporated in two types of biodegradable hydroxyapatite-based porous matrices (HA and HACL) through impregnation process from sodium iodine aqueous solutions with varying concentrations (0.5 and 1.0 mol/L) . The results revealed that both systems presented a high capacity of incorporating iodine into their matrices. The quantity of incorporated iodine was measured through Neutron Activation Analysis (NAA). The porous ceramic matrices based on hydroxyapatite demonstrated a great potential for uses in low dose rate (LDR) brachytherapy. (author)

  12. A case of xerostomia caused by exposure to radioactive iodine

    International Nuclear Information System (INIS)

    Kusafuka, Yuji; Kamata, Takahiro; Nakanishi, Yoshitaka; Kurita, Hiroshi; Sakai, Hironori

    2012-01-01

    Oral radioiodine ( 131 I) therapy is known to be an effective treatment for differentiated thyroid carcinoma, but it can cause salivary gland impairment. We report a case of xerostomia caused by oral radioiodine therapy for thyroid cancer. A 47-year-old woman consulted our hospital because of tongue pain accompanied by xerostomia. The patient had a history of receiving radioiodine therapy for metastatic thyroid carcinoma 3 times (total 9,990 MBq). Clinical examination demonstrated oral dryness and reduced salivary gland function. On the gum test, the salivary flow was 2 ml in 6 minutes. It was hard to continue chewing for more than 6 minutes because of irritation. A computed tomographic scan showed atrophic changes of both parotid glands. On radioiodine whole-body imaging, uptake of radioiodine was evident in both the parotid and submandibular glands. Based on these findings, xerostomia caused by salivary gland injury due to radioiodine therapy was clinically diagnosed. The salivary gland injury was irreversible, and the patient received symptomatic therapy and pilocarpine hydrochoride. Early intervention to avoid salivary gland injury is important in patients who receive radioactive iodine therapy. (author)

  13. Disturbances of immunological homeostasis induced by radioactive iodine agents

    International Nuclear Information System (INIS)

    Anokhin, Yu.N.; Norets, T.A.

    1986-01-01

    (CBAxC57B1/6)F 1 mice were injected with 125 I and 131 I-sodium iodide at a dose of 5.74x10 4 Bq/g. For a long time after such treatment the animals manifested an increased level of spleen cells humoral immune response to a foreign antigen (sheep erythrocytes). The autoreactivity of spleen and lymph node lymphocytes to autologous erythrocytes was also elevated. At the same time the selective migration of 51 Cr-labeled spleen lymphocytes to the peripheral lymphoid organs was suppressed. The use of a model system of adoptive cell transfer revealed an increase in the functional activity of cells suppressing a humoral response in mice treated with radiopharmaceuticals. The most pronounced disturbances of immunological reactivity in mice took place 6 mos. after the beginning of the experiment. The results obtained indicated that mechanisms of immune response regulation played a certain role in disturbances of immunological homeostasis induced by radioactive iodine agents

  14. Pretreatment method for radioactive iodine-containing liquid wastes and pretreatment device

    International Nuclear Information System (INIS)

    Wakaida, Yasuo.

    1996-01-01

    Heretofore, radioactive iodine-containing liquid wastes have been discharged directly to a storing and decaying storage vessel to conduct a water draining treatment. In the present invention, the radioactive iodine-containing liquid wastes to be discharged are not discharged to the storage vessel directly but injected to a filling tank, as a pretreatment, to distinguish whether proteins are mixed in the liquid wastes or not. When proteins are mixed, miscellaneous materials such as proteins are recovered and removed by a protein processing system. When proteins are not mixed, radioactive iodine is recovered and removed directly by an iodine processing system. With such procedures, water draining treatment in the storing and decaying storage vessel is mitigated, and even when the amount of the radioactive iodine-containing liquid wastes is increased, the existent maintaining and decaying storage vessel can be used as it is. Accordingly, a safe water draining treatment with good efficiency can be conducted relative to radioactive iodine-containing liquid wastes at a reduced cost. (T.M.)

  15. Radioactive iodine and environmental and sanitary effects - bibliographic study and quantification

    International Nuclear Information System (INIS)

    Guetat, Ph.; Armand, P.; Monfort, M.; Fritsch, P.; Flury Herard, A.; Menetrier, F.; Bion, L.; Schoech, C.; Masset, S.

    2004-01-01

    This document is intended to a large public. It reviews the different parameters needed to evaluate the potential act o radioactive releases from the emission to public. Its objectives are to evaluate the importance of different exposure pathways and to assess efficiency of the possible interventions for large public. The main conclusions are summarised hereafter: The radioactive decay chains have to be taken into account to evaluate the iodine source term in the nuclear plants in the case of fission accidents. The physico-chemical forms of iodine are important in order to determine the released activity and deposited activity on the soil. The isotopes to be taken into account are mainly iodine 131 for radiological assessments and also iodine 133 for the nuclear reactor accidents, and the chain Tellurium-Iodine 132 when no particulate filtration exists. Iodine 129 in French reprocessing plant cannot lead to significant accidents. The dominant exposure pathways are related to the consumption of contaminated food products (vegetable, milk) for the inorganic iodine. The iodine transfer to goat and sheep milk is greater than the one to cow milk. The meat production of herbivores at field is the most sensitive. The interest to remove rapidly herbivore from pasture appears relatively clearly. The banning of consumption of local contaminated food products (vegetables and meats) may reduce by about a factor of thirteen the impact due to iodine 131. The youngest the population is, the greatest are the thyroid radiosensitivity and variability within the population. Oral administration of stable iodine limits transfers to maternal milk and foetal thyroid. Ingestion of stable iodine is complementary to consumption banning of local contaminated food products. The earliest the ingestion is, the greatest is the efficiency. 0,1 TBq of 131 iodine released at a low height involves only limited and local actions whereas the release of 10 TBq involves direct and immediate protection

  16. Observation on the adverse reactions of different concentrations of povidone-iodine applied before cataract surgery

    Directory of Open Access Journals (Sweden)

    Shan-Jun Wu

    2013-12-01

    Full Text Available AIM: To evaluate the efficiency and safety of 50g/L povidone-iodine solution in preventing postoperative endophthalmitis through comparing the incidence of postoperative endophthalmitis and adverse reactions after conjunctival sac washing with povidone-iodine of different concentrations.METHODS: Totally 500 cataract patients were divided into 50g/L povidone-iodine group and 25g/L povidone-iodine group. All the operated eyes were observed during and after surgery.The patients' subjective discomfort was inquired and their signs of eyes were recorded. RESULTS: The eye irritation of 50g/L povidone-iodine group was more significant than 25g/L povidone-iodine group. No significant difference in the corneal epithelial loss and endophthalmitis was observed between two groups.CONCLUSION:Conjunctival sac washing with 50g/L povidone-iodine is an effective and safe measure to prevent endophthalmitis after cataract surgery.

  17. Production of adsorbent from palm shell for radioactive iodine scrubbing process

    International Nuclear Information System (INIS)

    Mohamad Azman Che Mat Isa; Ku Halim Ku Hamid; Muhd Noor Muhd Yunus; Mohamad Puad Abu; Abdul Halim Badaruddin; Mohammad Nizammudin Abd Aziz; Muhd Ridwan Abdul Rahim

    2010-01-01

    The biggest biomass source in Malaysia comes from oil palm industry. According to the statistic of year 2004, Malaysia produced 40 million tones per year of biomass which 30 million tones of biomass originated from the oil palm industries. Therefore, the biomass waste such as palm kernel shell can be used to produce granular adsorbent for radioactive materials. For that reason, a newly system, called Rocking Kiln - Fluidized Bed (RK - FB) was developed to utilize large amount of the biomass to produce high value added product. Charcoal or chemically produced activated carbon could be produced by using the kiln. Washing process was introduced to remove particles, minerals and volatile matters from charcoal produced and then would create more surface area in the adsorbent by creating more active sites. In this research, the adsorbent produced was used to scrub iodine 131. In nuclear power reactor, iodine isotope 131 is produced during nuclear fission, and this elementary radioactive iodine may pollute exhaust air streams that could cause thyroid cancer. For removal of radioactive iodine, normally a potassium iodide - impregnated activated carbon (KI - AC) is used. Thus, a process will be developed to produce KI - AC and this product will be used to calculate the efficiency to remove the radioactive iodine 131.The results obtain show that adsorbent produced has a high potential to be used in radioactive adsorbing and likely more economics. This paper will elaborate further the experimental set-up of in Kiln - Fluidized Bed (RK - FB), adsorbent quality and radioactive scrubbing process. (author)

  18. The behavior of radioactive iodine at the time of reactor accident and its counterplan

    International Nuclear Information System (INIS)

    Murata, Toshifumi

    1974-01-01

    When an accident occurs in a reactor, very volatile radioactive iodine is most dangerous among fission products. Among the isotopes of radioactive iodine, 131 I which has longer half-life is harmful. Supposing one-tenth of the radioactivity of 10 8 Ci in a reactor of 10 6 Kw heat output is due to 131 I, it weights about 100g. The behavior of the radioactive iodine is greatly subjected to the influence of inside temperature and other conditions. Therefore, very prudent policies are adopted by installing emergency core cooling system, containment vessels, and activated carbon filters. For the emergency core cooling system, water spraying, flooding with low pressure water, and maintaining of water level by high pressure water injection are adopted, while in the containment vessels, measures are taken so as to lower the inside pressure and minimize leakage. (Kobatake, H.)

  19. Impact of lithium on radioactive iodine therapy for hyperthyroidism

    Directory of Open Access Journals (Sweden)

    Brahmanandam Lingudu

    2014-01-01

    Full Text Available Context: Radioactive Iodine (RAI is a common therapy for hyperthyroidism. However hyperthyroidism recurs or persists in 15-18% of patients after RAI. Studies report variable percentage of failure after RAI therapy depending on several variables including I 1310 . Lithium enhances efficacy of treatment by increasing RAI retention in the thyroid. Aims: To evaluate the efficacy of Lithium to RAI therapy in terms of cure, reduction of mean thyroid volume, and its safety. Settings and Design: A prospective comparative study. Subjects and Methods: Forty hyperthyroid patients were assigned to two groups, RAI alone and RAI plus lithium and followed for 1 year. Lithium was given in a dose of 900 mg/day in three divided doses for 6 days starting on the day of RAI therapy. Total T3, total T4, and thyroid-stimulating hormone (TSH were done at baseline, 2,4,6,9, and 12 months. Ultrasound of thyroid was done at baseline and at the end of 1 year. Monitoring was done for side effects of lithium and RAI therapy. Statistical Analysis: Cure rate and time to cure were assessed by Chi-square test. Mean change in thyroid volume was compared by student′s t-test. P < 0.05 was considered significant. Results: RAI combined with lithium had a trend towards better cure rate (90% compared to RAI alone (70% (P 0.11. Mean time taken to cure was 4.69 months in RAI plus lithium and 7.12 months in RAI alone (P 0.001. Mean change in thyroid volume was similar in both the groups (P = 0.75. There were no side effects of Lithium or RAI. Conclusions: RAI therapy combined with lithium showed a trend towards higher cure rate, safe and time to cure was less than RAI alone. Hence RAI combined with lithium is a better option in the management of hyperthyroidism than RAI alone.

  20. The influence of non-radiation factors on the kinetics of radioactive iodine metabolism in thyroid

    International Nuclear Information System (INIS)

    Kalistratova, V.S.; Filatov, V.V.; Shavrina, E.A.

    1985-01-01

    Estimation of the role non-radiation factors which may influence the dose formation in the most of all irradiated organs is considered very important for the normalization of radioactive isotopes of iodine. The significance of this problem was noted in some recent publications of NCARE. Since a human population which is being irradiated can be affected by the environmental temperature (43-45 deg and 4-6 deg C) and light (complete darkness and darkness for 21 hours) as well as vaccines (dysentery and typhoid) and alcohol (ethanol solutions of 0,02; 0,2; 2,0; and 20,0% concentration) were used as modifying factors. Iodine-125 administrated per os (0,8-1,3 MBq/rat) was used as a model for studying metabolism kinetics of radioactive iodine isotopes. Vaccination of animals results in a change of iodine-125 accumulation level in the thyroid depending on the time interval between an injection of the vaccine and administration of the radionuclide: one day after vaccination the levels of accumulation and the tissue doses formed by radionuclide in the thyroid were decreased by 1,5-2,0 times;14 days after vaccination they were increased by 1,5 times. Accumulation of iodine-125 in other endocrinal organs (pituitary and adrenal glands) was increased. The effect is independent of the type of injected vaccine. A single administration of 2,0-20,0% ethanol caused an increase of iodine-125 content in the thyroid. Chronical exposure to ethanol resulted in a decrease of iodine accumulation in the critical organ by 30% and the tissue doses accumulated by the thyroid, accordingly. Administration 0,02-0,2% ethanol did not affect metabolism kinetics of iodine-125. A single and chronical exposure to higher temperatures (43-45 deg C) decreased accumulation levels and absorbed doses of iodine-125 in the thyroid (by 30-50%) and delayed an elimination of the radionuclide from this organ. Lower temperatures of the environment (4-6 deg C), shorter light day and complete darkness did not affect

  1. Study of behaviour of radioactive iodine inorganic compounds in PWR type reactor loops

    International Nuclear Information System (INIS)

    Alm, M.; Johannsen, K.-H.; Dreyer, R.

    1980-01-01

    Compounds of radioactive iodine and its distribution between water and vapour depending on temperature, pressure and water regime of reactor coolant with water under pressure are investigated. The field of variation of parameters indicated is widened as compared with operating reactor parameters (pressure 2-14 MPa, temperature 210-335 deg C). Distribution of iodine compounds has been studied by a statistical method. For WWER-type reactors the following conclusions have been drawn: radioactive iodine in water and vapor in the first and second loops exists in the form of iodide, radioactive iodine concentration in water vapour at constant temperature and pressure mainly is depended on water pH value, radioactive iodine solubility in water vapor at normal parameters of the reactor first loop can be approximately calculated by the equation: Ksub(d)=Csub(g)/Csub(l)=(rhosub(g)/rhosub(l))sup(2), where Ksub(d) is a coefficient of solid distribution between water and vapour, rho is density c is concentration [ru

  2. Radioactive iodine therapy: Effect on functioning metastases of adenocarcinoma of the thyroid

    Energy Technology Data Exchange (ETDEWEB)

    Seidlin, S.M.; Marinelli, L.D.; Oshry, E. (Montefiore Hospital, New York, NY (USA))

    1990-09-01

    A case of metastatic adenocarcinoma of the thyroid is reported in which treatment by means of radioactive iodine has been successful. The patient was completely thyroidectomized for malignant adenoma in 1923, with neither thyrotoxicosis then nor hypothyroidism postoperatively; 15 years later there developed classic symptoms of hyperthyroidism and severe pain in the lower back. In October 1939 a pulsating tumor removed from the level of the 12th thoracic vertebra proved to be metastatic thyroid adenocarcinoma (histologically well differentiated, with small follicles and colloid). In the next two years hyperthyroidism increased and roentgenograms revealed new metastases in the lungs, upper part of the right femur, second rib on the left side, left ilium, and skull. Roentgenologic irradiation of the metastases proved ineffectual. In March 1943 a tracer dose of radioactive iodine revealed iodine retention by all the known lesions and no evidence of residual thyroid tissue in the neck. Therapeutic amounts of radioactive iodine were administered orally between May and October 1943. Definite and lasting clinical improvement followed. In April 1944 and March 1945 additional I* was administered with a resultant disappearance of pain, increase in weight, and progressive change in all clinical criteria in the direction of hypothyroidism. Roentgenographic evidence pointed to an arrest if not a regression of the disease. No untoward effects followed this therapy. Radioactive iodine seems to be an effective therapeutic agent in the control of this type of tumor.

  3. Radioactive iodine therapy: Effect on functioning metastases of adenocarcinoma of the thyroid

    International Nuclear Information System (INIS)

    Seidlin, S.M.; Marinelli, L.D.; Oshry, E.

    1990-01-01

    A case of metastatic adenocarcinoma of the thyroid is reported in which treatment by means of radioactive iodine has been successful. The patient was completely thyroidectomized for malignant adenoma in 1923, with neither thyrotoxicosis then nor hypothyroidism postoperatively; 15 years later there developed classic symptoms of hyperthyroidism and severe pain in the lower back. In October 1939 a pulsating tumor removed from the level of the 12th thoracic vertebra proved to be metastatic thyroid adenocarcinoma (histologically well differentiated, with small follicles and colloid). In the next two years hyperthyroidism increased and roentgenograms revealed new metastases in the lungs, upper part of the right femur, second rib on the left side, left ilium, and skull. Roentgenologic irradiation of the metastases proved ineffectual. In March 1943 a tracer dose of radioactive iodine revealed iodine retention by all the known lesions and no evidence of residual thyroid tissue in the neck. Therapeutic amounts of radioactive iodine were administered orally between May and October 1943. Definite and lasting clinical improvement followed. In April 1944 and March 1945 additional I* was administered with a resultant disappearance of pain, increase in weight, and progressive change in all clinical criteria in the direction of hypothyroidism. Roentgenographic evidence pointed to an arrest if not a regression of the disease. No untoward effects followed this therapy. Radioactive iodine seems to be an effective therapeutic agent in the control of this type of tumor

  4. Radiation protection instrumentation. Monitoring equipment. Atmospheric radioactive iodine in the environment

    International Nuclear Information System (INIS)

    1995-01-01

    This international standard applies to portable or installed equipment for the monitoring of radioactive iodine (such as I-131 or I-125) in air in the environment of nuclear installations during normal operation, during design basis events, and in emergency situations. The monitoring involves continuous sample trapping and, where adequate, automatic start of sampling. The document deals with radioactive iodine monitor design, testing procedures, and documentation. Appended tables refer to the reference and normal testing conditions, tests in normal testing conditions, tests during changes of the affecting quantities, and tests of changes in the air circuit. (P.A.)

  5. Iodine

    Science.gov (United States)

    ... Health Information Supplement Fact Sheets Frequently Asked Questions Making Decisions What you Need To Know About Supplements Dietary ... mild iodine deficiency and of iodine supplements on cognitive ... breasts. It mainly affects women of reproductive age but can also occur ...

  6. Risk of parathyroid adenomas in patients with thyrotoxicosis exposed to radioactive iodine

    Energy Technology Data Exchange (ETDEWEB)

    Rasmuson, Torgny; Tavelin, Bjoern [Umeaa Univ. (Sweden). Dept. of Radiation Sciences, Oncology

    2006-12-15

    External ionizing radiation is a risk factor for primary hyperparathyroidism. Whether exposure to radioactive iodine contributes to the risk of primary hyperparathyroidism is unknown. Patients with thyrotoxicosis are often treated with radioactive iodine and its accumulation in the thyroid gland exposes the adjacent parathyroid glands to radioactivity. Six thousand and eighty two patients with thyrotoxicosis were identified from medical records. In a randomly selected subcohort we assessed the frequency of treatment with radioactive iodine to be 86%. The number of patient-years at risk was 77-118. Patients with parathyroid adenomas were recruited from the Swedish Cancer Registry. Eleven patients with parathyroid adenomas following the diagnosis of thyrotoxicosis were identified. The standard incidence ratio (SIR) compared to the reference population of 900,000 was 1.14. The median age at exposure was 59 years and the latency period between diagnosis of thyrotoxicosis and parathyroid adenoma was 7.4 years (range <1-19 years). This study does not indicate that patients with thyrotoxicosis treated with radioactive iodine in adult age have increased risk of developing parathyroid adenoma.

  7. Absorbing method of iodine in radioactive gaseous wastes

    International Nuclear Information System (INIS)

    Fukutome, Yutaka; Mifuji, Hiroshi; Ito, Sakae.

    1983-01-01

    Purpose: To maintain an iodine adsorbing efficiency at a high level by keeping the adsorbing atmosphere to more than a predetermined temperature to thereby suppress the degradation and the activity reduction in zeolite. Method: Adsorption and desorption-regeneration of gaseous wastes are performed in parallel by heating gaseous wastes in a heater and switchingly supplying the same to adsorption columns by way of valve operation. Processed gases are cooled in a cooler and desorbed gases are supplied to an after-treatment device to eliminate or recover iodine 131. In the adsorption column, iodine in gaseous wastes is adsorbed to remove by using zeolite, wherein the adsorbing atmosphere is kept at a temperature higher than 40 0 C. This can prevent the formation of an aqueous HNO 3 solution from NO 2 and H 2 O contained in the gaseous wastes and prevent the degradation of the zeolite adsorption layer. (Kawakami, Y.)

  8. Radioactivity of French coast of the Channel due to the release of technectium 99 and iodine 129: modelisation and measurements

    International Nuclear Information System (INIS)

    Robeau, D.; Patti, F.; Charmasson, S.

    1988-01-01

    Radioactive releases of Iodine 129 are controlled by measurements of the radioactivity in the liquid effluents before it is released in to the sea from the outlet of the reprocessing plant of La Hague. The effects on the marine environment are examined by a radioactive survey of Technecium 99 and Iodine 129 in Fucus (common seaweed). This radioactivity is measured along the north coast of France from Roscoff in the west of Brittany to Wimereux close to the Belgian frontier. The theoretical study of dispersion of radionuclides in the Channel has permitted a simulation model of the transfer of pollutants and particularly Technecium 99 and Iodine 129 to be formulated. (author)

  9. Radioactively labelled iodinated insulin and method of preparation

    Energy Technology Data Exchange (ETDEWEB)

    Geiger, R; Teetz, V; Eckert, H G

    1977-10-20

    Suitable tracers for RIA and substrates for pharmacokinetic investigations are insulin derivatives where B1 phenylalanine is substituted by a tyrosine derivative and part of the iodine is in the form of I-125 or I-131. The preparation of the insulin derivatives is described.

  10. Preliminary results of the TMI-2 radioactive iodine mass balance study

    International Nuclear Information System (INIS)

    Pelletier, C.A.; Cox, T.E.; Reeder, D.L.; Vollique, P.G.; Thomas, C.D.

    1982-01-01

    Analysis of samples taken from the Three Mile Island Unit 2 (TMI-2) reactor building following the 1979 accident indicates the fraction of the radioactive iodine (radioiodine) inventory in the core released to the uilding atmosphere is smaller tan assumed in Regulatory Guide 1.4. This summary presents analytical results supporting this conclusion

  11. Methodology study for fixation of radioactive iodine in polymeric substrate for brachytherapy sources

    International Nuclear Information System (INIS)

    Rodrigues, Bruna T.; Rostelato, Maria Elisa C.M.; Souza, Carla D.; Tiezzi, Rodrigo; Souza, Daiane B. de; Benega, Marcos A.G.; Souza, Anderson S. de; Peleias Junior, Fernando S.; Zeituni, Calos A.; Fernandes, Vagner; Melo, Emerson Ronaldo de; Camargo, Anderson Rogerio de

    2015-01-01

    Cancer is now the second leading cause of death by disease in several countries, including Brazil. Prostate cancer is the most common among men. Brachytherapy is a modality of radiotherapy in which radioactive seeds are placed inside or in contact with the organ to be treated. The most widely used radioisotope in prostate brachytherapy is Iodine-125 which is presented fixated on a silver substrate that is subsequently placed inside a titanium capsule. A large dose of radiation is released only in the targeted tumor protecting healthy surrounding tissues. The technique requires the application of 80 - 120 seeds per patient. The implants of seeds have low impact and non-surgical procedures. Most patients can return to normal life within three days with little or no pain. This work proposes an alternative to the seeds that have already been developed, in order to reduce the cost by obtaining a better efficiency on fixing the radioactive iodine onto the epoxy resin. Methods have been developed to perform the fixation of Iodine-125 onto polymeric substrates. The parameters analyzed were the immersion time, type of static or dynamic reaction, concentration of the adsorption solution, the specific activity of the radioactive source, the need for carrier and chemical form of the radioactive Iodine. These experiments defined the most effective method to fixate the Iodine onto the polymeric material (epoxy resin), the Iodine activity in the polymeric substrate, the activity of the distribution of variation in a plot of polymeric cores and the efficiency of the epoxy resin to seal the seed. (author)

  12. Thyroid storm following radioactive iodine (RAI) therapy for pediatric graves disease.

    Science.gov (United States)

    Rohrs, Henry J; Silverstein, Janet H; Weinstein, David A; Amdur, Robert J; Haller, Michael J

    2014-01-01

    Female, 11 FINAL DIAGNOSIS: Thyroid storm Symptoms: Diarrhea • tachycardia • tachypnea • tremor • wheezing - Clinical Procedure: - Specialty: - Rare disease. A growing number of pediatric endocrinologists treat Graves disease with radioactive iodine (RAI) therapy due to the typically definitive nature of I-131 therapy. Given the published benefits and perceived low risks of RAI when compared to surgery or long-term anti-thyroid medication, the trend towards therapy with RAI is likely to continue. Nevertheless, RAI is not without significant risk. An 11-year-old girl with newly diagnosed Graves disease received RAI for definitive treatment of her hyperthyroidism. Within 24 hours of receiving I-131, she developed increasing sleepiness and eventually became unresponsive. Upon arrival at the emergency department she had a tonic-clonic seizure and was diagnosed with thyroid storm. Despite best efforts to manage her hyperthyroidism, she suffered a stroke of the left cerebral hemisphere that left her with persistent neurological deficits. Although thyroid storm after thyroid ablation is rare, the significant morbidity and potential mortality of pediatric thyroid storm warrant further studies to determine if children with markedly elevated thyroid hormone concentrations at diagnosis should receive prolonged pretreatment with anti-thyroid drugs. While such an approach may reduce the efficacy of I-131 ablation, it can also reduce and hopefully eliminate the risk of post-ablative thyroid storm.

  13. Radioactive Iodine and Krypton Control for Nuclear Fuel Reprocessing Facilities

    Directory of Open Access Journals (Sweden)

    Nick R. Soelberg

    2013-01-01

    Full Text Available The removal of volatile radionuclides generated during used nuclear fuel reprocessing in the US is almost certain to be necessary for the licensing of a reprocessing facility in the US. Various control technologies have been developed, tested, or used over the past 50 years for control of volatile radionuclide emissions from used fuel reprocessing plants. The US DOE has sponsored, since 2009, an Off-gas Sigma Team to perform research and development focused on the most pressing volatile radionuclide control and immobilization problems. In this paper, we focus on the control requirements and methodologies for 85Kr and 129I. Numerous candidate technologies have been studied and developed at laboratory and pilot-plant scales in an effort to meet the need for high iodine control efficiency and to advance alternatives to cryogenic separations for krypton control. Several of these show promising results. Iodine decontamination factors as high as 105, iodine loading capacities, and other adsorption parameters including adsorption rates have been demonstrated under some conditions for both silver zeolite (AgZ and Ag-functionalized aerogel. Sorbents, including an engineered form of AgZ and selected metal organic framework materials (MOFs, have been successfully demonstrated to capture Kr and Xe without the need for separations at cryogenic temperatures.

  14. Microbial influences on the mobility and transformation of radioactive iodine in the environment

    International Nuclear Information System (INIS)

    Amachi, Seigo; Fujii, Takaaki; Shinoyama, Hirofumi; Muramatsu, Yasuyuki

    2005-01-01

    Long-lived radioactive iodine ( 129 I, half-life: 1.57x10 7 y) has been released into the environment from nuclear fuel reprocessing plants. 129 I may also be released from ground storage of nuclear waste. Given its long half-life, a better understanding of the behavior of iodine in the environment is necessary to ensure the safety of humans and the health of the environment. In this report, we summarize our recent results and new experimental data about microbial influences on the mobility and transformation of iodine. Microbial volatilization of organic iodine was observed in soil slurries and seawater samples, and various species of aerobic bacteria were considered to play a significant role through methylation of iodide (I - ) to form methyl iodide (CH 3 I). The volatilization of iodine was also found in iodide-rich natural gas brine water, where iodide concentration is approximately 2,000 times higher than that in seawater. In this case, however, a significant amount of molecular iodine (I 2 ) was produced together with organic iodine compounds. Iodide-oxidizing bacteria, which oxidize iodide to I 2 , were isolated from seawater and natural gas brine water. Phylogenetically, they were divided into two groups within the alpha-subclass of the Proteobacteria (Roseovarius sp. and unidentified bacteria), and they produced not only I 2 but also diiodomethane (CH 2 I 2 ) and chloroiodomethane (CH 2 CII). Iodide-accumulating bacteria, which accumulate iodide to concentrations 5,500-fold over that of the medium, were also isolated from marine sediment. They were closely related to Arenibacter troitsensis, and iodide uptake was medicated by an active transport system. Our results suggest that the fate of iodine can be affected by microorganisms, particularly by bacteria, through processes such as volatilization, oxidation, and accumulation. (author)

  15. Iodine

    Science.gov (United States)

    ... leg ulcers and reduce the chance of a future infection. Conjunctivitis (pinkeye). Research suggests that using eye ... National Institute of Medicine has set Adequate Intake (AI) of iodine for infants: 0 to 6 months, ...

  16. The treatment of iodine and chlorine chemistry in the risk assessment of deep radioactive waste disposal

    International Nuclear Information System (INIS)

    Jones, Michael A.

    1992-01-01

    The predicted contribution from 129 I, 131 I and 36 Cl to the radiological risk from a radioactive waste repository may be enhanced by the assumption of limited retardation in the near field and geosphere. However, migration of these radionuclides may be affected by their chemical speciation and retarded by a range of sorption processes. The chemical behaviour of iodine and chlorine is determined emphasizing i) aqueous speciations, ii) sorption onto inorganic substrates, and iii) the role of organic matter and microbes. Recommendations to enhance the methodology include i) consideration of aqueous speciation of iodine, both metal and organic complexes, ii) mechanistic simulation of iodine sorption by ion exchange and electrostatic/covalent adsorption, iii) simulation of enzymatically enhanced sorption of iodine and chlorine onto organic substrates, iv) enhancement of HMIP K d databases to include iodine and chlorine data for the geosphere and biosphere. A well defined programme of additional data collection, modelling studies and experimental investigations is recommended to achieve these enhancements. (author)

  17. Regional approaches to the management of patients with advanced, radioactive iodine-refractory differentiated thyroid carcinoma.

    Science.gov (United States)

    Brose, Marcia S; Smit, Johannes; Capdevila, Jaume; Elisei, Rossella; Nutting, Christopher; Pitoia, Fabian; Robinson, Bruce; Schlumberger, Martin; Shong, Young Kee; Takami, Hiroshi

    2012-09-01

    For patients with advanced, radioactive iodine-refractory differentiated thyroid cancer, current treatment guidelines recommend clinical trial enrollment or small-molecule kinase inhibitor therapy. However, details of patient management vary between countries depending on trial availability and national regulatory policies. Insufficient clinical trial data and variable disease characteristics challenge the creation of universal guidelines, and treatment plans often reflect regional influences. A multidisciplinary, multiregional panel of experts met to discuss regional approaches to managing patients with advanced, radioactive iodine-refractory differentiated thyroid cancer and the potential impact of emerging therapies on current treatment strategies. Despite process-oriented regional differences, the decision-making strategies were similar. Multidisciplinary teams used to manage high-risk patients varied in composition across regions, particularly regarding the responsible physician's specialty. Cytotoxic chemotherapy was viewed as limited in clinical benefit, and targeted agents as attractive, based on promising data. Panel members support clinical trial enrollment as the preferred treatment strategy for managing these patients.

  18. Radioactive iodine uptake: deriving new message from an old test

    International Nuclear Information System (INIS)

    Gonzales, R.R.; Magboo, M.L.C.; San Luis, T.O.L.

    1993-01-01

    92 patients with elevated 4 hour RAIU were divided into two groups and analyzed. Group I consisted of 42 patients with rapid iodine trapping and organification (4 hour>24 hour). Group II consisted of 50 patients with progressively increasing RAIU (24 hour>4 hour). Analysis of the clinical manifestations of both groups by using the J. Crooks Scoring System showed that 37 patients (88%) in group I belonged to the toxic group while only 7 (14%) of patients in group II showed clear signs and symptoms of thyrotoxicosis. Independent 2-tailed t-test between the Crooks score of both groups showed significant difference (t=8.42). The uptake pattern of both groups showed significant differences in their uptake levels at p value<0.001. All of the patients in group I received antithyroid regimen while in group II, 26 patients (56%) were given thyroid hormone preparations and only 16 (32%) patients received anti-thyroid drugs. In the final analysis, patterns wherein the 4 hour uptake is higher than the 24 hour uptake are highly associated with hyperthyroidism. Those with sustained elevations of the 4 hour and the 24 hour RAIU should merit good correlation between the clinical and thyroid hormone level before initiating any treatment regimen. (author). 8 refs.; 8 tabs

  19. Hyperparathyroidism after treatment with radioactive iodine: Not only a coincidence

    International Nuclear Information System (INIS)

    Bondeson, A.G.; Bondeson, L.; Thompson, N.W.

    1989-01-01

    Review of medical records in 600 consecutive cases of primary hyperparathyroidism revealed 10 patients with a documented history of iodine 131 ( 131 I) treatment. In seven cases 131 I had been given because of Graves' disease and in three cases for ablation of thyroid remnants after tumor operations. All but one of the patients were women. Their age at the time of 131I treatment ranged from 21 to 72 years, and the interval to detection of hypercalcemia was between 3 and 27 years. It is noteworthy that all patients treated for Graves' disease had absorbed radiation doses large enough to cause permanent hypothyroidism, and half of them showed complete absence of the thyroid gland at subsequent operation for hyperparathyroidism. Furthermore, parathyroid adenomas had developed at the sites of thyroid remnants in cases with 131 I ablation after tumor operations. Our findings support other observations indicating that not only external radiation but also radiation from 131 I is a risk factor for development of hyperparathyroidism, and it is emphasized that age at the time of radiation treatment may be of decisive importance in this context

  20. Treatments with radioactive iodine, 131 I. How, when and where?

    International Nuclear Information System (INIS)

    Ruiz J, A.; Gonzalez T, O.

    2006-01-01

    A great variety of approaches exists in the application of the treatments with radioactive materials, as the 131 I, but it is necessary to standardize them for the patient's benefit, because their doctor doesn't always know the principle that it bases this therapy, called metabolic therapy or radioiodine therapy (RYT). In this work the experience that was acquired by more of 50 years of RYT management in the Thyroid and Nuclear Medicine Clinic in patients with thyroid pathologies is informed, so that their management fulfills its function and it was carried out inside the corresponding juridical frame and the physicochemical and endocrinological principles that should take implicit. (Author)

  1. Radioactive iodine treatment of differentiated thyroid carcinoma in teenager

    International Nuclear Information System (INIS)

    Chen Yonghui

    2008-01-01

    Incidence rate of differentiated thyroid carcinoma in teenager is not high. It has some different characteristics compared to adult differentiated thyroid carcinoma. Such as larger tumor at diagnosis; greater prevalence of neck lymph node and distant metastases at diagnosis; more sodium-iodide symporter expression; high recurrence rate but higher overall survival rate. 131 I administration to remove residual thyroid tissue and treat metastases is still one of the important approaches after surgery. (authors)

  2. The uptake of radioactive iodine in rat intact Graafian follicles

    International Nuclear Information System (INIS)

    Lieberman, L.M.; Lieberman, G.L.; Lieberman, M.E.

    1984-01-01

    The concentration of iodine-131 in the ovaries of mammals has important implications in the use of I-131 for the diagnosis and treatment of thyroid disease in women. The authors studied the I-131 uptake in whole ovaries and in isolated Graafian follicles of sexually mature rats. Adult female Sprague-Dawley rats, in groups of 5-6 animals, were injected IP with 10-50 μCi of I-131, at 3, 12, and 24 hrs prior to the day of proestrus and killed on the day of proestrus. The thyroid gland and ovaries were removed intact and these organs, as well as eight other tissue specimens, were weighed. The large preovulatory follicles (6-9/ovary) were then isolated under a dissecting microscope and the remaining ovary weighed. All samples were counted in a gamma well counter and the % dose/g estimated. The thyroid gland showed 23.7% dose/organ at 24 hrs. Blood decreased from 1.6% dose/g at 3 hrs to 0.5% dose/g at 24 hrs with the uterus showing 1.1% dose/g and 0.4% dose/g at the same times. Ovarian tissue was 0.5, 0.1, and 0.1% dose/g at 3,12, and 24 hrs respectively, while the intact Graafian follicles had from one-tenth to one-third the concentration of the ovary at the same times. (0.05, 0.03, and 0.03% dose/g). The authors found that the intact Graafian follicle concentrates approximately one-thirtieth to one-sixteenth of the I-131 in the blood and one-tenth to one-third of the I-131 in the ovary. This suggests that there is no active uptake of I-131 in the follicle or follicular fluid

  3. Lacrimal drainage system obstruction associated to radioactive iodine therapy for thyroid carcinoma; Obstrucao de vias lacrimais associada ao tratamento radioiodoterapico de carcinoma de tireoide

    Energy Technology Data Exchange (ETDEWEB)

    Fonseca, Fabricio Lopes da; Lunardelli, Patricia; Matayoshi, Suzana, E-mail: suzana.matayoshi@gmail.com [Setor de Plastica Ocular, Divisao de Clinica Oftalmologica, Universidade de Sao Paulo (HC/FM/USP), Sao Paulo (SP) (Brazil)

    2012-03-15

    Purpose: To report the finding of nasolacrimal drainage system obstruction associated with radio iodine therapy and to review clinical data and the surgical treatment outcome of this rare complication. Methods: We retrospectively analyzed ophthalmological data of patients with history of thyroid carcinoma that underwent radioactive iodine I-131 therapy and were referred to lacrimal surgery. Results: 17 patients with thyroid cancer treated with thyroidectomy and radioactive iodine I-131 therapy presented symptomatic nasolacrimal duct obstruction after 13.2 months following cancer treatment. 11 patients presented bilateral epiphora, 8 had lacrimal sac mucocele. Age range was 30 to 80 years, 10 patients had less than or equal to 49 years. The mean cumulative dose of radioiodine was 571mCi (range: 200-1200 mCi). Nasal obstruction symptoms and increased salivary glands were also present in 53% of patients. All subjects underwent dacryocystorhinostomy. Dilation of the lacrimal sac and increased intraoperative bleeding was also observed in 3 younger patients. Complete epiphora and dacryocystitis resolution after surgery occurred in 82.4%, and partial in 17.6% (3 patients that still presented unilateral relapse after correction of bilateral obstruction). Mean follow-up was 6 months (range: 2-24 months). Conclusions: Cumulative high dose of radioiodine, nasal and salivary gland dysfunction are associated with lacrimal drainage obstruction. We observed a great percentage of younger patients presenting dacryocystitis when compared to the idiopathic dacryostenosis. Radioactive iodine uptake by nasolacrimal duct mucosa with subsequent inflammation, edema and fibrosis seems to have a relationship to lacrimal duct obstruction. The knowledge of this complication is important for the study and proper management of these patients (author)

  4. Evaluation of a potential parathyroid dysfunction under treatment with radioactive iodine of benign thyroid diseases

    International Nuclear Information System (INIS)

    Schumacher, Serena Christine

    2011-01-01

    The intention of the present thesis was the evaluation of a potential parathyroid dysfunction under treatment with radioactive iodine of benign thyroid diseases. It was to be examined whether a change in the parathyroid function would arise within the first week on treatment. So far there are some minor studies existing describing significant changes in the parathyroid hormone serum level within the first months after radioactive iodine therapy of benign and malignant thyroid diseases. Moreover, it is a fact that external beam-radiotherapy can induce neoplasia and that the risk for the subsequent development of primary hyperparathyroidism doubles or triples after external beam-radiotherapy of the head and neck. Up to now, however, an increased incidence for primary hyperparathyroidism following treatment with radioactive iodine ( 131 I) could not be proved. At the department of nuclear medicine of the university hospital Giessen-Marburg GmbH, location Marburg, a prospective cohort study was executed on radioactive iodine therapy of benign thyroid diseases with 105 probands (75 women / 30 men, mean age 60.62 ± 14.3 years). According to their thyroid diseases these 105 probands were classified into following subgroups: thyroid adenoma with 23 patients, multifocal thyroid autonomy with 8 patients, disseminated thyroid autonomy with 37 patients as well as the subgroup Graves' hyperthyroidism (without Graves' ophtalmopathy) and accordingly Graves' disease (with Graves' ophtalmopathy) with 37 patients. The serum level of the intact parathyroid hormone was determined directly before starting the radioactive iodine therapy on the admission day and on day 1, 3 and 5 of the radioactive iodine therapy as well as at the ambulant follow-up examination one month after the start of the therapy. In case of 99 of 105 probands the serum level of parathyroid hormone declined on treatment with 131 I with its nadir on day 3 of therapy (decline by 15.71 ng/l or 27

  5. Use of radioactive iodine: the new and the old

    International Nuclear Information System (INIS)

    Navarro Despaigne, Daysi A.

    2004-01-01

    The use of the biopsy for fine needle of the thyroid, of the ultrasound and of the TSH recombinant it introduced important changes in the diagnosis of the thyroid illnesses, in spite of having more than 50 years of use, the future of the 131 I is promissory, not alone as measure therapy but also as method diagnosis, because they are to solve relative multiple queries to the indications, the factors that influence in the answer, dose calculation, the patients' selection and long term absence of aleatory studies that allow to define in the treatment of the non toxic goiter the advantages of the use of the levotiroxina, of the surgery or of the 131 I

  6. Method for monitoring the course of oxidation of iodide ion during radioactive iodination operation

    Energy Technology Data Exchange (ETDEWEB)

    Xuezhong, Luo

    1986-05-01

    A micro-iodine ion selective electrode is developed to follow and monitor the course of oxidation of iodide ion during radioactive iodination operation. The experimental results indicate that this method can quickly respond to the course of oxidation if the reacting liquid is greater than 30 micro liter in volume. Therefore it can be used for accurate controlling the amount of oxidzing reagent used for the reaction, for example, the amount of chloroamine T can be reduced to 1/40 of the amount ordinarily used for the preparation of angiotonin II and insulin. The effect of pH and concentration of phosphate of the reacting liquid to the oxidation reaction of I with chloroamine T is also studied.

  7. Sequestration of radioactive iodine in silver-palladium phases in commercial spent nuclear fuel

    Energy Technology Data Exchange (ETDEWEB)

    Buck, Edgar C., E-mail: edgar.buck@pnnl.gov; Mausolf, Edward J.; McNamara, Bruce K.; Soderquist, Chuck Z.; Schwantes, Jon M.

    2016-12-15

    Radioactive iodine is the Achilles' heel in the design for the safe geological disposal of spent uranium oxide (UO{sub 2}) nuclear fuel. Furthermore, iodine's high volatility and aqueous solubility were mainly responsible for the high early doses released during the accident at Fukushima Daiichi in 2011. Studies Kienzler et al., however, have indicated that the instant release fraction (IRF) of radioiodine ({sup 131/129}I) does not correlate directly with increasing fuel burn-up. In fact, there is a peak in the release of iodine at around 50–60 MW d/kgU, and with increasing burn-up, the IRF of {sup 131/129}I decreases. The reasons for this decrease have not fully been understood. We have performed microscopic analysis of chemically processed high burn-up UO{sub 2} fuel (80 MW d/kgU) and have found recalcitrant nano-particles containing, Pd, Ag, I, and Br, possibly consistent with a high pressure phase of silver iodide in the undissolved residue. It is likely that increased levels of Ag and Pd from {sup 239}Pu fission in high burnup fuels leads to the formation of these metal halides. The occurrence of these phases in UO{sub 2} nuclear fuels may reduce the impact of long-lived {sup 129}I on the repository performance assessment calculations. - Highlights: • A Pd-Ag halide phase has been observed in a high burn-up UO{sub 2} reactor fuel. • The phases contains iodine and bromine. • Iodine release in high burnup fuels may be reduced through the formation of recalcitrant phases.

  8. Temporary ovarian failure in thyroid cancer patients after thyroid remnant ablation with radioactive iodine

    International Nuclear Information System (INIS)

    Raymond, J.P.; Izembart, M.; Marliac, V.; Dagousset, F.; Merceron, R.E.; Vulpillat, M.; Vallee, G.

    1989-01-01

    We studied ovarian function retrospectively in 66 women who had regular menstrual cycles before undergoing complete thyroidectomy for differentiated thyroid cancer and subsequent thyroid remnant ablation with 131 I. Eighteen women developed temporary amenorrhea accompanied by increased serum gonadotropin concentrations during the first year after 131 I therapy. No correlation was found between the radioactive iodine dose absorbed, thyroid uptake before treatment, oral contraceptive use, or thyroid autoimmunity. Only age was a determining factor, with the older women being the most affected. We conclude that radioiodine ablation therapy is followed by transient ovarian failure, especially in older women

  9. The effect of radioactive iodine treatment in well differentiated thyroid carcinoma with lymphnode metastasis

    International Nuclear Information System (INIS)

    Liou, M. J.; Lin, J. D.; Chao, T. C.; Wen, H. F.; Ho, Y. S.

    1994-01-01

    Background: To exam the effect of radioactive iodine treatment for thyroid remnant ablation and/or distant metastasis. A total of 134 well-differentiated thyroid cancer patients with cervical lymphnode metastasis at the time of diagnosis were retrospectively reviewed at Chang Gung Medical Center in Taiwan from 1977 to 1995. Methods: Among them, 126 cases were papillary carcinomas and 8 cases were follicular carcinomas. The mean age was 37.0 ± 14.6 years old. After the operation, 127 (95 %) patients received 131 I treatment (mean dose: 146.6 ± 109.5 mCi, range 30 - 550 mCi) and long-term follow-up. The mean follow-up period is 5.9 ± 3.9 yrs. All patients were restage at the end of 1995. Clinical biochemical results were also analyzed. Results: Among 127 cases who received postoperative radioactive iodine treatment, the majority of cases (92.5 % in papillary ca. vs. 57.1 % in follicular ca.) improved to stage I, 11 (8.6 %) cases remained on the same disease and stages. 13 cases (10.2 %, 10 papillary and 3 follicular) deteriorated to stage III or IV. However, in the non-treatment group, only 33.3 % of papillary carcinoma patients improved to stage I and 16.7 % of the patients remained as stage II. There were 5 cases (3.7 %) of mortality. Two cases with stage IV papillary carcinomas died of metastatic or recurrent malignancy, and the other 2 cases with stage I or III papillary carcinomas died of tracheal cancer or valvular heart disease. One patient with stage IV follicular carcinoma died of cerebral vascular accident. Conclusions: Radioactive iodine ( 131 I) treatment plays a significant role in the management of well-differentiated thyroid carcinoma patients with cervical lymphnode metastasis. The effect of postoperative 131 I treatment on papillary carcinoma was better than that on follicular carcinoma. The optimal dosage and frequency of radioactive iodine treatment warrant further study. (author)

  10. Postpartum thyrotoxicosis in a patient with Graves' disease. Association with low radioactive iodine uptake

    International Nuclear Information System (INIS)

    Eckel, R.H.; Green, W.L.

    1980-01-01

    A patient with previously diagnosed Graves' hyperthyroidism had a transient episode of thyrotoxicosis three months postpartum. This was associated with a diffusely enlarged thyroid gland, a rise in antithyroid microsomal antibody titer, a 24-hour radioactive iodine uptake (RAIU) of 1%, and an aspiration biopsy specimen suggestive of chronic lymphocytic thyroiditis. An alternative cause for the depressed RAIU was not discovered. This case would suggest that patients with previously diagnosed Graves' disease can have thyrotoxicosis without an enhanced RAIU and that the postpartum thyrotoxin syndrome may involve an immunologic injury causing a release of performed thyroid hormone

  11. Temporary ovarian failure in thyroid cancer patients after thyroid remnant ablation with radioactive iodine

    Energy Technology Data Exchange (ETDEWEB)

    Raymond, J.P.; Izembart, M.; Marliac, V.; Dagousset, F.; Merceron, R.E.; Vulpillat, M.; Vallee, G.

    1989-07-01

    We studied ovarian function retrospectively in 66 women who had regular menstrual cycles before undergoing complete thyroidectomy for differentiated thyroid cancer and subsequent thyroid remnant ablation with /sup 131/I. Eighteen women developed temporary amenorrhea accompanied by increased serum gonadotropin concentrations during the first year after /sup 131/I therapy. No correlation was found between the radioactive iodine dose absorbed, thyroid uptake before treatment, oral contraceptive use, or thyroid autoimmunity. Only age was a determining factor, with the older women being the most affected. We conclude that radioiodine ablation therapy is followed by transient ovarian failure, especially in older women.

  12. Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer

    DEFF Research Database (Denmark)

    Brose, Marcia S; Nutting, Christopher M; Jarzab, Barbara

    2014-01-01

    cancer that had progressed within the past 14 months. Adult patients (≥18 years of age) with this type of cancer were enrolled from 77 centres in 18 countries. To be eligible for inclusion, participants had to have at least one measurable lesion by CT or MRI according to Response Evaluation Criteria...... cancer. Adverse events were consistent with the known safety profile of sorafenib. These results suggest that sorafenib is a new treatment option for patients with progressive radioactive iodine-refractory differentiated thyroid cancer. FUNDING: Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals...

  13. Radioactive iodine therapy in a case of Graves' disease with allergy to antithyroid drugs (ATD) and propranolol

    International Nuclear Information System (INIS)

    Bahri, I.M.; San Luis, T.O.L.

    2007-01-01

    Full text: This is a case of V.C., 56 year old, female, from Las Pinas City, Philippines, diagnosed as a case of Graves' disease. During the course of therapy, the patient had allergy to antithyroid drugs (ATDs) and beta blocker (Propranolol). She developed rashes all over the body, sparing the face the day after taking her ATDs as well as Propranolol, thus all medications were discontinued. Other options, such as RAI therapy and surgery, with their respective advantages and disadvantages were fully explained to the patient who then opted to undergo RAI therapy. In our institution, we usually compute the dose based on the size of the gland and radioactive Iodine-131 uptake measurements (RAIU) rather than using fixed doses. Thyroid scintigraphy and RAIU were done which revealed poorly visualized thyroid gland and markedly diminished 24-hour uptake but normal 4-hour uptake [RAIU 4 hour uptake: 26% (NV= 15-25%); 24 hour uptake: 6% (NV25-45%)]. * Note: Variations in normal uptake values compared to US are due to iodine deficiency still existing in some regions. Because of the very low 24-hour uptake, we reviewed the probable causes which can result in low uptake values. All causes were ruled out and the patient was advised to undergo two weeks of strict low-iodine diet prior to repeat thyroid scintigraphy and RAIU. Thereafter, the result of repeat study showed diffuse thyromegaly with elevated uptake values indicating rapid trapping and organification processes [RAIU 4 hour uptake: 82% (NV= 15-25%); 24 hour uptake: 68% (NV25-45%)]. The day after the study, the patient was given 10 mCi I-131 based on the estimated weight of the gland, rapid thyroid iodine turnover ('small pool') and 24-hour uptake. This was considered to be the highest allowable dose of RAI to decrease the probability of relapse and the need for re-treatment. Approximately 4 weeks after the therapy, the patient is noted to have responded satisfactorily to therapy with resolution of symptoms. (author)

  14. Histologic Findings and Cytological Alterations in Thyroid Nodules After Radioactive Iodine Treatment for Graves' Disease: A Diagnostic Dilemma.

    Science.gov (United States)

    El Hussein, Siba; Omarzai, Yumna

    2017-06-01

    Unlike the well-documented relation between radiation to the neck and development of papillary thyroid carcinoma, a causal association between radioactive iodine treatment for Graves' disease and development of thyroid malignancy is less defined. However, patients with a background of thyroid dysfunction presenting with clinically palpable thyroid nodules are followed more closely than the average population, and fine needle aspiration is recommended in such circumstances. Cytological examination of aspirates, and histologic examination of tissue provided from patients with a known history of Graves' disease, managed by radioactive iodine therapy can create a diagnostic dilemma, as the distinction between radiation effect and a malignant primary thyroid neoplasm can be very challenging. Thus, pathologists should be aware of the existence of these changes in the setting of radiation therapy for Graves' disease. Providing pathologists with appropriate clinical history of Graves' disease treated with radioactive iodine is of paramount importance in order to prevent an overdiagnosis of malignancy.

  15. Radio-active pollution of milk by iodine from September 1, 1962 to February 1, 1963

    International Nuclear Information System (INIS)

    Michon, G.; Madelmont, C.

    1964-01-01

    The report presents the result of 840 examinations and analyses of 131 I in milk undertaken during the period from 1.9.1962 to. 1.2.1963 when young fission products were detectable in radioactive fallout. A short interpretation in health terms is given in the first part, the second part being devoted to the study of the correlation which may exist between the values found in the milk and the changes in atmospheric radioactivity on the one hand, and the rainfall on the other hand. Without being able to conclude with certainty, it appears that the rain is the most important factor in the pollution of milk by iodine-131. (authors) [fr

  16. Quantification of iodine in porous hydroxyapatite matrices for application as radioactive sources in brachytherapy

    Directory of Open Access Journals (Sweden)

    Kássio André Lacerda

    2007-07-01

    Full Text Available In this study, non-radioactive iodine was incorporated in two types of biodegradable hydroxyapatite-based porous matrices (HA and HACL through impregnation process from sodium iodine aqueous solutions with varying concentrations (0.5 and 1.0 mol/L . The results revealed that both systems presented a high capacity of incorporating iodine into their matrices. The quantity of incorporated iodine was measured through Neutron Activation Analysis (NAA. The porous ceramic matrices based on hydroxyapatite demonstrated a great potential for uses in low dose rate (LDR brachytherapy.Materiais cerâmicos porosos à base de compostos de fosfatos de cálcio (CFC vêm sendo estudados e desenvolvidos para várias aplicações biomédicas tais como implantes, sistemas para liberação de drogas e fontes radioativas para braquiterapia. Dois tipos de matrizes porosas biodegradáveis de hidroxiapatita (HA e HACL foram avaliadas em termos da capacidade de incorporação de iodo em suas estruturas. Resultados revelaram que as matrizes porosas a base de hidroxiapatita apresentaram alta capacidade de incorporar iodo em sua estrutura. A quantidade de iodo foi mensurada através da técnica de Análise por Ativação Nêutronica (AAN. As matrizes cerâmicas porosas à base de hidroxiapatita demostraram ter grande potencial para aplicação em braquiterapia de baixa taxa de dose (LDR - Low Dose Rate.

  17. Comparison between methods for fixing radioactive iodine in silver substrate for manufacturing brachytherapy sources

    International Nuclear Information System (INIS)

    Souza, Carla Daruich

    2012-01-01

    Among the different ways to treat prostate cancer, brachytherapy with iodine- 125 seeds is an option that provides good results and fewer side effects. In the present study several deposition methods of radioactive iodine in a silver substrate were compared in order to choose the most suitable alternative for the routine production to be implemented at IPEN's laboratory. The methodology used was chosen based on the available infrastructure and experience of the researchers present. Therefore, the 131 I was used for testing (same chemical behavior as 131 I). Four methods were selected: Method 1 (test based on electrodeposition method developed by D.Kubiatowicz) presented 65.16% efficiency; Method 2 (chemical reaction based on the method developed by D. Kubiatowicz - HCl) with the result of 70.80% efficiency; method 3 (chemical reaction based on the method developed by Dr. Maria Elisa Rostelato) with 55.80% efficiency; Method 4 (IQ-IPEN) resulted in 99% efficiency. Since this method has more radioactive material fixation (which represents virtually the entire cost of the seed), the final price is the cheapest. This method is the suggested one to be implemented in the IPEN's laboratory for brachytherapy sources production. Besides, the method is the fasted one. (author)

  18. On the fallout by nuclear explosion experiment and the radioactive iodine in animal organism

    International Nuclear Information System (INIS)

    Tanaka, Giichiro

    1974-01-01

    Radioactive iodine (mainly 131 I, 132 I, 133 I, and 135 I) was measured with fallout, cow milk, human urine, and thyroid glands (human and cattles) after the first nuclear explosion experiment in China. Analysing method was determined by placing emphasis on rapidity and perfect separation from other nuclides. The detectable limit employing this method was about several p Ci. The identification of radioactive iodine was performed with a simultaneous counting type β - ray spectrometer, and 131 I, 132 I, and 133 I were identified by their half lives. 131 I in cow milk increased from around the 4th day after the experiment, and it had been detected for a month continuously, the maximum amount being 437 p Ci/l. In thyroid glands, 131 I was detected for 100 days in a milch cow, the maximum being 88, 1p Ci/g, while it was somewhat low in Japanese cows and pigs. 131 I in the thyroid gland of a human infant (accidentally died after 12 days) was 1.29p Ci/g. 131 I in human urine was 6.3p Ci/l on the 7th day. (Kobatake, H.)

  19. Treatment of hyperthyroidism with radioactive iodine. Methodological changes and follow-up problems

    International Nuclear Information System (INIS)

    Gibold, C.; Delisle, M.J.; Maes, B.; Vaudrey, C.; Pochard, J.M.

    1988-01-01

    The experience of treatment of hyperthyroidism with radioactive iodine in the Nuclear Medicine department of the J. Godinot Institute, Rheims, from 1967 till 1987, is described. One thousand one hundred and fifty patients (723 with diffuse and 427 with nodular hyperthyroidism) received a total of 1 565 doses. The dosage calculation method was considerably simplified, enabling a patient to be treated in 24 hours. Thyroid gland mass evaluation, initially based on the scintigraphic projection area, is now performed by ultrasonography. The mean total radioactivity administered is 370 ± 320 MBq per patient. All patients are seen on the 8th post-treatment week for clinical examination and hormone control. Seven out of 10 patients are cured with a single dose. Long-term follow-up, based on a computer file, is effected by means of an annual letter sent to patient and to his family doctor, but in spite fo sustained efforts 36 per cent of the patients are lost sight of. The diagnosis of iodine 131-induced hypothyroidism is based on plasma levels of TSH which, since 1984, are measured by the ultrasensitive method. The overall incidence of hypothyroidism is 6.6 per cent in the first year and 3 per cent thereafter. Despite a simplified procedure, the results obtained by the authors are similar to those found in the literature, and the cost-efficiency ratio is excellent [fr

  20. Radioactive Iodine

    Science.gov (United States)

    ... order to limit radiation exposure to others (see chart). I-131 may occasionally cause mild pain in ... Statement on Thyroid Shielding During Diagnostic Medical and Dental Radiology By ATA | 2013 News Releases , News Releases , ...

  1. No impact of dietary iodine restriction in short term development of hypothyroidism following fixed dose radioactive iodine therapy for Graves' disease.

    Science.gov (United States)

    Jacob, Jubbin Jagan; Stephen, Charles; Paul, Thomas V; Thomas, Nihal; Oommen, Regi; Seshadri, Mandalam S

    2015-01-01

    The increased incidence of autoimmune thyroid disease with increasing dietary iodine intake has been demonstrated both epidemiologically and experimentally. The hypothyroidism that occurs in the first year following radioactive iodine therapy is probably related to the destructive effects of the radiation and underlying ongoing autoimmunity. To study the outcomes at the end of six months after fixed dose I, (131)therapy for Graves' disease followed by an iodine restricted diet for a period of six months. Consecutive adult patients with Graves' disease planned for I(131) therapy were randomized either to receive instructions regarding dietary iodine restriction or no advice prior to fixed dose (5mCi) I(131) administration. Thyroid functions and urinary iodine indices were evaluated at 3(rd) and 6(th) month subsequently. Forty seven patients (13M and 34F) were assessed, 2 were excluded, 45 were randomized (Cases 24 and Controls 21) and 39 patients completed the study. Baseline data was comparable. Median urinary iodine concentration was 115 and 273 μg/gm creat (p = 0.00) among cases and controls respectively. Outcomes at the 3(rd) month were as follows (cases and controls); Euthyroid (10 and 6: P = 0.24), Hypothyroid (3 and 5: P = 0.38) and Hyperthyroid (7 and 8: P = 0.64). Outcomes at the end of six months were as follows (cases and controls); Euthyroid (10 and 5: P = 0.12), Hypothyroid (3 and 5: P = 0.38) and Hyperthyroid (7 and 9: P = 0.43). Of the hypothyroid patients 5 (cases 1 and controls 4: P = 0.13) required thyroxine replacement. There was no statistical significant difference in the outcome of patients with dietary iodine restriction following I(131) therapy for Graves' disease.

  2. An improved analytical method for iodine-129 determination in low-level radioactive waste

    Energy Technology Data Exchange (ETDEWEB)

    Hsieh, Yi-Kong; Wang, TsingHai; Jian, Li-Wei; Chen, Wei-Han; Wang, Chu-Fang [National Tsing Hua Univ., Hsinchu, Taiwan (China). Dept. of Biomedical Engineering and Environmental Sciences; Tsai, Tsuey-Lin [Atomic Energy Council, Taiwan (China). Chemical Analysis Div.

    2014-07-01

    In this study, an alkaline-digestion pretreatment and a subsequent ICP-MS measurement were conducted for iodine-129 (I-129) determination in low-level radioactive waste. A TMAH + H{sub 2}O{sub 2} + Triton X-100 mixed alkaline digestion was the most effective mixture for I-129 determination. Using this alkaline reagent, a high level of I-129 recovery (101 ± 6%) was achieved for the analysis of the I-129-spiked standard reference materials NIST 2709 and 2711. Importantly, the I-129 concentrations determined for ten real samples provided by the Lan-Yu radioactive waste temporary storage site were found to be below the detection limit (0.011 mg/kg). This value was only approximately 30-70% of the values determined using the I-129/Cs-137 scaling factor. This means that using the I-129/Cs-137 scaling factor severely overestimates the I-129 concentration in these low-level radioactive wastes. We therefore suggest that a detailed re-inspection of the I-129/Cs-137 scaling factor should be performed to appropriately categorize these low-level radioactive wastes.

  3. Dicarbonic acid anilides containing radioactive iodine (iodine 131, 123, 125, or 132) as well as their metal and amine salts; methods for the preparation of these compounds and of radioactive functional diagnostics containing them

    International Nuclear Information System (INIS)

    Buttermann, G.

    1976-01-01

    A method for the preparation of dicarbonic acid anilides containing radioactive iodine is described. The initial substances are N,N dimethyl-p-toluene sulfonamide, N,N bis-dimethyl aminosulfon, or dimethyl sulfon, or mixtures of these, which are heated in aqueous solution or in a melt with an alkali or alkaline earth radioiodide as carrier-free as possible. From the water-soluble salts of the obtained iodine-labelled dicarbonic acid anilides aqueous solutions are produced with 1 mg up to 5 g iodine-labelled dicarbonic acid anilide per 10 ml and an activity of 0.025 and 25 mCi per ml with physiologically compatible bases as radioactive functional diagnostics. (RB) [de

  4. Behavior of radioactive iodine and technetium in the spray calcination of high-level waste

    International Nuclear Information System (INIS)

    Knox, C.A.; Farnsworth, R.K.

    1981-08-01

    The Remote Laboratory-Scale Waste Treatment Facility (RLSWTF) was designed and built as a part of the High-Level Waste Immobilization Program (now the High-Level Waste Process Development Program) at the Pacific Northwest Laboratory. In this facility, which is installed in a radiochemical cell, small volumes of radioactive liquid wastes can be solidified, the process off gas can be analyzed, and the methods for decontaminating this off gas can be tested. Initial operations were completed with nonradioactive, simulated waste solutions (Knox, Siemens and Berger 1981). The first radioactive operations in this facility were performed with a simulated, commercial waste composition containing tracer levels of 99 Tc and 131 I. This report describes the facility and test operations and presents the results of the behavior of 131 I and 99 Tc during solidification of radioactive liquid wastes. During the spray calcination of commercial high-level liquid waste spiked with 99 Tc and 131 I, there was a 0.3 wt% loss of particulates, a 0.15 wt% loss of 99 Tc and a 31 wt% loss of 131 I past the sintered-metal filters. These filters and a venturi scrubber were very efficient in removing particulates and 99 Tc from the off-gas stream. Liquid scrubbers were not efficient in removing 131 I, as 25% of the total lost went to the building off-gas system. Therefore, solid adsorbents will be needed to remove iodine. For all future RLSWTF operations where iodine is present, a silver zeolite adsorber will be used

  5. Radioactive iodine therapy and breast cancer. A follow-up study of hyperthyroid women

    Energy Technology Data Exchange (ETDEWEB)

    Goldman, M.B.; Maloof, F.; Monson, R.R.; Aschengrau, A.; Cooper, D.S.; Ridgway, E.C.

    1988-05-01

    A follow-up study of 1762 hyperthyroid women who were treated at the Massachusetts General Hospital Thyroid Unit between 1946 and 1964 was conducted. The average length of follow-up was 17.2 years. A 1978 mailing address or a death certificate was located for 92% of the women, and 88% of 1058 living patients responded to a mail questionnaire. The standardized mortality ratio (SMR) for all causes of death was 1.3 (95% confidence interval (CI) 1.2-1.4). The standardized mortality ratios for all malignant neoplasms and for breast cancer were 0.9 (95% CI 0.7-1.1) and 1.3 (95% CI 0.8-1.9), respectively. More deaths than expected were observed from endocrine and metabolic diseases (SMR = 1.8, 95% CI 1.2-2.7), circulatory system diseases (SMR = 1.4, 95% CI 1.3-1.6), and respiratory system diseases (SMR = 1.9, 95% CI 1.3-2.6). The standardized incidence ratios (SIR) for all malignant neoplasms and for breast cancer were 0.9 (95% CI 0.8-1.1) and 1.2 (95% CI 0.9-1.5), respectively. A nonsignificant excess breast cancer risk was observed 10 years after the onset of thyroid symptoms and was present at the end of 30 years of observation. A statistically significant excess number of pancreatic cancer cases (SIR = 2.0, 95% CI 1.0-3.7) and a nonsignificant excess of brain cancer cases (SIR = 2.3, 95% CI 0.7-5.3) were observed. Eighty per cent of the women were treated with radioactive iodine. When age at treatment and year of treatment were controlled, women who were ever treated with radioactive iodine had a standardized rate ratio for breast cancer of 1.9 (95% CI 0.9-4.1), compared with those who were never treated with radioactive iodine. Women who developed hypothyroidism as a result of their treatment for hyperthyroidism did not have an increased risk of developing breast cancer (SIR = 1.1, 95% CI 0.8-1.6).

  6. Radioactive iodine treatment of a struma ovarii with extensive peritoneal involvement: a dosimetric study

    International Nuclear Information System (INIS)

    Metivier, D.; Ricard, M.; Lamartina, L.; Hartl, D.; Lhomme, C.; Morice, P.; Lepoutre, C.; Deandreis, D.; Lumbroso, J.; Schlumberger, M.; Leboulleux, S.

    2015-01-01

    Full text of publication follows. Objective: we report a patient with a very large and unresectable peritoneal involvement from a struma ovarii who was treated with radioactive iodine (3.7 GBq). Methods: whole body retention was measured during hospital stay (10 days), 3 times a day, using a calibrated automatic gamma counter attached to the ceiling of the room. Radiation protection for the husband was monitored with a radiation dosimeter, during one month after hospital discharge. OLINDA software was used to evaluate the absorbed dose delivered to the red marrow, assuming that radioactive iodine was concentrated mainly in the abdomen. Results: a 53-year-old woman, treated 22 years before for bilateral ovarian cysts with thyroid elements (struma ovarii) but no sign of malignancy, was explored for hyperthyroid symptoms with undetectable TSH level (0.07 mUI/ml) and elevated FT3 level (11,6 pmol/l). Thyroglobulin (Tg) level was elevated (15,200 ng/ml). Thyroid uptake was low. Abdominal ultrasonography revealed liver nodules and multiple intra-abdominal masses, the largest measuring 140, 57 and 53 mm. Coelio-scopic exploration and histologic analysis found peritoneal metastasis of a follicular carcinoma. The masses did not disclose any FDG uptake. Lesions were considered non resectable and the patient was referred for total thyroidectomy and radioactive iodine treatment. The post-therapy whole-body scan revealed an intense 131 I uptake in all abdominal masses. Dosimetric study 131 I showed a very long whole body effective half-life (7 days compared to 0.3 days in non-metastatic patients). The mean red marrow dose ranged between 100 and 200 mGy. Effective dose delivered to her husband was 225 μSv. A transient and moderate decrease in lymphocyte (1.15 G/l) and platelet (178 G/l) counts was observed 3 weeks after the 131 I administration. FT3 decreased slowly after treatment. Tumour response according to RECIST will be shown during the congress presentation. Conclusion

  7. Radioactive iodine therapy and breast cancer. A follow-up study of hyperthyroid women

    International Nuclear Information System (INIS)

    Goldman, M.B.; Maloof, F.; Monson, R.R.; Aschengrau, A.; Cooper, D.S.; Ridgway, E.C.

    1988-01-01

    A follow-up study of 1762 hyperthyroid women who were treated at the Massachusetts General Hospital Thyroid Unit between 1946 and 1964 was conducted. The average length of follow-up was 17.2 years. A 1978 mailing address or a death certificate was located for 92% of the women, and 88% of 1058 living patients responded to a mail questionnaire. The standardized mortality ratio (SMR) for all causes of death was 1.3 (95% confidence interval (CI) 1.2-1.4). The standardized mortality ratios for all malignant neoplasms and for breast cancer were 0.9 (95% CI 0.7-1.1) and 1.3 (95% CI 0.8-1.9), respectively. More deaths than expected were observed from endocrine and metabolic diseases (SMR = 1.8, 95% CI 1.2-2.7), circulatory system diseases (SMR = 1.4, 95% CI 1.3-1.6), and respiratory system diseases (SMR = 1.9, 95% CI 1.3-2.6). The standardized incidence ratios (SIR) for all malignant neoplasms and for breast cancer were 0.9 (95% CI 0.8-1.1) and 1.2 (95% CI 0.9-1.5), respectively. A nonsignificant excess breast cancer risk was observed 10 years after the onset of thyroid symptoms and was present at the end of 30 years of observation. A statistically significant excess number of pancreatic cancer cases (SIR = 2.0, 95% CI 1.0-3.7) and a nonsignificant excess of brain cancer cases (SIR = 2.3, 95% CI 0.7-5.3) were observed. Eighty per cent of the women were treated with radioactive iodine. When age at treatment and year of treatment were controlled, women who were ever treated with radioactive iodine had a standardized rate ratio for breast cancer of 1.9 (95% CI 0.9-4.1), compared with those who were never treated with radioactive iodine. Women who developed hypothyroidism as a result of their treatment for hyperthyroidism did not have an increased risk of developing breast cancer (SIR = 1.1, 95% CI 0.8-1.6)

  8. The optimization of treatment with radioactive iodine (131I) of the hypersecretive ''hot'' tumors of the thyroid

    International Nuclear Information System (INIS)

    Gorowski, T.; Zgliczynski, S.

    1987-01-01

    The studies have been carried out in 50 patients with hyperthyroidism associated with the presence of ''hot'' thyroid tumor. The effectiveness of treatment with a standard dose of radioactive iodine, a dose which after 48 hours following the administration caused an appearance of 5.55 MBq (150 μCi) of 131 I in 1 cubic centimeter of the tumor, has been determined. In each case the condition of the patient was evaluated several times before and after the treatment, basing on clinical examination, scintigraphy of the thyroid, the determinations of T 3 , T 4 and TSH concentrations and, when needed, also the determination of TSH after stimulation with TRH. The period of observation after the administration of the first therapeutic dose of radioactive iodine was between 2 and 19 years (mean 6.5 years). The results obtained indicated that in 40 among 50 patients (80%) hyperthyroidism disappeared after administration of a single dose of radioactive iodine calculated as specified above. In two of these patients (4%) hypothyroidism resulted. In the remaining 10 patients (20%) the treatment with radioactive iodine had to be repeated. This resulted in disappearance of hyperthyroidism also in these 10 patients, bringing the total amount of cured patients to 50 (100%), and increasing the amount of patients with hypothyroidism to barely 3 cases (6%). 23 refs., 2 tabs. (author)

  9. Behavior of radioactive iodine and technetium in the spray calcination of high-level waste

    Science.gov (United States)

    Knox, C. A.; Farnsworth, R. K.

    1981-08-01

    The Remote Laboratory-Scale Waste Treatment Facility (RLSWTF) was designed and built as a part of the High-Level Waste Immobilization Program (now the High-Level Waste Process Development Program) at the Pacific Northwest Laboratory. In facility, installed in a radiochemical cell, is described in which installed in a radiochemical cell is described in which small volumes of radioactive liquid wastes can be solidified, the process off gas can be analyzed, and the methods for decontaminating this off gas can be tested. During the spray calcination of commercial high-level liquid waste spiked with Tc-99 and I-131 and 31 wt% loss of I-131 past the sintered-metal filters. These filters and venturi scrubber were very efficient in removing particulates and Tc-99 from the the off-gas stream. Liquid scrubbers were not efficient in removing I-131 as 25% of the total lost went to the building off-gas system. Therefore, solid adsorbents are needed to remove iodine. For all future operations where iodine is present, a silver zeolite adsorber is to be used.

  10. Radioactive iodine treatment of a functional thyroid carcinoma producing hyperthyroidism in a dog

    Energy Technology Data Exchange (ETDEWEB)

    Peterson, M.E.; Kintzer, P.P.; Hurley, J.R.; Becker, D.V.

    1989-01-01

    Radioactive iodine (/sup 131/I) was used in the treatment of a 12-year-old female dog with hyperthyroidism resulting from a large, unresectable (and metastatic) thyroid carcinoma associated with signs of severe inspiratory stridor and dyspnea. Hyperthyroidism was diagnosed on the basis of clinical signs (polyuria, polydipsia, polyphagia, weight loss, nervousness) and high basal serum thyroxine (T4) concentrations, as well as thyroid radioiodine kinetic studies that showed a high radioiodine uptake into the thyroid (% thyroid uptake) and markedly increased serum concentrations of protein-bound iodine-131 (PB/sup 131/I) after /sup 131/I tracer injection. Thyroid imaging revealed diffuse radionuclide accumulation by the tumor, which involved both thyroid lobes. The dog was treated with three large doses of radioiodine (/sup 131/I), ranging from 60 to 75 mCi, given at intervals of 5 to 7 months. The dog became euthyroid, and the size of the tumor decreased by approximately 25% after each /sup 131/I treatment, improving the severe inspiratory stridor and dyspnea, but both the hyperthyroid state and breathing difficulty recurred within a few months of each treatment. The dog was euthanatized 5 months after the last treatment because of progressive tracheal compression and pulmonary metastasis.

  11. Radioactive iodine treatment of a functional thyroid carcinoma producing hyperthyroidism in a dog

    International Nuclear Information System (INIS)

    Peterson, M.E.; Kintzer, P.P.; Hurley, J.R.; Becker, D.V.

    1989-01-01

    Radioactive iodine ( 131 I) was used in the treatment of a 12-year-old female dog with hyperthyroidism resulting from a large, unresectable (and metastatic) thyroid carcinoma associated with signs of severe inspiratory stridor and dyspnea. Hyperthyroidism was diagnosed on the basis of clinical signs (polyuria, polydipsia, polyphagia, weight loss, nervousness) and high basal serum thyroxine (T4) concentrations, as well as thyroid radioiodine kinetic studies that showed a high radioiodine uptake into the thyroid (% thyroid uptake) and markedly increased serum concentrations of protein-bound iodine-131 (PB 131 I) after 131 I tracer injection. Thyroid imaging revealed diffuse radionuclide accumulation by the tumor, which involved both thyroid lobes. The dog was treated with three large doses of radioiodine ( 131 I), ranging from 60 to 75 mCi, given at intervals of 5 to 7 months. The dog became euthyroid, and the size of the tumor decreased by approximately 25% after each 131 I treatment, improving the severe inspiratory stridor and dyspnea, but both the hyperthyroid state and breathing difficulty recurred within a few months of each treatment. The dog was euthanatized 5 months after the last treatment because of progressive tracheal compression and pulmonary metastasis

  12. Lacrimal system pathology in patients with malignant thyroid tumors after radioactive iodine therapy, and its correction methods

    Directory of Open Access Journals (Sweden)

    Natalya Yu. Beldovskaya

    2017-12-01

    Full Text Available Introduction. Radioactive iodine therapy after thyroidectomy is the standard of differentiated thyroid cancer treatment in the modern world. Main dose-dependent side effects described in the literature include: sialadenitis, xerostomia, taste and/or odor loss, swelling of surrounding tissues. Ophthalmic complications are rarely reported. Aim. To assess the lacrimal system condition in patients after radioactive iodine therapy for thyroid cancer. Material and methods. The study included 17 patients (34 eyes. There were female patients aged 19 to 43 years (mean age was 31 years who underwent a course of radioactive iodine therapy for thyroid cancer. All of them complained of periodic or constant tearing in the period from 2 months to 1 year after therapy course. In four patients, there was a permanent or periodic mucopurulent discharge when pressing on the lacrimal sac area. All patients underwent a standard ophthalmological examination, including visual acuity testing, anterior segment biomicroscopy, ophthalmoscopy, and tear production tests. Dye disappearance test, Jones I and II tests, lacrimal pathways irrigation, and, if necessary, cone-ray computer tomography with preliminary lacrimal pathways contrasting were performed to evaluate the tear outflow abnormalities. Results. Tear production disorders were detected in 20 eyes (58.8% (among them, moderate dry eye syndrome was diagnosed in 3 cases; tear outflow pathology was revealed in 14 eyes (41.2% (namely naso-lacrimal duct obstruction and stenosis, and chronic purulent dacryocystitis. For patients with tear production pathology artificial tears were prescribed, and endoscopic endonasal dacryocystorhinostomy was performed in cases of tear outflow disturbances. Conclusion. The use of radioactive iodine in doses exceeding 80 mCi leads to the development of lacrimal system pathology: dry eye syndrome of various severity, and tear outflow disorders. Lacrimal system pathology significantly worsens

  13. The assessment of adverse events of radioactive iodine therapy in patients with Graves disease

    International Nuclear Information System (INIS)

    Nechaeva, Olga; Dreval, Alexander; Chikh, Irina

    2005-01-01

    Full text: Aim: The aim of the study is to assess the adverse events of RAI in patients with Graves disease. Study design: have analyzed the data of 42 patients (33 women, 9 men, median age 46,6 years) with Graves disease without thyroid ophthalmopathy, who were treated with RAI to control thyrotoxicosis. Radioiodine dose was determent individually and was taken into consideration of goiter volume and turnover of 13 21I. Patients received one dose of 131 I - median 10,2 (from 2,0 to 34,1 m #N-tilde# i). We asked the patients to fill questionnaire of sings and symptoms about their complaints after treatment. Results: The most frequent adverse events after radioiodine treatment were: fallout hair - in 31%, headache - in 28,5%, muscle pain - in 24,0%, edema of upper and lower eyelids - in 20,0%, pain in joints - in 19,0%, pain in thyroid gland - in 14,0%. Other adverse events were determent rarer: pain in eyeballs - 12,0%, sensation of the pressure in eyeballs - in 12,0%, tension in the field of thyroid gland - in 9,5%, muscle compactions - in 9,5%, diplopia - in 7,1%, deterioration of concomitant chronic diseases - in 7,1%, pain in hypochondrium- in 7,1%, heartburn - in 7,1%, weakness in legs- in 4,8%, dryness skin cover -in 2,4%, sleeplessness - in 2,4%. All adverse events were not serious, were nor demand of administration of special treatment and ended in 5 days after using of radioactive iodine. Conclusion: Radioactive iodine treatment does not entail of significant deterioration of condition of the patients. (author)

  14. Can povidone-iodine solution be used safely in a spinal surgery?

    Science.gov (United States)

    Chang, Fang-Yeng; Chang, Ming-Chau; Wang, Shih-Tien; Yu, Wing-Kwang; Liu, Chien-Lin; Chen, Tain-Hsiung

    2006-06-01

    Intra-operative incidental contamination of surgical wounds is not rare. Povidone-iodine solution can be used to disinfect surgical wounds. Although povidone-iodine is a good broad-spectrum disinfecting agent, it has occasionally been reported to have a negative effect on wound healing and bone union. Therefore, its safety in a spinal surgery is unclear. A prospective, single-blinded, randomized study was accordingly conducted to evaluate the safety of povidone-iodine solution in spinal surgeries. Ascertained herein was the effect of wound irrigation with diluted povidone-iodine solution on wound healing, infection rate, fusion status and clinical outcome of spinal surgeries. From January 2002 to August 2003, 244 consecutive cases undergoing primary instrumented lumbosacral posterolateral fusion due to degenerative spinal disorder with segmental instability had been collected and randomly divided into two groups: the study group (120 cases, 212 fusion levels) and the control group (124 cases, 223 fusion levels). Excluded were those patients with a prior spinal surgery, spinal trauma, malignant tumor, infectious spondylitis, rheumatoid arthritis, ankylosing spondylitis, metabolic bone disease, skeletal immaturity or with an immunosuppressive treatment. In the former group, wounds were irrigated with 0.35% povidone-iodine solution followed by normal saline solution just before the bone-grafting and instrumentation procedure. However, only with normal saline solution in the latter. All the operations were done by the same surgeon with a standard technique. All the patients were treated in the same postoperative fashion as well. Later on, wound healing, infection rate, spinal bone fusion and clinical outcome were evaluated in both groups. A significant improvement of back and leg pain scores, modified Japanese Orthopedic Association function scores (JOA) and ambulatory capacity have been observed in both groups. One hundred and seven patients in the study group and one

  15. Marking with radioactive iodine of a plasma substitute and preliminary essays of his kinetic behaviour in rats

    International Nuclear Information System (INIS)

    Cova, Wilma Guimaraes

    1973-01-01

    A blood plasma substitute (Haem accel - PGO), which has as a base a degraded and polymerized gelatin, was labelled with radioactive iodine (I-131) and preliminary essays of its kinetic behavior was done. We have used the labelling method of McFarlaner. The results obtained - radiochemical yield and purity - were favorable. The kinetic behaviour the residual radioactivity studied by measuring the residual radioactivity of the body and excreta in groups of male Wistar rats for a maximum period of 150 hours. These results have shown and excellent correlation for a two components exponential function's adjustment, suggesting therefore a bi compartmental mathematical model. (author)

  16. Detriments of radioactive Iodine 131 in managing thyroid carcinoma - a retrospective study with review of the current scenario

    International Nuclear Information System (INIS)

    Mohan, Shaweta; Agnihotri, Gaurav

    2016-01-01

    Radioactive iodine (RAI) ablation following thyroidectomy is recommended for most patients diagnosed with papillary and follicular thyroid carcinoma. We performed a literature search on MEDLlNE and EMBASE, using keywords, such as, differentiated thyroid carcinoma, radioiodine therapy, "1"3"1I complications, adverse effects and side effects, and chose the most relevant studies till date to prepare this work on the side effects of RAIT (Radioactive Iodine Therapy) for thyroid cancer. We contacted authors of published studies where appropriate for further information. Also, the percentage incidence of the hazards was determined for North Indian population accessing data from Govt. Medical Colleges of Punjab, Haryana, and Postgraduate Institute of Medical Education and Research, Chandigarh. The most prominent side effect came out to be xerostomia with an incidence of 47%, followed by local neck pain and swelling (39%). The incidence of gastritis was also common (34%). Radioactive iodine therapy complications have been divided into early and late effects. Early complications include gastrointestinal symptoms, radiation thyroiditis, sialadenitis/xerostomia, bone marrow suppression, gonadal damage, dry eye, and nasolacrimal duct obstruction. Late complications include secondary cancers, pulmonary fibrosis, permanent bone marrow suppression, and genetic effects. As "1"3"1I is an efficacious form of treatment that can significantly decrease the rate of mortality, recurrence and metastasis, and as the side effects are often minor and well-tolerated, radio iodine therapy remains the principal mode of treatment for patients. (author)

  17. First-Line Use of Vemurafenib to Enable Thyroidectomy and Radioactive Iodine Ablation for BRAF-Positive Metastatic Papillary Thyroid Carcinoma

    Directory of Open Access Journals (Sweden)

    Bao D. Dao MD

    2015-09-01

    Full Text Available Background. Patients with metastatic or radioactive iodine refractory papillary thyroid carcinoma (PTC have poor prognosis due to ineffective therapy for this condition beyond surgery and radioactive iodine (RAI or 131I. BRAF mutation occurs in more than 44% of PCT. Tyrosine kinase inhibitors, the most commonly used agents for these patients, have weak BRAF inhibition activity. BRAF inhibitors have demonstrated promising efficacy in relapsed metastatic PCT after standard treatment, though they are not currently approved for this indication. Case Presentation. We present the case of a 48-year-old Hispanic male who initially presented with columnar-cell variant subtype of PTC and positive BRAFV600E mutation. The patient had widespread bulky metastases to lungs, chest wall, brain, and bone. Discussion. Initial use of vemurafenib demonstrated a 42% cytoreduction of targeted pulmonary metastases and facilitated thyroidectomy and RAI treatment. The patient achieved a durable response over 21 months in the setting of widely metastatic disease. Conclusion. Vemurafenib may be effectively used for cytoreduction in patients with bulky metastatic PTC to bridge them to thyroidectomy and RAI treatment.

  18. Thyroid gland protection against radioactive iodine. Fetus and preschool children are more sensitive; Bescherming van de schildklier tegen radioactief jodium. Foetus en kleuter zijn gevoeliger

    Energy Technology Data Exchange (ETDEWEB)

    Noteboom, J.L. [Integraal Kankercentrum, Rotterdam (Netherlands)

    1995-09-01

    The intake of iodine tablets can prevent the irradiation and accumulation of iodine in the thyroid of humans. The summary of the author`s thesis `Protection of the thyroid against radioactive iodine during fetal life and infancy. An experimental approach in chimpanzees` is presented in an edited form. The research was carried out on pregnant and very young chimpanzees. Based on the experimental results recommendations are made for radiation protection for pre-school children and pregnant women. 3 figs., 1 refs.

  19. Dose {sup 131}I radioactivity interfere with thyroglobulin measurement in patients undergoing radioactive iodine therapy with recombinant human TSH?

    Energy Technology Data Exchange (ETDEWEB)

    Park, So Hyun; Bang, Ji In; Lee, Ho Young; Kim, Sang Eun [Dept. of Nuclear Medicine, Seoul National University College of Medicine, Seoul (Korea, Republic of)

    2015-06-15

    Recombinant human thyroid-stimulating hormone (rhTSH) is widely used in radioactive iodine therapy (RIT) to avoid side effects caused by hypothyroidism during the therapy. Owing to RIT with rhTSH, serum thyroglobulin (Tg) is measured with high 131I concentrations. It is of concern that the relatively high energy of 131I could interfere with Tg measurement using the immunoradiometric assay (IRMA). We investigated the effect of 131I administration on Tg measurement with IRMA after RIT. A total of 67 patients with thyroid cancer were analysed retrospectively. All patients had undergone rhTSH stimulation for RIT. The patients’ sera were sampled 2 days after 131I administration and divided into two portions: for Tg measurements on days 2 and 32 after 131I administration. The count per minute (CPM) of whole serum (200 μl) was also measured at each time point. Student’s paired t-test and Pearson’s correlation analyses were performed for statistical analysis. Serum Tg levels were significantly concordant between days 2 and 32, irrespective of the serum CPM. Subgroup analysis was performed by classification based on the 131I dose. No difference was noted between the results of the two groups. IRMA using 125I did not show interference from 131I in the serum of patients stimulated by rhTSH.

  20. Effect of radioactive iodine therapy on lacrimal gland functions in patients with hyperthyroidism.

    Science.gov (United States)

    Aydogan, Fusun; Ayhan Tuzcu, Esra; Aydogan, Akin; Akkucuk, Seckin; Coskun, Mesut; Ustun, Ihsan; Gökçe, Cumali

    2014-04-01

    Radioactive iodine (RAI) therapy is preferred in the treatment of hyperthyroidism because of its effectiveness, noninvasiveness, and low costs. I has been detected in extrathyroidal tissues, such as in gastric mucosa, salivary glands, and lacrimal glands. To the best of our knowledge, there is no publication concerning the effects of RAI therapy for hyperthyroidism on tear production. In the present study, we evaluated whether or not the lacrimal glands are affected after RAI therapy when compared with pretreatment period. The Schirmer and tear break-up time (TBUT) tests were used to assess 32 eyes of 16 patients with conditions that were diagnosed as hyperthyroidism before and at 3 and 6 months after RAI treatment. In addition, pretreatment values of patients were compared with that of controls. It was evaluated whether or not a correlation exists between the results and the dose or iodine uptake values. There was no significant difference between pretreatment values of Schirmer and TBUT tests obtained in the patient group and those of the control group (P > 0.05). In the patient group, there was a significant difference between the posttreatment and pretreatment values (P < 0.05). There was a positive correlation between uptake values obtained at 24 hours and the values obtained by TBUT and Schirmer tests on both eyes at 3 and 6 months. At 6 months, the uptake value at 24 hours was 28.83 ± 60 for both eyes in patients with TBUT test values less than 10, whereas it was 39.25 ± 7.88 for the right eye and 39.00 ± 6.85 for the left eyes in patients with TBUT test values greater than 10. The difference was statistically significant (P < 0.05). In our study, we concluded that the decrease in mucin and aqueous production occurs due to affected lacrimal glands by RAI therapy; however, this effect is not dose dependent.

  1. Behavior of radioactive products in the containment. Behavior of iodine in accidental situation

    International Nuclear Information System (INIS)

    Lucas, M.; Fermandjian, J.

    1984-12-01

    The aim of studies on iodine is to demonstrate that in the case of failure in the containment occuring after more than one day, the total quantity of iodine released would be lower or equal to 1% of the inventory of the core at the moment of the begining of the accident. The first part describes the behavior of iodine in the containment of a PWR, in the case of an important accident. The second part deals with a synthesis of the knowledge about iodine. The third part presents the inventory of the main problems not resolved concerning the chemistry of iodine and the radiolysis of iodine. Finally, the program of studies on iodine is briefly presented; its aim is to develop the knowledge about iodine in accidental situations [fr

  2. Radioactive iodine therapy for patients with Graves' disease aged 18 or younger

    International Nuclear Information System (INIS)

    Ogawa, Takahiro; Goshi, Kazuto; Tajiri, Junichi

    2008-01-01

    There have been few reports concerning radioactive iodine therapy (RI therapy) for Graves' disease in children, even in the United States of America (USA), and there have been no reports of such treatment in Japan. We evaluated the short-term results of RI therapy for Graves' disease aged 18 or younger. A total of 36 patients (10 male and 26 female) with Graves' disease, aged 18 and younger (range, 13 to 18 years; mean age, 15.8±1.5 years), received RI therapy on an outpatient basis at our clinic between July 1999 and July 2005. The mean interval from initiation of an antithyroid drug (ATD) to RI therapy was 25.3±21.5 months (range, 1 to 78 months). Twenty patients received therapy once, 14 twice, and 2 three times. The mean initial dose of radioactive iodine was 7.8±2.9 mCi (range, 3.6 to 13.0 mCi) and the mean total dose was 12.3±7.7 mCi (range, 3.6 to 29.8 mCi). The mean estimated weight of the thyroid gland was 42.6±23.4 g (range, 15.5 to 99.4 g) before RI therapy and 7.1±3.0 g (range, 2.0 to 13.6 g) after RI therapy. The mean follow-up period after RI therapy was 41.1±18.0 months (range, 6 to 71 months). Currently, 15 patients (42%) have hypothyroidism, 8 (22%) have subclinical hypothyroidism, 5 (14%) have euthyroidism, and 8 (22%) have subclinical hyperthyroidism. Patients taking thyroid hormone were considered hypothyroid. Patients with subclinical hypothyroidism are currently being monitored without treatment. No patients with subclinical hyperthyroidism are taking an ATD or KI (potassium iodide). A total of 36 patients with Graves' disease, aged 18 and younger, received RI therapy, and the short-term outcome in these patients were favorable. However, prolonged follow-up observation is required to confirm long-term safety. (author)

  3. OPTIMIZING LENVATINIB THERAPY IN PATIENTS WITH METASTATIC RADIOACTIVE IODINE-RESISTANT DIFFERENTIATED THYROID CANCERS.

    Science.gov (United States)

    Jasim, Sina; Iniguez-Ariza, Nicole M; Hilger, Crystal R; Chintakuntlawar, Ashish V; Ryder, Mabel M; Morris, John C; Bible, Keith C

    2017-10-01

    Lenvatinib is approved for use in advanced radioactive iodine-resistant differentiated thyroid cancers (RAIR-DTCs). Its efficacy is indisputable, but toxicities are great, creating daunting challenges for patients and providers. Few data regarding early adverse events and impact on quality of life (QOL) exist; we sought to clarify these issues by analyzing our initial postapproval lenvatinib experience. Standardized patient education was implemented, providing detailed instructions and expert provider contacts to facilitate timely reporting of toxicities and guide responsive actions. Early adverse events, QOL outcomes, and response data from 25 consecutively treated DTC patients (02/2015 and 05/2016) were retrospectively analyzed. The median age was 55 years (range 27-81); 52% were female. Fourteen (56%) were on antihypertensive medication(s) at baseline. Most patients (21/25, 84%) developed adverse events during the first month of therapy. Hypertension arose in 16/25 (64%), requiring antihypertensive dose adjustment/addition in 6 (24%)/12 (48%) patients, respectively, during the first month of therapy. Dose reduction was required in 11 (44%) due to multiple adverse events; the median time to first dose reduction was 33 days (range 11-84); 8 (32%) required multiple dose reductions. Therapy interruption >3 weeks occurred in 4 (16%). The median change in patient-reported fatigue score was +2 (worsening, range -2 to +10, P<.007; 0-10 scales), but the median QOL change was 0 (range +4 to -9, P = .57). The mean duration of lenvatinib therapy was 6.5 months (range 1-12); median overall and progression-free survival have not yet been reached. Lenvatinib was discontinued in 7 (28%) patients; among 20 patients with available RECIST (Response Evaluation Criteria In Solid Tumors) measurements, 10 (50%) achieved partial response. Lenvatinib has promising efficacy in RAIR-DTC, but toxicities require frequent early interventions. QOL can be maintained on lenvatinib therapy. DTC

  4. Prospective study in the management of high-dose radioactive iodine therapy induced gastritis

    International Nuclear Information System (INIS)

    Carbonell, C.; Ogbac, R.V.

    2007-01-01

    Full text: Gastritis is simply defined as inflammation of the gastric mucosa. In post-RAI patients, this is one of the most common complications that are encountered. Some patients may even require repetitive administration of high doses of radioactive iodine (I-131). Small doses of radiation (up to 1500 R) cause reversible mucosal damage, whereas higher radiation doses cause irreversible damage with atrophy and ischemic-related ulceration. Reversible changes consist of degenerative changes in epithelial cells and nonspecific chronic inflammatory infiltrate in the lamina propria. Higher amounts of radiation cause permanent mucosal damage, with atrophy of fundic glands, mucosal erosions, and capillary hemorrhage. Associated submucosal endarteritis results in mucosal ischemia and secondary ulcer development. Recurrent gastritis, if left untreated, may be a predisposing factor for gastric malignancy. Methods:A total of thirty post-RAI subjects were evaluated for signs and symptoms of gastritis and were divided into 3 groups which were given drugs for gastritis (H2-receptor antagonist, proton pump inhibitor, and sucralfate). Survey forms were distributed to evaluate the presence of nausea, vomiting, epigastric pain (graded according to severity of pain), and gastrointestinal bleeding. Results were tallied accordingly. Results and Discussion: In a total of 3 subjects who were given sucralfate, all of them did not experience any nausea and vomiting. One subject experienced mild epigastric discomfort and another subject was able to experience a non-specific symptom of abdominal bloatedness. (Note: Subjects are still for completion) In theory, radiation irritates the mucosa causing inflammation and mucosal damage which is further irritated by gastric acid secretion. The administration of H2-receptor blockers and proton pump inhibitors only inhibit gastric acid secretion while existing inflammation of mucosa due to high doses of radiation is left untreated. However

  5. A case of propylthiouracil-induced antineutrophilic cytoplasmic antibody-positive vasculitis successfully treated with radioactive iodine

    Directory of Open Access Journals (Sweden)

    C. Bes

    2013-07-01

    Full Text Available Antineutrophilic cytoplasmic antibody (ANCA associated vasculitis is one of the rare complications of propylthiouracil treatment. Having a variable clinical spectrum, it may be presented with both skin limited vasculitis and life-threatening systemic vasculitis. In this study, we present a case that developed ANCA-positive vasculitis with skin and kidney involvement (hematuria and proteinuria six months after propylthiouracil treatment was initiated for toxic nodular goiter. Proteinuria recovered dramatically subsequent to radioactive iodine treatment following ceasing the drug.

  6. Gaseous release of radioactive iodine from decaying plants. I. Release following foliar and root uptake

    International Nuclear Information System (INIS)

    Saas, Arsene; Grauby, Andre

    1975-12-01

    Iodine uptake by plants is a significant link in the contamination of the food chain. Long half-live iodine was studied considering foliar and root uptake, loss by rain scavenging, residue decay or outgassing in order to assess two aspects of the problem: the importance of outgassing and the effect of the route of transfer on iodine losses. It appeared that iodine release was a function of the vegetal type, there were differences according to the pattern of absorption (via leaf or root) and the processes of iodine release were usually related to biochemical mechanisms [fr

  7. Silver oxide nanocrystals anchored on titanate nanotubes and nanofibers: promising candidates for entrapment of radioactive iodine anions.

    Science.gov (United States)

    Yang, Dongjiang; Liu, Hongwei; Liu, Long; Sarina, Sarina; Zheng, Zhanfeng; Zhu, Huaiyong

    2013-11-21

    Iodine radioisotopes are released into the environment by the nuclear industry and medical research institutions using radioactive materials. The (129)I(-) anion is one of the more mobile radioactive species due to a long half-life, and it is a great challenge to design long-term management solutions for such radioactive waste. In this study, a new adsorbent structure with the potential to efficiently remove radioactive iodine anions (I(-)) from water is devised: silver oxide (Ag2O) nanocrystals firmly anchored on the surface of titanate nanotubes and nanofibers via coherent interfaces between Ag2O and titanate phases. I(-) anions in fluids can easily access the Ag2O nanocrystals and be efficiently trapped by forming AgI precipitate that firmly attaches to the adsorbent. Due to their one-dimensional morphology, the new adsorbents can be readily dispersed in liquids and easily separated after purification; and the adsorption beds loaded with the adsorbents can permit high flux. This significantly enhances the adsorption efficiency and reduces the separation costs. The proposed structure reveals a new direction in developing efficient adsorbents for the removal of radioactive anions from wastewater.

  8. Therapeutic applications of radioactive 131iodine: Procedures and incidents with capsules

    International Nuclear Information System (INIS)

    Al Aamri, Marwa; Ravichandran, Ramamoorthy; Binukumar, John Pichy; Al Balushi, Naima

    2016-01-01

    Treatments for thyrotoxicosis and carcinoma thyroid are carried out by oral administration of radioactive iodine ( 131 I) in the form of liquid or capsules. The liquid form of 131 I has higher risk factors such as vapourization, spillage and need for management of higher activity wastes. Use of 131 I in capsule form simplify procedures of handling compared to liquid form of 131 I. The guidelines of safe handling and quality assurance aspects for therapeutic use 131 I are well outlined by International Atomic Energy Agency (IAEA) reports. A few unusual incidents with I-131 capsules encountered in the past need to be highlighted from health physics point of view. In Royal Hospital, Oman, I-131 is imported in capsules, and the total activity handled/year steadily increased over 10 years. Discrete activities range from 185 MBq (5 mCi) up to 7.4 GBq (200 mCi). In four incidents deviations in standard operational procedures were recorded. Nature of incidents is described as follows: (1) After assay of activity, the capsule was directly put in the lead container with missing of inner cap. (2) Patient poured water in the Perspex tube, when the capsule was handed over to her, making an emergency situation. (3) In 3 high activity capsules (2 nos 2.96 GBq, 1 no. 4.26 GBq), observed sticky behavior in capsule holder on the 2 nd day post receipt, which were in order on the 1 st day. (4) A capsule could not be swallowed by a patient, which was taken back from the mouth. Monitoring of patient later did not show residual ingested activity. The report documents some of the unusual incidents for information to other centers engaged in such radioactive administrations

  9. Chalcogen-based aerogels as a multifunctional platform for remediation of radioactive iodine

    International Nuclear Information System (INIS)

    Riley, Brian J.; Chun, Jaehun; Ryan, Joseph V.; Matyas, Josef; Li, Xiaohong S.; Matson, Dean W.; Sundaram, S.K.; Strachan, Denis M.; Vienna, John D.

    2011-01-01

    Aerogels employing chalcogen-based (i.e., S, Se, and/or Te) structural units and interlinking metals are termed chalcogels and have many emerging applications. Here, chalcogels are discussed in the context of nuclear fuel reprocessing and radioactive waste remediation. Motivated by previous work on removal of heavy metals in aqueous solution, we explored the application of germanium sulfide chalcogels as a sorbent for gas-phase I2 based on Pearson's Hard/Soft Acid-Base (HSAB) principle. This work was driven by a significant need for high-efficiency sorbents for I-129, a long-lived isotope evolved during irradiated UO2 nuclear fuel reprocessing. These chalcogel compositions are shown to possess an affinity for iodine gas, I2(g), at various concentrations in air and the affinity is attributed to a strong chemical attraction between the chalcogen and I2(g), according to the HSAB principle. The high sorption efficiency is facilitated by the high porosity as well as the exceptionally large surface area of the chalcogels.

  10. The Treatment of Differentiated Thyroid Cancer in Children: Emphasis on Surgical Approach and Radioactive Iodine Therapy

    Science.gov (United States)

    Mazzaferri, Ernest L.; Verburg, Frederik A.; Reiners, Christoph; Luster, Markus; Breuer, Christopher K.; Dinauer, Catherine A.; Udelsman, Robert

    2011-01-01

    Pediatric thyroid cancer is a rare disease with an excellent prognosis. Compared with adults, epithelial-derived differentiated thyroid cancer (DTC), which includes papillary and follicular thyroid cancer, presents at more advanced stages in children and is associated with higher rates of recurrence. Because of its uncommon occurrence, randomized trials have not been applied to test best-care options in children. Even in adults that have a 10-fold or higher incidence of thyroid cancer than children, few prospective trials have been executed to compare treatment approaches. We recognize that treatment recommendations have changed over the past few decades and will continue to do so. Respecting the aggressiveness of pediatric thyroid cancer, high recurrence rates, and the problems associated with decades of long-term follow-up, a premium should be placed on treatments that minimize risk of recurrence and the adverse effects of treatments and facilitate follow-up. We recommend that total thyroidectomy and central compartment lymph node dissection is the surgical procedure of choice for children with DTC if it can be performed by a high-volume thyroid surgeon. We recommend radioactive iodine therapy for remnant ablation or residual disease for most children with DTC. We recommend long-term follow-up because disease can recur decades after initial diagnosis and therapy. Considering the complexity of DTC management and the potential complications associated with therapy, it is essential that pediatric DTC be managed by physicians with expertise in this area. PMID:21880704

  11. The acute myxedema after hyperthyroidism treated by radioactive iodine and its sequelae

    Directory of Open Access Journals (Sweden)

    Ivković Staša

    2013-01-01

    Full Text Available This is a case report of a female patient who developed, after radioactive iodine therapy for Grave's hyperthyroidism, a severe clinically manifested hypothyroidism, which was accompanied by predominantly sensory neuropathy of dominant axonal type. Besides symptoms and neurophysiological signs of polyneuropathy, the patient, in spite of seemingly adequate levothyroxine monotherapy for hypothyroidism during the last 2 years, still manifested persistent hypothyroid symptoms by CNS, higher serum concentrations of total and LDL cholesterol and clinical signs of the increased peripheral vascular resistance. Non-physiological serum FT3 and FT4 ratio was maintained, together with serum TSH and FT4 concentrations, which suggested lower sensitivity of thyroid-hypophyseal negative feedback. The introduced combined LT4/LT3 substitution therapy resulted in quick subsidence of CNS-related hypothyroid symptoms, significant reduction of serum concentrations of total and LDL cholesterol, FT3/FT4 ratio normalization, at least in the first hours of drug administration, and disappearance of clinical signs of the increased peripheral vascular resistance. The extent of polyneuropathic difficulties was reduced to the level of not disturbing the sleep. Time and control ENG will show the final effects of combined T4/FT3 therapy on the peripheral nerve injuries. In the first 6 months, no adverse effects of this therapy were recorded.

  12. Effect of radioactive iodine therapy on carotid intima media thickness in patients with hyperthyroidism.

    Science.gov (United States)

    Şanal, Bekir; Işık, İlknur; Korkmaz, Mehmet; Kucur, Cüneyt; Can, Fatma; Kilit, Türkan Paşalı; Kahraman, Cüneyt; Kaçar, Emre; Koçak, Ahmet

    2016-01-01

    The aim of this study was to evaluate the carotid intima media thickness (IMT) in patients with thyrotoxicosis who received radioactive iodine (RAI) treatment. This study was planned to be conducted with two different groups of people. There were 87 patients in the patient group and 98 controls. Participants were evaluated for atherosclerosis risk factors. Mean carotid IMT was measured from three consecutive traces at the common carotid artery bifurcation. The mean carotid IMT was 0.81 ± 0.20 in patient group and this was higher than the controls (0.68 ± 0.19) (p treatment group (p = 0.029). In patients with only HT, the data of the two groups showed a significant difference, with the average IMT being higher in the patient group than that of the control group (p: 0.011). RAI used in the treatment of thyrotoxicosis increases the IMT of carotid artery independent of age and sex. This treatment yields better results with higher doses, and this effect is more marked in patients with HT. Hence, we believe that it is necessary to calculate the dose properly for hyperthyroid cases in which treatment with RAI is planned. In particular, the patients with HT need to be treated with the minimum possible dose. Further, carotid arteries should be evaluated with US following RAI treatment.

  13. Serum thyroxine concentrations after radioactive iodine therapy in cats with hyperthyroidism

    International Nuclear Information System (INIS)

    Meric, S.M.; Hawkins, E.C.; Washabau, R.J.; Turrel, J.M.; Feldman, E.C.

    1986-01-01

    Thirty-one cats with hyperthyroidism were given one dose of radioactive iodine (131I) IV. Serum thyroxine (T4) concentrations were measured before treatment in all cats, at 12-hour intervals after treatment in 10 cats, and at 48-hour intervals after treatment in 21 cats. Serum T4 concentrations also were measured one month after 131 I therapy in 29 cats. Activity of 131I administered was 1.5 to 6.13 mCi, resulting in a dose of 20,000 rads to the thyroid. Serum T4 concentrations before 131 I administration were 5.3 to 51.0 micrograms/dl, with a median T4 concentration of 11.0 micrograms/dl. Serum T4 decreased most rapidly during the first 3 to 6 days after treatment. Sixteen cats (55%) had normal serum thyroxine concentrations by day 4 after 131I administration, and 23 cats (74%) were euthyroxinemic by day 8 after treatment. One month after administration of 131I, the 29 cats evaluated were clinically improved, and 24 (83%) of the 29 cats evaluated had normal serum T4 concentrations, 3 cats (10%) remained hyperthyroxinemic, and 2 cats (7%) were hypothyroxinemic. Therefore, administration of 131I was a safe and effective method to quickly decrease serum T4 concentrations in hyperthyroid cats

  14. Spanish consensus for the management of patients with advanced radioactive iodine refractory differentiated thyroid cancer.

    Science.gov (United States)

    Riesco-Eizaguirre, Garcilaso; Galofré, Juan Carlos; Grande, Enrique; Zafón Llopis, Carles; Ramón y Cajal Asensio, Teresa; Navarro González, Elena; Jiménez-Fonseca, Paula; Santamaría Sandi, Javier; Gómez Sáez, José Manuel; Capdevila, Jaume

    2016-04-01

    Approximately one third of the patients with differentiated thyroid cancer (DTC) who develop structurally-evident metastatic disease are refractory to radioactive iodine (RAI). Most deaths from thyroid cancer occur in these patients. The main objective of this consensus is to address the most controversial aspects of management of these patients. On behalf of the Spanish Society of Endocrinology & Nutrition (SEEN) and the Spanish Group for Orphan and Infrequent Tumors (GETHI), the Spanish Task Force for Thyroid Cancer, consisting of endocrinologists and oncologists, reviewed the relevant literature and prepared a series of clinically relevant questions related to management of advanced RAI-refractory DTC. Ten clinically relevant questions were identified by the task force. In answering to these 10 questions, the task force included recommendations regarding the best definition of refractoriness; the best therapeutic options including watchful waiting, local therapies, and systemic therapy (e.g. kinase inhibitors), when sodium iodide symporter (NIS) restoration may be expected; and how recent advances in molecular biology have increased our understanding of the disease. In response to our appointment as a task force by the SEEN and GHETI, we developed a consensus to help in clinical management of patients with advanced RAI-refractory DTC. We think that this consensus will provide helpful and current recommendations that will help patients with this disorder to get optimal medical care. Copyright © 2015 SEEN. Published by Elsevier España, S.L.U. All rights reserved.

  15. Does thyroidectomy, radioactive iodine therapy, or antithyroid drug treatment alter reactivity of patients` T cells to epitopes of thyrotropin receptor in autoimmune thyroid diseases?

    Energy Technology Data Exchange (ETDEWEB)

    Soliman, M.; Kaplan, E.; Abdel-Latif, A. [Univ. of Chicago, IL (United States)] [and others

    1995-08-01

    The effect of treatment on thyroid antibody production and T cell reactivity to thyroid antigens was studied in 15 patients with Graves` disease (GD) before and after thyroidectomy, 19 patients with GD before and after radioactive iodine (RAI) therapy, and 9 patients maintained euthyroid on antithyroid drugs (ATD). In GD patients, the responses of peripheral blood mononuclear cells (PBMC) and TSH receptor (TSHR)-specific T cell lines to recombinant human TSHR extracellular domain, thyroglobulin, and TSHR peptides were examined on the day of surgery or RAI therapy (day 0) and also 6-8 weeks and 3-6 months thereafter. Reactivity to TSHR peptides before surgery was heterogeneous and spanned the entire extracellular domain. Six to 8 weeks after subtotal thyroidectomy, the number of patients` PBMC responding to any peptide and the average number of recognized peptides decreased. A further decrease in the T cell reactivity to TSHR peptides was observed 3-6 months after surgery. The responses of PBMC from Graves` patients before RAI therapy were less than those in the presurgical group. Six to 8 weeks after RAI therapy, the number of patients responding to any peptide and the average number of recognized peptides increased. Three to 6 months after RAI, T cell responses to TSHR peptides were less than those 6-8 weeks after RAI therapy, but still higher than the values on day 0. Responses of PBMC from patients with GD, maintained euthyroid on ATD, were lower than those before surgery or RAI therapy. The reactivity of T cell lines in different groups reflected a pattern similar to PBMC after treatment. TSHR antibody and microsomal antibody levels decreased after surgery, but increased after RAI therapy. The difference in the number of recognized peptides by patients` PBMC before RAI and surgery may reflect the effect of long term therapy with ATD in the patients before RAI vs. the shorter period in patients before surgery. 38 refs., 2 figs., 5 tabs.

  16. Radioactive iodine and environmental and sanitary effects - bibliographic study and quantification; Iodes radioactifs et impacts environnemental et sanitaire - etude bibliographique et quantification

    Energy Technology Data Exchange (ETDEWEB)

    Guetat, Ph.; Armand, P.; Monfort, M.; Fritsch, P. [CEA Bruyeres-le-Chatel, 91 (France); Flury Herard, A. [CEA, Dir. des Sciences du Vivant, 75 - Paris (France); Menetrier, F. [CEA Fontenay-aux-Roses, Dir. des Sciences du Vivant, 92 (France); Bion, L. [CEA Saclay, Dir. de l' Energie Nucleaire (DEN), 91 - Gif sur Yvette (France); Schoech, C.; Masset, S. [Societe EX-IN - Expertise et Ingenierie, 92 - Le Plessis-Robinson (France)

    2004-07-01

    This document is intended to a large public. It reviews the different parameters needed to evaluate the potential act o radioactive releases from the emission to public. Its objectives are to evaluate the importance of different exposure pathways and to assess efficiency of the possible interventions for large public. The main conclusions are summarised hereafter: The radioactive decay chains have to be taken into account to evaluate the iodine source term in the nuclear plants in the case of fission accidents. The physico-chemical forms of iodine are important in order to determine the released activity and deposited activity on the soil. The isotopes to be taken into account are mainly iodine 131 for radiological assessments and also iodine 133 for the nuclear reactor accidents, and the chain Tellurium-Iodine 132 when no particulate filtration exists. Iodine 129 in French reprocessing plant cannot lead to significant accidents. The dominant exposure pathways are related to the consumption of contaminated food products (vegetable, milk) for the inorganic iodine. The iodine transfer to goat and sheep milk is greater than the one to cow milk. The meat production of herbivores at field is the most sensitive. The interest to remove rapidly herbivore from pasture appears relatively clearly. The banning of consumption of local contaminated food products (vegetables and meats) may reduce by about a factor of thirteen the impact due to iodine 131. The youngest the population is, the greatest are the thyroid radiosensitivity and variability within the population. Oral administration of stable iodine limits transfers to maternal milk and foetal thyroid. Ingestion of stable iodine is complementary to consumption banning of local contaminated food products. The earliest the ingestion is, the greatest is the efficiency. 0,1 TBq of 131 iodine released at a low height involves only limited and local actions whereas the release of 10 TBq involves direct and immediate protection

  17. Radioactive implant induced x-ray emission technique for noninvasive determination of iodine content in thyroid: experimental study

    Energy Technology Data Exchange (ETDEWEB)

    Amano, R; Ando, A; Hiraki, T [Kanazawa Univ. (Japan). School of Allied Medical Professions; Tonami, N; Hisada, K [Kanazawa Univ. (Japan). School of Medicine

    1984-02-01

    A new technique, radioactive implant x-ray emission spectrometry to determine the in vivo iodine content of the human thyroid is proposed. The variations of counting rate and effective excitation efficiencies of I Ksub(..cap alpha..) (28.6 keV) with iodine content, thyroid volume and skin-thyroid distance were studied for the /sup 201/Tl source to examine the properties of excitation and photon attenuation. As a result, the gland depth and volume could be estimated from the peak ratios of 30.7 keV/167.6 keV and 28.6 keV/167.6 keV. Using a 1 MBq /sup 201/Tl implant source, the detectable minimum iodine concentration found was approximately 70 ..mu..g/g for 2000 s measuring time in the phantom experiment. The effectiveness of the RIXE technique is discussed. It was concluded that the /sup 201/Tl RIXE spectrometry might serve to determine the in vivo iodine content of the human thyroid.

  18. Radioactive implant induced x-ray emission technique for noninvasive determination of iodine content in thyroid: experimental study

    Energy Technology Data Exchange (ETDEWEB)

    Amano, R; Tonami, N; Ando, A; Hiraki, T; Hisada, K

    1984-02-01

    A new technique, radioactive implant x-ray emission spectrometry to determine the in vivo iodine content of the human thyroid is proposed. The variations of counting rate and effective excitation efficiencies of I K alpha (28.6 keV) with iodine content, thyroid volume and skin-thyroid distance were studied for the /sup 201/Tl source to examine the properties of excitation and photon attenuation. As a result, the gland depth and volume could be estimated from the peak ratios of 30.7 keV/167.6 keV and 28.6 keV/167.6 keV. Using a 1 MBq /sup 201/Tl implant source, the detectable minimum iodine concentration found was approximately 70 micrograms/g for 2000 s measuring time in the phantom experiment. The effectiveness of the RIXE technique is discussed. It was concluded that the /sup 201/Tl RIXE spectrometry might serve to determine the in vivo iodine content of the human thyroid.

  19. Extensive Evaluation of a Diffusion Denuder Technique for the Quantification of Atmospheric Stable and Radioactive Molecular Iodine

    DEFF Research Database (Denmark)

    Huang, Ru-Jin; Hou, Xiaolin; Hoffmann, Thorsten

    2010-01-01

    In this paper we present the evaluation and optimization of a new approach for the quantification of gaseous molecular iodine (I2) for laboratory- and field-based studies and its novel application for the measurement of radioactive molecular iodine. α-Cyclodextrin (α-CD) in combination with 129I......, and condition of release and derivatization of iodine, is extensively evaluated and optimized. The collection efficiency is larger than 98% and the limit of detection (LOD) obtained is 0.17 parts-per-trillion-by-volume (pptv) for a sampling duration of 30 min at 500 mL min−1. Furthermore, the potential use...... of this protocol for the determination of radioactive I2 at ultra trace level is also demonstrated when 129I− used in the coating is replaced by 127I− and a multiple denuder system is used. Using the present method we observed 25.7−108.6 pptv 127I2 at Mweenish Bay, Ireland and 108 molecule m−3 129I2 at Mainz...

  20. Effect of adjuvant lithium on thyroxine (T4) concentration after radioactive iodine therapy

    Energy Technology Data Exchange (ETDEWEB)

    Hammond, Emmanuel NiiBoye; Vangu, Mboyo-Di-Tamba Heben Willy [University of the Witwatersrand, Division of Nuclear Medicine and Molecular Imaging, Department of Radiation Sciences, Johannesburg (South Africa)

    2016-10-15

    To study the effect of adjuvant lithium on serum thyroxine (T4) concentrations in patients treated with radioactive iodine (RAI) therapy in our environment. This was a prospective simple randomized comparative, experimental cohort study of patients with hyperthyroidism referred for RAI ablation therapy in the two main academic hospitals in Johannesburg between February 2014 and September 2015. Amongst the 163 participants in the final analysis, 75 received RAI alone and 88 received RAI with lithium. The difference in mean T4 concentrations at 3 months between the RAI-only group (17.67 pmol/l) and the RAI with lithium group (11.55 pmol/l) was significant with a small effect size (U = 2328.5, Z = -2.700, p = 0.007, r = 0.01). Significant decreases in T4 concentrations were observed as early as 1 month after RAI (p = 0.0001) in the RAI with lithium group, but in the RAI-only group, significant decreases in T4 concentrations were observed only at 3 months after RAI therapy (p = 0.000). Women and patients with Graves' disease who received RAI with adjuvant lithium also showed significant decreases in T4 concentrations at 1 month (p = 0.002 and p = 0.003, respectively). Adjuvant lithium leads to an earlier and better response to RAI therapy with lower T4 concentrations that are achieved earlier. This earlier response and decrease in T4 concentrations were noted in patients with Graves' disease and nodular goitre, and in women with hyperthyroidism who received adjuvant lithium therapy. (orig.)

  1. Outcomes analysis of radioactive iodine and total thyroidectomy for pediatric Graves' disease.

    Science.gov (United States)

    Cohen, Reuven Zev; Felner, Eric I; Heiss, Kurt F; Wyly, J Bradley; Muir, Andrew B

    2016-03-01

    The majority of pediatric patients with Graves' disease will ultimately require definitive therapy in the form of radioactive iodine (RAI) ablation or thyroidectomy. There are few studies that directly compare the efficacy and complication rates between RAI and thyroidectomy. We compared the relapse rate as well as the acute and long-term complications of RAI and total thyroidectomy among children and adolescents with Graves' disease treated at our center. Medical records from 81 children and adolescents with a diagnosis of Graves' disease who received definitive therapy over a 12-year period were reviewed. Fifty one patients received RAI and 30 patients underwent thyroidectomy. The relapse rate was not significantly different between RAI and thyroidectomy (12.1% vs. 0.0%, p=0.28). There were no acute or long-term complications in the RAI group, but there were eight cases of hypoparathyroidism (two transient and six permanent) in the thyroidectomy group. None of the patients developed a recurrent laryngeal nerve injury. RAI is a safe and effective option for treatment of children and adolescents with Graves' disease. In light of the rate of permanent hypoparathyroidism seen at our center with thyroidectomy and previously published long-term safety of RAI, we recommend RAI as the first line treatment for children and adolescents with Graves' disease. For those centers performing thyroidectomies, we recommend that each center select 1-2 high-volume pediatric surgeons to perform all thyroid procedures, allowing individuals to increases case volume and potentially decrease long-term complications of thyroidectomy.

  2. Study and methodology development for quality control in the production process of iodine-125 radioactive sealed sources applied to brachytherapy

    International Nuclear Information System (INIS)

    Moura, Joao Augusto

    2009-01-01

    Today cancer is the second cause of death by disease in several countries, including Brazil. Excluding skin cancer, prostate cancer is the most incident in the population. Prostate tumor can be treated by several ways, including brachytherapy, which consists in introducing sealed radioactive sources (Iodine - 125 seeds) inside the tumor. The target region of treatment receives a high radiation dose, but healthy neighbor tissues receive a significantly reduced radiation dose. The seed is made of a welding sealed titanium capsule, 0.8 mm external diameter and 4.5 mm length, enclosing a 0.5 mm diameter silver wire with Iodine-125 adsorbed. After welded, the seeds have to be submitted to a leak test to prevent any radioactive material release. The aims of this work were: (a) the study of the different leakage test methods applied to radioactive seeds and recommended by the ISO 997820, (b) the choice of the appropriate method and (c) the flowchart determination of the process to be used during the seeds production. The essays exceeded the standards with the use of ultra-sound during immersion and the corresponding benefits to leakage detection. Best results were obtained with the immersion in distilled water at 20 degree C for 24 hours and distilled water at 70 degree C for 30 minutes. These methods will be used during seed production. The process flowchart has all the phases of the leakage tests according to the sequence determined in the experiments. (author)

  3. Study and development of methodology for radioactive iodine fixation in polymeric substrate for manufacturing sources used in brachytherapy

    International Nuclear Information System (INIS)

    Rodrigues, Bruna T.; Souza, Carla D.; Benega, Marcos A.G. and others

    2014-01-01

    According global estimates of Globocan 2012 project of the International Agency for Research of Cancer, of the World Health Organization, there were 14,1 million new cases of cancer and a total of 8,2 million deaths from cancer. Also show that in 2030, the overall load will be 21,4 million new cases and 13,2 million cancer deaths. One of the prostate cancer therapy is brachytherapy, used in early and middle stages of the disease. It is made with the introduction of seeds with radioactive material within the tumor or in nearby regions, affecting the minimum surrounding tissues. The aim of this work is the study and developing the deposition of radioactive iodine on the polymeric substrate method, and an analysis relating the efficiency of the method to implementation in the laboratory of brachytherapy from IPEN. Iodine-125 is adsorbed on an epoxy resin solution. The objective of this study is to offer a new proposal for seeds. The results will give the data for the radiation protection and the procedures for radioactive waste management

  4. Image findings of a false positive radioactive iodine-131 uptake mimicking metastasis in pulmonary aspergillosis identified on single photon emission computed tomography-computed tomography

    Directory of Open Access Journals (Sweden)

    Kamaleshwaran Koramadai Karuppusamy

    2015-01-01

    Full Text Available High doses of iodine-131 are commonly used in patients with differentiated thyroid cancer after total or subtotal thyroidectomy, in order to ablate the remaining cancer or normal thyroid tissue. Multiple different false-positive scans can occur in the absence of residual thyroid tissue or metastases. The authors present a case of abnormal uptake of radioactive iodine in the aspergilloma, potentially masquerading as pulmonary metastases.

  5. Immobilization and bonding scheme of radioactive iodine-129 in silver tellurite glass

    Science.gov (United States)

    Lee, Cheong Won; Pyo, Jae-Young; Park, Hwan-Seo; Yang, Jae Hwan; Heo, Jong

    2017-08-01

    Silver tellurite glasses with melting temperatures disposal site. Iodine waste loading in glasses was as high as 12.64 wt% of all metallic elements and 11.21 wt% including oxygen. Normalized elemental releases obtained from the product consistency test were well below US regulation of 2 g/m2. Iodines are surrounded by four Ag+ ions forming [Ag4I]3+ units that are further connected to tellurite network through bonds with non-bridging oxygens.

  6. Parathyroid changes after high dose radioactive iodine in patients with thyroid cancer

    International Nuclear Information System (INIS)

    Guven, A.; Salman, S.; Boztepe, H.; Yarman, S.; Tanakol, R.; Azizlerli, H.; Alagol, F.

    2009-01-01

    The study aimed to investigate the effect of high dose radioactive iodine (RAI) on parathyroid function in patients with differentiated thyroid cancer. Nineteen patients (8 men/11 women, age 46.5±13.2 years) undergoing RAI for thyroid remnant ablation were enrolled in the study. The biochemical parameters related to parathyroid function [serum calcium (Ca), phosphate (P), creatinine (Cr), alkaline phosphatase (ALP), intact parathyroid hormone (iPTH), urinary Ca, cAMP concentrations and the maximum tubular capacity for phosphate per unit volume of glomerular filtrate (TmP/GFR)] were evaluated at baseline and at the 1st, 3rd, 6th and 12th months of RAI administration. SPSS 15.0 was used for statistical analysis. For all patients, thyroid-stimulating hormone levels were >30 U/ml at baseline and <0.1 U/ml at the following visits. Serum iPTH levels were decreased significantly at the 6th month and reached basal levels at the 12th month (baseline vs. 6th p=0.027, 1st vs. 6th p=0.011, 3rd vs. 6th p=0.047, 3rd vs. 12th p=0.014, 6th vs. 12th p=0.001). At the 6th month, P and TmP/GFR levels were higher (p=0.036, 0.017, respectively), and urinary cAMP measurements were lower (p=0.020) compared to those of the 1st month. No difference was detected concerning the other parameters. Serum Ca levels decreased below 2.1 mmol/l in several patients (n=5 at 1st month, n=4 at 3rd month, n=8 at 6th month and n=3 at 12th month) without clinical symptoms. The study indicated a transient decline in PTH levels at the 6th month following RAI therapy. Although this decrease did not cause symptoms in any of the present cases, this pattern might be important especially in individuals with diminished parathyroid background. (author)

  7. Differentiated thyroid cancer lymph-node relapse. Role of adjuvant radioactive iodine therapy after lymphadenectomy

    Energy Technology Data Exchange (ETDEWEB)

    Piccardo, Arnoldo; Bottoni, Gianluca; Dib, Bassam; Altrinetti, Vania; Massollo, Michela; Bossert, Irene; Cabria, Manlio [E.O. Ospedali Galliera, Department of Nuclear Medicine, Genoa (Italy); Puntoni, Matteo [Galliera Hospital, Clinical Trial Unit, Office of the Scientific Director, Genoa (Italy); Treglia, Giorgio; Giovanella, Luca [Oncology Institute of Southern Switzerland, Department of Nuclear Medicine and PET/CT Centre, Bellinzona (Switzerland); Foppiani, Luca [Galliera Hospital, Internal Medicine, Genoa (Italy); Bertoli, Mattia; Bertagna, Francesco [University of Brescia and Spedali Civili di Brescia, Department of Nuclear Medicine, Brescia (Italy); Catrambone, Ugo; Arlandini, Anselmo [Galliera Hospital, Department of Surgery, Thyroid Centre, Genoa (Italy)

    2017-06-15

    Our purpose as to evaluate the impact of adjuvant radioactive iodine therapy (RAI) on prognosis, as assessed by progression-free survival (PFS) and overall survival (OS), in patients affected by differentiated thyroid carcinoma (DTC) lymph-node relapse and previously treated with lymphadenectomy. We retrospectively evaluated DTC patients treated with lymph-node dissection for disease relapse. All patients had previously undergone total thyroidectomy and radioiodine remnant ablation (RRA). We used clinical and histological data obtained during follow-up to assess response and outcome. By means of univariate and multivariate time-to-event analyses, we assessed the impact of RAI on outcome (PFS and OS) and the prognostic role of thyroglobulin (Tg) levels under suppression with levothyroxine (Tg-on) measured 1-3 months after lymphadenectomy and of other risk factors. We evaluated 113 patients (age at diagnosis: median 41 years, interquartile range: 31-59), 64 of whom were treated with RAI. Over a median follow-up time of 5.7 years, 27 patients showed disease progression and 13 died. Kaplan-Meier PFS and OS curves showed that age on diagnosis, tumor histology, tumor size, DTC aggressive variant, and Tg-on were associated with prognosis. Patients with Tg-on ≥1 ng/ml treated with RAI showed a better PFS (Log-rank pp 0.001) and OS (p = 0.005) than untreated patients, while no effect of RAI was observed in patients with Tg-on <1 ng/ml. Multivariate models showed that age, Tg-on (≥1 vs. < 1 ng/ml, HR: 18.2, 95% CI: 5.09-64.8, p = 0.001) and RAI (Yes vs. No, HR: 0.36,95%CI: 0.15-0. 9, p = 0.02) remained the only independent factors associated with PFS, but only age and Tg-on remained significantly associated with OS (HR: 8.31, 95%CI:1.56-44.3, p = 0.01). Nonetheless, patients treated with RAI showed a lower risk of mortality (HR: 0.34, 95%CI: 0.1-1.15 p = 0.08) than untreated patients. RAI after lymphadenectomy for DTC relapse is significantly associated with better PFS

  8. Observation of radioactive iodine ({sup 131}I, {sup 129}I) in cropland soil after the Fukushima nuclear accident

    Energy Technology Data Exchange (ETDEWEB)

    Fujiwara, Hideshi, E-mail: hfuji@affrc.go.jp

    2016-10-01

    During the early stages of the Fukushima nuclear accident, the temporal variations of {sup 131}I deposited on the ground and of {sup 131}I accumulated in cropland soil were monitored at a fixed location in Japan. Moreover, concentrations of long-lived radioactive iodine ({sup 129}I) in atmospheric deposits and soil were measured to examine the feasibility of retrospectively reconstructing {sup 131}I levels from the levels of accident-derived {sup 129}I. The exceptionally high levels of {sup 131}I in deposits and soil were attributed to rainfall-related deposition of radionuclides. In the crop field studied, the losses of deposited {sup 131}I and {sup 129}I due to volatilization were small. The atomic ratio {sup 129}I/{sup 131}I in the topsoil corresponded to the same ratio in deposits. The {sup 131}I concentrations measured in the topsoil were very consistent with the {sup 131}I concentrations reconstructed from the {sup 129}I concentrations in the soil. - Highlights: • A high level of {sup 131}I contamination occurs through rainfall-related deposition. • Only a small loss of deposited radioactive iodine occurs via volatilization. • The {sup 129}I/{sup 131}I ratio in soil corresponds to the ratio in atmospheric deposit. • The feasibility of retrospectively reconstructing {sup 131}I is confirmed.

  9. Salts of the iodine oxyacids in the impregnation of adsorbent charcoal for trapping radioactive methyliodide

    International Nuclear Information System (INIS)

    1980-01-01

    A method of removing methyliodide 131 gas from the effluent of a reactor, comprises passing the effluent gas through a charcoal sorbent formed by first contacting charcoal with a liquid containing a hypoiodite obtained when an aqueous mixture of a first component comprising a salt of an iodine oxyacid selected from periodate, iodate and hypoiodite and a second component selected from iodine and/or an iodide salt is adjusted to a pH of about 10 by the addition of an inorganic base, and then contacting the resulting impregnated charcoal with a tertiary amine. (author)

  10. Use of Iodine-131 to Tellurium-132 Ratios for Assessing the Relationships between Human Inhaled Radioactivity and Environmental Monitoring after the Accident in Fukushima

    Directory of Open Access Journals (Sweden)

    Koji Uchiyama

    2018-03-01

    Full Text Available Significant differences in findings were seen between the intake amounts of iodine-131 that were derived from direct measurements and the estimated intake from environmental monitoring data at the Fukushima accident. To clarify these discrepancies, we have investigated the iodine-131 and tellurium-132 body burdens of five human subjects, who after being exposed to a radioactive plume, underwent 21.5 h whole body counter measurements at Fukui Prefectural Hospital, so clear intake scenario and thyroid counter measurement data were available. To determine the iodine-131 and tellurium-132 body burdens, we introduced a new method of whole body counter calibration composed of a self-consistent approach with the time-dependent correction efficiency factors concept. The ratios of iodine-131 to tellurium-132, ranging from 0.96 ± 0.05 to 2.29 ± 0.38, were consistent with results of the environmental measurements. The 24 h iodine uptake values ranging from 12.1–16.0% were within euthyroid range in Japanese people. These results suggest, even if the relatively low thyroid iodine uptake in the Japanese population was taken into consideration, that there is no doubt about the consistency between direct measurements and environmental monitoring data. Adequate intake scenario is suggested to be principally important to estimate the inhaled radioactivity in areas in or around nuclear accidents.

  11. Iodine intake in Ireland

    International Nuclear Information System (INIS)

    Smith, P.P.A.; Hetherton, A.M.; O'Carroll, D.; Smith, D.F.; O'Halloran, M.J.; O'Donovan, D.K.

    1988-01-01

    A study of urinary iodine excretion and thyroid gland uptake of radioactive iodine 131 I was undertaken in the Dublin area with a view to providing data on the current iodine status in Ireland. A mean urinary iodine excretion of 118±82μg/gram creatinine (Median 96) obtained from 821 subjects attending general hospital outpatient clinics in the Dublin area in 1987, while excluding severe iodine deficiency in this particular cohort, obscured the fact that 250 (30%) had iodine excretion values ≤70 μ/g creatinine, a value approximating to the minimum daily iodine requirement. The results provide sufficient evidence of sporadic iodine deficiency to justify a more widespread study of the iodine status of the Irish population with a view to making recommendations on the possible need for iodine prophylaxis

  12. Permanent Hypothyroidism after Radioactive Iodine(131I) Treatment in Diffuse Toxic Goiter

    International Nuclear Information System (INIS)

    Park, Soon Yang; Lee, Jung Sang; Lee, Hong Kyu; Koh, Chang Soon; Lee, Mun Ho

    1977-01-01

    Radioactive iodine (RAI), principally 131 I, effectively controls hyperthyroidism in the majority of patients. The subsequent development of hypothyroidism, however, has been of increasing concern since it was first pointed out by Chapman and Maloof in 1955. And the steady increase of late hypothyroidism during the passage of time was known with its relation with dosage of RAI. The authors have investigated the development of hypothyroidism in 935 patients with diffuse toxic goiter (DTG) who were treated with RAI ( 131 I) at the Seoul National University Hospital from 1960 to 1977 to reveal its relation with the number of RAI treatments, dosage of RAI, age of patients and exophthalmos with the following results. 1) The incidence of hypothyroidism by year after RAI therapy among 631 patients with DTG who were treated with single RAI regimen was 7.4% (1 year), 11.8% (2 year), 16.2% (3 year), 22.1% (4 year) and 25.5% (5 year), and that among 163 patients given multiple RAI treatments was 8.6% (1 year), 10.4% (2 year), 13.3% (3 year), 29.1% (4 year), and 54.1% (5 year) respectively showing much higher yearly increments from 4 years after RAI treatment in comparison with the former. 2) Among 550 patients in the lower dose group treated with single RAI regimen less than 5.0 mCi (Mean±S.D.: 4.3±0.6 mCi), the incidence of hypothyroidism by year after RAI treatment was 6.8% (1 year), 11.4% (2 year), 15.4% (3 year), while among 81 patients in the higher dose group given single RAI treatment not less than 5.5 mCi (Mean±S.D.: 6.3±0.5 mCi) it was 12.0% (1 year), 15.4% (2 year) and 20.4% (3 year) respectively. However, the duration till euthyroid state after RAI therapy in the two groups was 5.1±3.6 months and 4.8±2.8 months respectively showing no statistically significant difference (p>0.1). 4) The incidence of hypothyroidism after RAI treatment in patients younger than 30 years of age was 4.3% (1 year) and 7.7% (2 year); in patients from 30 years to 49 years of age, 5

  13. Histopathological Studies of Mice after Administration of Radioactive Iodine ({sup 131}I)

    Energy Technology Data Exchange (ETDEWEB)

    Ro, Chae Song; Lee, Mun Ho [Seoul National University College of Medicine, Seoul (Korea, Republic of)

    1967-09-15

    Histopathological changes of various organs of the mice after intra-peritoneal injections of radioactive iodine ({sup 131}I) were experimentally observed. Sixty healthy female mice, weighing average 25 gm, divided into 6 groups, were used. The various doses of {sup 131}I were injected intraperitoneally at different intervals. The histopathological changes after these treatments were observed in organs such as thyroids, parathyroids, livers, kidneys and gonads. Following were the results; 1) Thyroid: In the group A given {sup 131}I with a single dose of 10{mu}C per gm body weight, it was observed that the protoplasms of follicular epithelial cells were destroyed, the nuclei were expanded or dissoluted, showing pyknotic changes of nuclei and vacuolizations of protoplasms. In the group B given {sup 131}I with a single dose of 5{mu}C per gm body weight, hyperemias, hemorrhages and hyaline degenerations in the whole area were observed. In the group C given {sup 131}I with 3 doses of 2.5{mu}C per gm body weight every week, the thyroid parenchyma were destroyed and epithelial cells of varing size were observed in the filbrinous tissues. In the group D given {sup 131}I with 6 doses of 0.5{mu}C per gm body weight every week, some destroyed follicles and new borne follicles were observed. But the histopathological changes resemble the follicles of the normal thyroid gland. In the group E and F given {sup 131}I with 8 and 10 doses of 0.2{mu}C and 0.01{mu}C for each group per gm body weight every two days, both pyknotic changes of nuclei and cytoplasmic vacuolizations of the follicular epithelia, hypertrophies of follicles and abnormal irregular follicular structures were observed, and in the group F, lymphocytes appeared around the thyroid glands. 2) Parathyroid: In the group A, hyperemia, proliferations of connective tissues, karyorrhexes and vacuolizations were observed. In other experimental groups, no particular pathological change was observed. 3) Liver: The degenerative

  14. Human thyroid cancer induction by ionizing radiation: summary of studies based on external irradiation and radioactive iodines

    International Nuclear Information System (INIS)

    Shore, R.E.

    1996-01-01

    To provide a context for the Chernobyl thyroid cancer experience, a summary of the findings from other studies is given. The data on external radiation and thyroid cancer come primarily from studies of children irradiated for a variety of benign medical conditions and the Japanese atomic bomb cohort. Unfortunately, only small amounts of data are currently available on thyroid cancer following radioactive iodine exposure in childhood. In order to predict the risk of thyroid cancer in the Chernobyl experience, a number of radiation-related factors need to be considered: the magnitude of radiation risk from available studies; shape of the dose-response curve; variations in risk by gender, time since irradiation, and age at irradiation; the effects of dose fractionation or dose protraction. Other considerations pertaining to the frequency of thyroid cancer and its outcome are thyroid-tumor surveillance effects and background iodine intake. The data to date suggest that 131 I produces less thyroid cancer than a comparable dose of external radiation, but the Chernobyl experience will provide extensive new information on this issue. Principles are discussed as to how to maximize the scientific validity and informativeness of Chernobyl thyroid studies

  15. Model investigations for trace analysis of iodine, uranium, and technetium in saturated sodium chloride leaching solutions of stored radioactive waste

    International Nuclear Information System (INIS)

    Jegle, U.

    1989-02-01

    This paper describes the development of a time and cost saving chromatographic technique, which allows the matrix to be separated and the most important species to be analyzed in a leaching solution of vitrified radioactive waste. Uranium, iodine, and technetium were chosen for the model technique to be elaborated. In a first step, iodide and pertechnetate were separated from the matrix by the strongly basic AG 1X 8 anion exchange resin and then separated from each other by selective elution. The uranyl ions eluted with the sodium chloride matrix were separated from the excess of sodium chloride in a second step, again by adsorption to the strongly basic resin. The ion-selective electrode was found to be a suitable tool for iodide analysis. Pertechnetate was analysed by means of liquid scintillation. Uranium was determined by ICP-AES. (orig./RB) [de

  16. Serum thyroxine concentrations following fixed-dose radioactive iodine treatment in hyperthyroid cats: 62 cases (1986-1989)

    International Nuclear Information System (INIS)

    Meric, S.M.; Rubin, S.I.

    1990-01-01

    The medical records of 62 hyperthyroid cats treated with a fixed dose of 4 mCi of radioactive iodine (131I) were reviewed. In 60 cats, serum thyroxine concentrations were determined after treatment, allowing evaluation of treatment success. Eighty-four percent of the cats had normal serum thyroxine concentrations after treatment. Five of the 60 cats (8%) remained hyperthyroxinemic after treatment. Five cats (8%) were hypothyroxinemic when evaluated within 60 days of treatment. Three of these cats had normal serum thyroxine concentrations 6 months after treatment, and none had clinical signs of hypothyroidism. The administration of a fixed dose of 4 mCi of 131I was determined to be an effective treatment for feline hyperthyroidism

  17. Absence of survival benefit of radioactive iodine (RAI) after thyroidectomy in low risk differentiated thyroid cancer (DTC) patients

    International Nuclear Information System (INIS)

    Schwartz, C.; Fieffe, S.; Pochart, J.M.; Bonnetain, F.; Gauthier, M.; Cueff, A.; Crevisy, E.; Dygai-Cochet, I.; Toubeau, M.

    2012-01-01

    After thyroidectomy, the goal of the first dose of radioactive iodine (RAI) is remnant ablation to facilitate the initial staging with the post-therapy scan and to facilitate the early detection of recurrences. The purpose of this study is to the survival benefit of RAI in low-risk thyroid cancer patients. Using Cancer thyroid registry of Marne Ardennes (1041 patients) and hospital data base of centre Leclerc (257 patients), we included all differentiated thyroid cancer (DTC) patients at low risk from 1975 to 2005. Median follow-up was 10.3 years, during which 19 recurrences, 61 other malignant diseases and 105 deaths were registered. 387 patients (30%) received no RAI and 911 had RAI (70%). If we confirmed that some clinical characteristics were associated with RAI intake, the study failed to demonstrate any survival benefit of RAI in low risk DTC patients

  18. Absence of survival benefit of radioactive iodine (RAI) after thyroidectomy in low risk differentiated thyroid cancer (DTC) patients

    Energy Technology Data Exchange (ETDEWEB)

    Schwartz, C.; Fieffe, S.; Pochart, J.M. [Endocrinology Nuclear Medicine, Institut Jean Godinot, Reims (France); Bonnetain, F.; Gauthier, M.; Cueff, A. [Statistics and Epidemiology, Centre Georges Francois Leclerc, Dijon (France); Crevisy, E.; Dygai-Cochet, I.; Toubeau, M. [Nuclear Medicine, Centre Georges Francois Leclerc, Dijon (France)

    2012-07-01

    After thyroidectomy, the goal of the first dose of radioactive iodine (RAI) is remnant ablation to facilitate the initial staging with the post-therapy scan and to facilitate the early detection of recurrences. The purpose of this study is to the survival benefit of RAI in low-risk thyroid cancer patients. Using Cancer thyroid registry of Marne Ardennes (1041 patients) and hospital data base of centre Leclerc (257 patients), we included all differentiated thyroid cancer (DTC) patients at low risk from 1975 to 2005. Median follow-up was 10.3 years, during which 19 recurrences, 61 other malignant diseases and 105 deaths were registered. 387 patients (30%) received no RAI and 911 had RAI (70%). If we confirmed that some clinical characteristics were associated with RAI intake, the study failed to demonstrate any survival benefit of RAI in low risk DTC patients

  19. Analysis of the effects of 50g/L povidone iodine in conjuncfival sac before cataract surgery

    Directory of Open Access Journals (Sweden)

    Wen Yang

    2013-12-01

    Full Text Available AIM: To evaluate the sterilizing effects of 50g/L povidone Iodine used in conjunctival sag before cataract surgery.METHODS: Totally, 58 eyes of 45 cataract patients underwent phacoemulsification aspiration with intraocular lens implantation. The cojunctival sac secretions at three time points(admission, before and after disinfection with povidone iodinewere obtained and then cultured under the same condition and at the same time. The results were observed and identified.RESULTS: At the three points, the positive rate of bacterial culture was 79.3%, 41.9% and 3.4%, respectively. The positive rate significantly reduced gradually. CONCLUSION: The application effect of 50g/L povidone iodine in killing conjunctival sac bacteria is remarkable, which can avoid the postoperative endophthalmitis effectively.

  20. Radiation of the thyroid during examination of patients with thyroid diseases using radioactive iodine

    Energy Technology Data Exchange (ETDEWEB)

    Zvonova, I.A.; Likhtarev, A.A.; Nikolaeva, A.A.

    1984-02-01

    Basing on 131I uptake functions in the thyroid of 109 patients irradiation doses of this organ were evaluated for persons with normal iodine metabolism and in the following diseases: hypothyrosis, moderate thyrotoxicosis, nodular toxic and nontoxic goiter, vegetative neurosis. Maximum tolerant doses of 123I, 125I, 131I and 132I are recommended for diagnostic examination of thyroid function and scanning of this organ.

  1. Iodine uptake patterns om post-ablation whole body scans are related to elevated serum thyroglobulin levels after radioactive iodine therapy in patients with papillary thyroid carcinoma

    Energy Technology Data Exchange (ETDEWEB)

    Jeong, Geum Cheol; Song, Min Chul; Min, Jung Joon; Cho, Sang Geon; Kwon, Seong Young [Dept. of Nuclear Medicine, Chonnam National University Hwasun Hospital, Hwasun (Korea, Republic of); Park, Ki Seong; Kang, Sae Ryung; Kim, Ja Hae; Song, Ho Chun [Dept. of Nuclear Medicine, Chonnam National University Hospital, Gwangju (Korea, Republic of)

    2016-12-15

    Serum thyroglobulin (Tg) level is frequently elevated shortly after radioactive iodine (RAI) ablation therapy. The authors studied the relationship between the elevation of serum Tg after RAI therapy and iodine uptake pattern on post-ablation whole body scans (RxWBSs) in patients with papillary thyroid carcinoma (PTC). The study subjects were patients with PTC that had undergone first RAI therapy with thyroid hormone withdrawal after total thyroidectomy. Patients with a high level of serum anti-Tg antibody (TgAb, ≥ 60 U/mL), possible regional or distant metastasis as determined by pre-ablation or post-ablation studies, and negative iodine uptake of the anterior neck on RxWBS were excluded. Serum Tg was checked twice, that is, 7 days after (post-ablation Tg) and on the day of RAI therapy (pre-ablation Tg). Ratio of pre-ablation Tg to post-ablation Tg (Tg ratio) was used to assess changes in serum Tg levels after RAI therapy. Patients were classified into two groups according to the presence of midline uptake above the thyroidectomy bed on RxWBS (negative (group 1) or positive (group 2) midline uptake). Variables were subjected to analysis to identify differences between the two groups. Two hundred and fifty patients were enrolled in this study; 101 in group 1 and 149 in group 2. Based on univariate analysis, post-ablation Tg (8.12 ± 11.05 vs. 34.12 ± 54.31; P < 0.001) and Tg ratio (7.81 ± 8.98 vs. 20.01 ± 19.84; P < 0.001) were significantly higher in group 2. On the other hand, gender, tumor (T) stage, lymph node (N) stage, size, multiplicity or bilaterality of primary tumor, dose of 131I, serum TgAb and thyroid-stimulating hormone (TSH) level (before or after RAI therapy) were not significantly different in the two groups. Variables with P values of < 0.25 by univariate analysis were subjected to multivariate analysis, which showed post-ablation Tg (OR 1.060, 95 % CI = 1.028–1.092; P < 0.001) and Tg ratio (OR 1.059, 95 % CI

  2. Treatment patterns, health state, and health care resource utilization of patients with radioactive iodine refractory differentiated thyroid cancer

    International Nuclear Information System (INIS)

    Gianoukakis, Andrew G; Flores, Natalia M; Pelletier, Corey L; Forsythe, Anna; Wolfe, Gregory R; Taylor, Matthew H

    2016-01-01

    Patients with differentiated thyroid cancer (DTC) often respond well to treatment but some become refractory to radioactive iodine (RAI) treatment, and treatment options are limited. Despite the humanistic and economic burden RAI refractory disease imposes on patients, published research concerning treatment patterns and health care resource utilization is sparse. Data were collected from an online retrospective chart review study in the US and five European Union (EU) countries (France, Germany, Italy, Spain, and UK) with physicians recruited from an online panel. Physicians (N=211) provided demographics, disease history, treatment information, and health care resource utilization for one to four of their patients with radioactive iodine refractory differentiated thyroid cancer (RR-DTC). The majority of the patients with RR-DTC (N=623) were female (56%), and their mean age was 58.2 years. In this sample, 63.2% had papillary thyroid cancer and 57.0% were in Stage IV when deemed RAI refractory. Patients with RR-DTC experienced regional recurrence in the thyroid bed/central neck area (25.3%) and had distant metastatic disease (53.6%). At the time data were collected, 50.7% were receiving systemic treatment. Of those, 78.5% were on first-line treatment and 62.7% were receiving multikinase inhibitors. Regional differences for prescribed treatments were observed; the US was more likely to have patients receiving multikinase inhibitors (79.2%) compared with UK (41.2%) and Italy (17.1%). Additional details regarding treatment patterns and resource utilization are discussed. The current study aimed to obtain a greater understanding of RR-DTC treatment globally. These results can assist in the development and implementation of treatment guidelines and ultimately enhance the care of patients with RR-DTC

  3. Radioactive iodine (131I) therapy for differentiated thyroid cancer in Japan. Current issues with historical review and future perspective

    International Nuclear Information System (INIS)

    Higashi, Tatsuya; Kudo, Takashi; Kinuya, Seigo

    2012-01-01

    Radioactive iodine (RAI, 131 I) has been used as a therapeutic agent for differentiated thyroid cancer (DTC) with over 50 years of history. Recently, it is now attracting attention in medical fields as one of the molecular targeting therapies, which is known as targeted radionuclide therapy. Radioactive iodine therapy (RIT) for DTC, however, is now at stake in Japan, because Japan is confronting several problems, including the recent occurrence of the Great East Japan Disaster (GEJD) in March 2011. RIT for DTC is strictly limited in Japan and requires hospitalization. Because of strict regulations, severe lack of medical facilities for RIT has become one of the most important medical problems, which results in prolonged waiting time for Japanese patients with DTC, including those with distant metastasis, who wish to receive RIT immediately. This situation is also due to various other factors, such as prolonged economic recession, super-aging society, and subsequent rapidly changing medical environment. In addition, due to the experience of atomic bombings in Hiroshima and Nagasaki, Japanese people have strong feeling of ''radiophobia ''. There is fear that GEJD and related radiation contamination may worsen this feeling, which might be reflected in more severe regulation of RIT. To overcome these difficulties, it is essential to collect and disclose all information about the circumstances around this therapy in Japan. In this review, we would like to look at this therapy through several lenses, including historical, cultural, medical, and socio-economic points of view. We believe that clarifying the problems is sure to lead to the resolution of this complicated situation. We have also included several recommendations for future improvements. (author)

  4. Patient release criteria following radioactive iodine-131 treatment in the light of international practice: where does South Africa fit in?

    Science.gov (United States)

    Mongane, Modisenyane S; Rae, William I D

    2017-10-01

    The release from hospital of patients treated with radioactive iodine-131 (I) remains a controversial issue as a result of the range of guidelines implemented by national regulatory bodies responsible for radiation protection in various countries worldwide. The aim of this study was to review and analyse the literature on patient release criteria (PRC) applied internationally in an attempt to achieve a justifiable approach to setting equivalent criteria in South Africa. In 2016, the South African Department of Health, Directorate: Radiation Control added conditions (numbers 50 and 90), to licences to use radioactive nuclides. These conditions state that patients must be hospitalized when the dose rate at 1 m is above 25 μSv/h, or more than 555 MBq of iodine-131 was administered to the patient. However, these criteria do not consider patients' socioeconomic conditions. A literature survey was carried out of articles detailing PRC from high-income countries as well as those in the middle-income and lower-income groups. Socioeconomic conditions within countries were determined using the International Monetary Fund lists of gross domestic product. The results from the literature have shown that in setting PRC, several countries have considered the socioeconomic conditions prevailing in their countries to achieve harmony between public protection and cost associated with hospitalization. The South African authority conditions must be seen in the context of the approach followed by other countries. Considering the international context, a justifiable, and potentially implementable, guideline or policy for improving individualized and more caring patient management is advocated.

  5. The effect of radioactive iodine treatment on 14C urea breath test results in patients with hyperthyroidism.

    Science.gov (United States)

    Arduc, Ayse; Dogan, Bercem Aycicek; Ozuguz, Ufuk; Tuna, Mazhar Muslim; Gokay, Ferhat; Tutuncu, Yasemin Ates; Isik, Serhat; Aydin, Yusuf; Peksoy, Irfan; Berker, Dilek; Guler, Serdar

    2014-12-01

    Radioactive Iodine therapy (RAIT) plays a major role in the treatment of hyperthyroidism. In addition to the thyroid gland, significant amounts of radioactive iodine are maintained in the stomach. The aim of this study was to determine if RAIT has any effect on Helicobacter pylori infection, based on the C urea breath test (UBT). The study included 85 patients with hyperthyroidism scheduled to undergo RAIT and 69 hyperthyroid subjects in whom methimazole treatment was planned. All subjects had pretreatment-positive UBT results, and the test was repeated on the first and third months after RAIT and methimazole treatment. After a mean RAIT dose of 15 mCi (range, 10-20 mCi), UBT became negative in 13 (15.3%) of 85 patients on the first month and 18 (21.2%) of 85 patients on the third month. All subjects treated with methimazole remained UBT positive on the first and third months of methimazole treatment (100%). Reduction in the number of UBT-positive patients on both the first and the third months after RAIT was statistically significant (P hyperthyroidism etiologies and thyroid autoantibody levels in subjects with UBT that became negative and in subjects with UBT that remained positive were similar in the RAIT group (P > 0.05). Urea breath test negativity rates did not differ according to the radioiodine dose. Our findings indirectly showed that RAIT might have an antimicrobial effect on H. pylori. Clinical applications of this beneficial effect of RAIT on H. pylori should be further evaluated.

  6. Injectable iodine-125 labeled tissue marker for radioactive localization of non-palpable breast lesions

    DEFF Research Database (Denmark)

    Schaarup-Jensen, Henrik; Jensen, Andreas Ingemann; Hansen, Anders Elias

    2018-01-01

    to be spatially well-defined and stable over a seven day period with excellent CT contrast (>1500 HU), enabling fluoroscopic visualization of markers during placement. The radioactivity remains strongly associated with the marker during the implantation period, which limits exposure to healthy tissue....... The surgical guidance marker is based on derivatives of the biomaterial sucrose acetate isobutyrate and unlike currently used markers it is injectable in the tissue using thin needles, reducing the discomfort to the patients significantly. The marker confers CT contrast and has radioactive properties, meaning...

  7. Reevaluation of the thyroidal radioactive iodine uptake test, with special reference to reversible primary hypothyroidism with elevated thyroid radioiodine uptake

    International Nuclear Information System (INIS)

    Okamura, K.; Sato, K.; Ikenoue, H.; Yoshinari, M.; Nakagawa, M.; Kuroda, T.; Fujishima, M.

    1988-01-01

    The clinical significance of the thyroidal radioactive iodine uptake (RAIU) test was reevaluated in patients with various thyroid disorders. Compared with 262 normal subjects or 194 patients with euthyroid diffuse goiter with normal serum TSH levels, RAIU values were significantly higher in 100 patients with latent primary hypothyroidism (serum TSH, 5-40 mU/L). In 126 patients with overt primary hypothyroidism (serum TSH, greater than 40 mU/L), RAIU values were either extremely high (49 patients with reversible hypothyroidism and 10 patients with postpartum hypothyroidism) or low (67 patients with irreversible hypothyroidism). The increase in RAIU values in latent, or reversible overt hypothyroidism was TSH dependent, and there was a good correlation between RAIU values and serum TSH levels (r = 0.6203; P less than 0.001). In overt primary hypothyroidism, spontaneous recovery of thyroid function during iodide restriction alone occurred in 52 of 53 patients with RAIU values above 35%, in only 7 of 23 patients with RAIU values between 10-35%, and in none of 50 patients with RAIU below 10%. Thus, recovery was predicted by high RAIU values (P less than 0.001; prediction rate, 91.4%). Goiter was found in about 80% of the patients with reversible hypothyroidism, compared with only 34% of the patients with irreversible hypothyroidism. Recovery of thyroid function during iodide restriction also occurred in 71% of the patients with latent hypothyroidism. However, RAIU measurements did not predict the prognosis of patients with latent hypothyroidism. We conclude that iodine-induced reversible hypothyroidism is common in our patient population, and RAIU measurements may be helpful in determining the prognosis of patients with overt primary hypothyroidism

  8. Lithium as an adjunct to radioactive iodine for the treatment of hyperthyroidism: a systematic review and meta-analysis.

    Science.gov (United States)

    Kessler, Lynn; Palla, Jyothsna; Baru, Joshua S; Onyenwenyi, Chioma; George, Amrutha M; Lucas, Brian P

    2014-07-01

    Radioactive iodine (RAI) is commonly used in the treatment of hyperthyroidism but is not uniformly successful. Lithium increases thyroidal iodine retention without reducing iodide uptake, increasing the radiation dose to the thyroid when administered with RAI. Although these actions suggest that adjuvant lithium may increase the efficacy of RAI, its role as an adjunct to RAI remains contentious. To evaluate the safety and efficacy of adding lithium to RAI to treat hyperthyroidism. Relevant studies were identified by a search of Medline and the Cochrane Central Register of Controlled Trials. To be included, a study had to be a controlled trial comparing the effect of RAI alone to RAI with lithium in the treatment of hyperthyroidism. Relevant data were extracted and meta-analyses were performed. Of the 75 identified studies, 6 met the inclusion criteria; 4 of these studies were interventional and 2 were observational trials. Meta-analysis of the observational trials (N = 851), both of which were retrospective cohort studies, showed significant improvement in the primary outcome (i.e., cure rate) with adjunctive lithium (odds ratio [OR], 1.92; 95% confidence interval [CI], 1.24 to 2.96). The combined interventional trials (N = 485) also showed an improvement in cure rate, but the difference did not reach statistical significance (OR, 1.28; 95% CI, 0.85 to 1.91). Adjunctive lithium reduced time to cure and blunted thyroid hormone excursions after RAI. Lithium-related side effects were infrequent and usually mild. The observational trials demonstrated significant improvement in the cure rate of hyperthyroidism when lithium is added to RAI. The improvements shown in the interventional trials did not reach statistical significance due to the effect of a single, large negative trial.

  9. Normalization of thyroid blood flow in Graves' hyperthyroidism following radioactive iodine therapy

    Energy Technology Data Exchange (ETDEWEB)

    Chang, D.C.S.; Woodcock, J.P.; Shedden, E.J.; Lazarus, J.H.; Wheeler, M.H.; McGregor, A.M. (University Hospital of Wales, Cardiff (UK). Medical Physics Dept.)

    1990-05-01

    In a group of 12 patients with Graves' hyperthyroidism, administration of 514 {plus minus} 43 (mean {plus minus} SD) MBq iodine-131 was associated with a fall of superior thyroid artery (STA) blood flow in two at 6 months and in eight at 11 months. The reduction in time-averaged velocity at 11 months correlated with the reduction in FT4 and in FT3 at this time. In four patients who had persistent elevated STA blood flow, two were still hyperthyroid. The diameter of the STA was unchanged at 6 months and only half the patients had reduction of their STA size at 11 months after radioiodine (RAI) therapy. These data indicate that normalization of STA blood flow precedes normalization of STA size in patients treated with RAI. Further work is required to determine whether STA blood flow measurements are of predictive value in treatment outcome. (author).

  10. Chemical and biological consequences of the radioactive decay of iodine-125 in plasmid DNA

    International Nuclear Information System (INIS)

    Linz, U.

    1983-09-01

    The consequences of the decay of iodine-125 incorporated into DNA were studied on a molecular basis. Doubly ( 14 C and 125 I) labelled 5-iodo-2'-deoxycytidine 5'-triphosphate (IdCTP) was synthesized and incorporated enzymatically into the SalI-cutting site of the plasmid pBR 322. Part of the radioiodinated DNA was treated with T4-DNA ligase in order to restore the circular structure of the native plasmid molecule. After 4 months of storage under various conditions the stable end products were analyzed by radio GC, radio HPLC and electron microscopy. The experiments were not only carried out with doubly-labelled DNA but also with solutions of 14 C-labelled DNA containing Na 125 I as internal radiation source. The results clearly indicate that radiolysis alone causes only minor damage. Transmutation of the covalently bound iodine, on the other hand, leads to complete destruction of the labelled nucleotide, giving rise to 14 CO 2 and 14 CO as main products. The production of 14 CO 2 which originates from both the base as well as the sugar component shows a strong solvent effect. The electron microscopy analysis of the DNA reveals that the local effects are always connected with at least one double strand break directly at the site of decay. In addition, one finds DNA double strand breaks in areas which are hundreds of base pairs apart from that site. Under certain circumstances most of the DNA molecules exhibit up to 10 breaks. A comparison between ligase-treated and untreated DNA shows that the configuration of the DNA and the position of the labelled nucleotide play in important role in the extent of the overall damage. It could be demonstrated that there is a linear correlation between gaseous fragmentation products and the number of double strand breaks. (orig./MG) [de

  11. A Mild Method for Regioselective Labeling of Aromatics with Radioactive Iodine

    DEFF Research Database (Denmark)

    Rønnest, Mads Holger; Nissen, Felix; Pedersen, Palle Jacob

    2013-01-01

    A novel technique to label ortho‐, meta‐, and para‐trimethylsilyl‐substituted aryl substituents with radioactive iodide is described. The method takes advantage of the ipso‐directing and activating properties of trimethylsilyl substituents on the arenes. The method was demonstrated on a griseoful...

  12. Derivation of the critical effect size/benchmark response for the dose-response analysis of the uptake of radioactive iodine in the human thyroid.

    Science.gov (United States)

    Weterings, Peter J J M; Loftus, Christine; Lewandowski, Thomas A

    2016-08-22

    Potential adverse effects of chemical substances on thyroid function are usually examined by measuring serum levels of thyroid-related hormones. Instead, recent risk assessments for thyroid-active chemicals have focussed on iodine uptake inhibition, an upstream event that by itself is not necessarily adverse. Establishing the extent of uptake inhibition that can be considered de minimis, the chosen benchmark response (BMR), is therefore critical. The BMR values selected by two international advisory bodies were 5% and 50%, a difference that had correspondingly large impacts on the estimated risks and health-based guidance values that were established. Potential treatment-related inhibition of thyroidal iodine uptake is usually determined by comparing thyroidal uptake of radioactive iodine (RAIU) during treatment with a single pre-treatment RAIU value. In the present study it is demonstrated that the physiological intra-individual variation in iodine uptake is much larger than 5%. Consequently, in-treatment RAIU values, expressed as a percentage of the pre-treatment value, have an inherent variation, that needs to be considered when conducting dose-response analyses. Based on statistical and biological considerations, a BMR of 20% is proposed for benchmark dose analysis of human thyroidal iodine uptake data, to take the inherent variation in relative RAIU data into account. Implications for the tolerated daily intakes for perchlorate and chlorate, recently established by the European Food Safety Authority (EFSA), are discussed. Copyright © 2016 The Author(s). Published by Elsevier Ireland Ltd.. All rights reserved.

  13. Experience in the patients management which received treatments with radioactive iodine (131I). Measurements and dosimetry pertaining to the personnel related

    International Nuclear Information System (INIS)

    Ruiz J, A.

    1999-01-01

    In the INNSZ there are administering ablative doses of radioactive iodine to patients with problems of the thyroid gland from 40 years ago. Starting from 1992 was initiated the restlessness to inform to the patients verbally and in writing over the measurements of radiological safety that must be followed for the protection of their families. In this work it is commented, the benefits obtained with the patients and the teachings to give to the personnel what attend the patients which receive treatments with iodine-131 and must be hospitalized. It is commented too over the standardization standing of the patients discharged whom received radioactive material and lastly, it was make a dosimetric study of the nurses, radiotherapeutic and control area. (Author)

  14. Experimental study of contamination by inhalation of radioactive iodine aerosols. Biological balance; Etude experimentale de la contamination par inhalation d'aerosols d'iode radioactif bilan biologique

    Energy Technology Data Exchange (ETDEWEB)

    Marble, G [Commissariat a l' Energie Atomique, 92 - Fontenay-aux-Roses (France). Centre d' Etudes Nucleaires

    1968-07-01

    Several articles have been published concerning research into contamination produced by inhalation of radioactive iodine aerosols in monkeys. Results dealing with the biological balance of this contamination are presented and discussed in this report. (author) [French] L'etude experimentale de la contamination par inhalation d'aerosols d'iode radioactif effectuee chez le singe a fait l'objet de plusieurs publications. Les resultats concernant le bilan biologique de cette contamination sont presentes et discutes dans ce rapport. (auteur)

  15. Effect of decicurie doses of radioactive iodine 131 on parathyroid function

    International Nuclear Information System (INIS)

    Glazebrook, G.A.

    1987-01-01

    Although parathyroid deficiency has been reported after administration of relatively small doses of iodine 131, reports of such deficiency after the much larger doses given in the management of thyroid cancer are notable by their absence in the literature. We observed one such patient, then instituted a prospective study. We observed a 58 percent incidence of apparently diminished parathyroid reserve among 53 patients given high doses of I 131. Susceptibility does not appear to be related to age, sex, extent of thyroid operation, operative technique, the amount of thyroidal I 131 uptake, the use of external radiation to the neck, or to the presence of parathyroid glands or of Hashimoto's disease in the operative specimen; however, susceptibility may be related to the anatomic location of the parathyroid glands in relation to the thyroid gland. The administered dose of I 131 almost reached significant levels (p = 0.1) in the present study. The initial pretreatment serum calcium levels were consistently lower among affected patients (p = 0.01), suggesting the presence of a preexisting latent impairment of parathyroid reserve which was subsequently unmasked after the administration of I 131. Thyroid cancer is compatible with very long-term survival, and therefore, there is a considerable risk of delayed chronic hypocalcemia among patients who have received large doses of I 131, particularly female patients in the premenopausal age group. These patients deserve special management surveillance

  16. Long-term follow-up in toxic solitary autonomous thyroid nodules treated with radioactive iodine

    International Nuclear Information System (INIS)

    Huysmans, D.A.; Corstens, F.H.; Kloppenborg, P.W.

    1991-01-01

    The long-term effects of radioiodine treatment on thyroid function in patients with a toxic solitary autonomous thyroid nodule were evaluated. Fifty-two patients received a therapeutic dose of 20 mCi of iodine-131 ( 131 I). Duration of follow-up was 10 +/- 4 yr. Follow-up data included a biochemical evaluation of thyroid function. The failure rate (recurrent hyperthyroidism) was 2%. The incidence of hypothyroidism was 6% and was not related to the dose per gram of nodular tissue. Oral administration of 20 mCi of radioiodine is a simple and highly effective method for the treatment of patients with a toxic autonomous thyroid nodule. The risk of development of hypothyroidism is low if extranodular uptake of 131 I is prevented. This can be achieved by not treating euthyroid patients, by no longer using injections of exogenous thyroid stimulating hormone in the diagnostic work-up of the patients and by always performing radioiodine imaging shortly before treatment

  17. Radioactive iodine in thyroid medicine-How it started in Sweden and some of today's challenges

    International Nuclear Information System (INIS)

    Mattsson, Soeren; Nosslin, Bertil

    2006-01-01

    The paper describes the start of the clinical use of radioiodine, the various iodine isotopes available, measurement techniques and dosimetry. There are still problems to solve in relation to an optimal clinical use of radioiodine. One of the remaining challenges is to get consensus about the goal of the treatment of hyperthyreosis, as well as about a method for individual absorbed dose calculations. Careful dose estimates will prevent unnecessary radiation exposure and constitute a base for a future optimised radioiodine therapy. For the dose calculation, it is important to understand if there is any clinically significant temporary reduction in the ability of thyroid tissue to trap or retain 131 I-iodide following prior administration of a diagnostic activity of 131 I-iodide (stunning of the thyroid). This may be of special concern in connection with treatment of thyroid cancer and its metastases. Finally, the production capacity, availability and delivery of 123 I have to be improved to increase clinical access to this radionuclide, which is optimal for diagnostic imaging and which gives lower absorbed dose and therefore also less risk for thyroid stunning than 131 I

  18. Association of Xerostomia and Ultrasonographic Features of the Major Salivary Glands After Radioactive Iodine Ablation for Papillary Thyroid Carcinoma.

    Science.gov (United States)

    Soo Roh, Sang; Wook Kim, Dong; Jin Baek, Hye

    2016-11-01

    The objective of this study is to evaluate the association between xerostomia and sonographic features of the major salivary glands after patients undergo radioactive iodine ablation (RIA) for papillary thyroid carcinoma (PTC). The study included 256 consecutive patients who underwent total thyroidectomy, RIA, and neck ultrasound examinations. Changes in the ultrasound features of the parotid and submandibular glands after RIA were evaluated retrospectively by a single radiologist, on the basis of direct comparison of sonograms obtained before and after RIA. Clinical data, including the presence of xerostomia, were investigated retrospectively by the same radiologist via a review of the electronic medical records. For 111 of the 256 patients (43.4%), ultrasound examination revealed changes in the major salivary glands after RIA. The presence of xerostomia was undetermined in 85 of the 256 patients. Among the remaining 171 patients, the frequency of xerostomia was 36.8% (63/171). When patients with xerostomia were compared with those without xerostomia, no statistically significant differences in patient sex and age, the dose of RIA received, or the number of RIA sessions were noted (p > 0.05). Considering the changes in the ultrasound features of the major salivary glands after RIA, no statistically significant association was found between xerostomia and the number of involved major salivary glands or the presence of an involved submandibular gland (p > 0.05). In this study, ultrasound was unhelpful for evaluating xerostomia after RIA in patients with PTC.

  19. Cohort study on radioactive iodine-induced hypothyroidism: implications for Graves' ophthalmopathy and optimal timing for thyroid hormone assessment.

    Science.gov (United States)

    Stan, Marius N; Durski, Jolanta M; Brito, Juan P; Bhagra, Sumit; Thapa, Prabin; Bahn, Rebecca S

    2013-05-01

    Graves' ophthalmopathy (GO) develops or worsens in up to one-third of patients treated with radioactive iodine (RAI) for Graves' hyperthyroidism. We sought to identify the prevalence of development or worsening of GO in patients treated with RAI for Graves' hyperthyroidism and to identify the risk factors associated with that outcome. We identified a retrospective cohort of consecutive patients treated with RAI at Mayo Clinic (Rochester, MN) between 2005 and 2006. We assessed their medical records for evidence of hypothyroidism and development or worsening of GO in the year after therapy. Hypothyroidism was defined as thyrotropin >3.0 mIU/L or free thyroxine hyperthyroidism was only 20%. The presence of hypothyroidism at the first assessment of thyroid function after RAI administration is a strong predictor for adverse GO outcome. This risk is highest in patients with preexisting GO. We suggest that in order to prevent clinical hypothyroidism and the associated risk for GO, the optimal time for first measurement of fT4 is before 6 weeks after RAI therapy.

  20. A False Positive I-131 Metastatic Survey Caused by Radioactive Iodine Uptake by a Benign Thymic Cyst

    Directory of Open Access Journals (Sweden)

    Avneet K. Singh

    2017-01-01

    Full Text Available Thyroid carcinoma is the most common endocrine malignancy in the United States with increasing incidence and diagnosis but stable mortality. Differentiated thyroid cancer rarely presents with distant metastases and is associated with a low risk of morbidity and mortality. Despite this, current protocols recommend remnant ablation with radioactive iodine and evaluation for local and distant metastasis in some patients with higher risk disease. There are several case reports of false positive results of metastatic surveys that are either normal physiologic variants or other pathological findings. Most false positive findings are associated with tissue that has physiologic increased uptake of I-131, such as breast tissue or lung tissue; pathological findings such as thymic cysts are also known to have increased uptake. Our case describes a rare finding of a thymic cyst found on a false positive I-131 metastatic survey. The patient was taken for surgical excision and the final pathology was a benign thymic cyst. Given that pulmonary metastases of differentiated thyroid cancer are rare, thymic cysts, though also rare, must be part of the differential diagnosis for false positive findings on an I-131 survey.

  1. Efficiency of moso bamboo charcoal and activated carbon for adsorbing radioactive iodine

    Energy Technology Data Exchange (ETDEWEB)

    Chien, Chuan-Chi; Huang, Ying-Pin; Wang, Wie-Chieh [ITRI South, Industrial Technology Research Institute, Tainan (China); Chao, Jun-Hsing; Wei, Yuan-Yao [Nuclear Science and Technology Development Center, National Tsing Hua University, Hsinchu (China)

    2011-02-15

    Preventing radioactive pollution is a troublesome problem but an urgent concern worldwide because radioactive substances cause serious health-related hazards to human being. The adsorption method has been used for many years to concentrate and remove radioactive pollutants; selecting an adequate adsorbent is the key to the success of an adsorption-based pollution abatement system. In Taiwan, all nuclear power plants use activated carbon as the adsorbent to treat radiation-contaminated air emission. The activated carbon is entirely imported; its price and manufacturing technology are entirely controlled by international companies. Taiwan is rich in bamboo, which is one of the raw materials for high-quality activated carbon. Thus, a less costly activated carbon with the same or even better adsorptive capability as the imported adsorbent can be made from bamboo. The objective of this research is to confirm the adsorptive characteristics and efficiency of the activated carbon made of Taiwan native bamboo for removing {sup 131}I gas from air in the laboratory. The study was conducted using new activated carbon module assembled for treating {sup 131}I-contaminated air. The laboratory results reveal that the {sup 131}I removal efficiency for a single-pass module is as high as 70%, and the overall efficiency is 100% for four single-pass modules operated in series. The bamboo charcoal and bamboo activated carbon have suitable functional groups for adsorbing {sup 131}I and they have greater adsorption capacities than commercial activated carbons. Main mechanism is for trapping of radioiodine on impregnated charcoal, as a result of surface oxidation. When volatile radioiodine is trapped by potassium iodide-impregnated bamboo charcoal, the iodo-compound is first adsorbed on the charcoal surface, and then migrates to iodide ion sites where isotope exchange occurs. (Copyright copyright 2011 WILEY-VCH Verlag GmbH and Co. KGaA, Weinheim)

  2. Use of the radioactive iodine: the new thing and the old thing

    International Nuclear Information System (INIS)

    Navarro Despaine, Daysi

    2004-01-01

    For more than one decade it began to be used the 131 I in patient with goiters sporadic eufuncionantes, aspect in that one needs to continue working, because the clinical answer in general showed that the nodules didn't always change size. It is to establish the dose to administer, while the risk exists of developing hypothyroidism, as well as the possibility to have to carry out a surgery of the thyroid for nodular growth after receiving the 131 I. The future of the 131 I is promissory, not alone as measure therapy but also as diagnostic method, because they are to solve relative multiple queries to the indications, the factors that influence in the answer, dose calculation, the patients' selection and long term absence of random studies that allow to define in the treatment of the non toxic goiter the advantages of the use of the levotiroxina, of the surgery or of the 131 I

  3. The rate of depression and its risk stratification in patients with differentiated thyroid cancers treated with radioactive iodine

    International Nuclear Information System (INIS)

    Eftekhari, M.; Fallahi, B.; Ansari, S.; Izadian, E.S.; Esfahani, A.F.; Beiki, D.; Saghari, M.

    2005-01-01

    Full text: Depression is a common disease in general population and may be more frequent in the cases of malignant diseases. Diagnosis and treatment of depressions in such patients may improve the quality of life. The aim of this study was to determine the risk of depression in patients diagnosed as differentiated thyroid cancers (DTC) and treated with radioactive iodine ( 131 I). In a historical Cohort study, 390 DTC patients, 312 female and 78 male, 18-68 years with median age of 41 years who were treated with 131 I and 390 control cases selected from the patients' relatives and matched with DTC cases by age, sex, wedding state and socioeconomic status were entered the study. Each patient and his/her control were concurrently assessed with Beck's questionnaire for diagnosis of depression. The data was analyzed to detect the rate, severity and relative risk of depression and the effect of some variables on the severity of depression in these patients. Of 390 patients, 179(45.9%) showed some degree of depression, 20.3% mild, 14.1% moderate, 11% partially severe and 0.5% severe according to Beck score, while the proportional frequency of different grades of depression among the control group was 15.5% and overall relative risk of depression in DTC patients was 2.96. The frequency of depression in female patients, 47.8% was lesser than male, 38.5% (p=0.013) and in married female (46.2%) was greater than single (14.3%) but lesser than divorced or widow female patients (82.4%), (p<0.0001). Depression was more prevalent and more severe in cases of papillary, 47.9% than follicular carcinoma, 33.3% (p=0.014) and also was more predominant in less-educated than in high-educated patients (p<0.0001). In DTC patients with history of radio-iodine therapy, the rate of depression is almost three times of the general population, so screening and treatment of depression especially in high risk patients like married or divorced female and less-educated patients may be of great

  4. Evaluation of a potential parathyroid dysfunction under treatment with radioactive iodine of benign thyroid diseases; Pruefung einer potentiellen strahleninduzierten Nebenschilddruesenfunktionsstoerung waehrend einer Radioiodtherapie benigner Schilddruesenerkrankung

    Energy Technology Data Exchange (ETDEWEB)

    Schumacher, Serena Christine

    2011-09-28

    The intention of the present thesis was the evaluation of a potential parathyroid dysfunction under treatment with radioactive iodine of benign thyroid diseases. It was to be examined whether a change in the parathyroid function would arise within the first week on treatment. So far there are some minor studies existing describing significant changes in the parathyroid hormone serum level within the first months after radioactive iodine therapy of benign and malignant thyroid diseases. Moreover, it is a fact that external beam-radiotherapy can induce neoplasia and that the risk for the subsequent development of primary hyperparathyroidism doubles or triples after external beam-radiotherapy of the head and neck. Up to now, however, an increased incidence for primary hyperparathyroidism following treatment with radioactive iodine ({sup 131}I) could not be proved. At the department of nuclear medicine of the university hospital Giessen-Marburg GmbH, location Marburg, a prospective cohort study was executed on radioactive iodine therapy of benign thyroid diseases with 105 probands (75 women / 30 men, mean age 60.62 ± 14.3 years). According to their thyroid diseases these 105 probands were classified into following subgroups: thyroid adenoma with 23 patients, multifocal thyroid autonomy with 8 patients, disseminated thyroid autonomy with 37 patients as well as the subgroup Graves' hyperthyroidism (without Graves' ophtalmopathy) and accordingly Graves' disease (with Graves' ophtalmopathy) with 37 patients. The serum level of the intact parathyroid hormone was determined directly before starting the radioactive iodine therapy on the admission day and on day 1, 3 and 5 of the radioactive iodine therapy as well as at the ambulant follow-up examination one month after the start of the therapy. In case of 99 of 105 probands the serum level of parathyroid hormone declined on treatment with {sup 131}I with its nadir on day 3 of therapy (decline by 15.71 ng

  5. Migration chemistry and behaviour of iodine relevant to geological disposal of radioactive wastes. A literature review with a compilation of sorption data

    International Nuclear Information System (INIS)

    Liu, Y.; Gunten, H.R. von

    1988-09-01

    This report reviews the literature on iodine migration, chemistry and behaviour in the environment up to November 1987. It deals mainly with 129 I released from a land repository, with particular consideration of the Swiss scenario for the disposal of low- and medium-level radioactive waste. As a background to this review, the basic properties of radioiodine, its distribution, circulation in nature and radiological impact are presented. A large number of sorption and diffusion data for iodine on rocks, sediments, minerals, cements and other materials have been compiled from many different laboratories. Based on this information, an assessment of the sorption and retardation of radioiodine in geomedia is made and methodologies for obtaining sorption distribution ratios (R D values) are discussed. The review also covers natural analogue studies of 129 I, retardation of iodine by cement barriers and the possible influences of organic compounds and microorganisms on the behaviour of iodine. Some possibilities for further research on diffusion measurements and near-field chemistry of radioiodine are outlined. (author) 259 refs., 9 figs., 32 tabs

  6. Iodine removal from a gas phase

    International Nuclear Information System (INIS)

    Vikis, A. Ch.

    1982-01-01

    Iodine, e.g. radioactive iodine, present as one or more organic iodides, optionally with elemental iodine, in a gas phase (e.g. air) are removed by photochemically decomposing the organic iodides to elemental iodine, reacting the iodine produced, and any initially present with excess ozone, preferably photochemically produced in situ in the gas phase to produce solid iodine oxides, and removing the solid oxides from the gas phase. (author)

  7. Iodine removal from a gas phase

    International Nuclear Information System (INIS)

    Vikis, A.C.

    1984-01-01

    Iodine, e.g. radioactive iodine, present as one or more organic iodides, optionally with elemental iodine, in a gas phase (e.g. air) are removed by photochemically decomposing the organic iodides to elemental iodine, reacting the iodine produced, and any initially present with excess ozone, preferably photochemically produced in situ in the gas phase to produce solid iodine oxides, and removing the solid oxides from the gas phase

  8. Removal efficiency of radioactive cesium and iodine ions by a flow-type apparatus designed for electrochemically reduced water production.

    Directory of Open Access Journals (Sweden)

    Takeki Hamasaki

    Full Text Available The Fukushima Daiichi Nuclear Power Plant accident on March 11, 2011 attracted people's attention, with anxiety over possible radiation hazards. Immediate and long-term concerns are around protection from external and internal exposure by the liberated radionuclides. In particular, residents living in the affected regions are most concerned about ingesting contaminated foodstuffs, including drinking water. Efficient removal of radionuclides from rainwater and drinking water has been reported using several pot-type filtration devices. A currently used flow-type test apparatus is expected to simultaneously provide radionuclide elimination prior to ingestion and protection from internal exposure by accidental ingestion of radionuclides through the use of a micro-carbon carboxymethyl cartridge unit and an electrochemically reduced water production unit, respectively. However, the removability of radionuclides from contaminated tap water has not been tested to date. Thus, the current research was undertaken to assess the capability of the apparatus to remove radionuclides from artificially contaminated tap water. The results presented here demonstrate that the apparatus can reduce radioactivity levels to below the detection limit in applied tap water containing either 300 Bq/kg of 137Cs or 150 Bq/kg of 125I. The apparatus had a removal efficiency of over 90% for all concentration ranges of radio-cesium and -iodine tested. The results showing efficient radionuclide removability, together with previous studies on molecular hydrogen and platinum nanoparticles as reactive oxygen species scavengers, strongly suggest that the test apparatus has the potential to offer maximum safety against radionuclide-contaminated foodstuffs, including drinking water.

  9. The Incidence of Hypothyroidism Following the Radioactive Iodine Treatment of Graves’ Disease and the Predictive Factors Influencing its Development

    International Nuclear Information System (INIS)

    Husseni, Maha Abd El-Kareem El-Sayed

    2016-01-01

    The purpose of this study is to evaluate and compare the incidence of hypothyroidism following different fixed radioactive iodine-131 ( 131 I) activities in the treatment of Graves’ disease (GD) and to investigate the predictive factors that may influence its occurrence. This retrospective analysis was performed on 272 patients with GD who were treated with 131 I, among whom 125 received 370 MBq and 147 received 555 MBq. The outcome was categorized as hypothyroidism, euthyroidism, and persistent hyperthyroidism. Multiple logistic regression analysis was performed to identify significant risk factors that affect the development of hypothyroidism. The incidence of hypothyroidism following the first low activity was 24.8% with a high treatment failure rate of 58.4%, compared with 48.3% and 32% following high activity. The overall cumulative incidence of hypothyroidism following repeated activities was 50.7%, out of which 73.9% occurred after the first activity and 20.3% after the second activity. The higher 131 I activity (P < 0.001) and average and mild enlargement of the thyroid gland (P = 0.004) were identified as significant independent factors that increase the rate of incidence of hypothyroidism (Odds ratios were 2.95 and 2.59). No correlation was found between the development of hypothyroidism and the factors such as age, gender, presence of exophthalmos, previous antithyroid medications, and the durations, and Technetium-99m (Tc-99m) pertechnetate thyroid uptake. In view of the high treatment failure rate after first low activity and lower post high activity hypothyroid incidence, high activity is recommended for GD patients, reserving the use of 370MBq for patients with average sized and mildly enlarged goiter; this increases patient convenience by avoiding multiple activities to achieve cure and long-term follow-up

  10. Cost-utility analysis comparing radioactive iodine, anti-thyroid drugs and total thyroidectomy for primary treatment of Graves' disease.

    Science.gov (United States)

    Donovan, Peter J; McLeod, Donald S A; Little, Richard; Gordon, Louisa

    2016-12-01

    Little data is in existence about the most cost-effective primary treatment for Graves' disease. We performed a cost-utility analysis comparing radioactive iodine (RAI), anti-thyroid drugs (ATD) and total thyroidectomy (TT) as first-line therapy for Graves' disease in England and Australia. We used a Markov model to compare lifetime costs and benefits (quality-adjusted life-years (QALYs)). The model included efficacy, rates of relapse and major complications associated with each treatment, and alternative second-line therapies. Model parameters were obtained from published literature. One-way sensitivity analyses were conducted. Costs were presented in 2015£ or Australian Dollars (AUD). RAI was the least expensive therapy in both England (£5425; QALYs 34.73) and Australia (AUD5601; 30.97 QALYs). In base case results, in both countries, ATD was a cost-effective alternative to RAI (£16 866; 35.17 QALYs; incremental cost-effectiveness ratio (ICER) £26 279 per QALY gained England; AUD8924; 31.37 QALYs; ICER AUD9687 per QALY gained Australia), while RAI dominated TT (£7115; QALYs 33.93 England; AUD15 668; 30.25 QALYs Australia). In sensitivity analysis, base case results were stable to changes in most cost, transition probabilities and health-relative quality-of-life (HRQoL) weights; however, in England, the results were sensitive to changes in the HRQoL weights of hypothyroidism and euthyroidism on ATD. In this analysis, RAI is the least expensive choice for first-line treatment strategy for Graves' disease. In England and Australia, ATD is likely to be a cost-effective alternative, while TT is unlikely to be cost-effective. Further research into HRQoL in Graves' disease could improve the quality of future studies. © 2016 European Society of Endocrinology.

  11. Leptin and ghrelin concentration in hyperthyroid cats before and after radioactive iodine therapy compared to euthyroid control cats.

    Science.gov (United States)

    Marsilio, Sina; Glanemann, Barbara; Martin, Lucile; Szladovits, Balazs; Neiger, Reto

    2017-04-19

    Leptin and ghrelin, two peptide hormones with antagonistic effects on satiety and energy balance, could be involved in the pathogenesis of weight loss and polyphagia in cats with hyperthyroidism. Leptin generally decreases appetite and increases energy expenditure, while ghrelin exerts the opposite effects. Leptin and ghrelin were measured in 42 client owned hyperthyroid cats with a body condition score (BCS) ≤ 5/9 before (T0) and 4 weeks after radioactive iodine treatment (RAIT) (T1). Dependent on the serum total thyroxine concentration concentration at T1, cats were sub-classified as still hyperthyroid (ht-ht) (n = 4), euthyroid (ht-eu) (n = 10) or hypothyroid (ht-hypo) (n = 28). Results were compared to those of 22 healthy, euthyroid control cats with a comparable BCS (≤ 5/9) and age (≥ 8 years) to hyperthyroid cats. At T0, there were no significant differences between hyperthyroid and control cats for leptin (p = 0.06) or ghrelin concentrations (p = 0.27). At T1, leptin significantly decreased in ht-hypo cats compared to T0 (p = 0.0008) despite a significantly increased body weight in this group (p = 0.0001). Serum ghrelin concentrations did not differ between hyperthyroid cats with a history of polyphagia compared to non-polyphagic cats (p = 0.42). After RAIT, ghrelin concentration significantly increased in all hyperthyroid cats (p weight in different states of thyroid dysfunction; increasing ghrelin concentrations after RAIT suggest a ghrelin-independent mechanism for polyphagia in hyperthyroid cats.

  12. Radioimmunoguided surgery using iodine 125 B72.3 in patients with colorectal cancer

    International Nuclear Information System (INIS)

    Cohen, A.M.; Martin, E.W. Jr.; Lavery, I.; Daly, J.; Sardi, A.; Aitken, D.; Bland, K.; Mojzisik, C.; Hinkle, G.

    1991-01-01

    Preliminary data using B72.3 murine monoclonal antibody labeled with iodine 125 suggested that both clinically apparent as well as occult sites of colorectal cancer could be identified intraoperatively using a hand-held gamma detecting probe. We report the preliminary data of a multicenter trial of this approach in patients with primary or recurrent colorectal cancer. One hundred four patients with primary, suspected, or known recurrent colorectal cancer received an intravenous infusion of 1 mg of B72.3 monoclonal antibody radiolabeled with 7.4 x 10 Bq of iodine 125. Twenty-six patients with primary colorectal cancer and 72 patients with recurrent colorectal cancer were examined. Using the gamma detecting probe, 78% of the patients had localization of the antibody in their tumor; this included 75% of primary tumor sites and 63% of all recurrent tumor sites; 9.2% of all tumor sites identified represented occult sites detected only with the gamma detecting probe. The overall sensitivity was 77% and a predictive value of a positive detection was 78%. A total of 30 occult sites in 26 patients were identified. In patients with recurrent cancer, the antibody study provided unique data that precluded resection in 10 patients, and in another eight patients it extended the potentially curative procedure

  13. Long term effect of radioactive iodine treatment in nontoxic multinodular goitre

    International Nuclear Information System (INIS)

    Nygaard, B.; Hegedues, L.; Gervil, M.; Hjalgrim Jensen, H.; Soee-Jensen, P.; Moelholm hansen, J.E.

    1994-01-01

    The aim of this study was to investigate the long term effect of 131 I treatment on thyroid function and size in patients with non-toxic multinodular goitre. The subjects were 69 consecutive patients with multinodular non-toxic goitre selected for 131 I treatment and followed for a minimum of 12 months. Outcome measures were standard thyroid function variable and ultrasonically determined thyroid volume before and after treatment. Fifty-nine patients were treated with a single dose of 131 I, 12 with tow doses, and one with four doses. In 45 patients treated with one dose who remained euthyroid the median thyroid volume was reduced from 73 (interquartile range 50-106) ml to 29 (interquartile range 23-48) ml at 24 months. The median reuction was 40 (22-48) ml, half of which occurred within three months. Patients treated with two doses as well as those developing hypo- or hyper-thyroidism also had a significant reduction in thyroid volume. Eleven patients develeoped hypothyroidism (cumulative five year risk 22%). Side effects were few. In conclusion we find that 131 I treatment of multinodular non-toxic goitre is an attractive alternative to surgery. (au) (19 refs.)

  14. Volatilization of iodine from vegetation

    International Nuclear Information System (INIS)

    Amiro, B.D.; Johnston, F.L.

    1989-01-01

    Gaseous emissions of iodine were measured from bean plant foliage. A gamma-emitting iodine tracer, Na 125 I, was taken up by the plants from a hydroponic growth medium and released to a cuvette atmosphere. The dynamics of the flux were studied using a flow-through gamma detector. The relationship between leaf radioactive tracer activity and growth-medium activity was linear, as was the relationship between the iodine flux and both leaf and growth-medium activity. Iodine flux and leaf conductance to water responded similarly to changes in light levels, suggesting that the stomata may partially control the flux. The flux was inhibited by aeration of the hydroponic growth media, and we postulate that methylation causes the iodine flux. Iodine emissions from living vegetation probably contribute < 0.1% to the stable iodine concentration in the atmosphere above terrestrial areas. However, this pathway may be a direct route for radioactive iodine transport from contaminated soils to the atmosphere. (author)

  15. Establishment of an animal model of internal exposure to radioactive iodine

    Energy Technology Data Exchange (ETDEWEB)

    Nitta, Y.; Hoshi, M. [Research Institute for Radiation Biology and Medicine, Hiroshima (Japan); Endo, S. [Hiroshima Univ., Hiroshima (Japan)

    2002-07-01

    Age is a potent modifier of the thyroid cancer risk at internal as well as external exposure. The short latency for the development of thyroid cancer in the post-Chernobyl cases proposes us to make sure the thyroid susceptibility to internal exposure at young ages. At the beginning of a large-scale carcinogenesis experiment for the induction of thyroid cancer by the internal exposure of 131 I into rats, we established the way to estimate absorbed doses in the thyroid and total body of rats at different ages: newborn, puberty and adult. Female rats of the Fischer 344 strain were exposed to {sub 131} I at the age of 1, 4 and 9 weeks, and have been kept for 16 days (twice of the {sub 131} I-half life) to draw kinetic curves of the isotope in the thyroid and total body. We drew the standard curve to estimate absorbed fraction of radioactivity from {beta} - and {gamma} -rays from the {sub 131} I in the thyroids of different sizes, because the thyroid size differs depending on age. Then we drew the standard curve to estimate absorbed doses in the thyroid and total body from the injected activities. Irradiation at 1 week of age caused heavier exposure than at 4 and 9 weeks of ages by 8 times in the thyroid. We tested the acute effects of radiation on the thyroid epithelium at the three ages. Radiation-induced apoptosis and post apoptotic cell proliferation of the thyroid epithelium were investigated. Apoptosis was not obvious in all the three age groups. Labeling index of the proliferating cell nuclear antigen (PCNA) increased in the 4 weeks old groups of both SD and IDD treatment. While in the 9 weeks old groups, it increased only by the treatment of IDD. One-week-old rats did not show any increase in the cell proliferation activity by{sub 60} Co {gamma} -irradiation, and did show small increase in the Sodium- {sub 131} I ( {sub 131} I)-injected IDD group.

  16. A Dual Reporter Iodinated Labeling Reagent for Cancer Positron Emission Tomography Imaging and Fluorescence-Guided Surgery

    Science.gov (United States)

    2018-01-01

    The combination of early diagnosis and complete surgical resection offers the greatest prospect of curative cancer treatment. An iodine-124/fluorescein-based dual-modality labeling reagent, 124I-Green, constitutes a generic tool for one-step installation of a positron emission tomography (PET) and a fluorescent reporter to any cancer-specific antibody. The resulting antibody conjugate would allow both cancer PET imaging and intraoperative fluorescence-guided surgery. 124I-Green was synthesized in excellent radiochemical yields of 92 ± 5% (n = 4) determined by HPLC with an improved one-pot three-component radioiodination reaction. The A5B7 carcinoembryonic antigen (CEA)-specific antibody was conjugated to 124I-Green. High tumor uptake of the dual-labeled A5B7 of 20.21 ± 2.70, 13.31 ± 0.73, and 10.64 ± 1.86%ID/g was observed in CEA-expressing SW1222 xenograft mouse model (n = 3) at 24, 48, and 72 h post intravenous injection, respectively. The xenografts were clearly visualized by both PET/CT and ex vivo fluorescence imaging. These encouraging results warrant the further translational development of 124I-Green for cancer PET imaging and fluorescence-guided surgery. PMID:29388770

  17. Immobilization of iodine in concrete

    International Nuclear Information System (INIS)

    Clark, W.E.; Thompson, C.T.

    1977-01-01

    A method for immobilizing fission product radioactive iodine recovered from irradiated nuclear fuel comprises combining material comprising water, Portland cement and about 3 to 20 wt percent iodine as Ba(IO 3 ) 2 to provide a fluid mixture and allowing the fluid mixture to harden, said Ba(IO 3 ) 2 comprising said radioactive iodine. An article for solid waste disposal comprises concrete prepared by this method. 10 claims, 2 figures

  18. Cement materials for cesium and iodine confinement

    International Nuclear Information System (INIS)

    Nicolas, G.; Lequeux, N.; Boch, P.; Prene, S.

    2001-01-01

    The following topics were dealt with: radioactive waste storage, cement materials reacting with radioactive cesium and iodine, chemical barrier formation against radioactive pollution, ceramization, long term stability, XRD, PIXE analysis

  19. Suppression of [sup 125]I-uptake in mouse thyroid by seaweed feeding; Possible preventative effect of dietary seaweed on internal radiation injury of the thyroid by radioactive iodine

    Energy Technology Data Exchange (ETDEWEB)

    Maruyama, Hiroko; Yamamoto, Ichiro (Kitasato Univ., Sagamihara, Kanagawa (Japan). School of Hygienic Sciences)

    1992-12-01

    We conducted an animal experiment to determine how dietary seaweeds rich in iodine and dietary fibers suppress radioactive iodine uptake by the thyroid, using mice and four kinds of experimental diets, three with 1% or 2% powdered fronds of the kelp Laminaria religiosa and 2% powdered laver Porphyra yezoensis, and one with cellulose. Iodine content of a hot-water extract of the kelp was 0.530[+-]0.001%, and its dietary fiber (DF) values were 52.8[+-]1.2%. Iodine in an extract of the laver was 0.008[+-]0.001%, and its DF values were 41.4%[+-]0.7%. A statistically significant reduction of [sup 125]I uptake by the thyroid, 3 hours after intragastric administration of the radionuclide at a dosage of 18.5 kBq or 185 kBq in 0.3 ml aqueous solution per mouse, was observed in mice previously fed the experimental diets containing 1% and 2% kelp during periods varying from 24 hours to 7 days. The degree of the suppression was observed to depend on the amount of iodine in the diet or in the injected sample, no matter whether organic or inorganic, judging from the results of an additional experiment. Thus, we conclude that previously fed iodine-rich material, especially dietary seaweeds rich in iodine and other minerals, vitamins, and [beta]-carotene, such as kelps or laver supplemented with inorganic iodine, may be effective in prevention of internal radiation injury of the thyroid. (author).

  20. Treatment of hepatocellular carcinoma adjacent to large blood vessels using 1.5T MRI-guided percutaneous radiofrequency ablation combined with iodine-125 radioactive seed implantation

    Energy Technology Data Exchange (ETDEWEB)

    Lin, Zheng-Yu, E-mail: linsinlan@yahoo.com.cn [The Department of Radiology, First Affiliated Hospital of Fujian Medical University, 20 Chazhong Road, Fuzhou 350005 (China); Chen, Jin, E-mail: snow8968851@163.com [The Department of Radiology, First Affiliated Hospital of Fujian Medical University, 20 Chazhong Road, Fuzhou 350005 (China); Deng, Xiu-Fen, E-mail: dxf197286@yahoo.com.cn [The Department of Radiology, First Affiliated Hospital of Fujian Medical University, 20 Chazhong Road, Fuzhou 350005 (China)

    2012-11-15

    Objective: The objective is to study the technology associated with and feasibility of the treatment of hepatocellular carcinoma (HCC) adjacent to large blood vessels using 1.5T MRI-guided radiofrequency ablation combined with iodine-125 (I-125) radioactive seed implantation. Methods: Sixteen patients with a total of 24 HCC lesions (average maximum diameter: 2.35 {+-} 1.03 cm) were pathologically confirmed by biopsy or clinically diagnosed received 1.5T MRI-guided percutaneous radiofrequency ablation (RFA) treatment. Each patient had one lesion adjacent to large blood vessels ({>=}3 mm); after the ablation, I-125 radioactive seeds were implanted in the portions of the lesions that were adjacent to the blood vessels. Results: All the ablations and I-125 radioactive seed implantations were successful; a total of 118 seeds were implanted. The ablated lesions exhibited hypointense signals on the T2WI sequence with a thin rim of hyperintense signals; they also exhibited significant hyperintense signals on the T1WI sequence with clear boundaries. The average follow-up period was 11.1 {+-} 6.2 months. There were 23 complete responses and one partial response in the 24 lesions. The alpha-fetoprotein (AFP) levels of the patients significantly decreased. Conclusion: The 1.5T MRI-guided RFA combined with I-125 radioactive seed implantation for the treatment of HCC adjacent to large blood vessels is an effective technology.

  1. Iodine tablets and a nuclear accident

    International Nuclear Information System (INIS)

    Paile, W.

    1992-01-01

    Radioactive iodine is one of the major substances released during severe nuclear accidents. Radioactive iodine is easily gasified, and if present in fallout it can enter the lungs, and thereby the circulatory system, with the inhalation of air. Once in a body, radioactive iodine accumulates in the thyroid and may result in tumours in the thyroid and, in extreme cases, impaired thyroid function. Accumulation of radioactive iodine can be prevented by taking non-radioactive, 'cold' iodine as tablets. Iodine tablets dilute the radioactive iodine that has entered the body. A dose of iodine also paralyses the thyroid temporarily by saturating its iodine-carrying capacity. To be useful iodine tablets should be taken immediately when a radioactive emission has occurred. If the tablets are taken too early or too late, they give little protection. Iodine tablets should not be taken just to be on the safe side, since their use may involve harmful side effects. Dosing instructions should also be followed with care. (orig.)

  2. Iodine Deficiency

    Science.gov (United States)

    ... Fax/Phone Home » Iodine Deficiency Leer en Español Iodine Deficiency Iodine is an element that is needed ... world’s population remains at risk for iodine deficiency. Iodine Deficiency FAQs WHAT IS THE THYROID GLAND? The ...

  3. Treatment and separation of radioactive fission products tritium, rare gases and iodine in nuclear fuel reprocessing plants

    Energy Technology Data Exchange (ETDEWEB)

    Schnez, H.

    1975-07-15

    Rare gases must be separated from the process off-gases of the head-end of the Purex and Thorex processes. To achieve high decontamination factors, the quantity of off-gas should be kept as low as possible. For rare gas separation, there are two possible methods of routing the off-gas: (a) the open flushing gas circuit, in which the purified off-gas (generally air) is passed off via the stack and (b) the closed circuit in which the off-gas (nitrogen or rare gases) is recycled to the dissolver after purification. Tritium must not be entrained into the second extraction cycle or be emitted with off-gases in the form of water vapor (HTO) or HT, but must remain completely in the aqueous phase. Most of the process water is recycled, as a result of which the tritium becomes concentrated in it. This tritiated water is then subjected to tritium rectification at a suitable point in the process. Iodine is very difficult to isolate to a small number of process stages. Present aim is to release the iodine in the dissolver stage into the off-gas, so as to prevent it being entrained into the extraction part. By the injection of hot nitrogen or water vapor into the dissolver or into iodine-containing condensates, all of the iodine is passed into the gaseous phase. Scrubbers can also be used together with iodine-containing condensates to adjust the scrubbing solution. Capital cost of separation plants account for 1 to 10 percent of the total cost of the reprocessing installation, and even more if a sophisticated tritium separation system is required. (DLC)

  4. Evolución oftalmológica en pacientes hipertiroideos tratados con yodo radiactivo Ophthalmological evolution in hyperthyroid patients treated with radioactive iodine

    Directory of Open Access Journals (Sweden)

    María Teresa Marrero Rodríguez

    2005-08-01

    Full Text Available El objetivo del presente estudio fue realizar un análisis de la evolución oftalmológica en pacientes hipertiroideos tratados con yodo radiactivo. Se estudiaron 100 casos (88 mujeres y 12 hombres procedentes de la consulta de tiroides del Instituto Nacional de Endocrinología, con diagnóstico clínico y bioquímico de hipertiroidismo y con una edad media de 40 ± 10 años. Estos pacientes fueron sometidos a un tratamiento con yodo radiactivo a una dosis de 80 µCi/g de tejido tiroideo. A cada uno de ellos se le realizó una oftalmometría bilateral antes del tratamiento y 12 meses después de este. La oftalmometría media del ojo derecho antes del tratamiento fue de 14,51 ± 2,86 mm y posterior al tratamiento de 13,92 ± 2,83 mm, mientras que para el ojo izquierdo fue de 14,98 ± 2,91 mm y 14,27 ± 2,83 mm, respectivamente. Teniendo en cuenta los resultados de la oftalmometría, concluimos que el uso del yodo radiactivo en el tratamiento de pacientes hipertiroideos no tuvo efectos negativos sobre la evolución oftalmológica de los pacientes estudiados.This study was aimed at analyzing the ophthalmolgical evolution in hyperthyroid patients treated with radioactive iodine. 100 patients (88 females and 12 males from the thyroid department of the National Institute of Endocrinology with clinical and biochemical diagnosis of hyperthyroidism and with a mean age of 40 ± 10 years old, were studied. These patients underwent a treatment with radioactive iodine at a dose of 80 m Ci/g of thyroid tissue. A bilateral ophthalmometry was performed to each patient before the treatment and 12 months after it. Mean ophthalmometry of the right eye was 14.51 ± 2.86 mm before the treatment and 13.92 ± 2.83 mm after the treatment, whereas for the left eye it was 14.98 ± 2.91 mm and 14.27 ± 2.83 mm , respectively. Taking into account the results of the ophthalmometry, we concluded that the use of radioactive iodine in the treatment of hyperthyroid patients had

  5. Can thyroid parotid ratio replace radioactive iodine uptake as a new objective parameter in the evaluation of thyroid function in cases of hyperthyroidism? A comparative study

    International Nuclear Information System (INIS)

    Malhotra, G.; Seshadri, N.; Gupta, A.; Das, B.K.; Gambhir, S.; Pradhan, P.K.; Bhagat, J.K.

    2002-01-01

    Aim: Radioactive iodine uptake (RAIU) measurements are used to distinguish other causes of thyrotoxicosis from hyperthyroidism. However it is a cumbersome technique requiring patients' visit for two or more days. Thyroid to parotid ratio (TP ratio) which is a ratio of Technetium-99m pertechnetate counts in thyroid to those in parotid glands is a new objective parameter for evaluation of thyroid function. The aim of present study was to compare TP ratio with RAIU in patients of thyrotoxicosis. Materials and Methods: The study group comprised of 15 patients (13 males and 2 females) who were clinically and biochemically hyperthyroid. All of these patients underwent Tc-99m pertechnetate thyroid scintigraphy followed by RAIU on two separate occasions. The technetium thyroid scan was done 20 minutes after intravenous application of 185 MBq (5 mCi) of the radiotracer. Both anterior and oblique views of the neck region were acquired under a standard large field of view gamma camera with LEAP collimation. The TP ratio was calculated from anterior view by drawing the region of interest over the thyroid and two regions of interest over each parotid gland. The counts of thyroid region were compared with each parotid and average of two sides was taken as TP ratio. The radioactive iodine uptake was estimated at 2,4,24, and 48 hours after oral administration of 925 KBq (25 microcuries) of I-131 in all patients with a thyroid probe by the standard technique. Apart from this 10 controls (5 males and 5 females) who were clinically and biochemically euthyroid were also included in the study and they underwent same studies as the cases. All patients with nodular disease of thyroid, past history of thyroiditis and parotitis were excluded from the study. Results: The scintigraphic findings in all patients revealed a diffusely concentrating thyroid gland with no evidence of hot or cold areas. The RAIU and TP ratio in both cases and controls is presented.: S.E: Standard error. There was a

  6. The influence of radioactive contamination and iodine prophylaxis after Chernobyl accident on the thyroid morphology and function of the inhabitants of Poznan region

    International Nuclear Information System (INIS)

    Gembicki, M.; Sowinski, J.; Ruchala, M.; Bednarek, J.

    1991-01-01

    The radioactive contamination of Poznan region was recognized after Chernobyl accident as average. The predicted values of minimal (inhalation) and maximal (inhalation and ingestion) committed dose equivalent to the thyroid varied from 2.5 (min) to 24.7 (max) mSv in different groups of adults and children. To follow up the results of iodine prophylaxis and some aspects of possible thyroid gland morphological and functional changes 11086 persons were carefully investigated clinically and biochemically. Among these 11086 persons were 42.6% males and 57.4% females both adults from 17 till 40 year and children up to 16 years. The following parameters were reviewed: pregnancy, time of residence in the region, thyroid abnormalities, family history concerning thyroid diseases, iodine intake in April and May 1986 with possible side effects, changes in the thyroid size observed before and after 1986, degree and kind of thyroid enlargement, serum concentration of T 3 , T 4 , TSH, ATMA and ATG titration and finally the effectiveness of thyroid blockade at 24, 48 and 72 h after ingestion of Lugol's solution. Side effects of the ingestion of potassium iodine from 30-70 mg were observed in 153 cases, 36 of them consulted medicals doctors but in no case the side effects (dominated by vomiting) threatened the life. The data obtained indicated the existence in Poznan. Region the goiter endemic because 27.5% of investigated children and adults had goiter classified as grades O-B, I, II and III. The elevation or diminution of T 3 values were noted in 1164 cases, for T 4 in 418 cases and for TSH in 1412 cases. The presence of anti membrane and anti thyroglobulin antibodies were observed in 303 cases. (author). 18 refs, 3 figs, 18 tabs

  7. The iodine reactivity

    International Nuclear Information System (INIS)

    2003-01-01

    The iodine is an important element because it has long life isotopes (such as iodine 129) and a great mobility in natural media. Iodine presents a complex chemistry because of its volatility and its strong redox reactivity. The S.E.C.R. works to better understand the reactivity of this element in different natural, industrial or biological environments. It plays a part in thermochemical sites as a possible way of hydrogen formation. This seminar gives some aspects relative to the chemical reactivity of iodine, since its thermochemistry in the I/S cycles to produce hydrogen to its reactivity in the natural medium and its potential radiological impact. This document includes 4 presentations transparencies) dealing with: the 129 I cycle rejected in the low radioactive gaseous and liquid effluents of the La Hague reprocessing plant (C. Frechou); a bibliographic review of iodine retention in soils (F. Bazer-Bachi); the hydrogen production and the iodine/sulfur thermochemical cycle (role of iodine in the process); and the direct characterization by electro-spray ionization mass spectroscopy of iodine fixation by fulvic acids (P. Reiller, B. Amekraz, C. Moulin, V. Moulin)

  8. Psychological and behavioral intervention improves the quality of life and mental health of patients suffering from differentiated thyroid cancer treated with postoperative radioactive iodine-131

    Directory of Open Access Journals (Sweden)

    Wu HX

    2016-05-01

    Full Text Available Hong-Xia Wu,1,* Hua Zhong,2,3,* Yue-Dong Xu,1 Cui-Ping Xu,4 Ying Zhang,5 Wei Zhang1 1Department of Endocrinology, Shandong Provincial Qianfoshan Hospital, Shandong University, 2Department of Oncology, Shandong University of Traditional Chinese Medicine, 3Department of Traditional Chinese Medicine, Shandong Provincial Qianfoshan Hospital, Shandong University, 4Department of Nursing, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, Shandong, 5Department of Nursing, Tianjin Chest Hospital, Tianjing, People’s Republic of China *These authors contributed equally to this work Background: We examined the effects of psychological and behavioral intervention on health-related quality of life and mental health among patients suffering from differentiated thyroid cancer (DTC treated with postoperative radioactive iodine-131 (RAI.Methods: Sixty patients with DTC, undergoing RAI, were randomly assigned to receive either conventional nursing (n=30 or a 1-year psychological and behavioral intervention based on conventional nursing (n=30. Health-related quality of life and mental health issues, depression, and anxiety were measured using the Quality of Life Core Questionnaire, Self-rating Depression Scale, and Self-rating Anxiety Score, respectively.Results: After RAI treatment, patients in both groups showed improved functional capacities (ie, physical, role, cognitive, emotional, and social and global quality of life, along with reduced depression and anxiety (P<0.05. At 1-year follow-up, compared with patients in the routine nursing group, those in the psychological and behavioral intervention group demonstrated greater improvements in functional capacities, global quality of life, and depression and anxiety symptoms (P<0.05.Conclusion: Psychological and behavioral interventions for patients with DTC undergoing RAI facilitated positive outcomes, suggesting that nursing care models that include psychological and behavioral interventions

  9. Marking with radioactive iodine of a plasma substitute and preliminary essays of his kinetic behaviour in rats; Marcacao com radioiodo de um sucedaneo do plasma e ensaios preliminares de seu comportamento cinetico em ratos

    Energy Technology Data Exchange (ETDEWEB)

    Cova, Wilma Guimaraes

    1973-07-01

    A blood plasma substitute (Haem accel - PGO), which has as a base a degraded and polymerized gelatin, was labelled with radioactive iodine (I-131) and preliminary essays of its kinetic behavior was done. We have used the labelling method of McFarlaner. The results obtained - radiochemical yield and purity - were favorable. The kinetic behaviour the residual radioactivity studied by measuring the residual radioactivity of the body and excreta in groups of male Wistar rats for a maximum period of 150 hours. These results have shown and excellent correlation for a two components exponential function's adjustment, suggesting therefore a bi compartmental mathematical model. (author)

  10. Marking with radioactive iodine of a plasma substitute and preliminary essays of his kinetic behaviour in rats; Marcacao com radioiodo de um sucedaneo do plasma e ensaios preliminares de seu comportamento cinetico em ratos

    Energy Technology Data Exchange (ETDEWEB)

    Cova, Wilma Guimaraes

    1973-07-01

    A blood plasma substitute (Haem accel - PGO), which has as a base a degraded and polymerized gelatin, was labelled with radioactive iodine (I-131) and preliminary essays of its kinetic behavior was done. We have used the labelling method of McFarlaner. The results obtained - radiochemical yield and purity - were favorable. The kinetic behaviour the residual radioactivity studied by measuring the residual radioactivity of the body and excreta in groups of male Wistar rats for a maximum period of 150 hours. These results have shown and excellent correlation for a two components exponential function's adjustment, suggesting therefore a bi compartmental mathematical model. (author)

  11. Thyrotoxicosis caused by functioning metastatic thyroid carcinoma. A rare and elusive cause of hyperthyroidism with low radioactive iodine uptake

    International Nuclear Information System (INIS)

    Ober, K.P.; Cowan, R.J.; Sevier, R.E.; Poole, G.J.

    1987-01-01

    A patient with progressively worsening thyrotoxicosis, refractory to medical therapy, is described. Repeated measurements of thyroidal RAI uptake over a 13 month period were low consistently and could not be explained by iodine ingestion, thyroiditis, or administration of exogenous thyroid hormone. An I-131 scan ultimately revealed striking activity at the base of the skull, reflecting ectopic excessive production of thyroid hormone by a solitary functioning metastatic thyroid carcinoma. The thyrotoxic state resolved after large doses of therapeutic I-131. Typical features of this rare cause of hyperthyroidism are discussed

  12. Iodine volatility

    International Nuclear Information System (INIS)

    Beahm, E.C.; Shockley, W.E.

    1984-01-01

    The ultimate aim of this program is to couple experimental aqueous iodine volatilities to a fission product release model. Iodine partition coefficients, for inorganic iodine, have been measured during hydrolysis and radiolysis. The hydrolysis experiments have illustrated the importance of reaction time on iodine volatility. However, radiolysis effects can override hydrolysis in determining iodine volatility. In addition, silver metal in radiolysis samples can react to form silver iodide accompanied by a decrease in iodine volatility. Experimental data are now being coupled to an iodine transport and release model that was developed in the Federal Republic of Germany

  13. Investigating an organ-targeting platform based on hydroxyapatite nanoparticles using a novel in situ method of radioactive ¹²⁵Iodine labeling.

    Science.gov (United States)

    Ignjatović, Nenad; Vranješ Djurić, Sanja; Mitić, Zarko; Janković, Drina; Uskoković, Dragan

    2014-10-01

    In this study, we have investigated the synthesis of nanoparticles of hydroxyapatite (HAp) and hydroxyapatite coated with chitosan (HAp/Ch) and the chitosan-poly-d,l-lactide-co-glycolide polymer blend (HAp/Ch-PLGA) as an organ-targeting system. We have examined and defined the final destination, as well as the dynamics and the pathways of the synthesized particles following intravenous administration in vivo. The XRD, ZP, FT-IR and SEM analyses have confirmed that the hydroxyapatite nanoparticles with d50=72 nm are coated with polymers. Radioactive 125-Iodine ((125)I), a low energy gamma emitter, was used to develop a novel in situ method for the radiolabeling of particles and investigation of their biodistribution. (125)I-labeled particles exhibited high stability in saline and serum over the second day, which justified their use in the following in vivo studies. The biodistribution of (125)I-labeled particles after intravenous injection in rats differed significantly: HAp particles mostly targeted the liver, HAp/Ch the spleen and the liver, while HAp/Ch-PLGA targeted the lungs. Twenty-four hours post injection, HAp particles were excreted completely, while both (125)I-HAp/Ch and (125)I-HAp/Ch-PLGA were retained in the body for a prolonged period of time with more than 20% of radioactivity still found in different organs. Copyright © 2014 Elsevier B.V. All rights reserved.

  14. Prophylactic iodine treatment in radiation protection

    International Nuclear Information System (INIS)

    Oberhausen, E.

    1980-01-01

    Prophylactic iodine treatment is to prevent accumulation of radioactive iodine in the thyroid. This is done by administering a large amount of stable iodine before uptake of radioactive iodine so that further accummulation of iodine in the thyroid will be impossible. This blocking effect should be as complete as possible. This is achieved by administering an initial dose of 200 mg potassium iodide. As the release of radioactive iodine may last several hours or even days; for this reason, maintenance doses of 100 mg potassium iodide should be administered in 8-hour intervals. The risk of prophylactiv iodine treatment is rather low; however, provocation of latent hyperthyreoses must be expected in, at the most, 0.2% of the exposed population. (orig./MG) [de

  15. CLINICAL EVALUATION OF PREOPERATIVE SKIN PREPARATION WITH AQUEOUS POVIDONE IODINE ONLY AND IN COMBINATION WITH ALCHOLIC CHLORHEXIDINE IN PATIENTS UNDERGOING ELECTIVE AND EMERGENCY SURGERIES

    Directory of Open Access Journals (Sweden)

    Latchu

    2015-10-01

    Full Text Available INTRODUCTION: Many techniques are there for skin preparation before surgery, the commonest being initial scrub with antiseptic soap solution, followed by painting the prepared area with antiseptic paint solution. But degerming of the skin can be done with antiseptics us ed for less than one minute which is as effective as five minute scrub with germicidal soap solution followed by painting with antiseptics . AIMS AND OBJECTIVES : 1. To evaluate the efficacy of povidone iodine alone and antiseptic agent containing alcoholic chlorhexidine with povidone iodine in preoperative skin preparation by taking swab culture. 2. To compare the rate of postoperative wound infection in both the groups . METHODS: STUDY DESIGN: Comparative study conducted on 100 patients in two groups. STUDY SETTING: Sri Venkateswara Medical College Tirupathi SOURCE OF DATA: 100 Patients (50 in each Group undergoing elective and emergency surgery admitted in the Department of General Surgery in S.V.R.R. Government General Hospital, Tirupati from 2013 to 2014. INCLUSION CRITERIA: 1. Patients undergoing elective & emergency surgery in department of general surgery. 2. Patients with no focus of infection anywhere on the body. 3. Patients irrespective of their age and sex. 4. Patients neither immunocompromised nor on any long term steroids. 5. Patients undergoing mes h repair of hernia are also included. EXCLUSION CRITERIA: 1. Immuno compromised patients and patients on long term steroids. 2. Patients with septicemia. 3. Patients suffering from malignancies or undergoing chemotherapy or radiation therapy. 4. Contaminat ed surgeries in which viscus was opened were excluded from the study. 5. Patients with co - morbid medical conditions like diabetes, hypertension etc. METHOD OF COLLECTION OF DATA: In each case preoperatively, detailed history was taken and routine investiga tions like haemoglobin, total count, differential count, ESR, RBS and chest X - ray, ultrasound were done to

  16. Iodine isotopes and radiation safety

    International Nuclear Information System (INIS)

    Styro, B.; Nedvekajte, T.; Filistovich, V.

    1992-01-01

    Methods of concentration determination of stable and radioactive iodine isotopes in the Earth's different geospheres are described. Iodine isotopes concentration data, chemical forms and transformations as well as their exchange among separate geospheres of their global biochemical circulation (ocean, atmosphere, lithosphere and biosphere) are presented. Information on iodine isotopes as after-effects of nuclear installations accident (in particular, the Chernobyl accident) is generalized. The book is intended for scientists and practical workers in ecology and radioactivity protection and for a students of physics. 442 refs.; 82 figs.; 36 tabs

  17. Experimental dosimetry and kinetics of radioactive tracers for human applications: example of therapeutic injection of Lipiodol labelled with Iodine 131

    International Nuclear Information System (INIS)

    Ahmed Mahidi, N.

    1992-10-01

    We have evaluated the radiation dose received by the liver and lungs for 10 patients with a hepatic carcinoma after surgical operation followed by a therapeutic dose of Lipiodol labelled with iodine 131. The cumulated activities have been obtained by using a calibrated gamma camera. Fixation and kinetics of the I 131 Lipiodol in normal and cancers livers have been measured with the determination of the effective and biological half-lives. The calculated doses are based on the MIRD method. Results confirm that Lipiodol fixation is important in the liver at J1 (about 74% of the injected activity). Its elimination is essentially urinary, pulmonary fixation remained low, the dose received by the healthy part of liver is acceptable. These values have been compared with those obtained by another method using a thermoluminescent dosimeter (LiF) installed on the skin over the liver. Comparison between results obtained by the 2 methods shows a good correlation

  18. Alternative Dose for Choroidal Melanoma Treated With an Iodine-125 Radioactive Plaque: A Single-Institution Retrospective Study

    International Nuclear Information System (INIS)

    Saconn, Paul A.; Gee, Christopher J.; Greven, Craig M.; McCoy, Thomas P.; Ekstrand, Kenneth E.; Greven, Kathryn M.

    2010-01-01

    Purpose: The Collaborative Ocular Melanoma Study (COMS) established iodine-125 plaque brachytherapy as an accepted standard treatment for medium-size choroidal melanoma. In the COMS, the prescription dose was 85 Gy. This is a retrospective review of our outcomes in patients treated with lower doses than those used in the COMS. Methods and Materials: From 1990 to 2004, 62 patients were treated with iodine-125 plaque brachytherapy for choroidal melanoma. COMS eye plaques were used with dose prescribed to the apex of the tumor. The median and average dose rates at the tumor apex were 63.5 cGy/h and 62.7 cGy/h, respectively. The median and average total doses were 63.0 Gy and 62.5 Gy (range, 56-69 Gy), respectively. The median and mean durations of implant were 100.0 hours and 101.1 hours (range, 71-165 hours). Results: Median follow-up time was 58.2 months. The 5-year outcomes including overall survival, disease-free survival, cause-specific survival, local failure, secondary enucleation rate, and visual acuity (VA) <20/200 were estimated using the Kaplan-Meier method. Overall, there were 7 local failures, 4 distant failures, and 10 secondary enucleations (6 due to local failure and 4 due to treatment complications). Univariate analysis was performed to identify significant prognostic factors associated with disease-free survival (baseline VA in tumor eye, tumor shape), cause-specific survival (diabetic retinopathy), local failure (none found), secondary enucleation rate (diabetic retinopathy, basal tumor dimension) and VA <20/200 (diabetic retinopathy, tumor shape, age, retinal detachment, treatment depth, and history of vision-limiting condition). Conclusions: Our survival and local control outcomes are comparable to those of the COMS. However, VA at 5 years seems to be better. Lower doses of radiation could potentially lead to better visual outcomes.

  19. Immobilization of iodine in concrete

    Science.gov (United States)

    Clark, Walter E.; Thompson, Clarence T.

    1977-04-12

    A method for immobilizing fission product radioactive iodine recovered from irradiated nuclear fuel comprises combining material comprising water, Portland cement and about 3-20 wt. % iodine as Ba(IO.sub.3).sub.2 to provide a fluid mixture and allowing the fluid mixture to harden, said Ba(IO.sub.3).sub.2 comprising said radioactive iodine. An article for solid waste disposal comprises concrete prepared by this method. BACKGROUND OF THE INVENTION This invention was made in the course of, or under a contract with the Energy Research and Development Administration. It relates in general to reactor waste solidification and more specifically to the immobilization of fission product radioactive iodine recovered from irradiated nuclear fuel for underground storage.

  20. Radioactive iodine in thyroid medicine-How it started in Sweden and some of today's challenges

    Energy Technology Data Exchange (ETDEWEB)

    Mattsson, Soeren; Nosslin, Bertil [Malmoe Univ. Hospital (Sweden). Dept. of Radiation Physics; Johansson, Lennart [Univ. Hospital, Umeaa (Sweden). Dept. of Radiation Physics; Joensson, Helene [Swedish Radiation Protection Authority, Stockholm (Sweden)

    2006-12-15

    The paper describes the start of the clinical use of radioiodine, the various iodine isotopes available, measurement techniques and dosimetry. There are still problems to solve in relation to an optimal clinical use of radioiodine. One of the remaining challenges is to get consensus about the goal of the treatment of hyperthyreosis, as well as about a method for individual absorbed dose calculations. Careful dose estimates will prevent unnecessary radiation exposure and constitute a base for a future optimised radioiodine therapy. For the dose calculation, it is important to understand if there is any clinically significant temporary reduction in the ability of thyroid tissue to trap or retain {sup 131}I-iodide following prior administration of a diagnostic activity of {sup 131}I-iodide (stunning of the thyroid). This may be of special concern in connection with treatment of thyroid cancer and its metastases. Finally, the production capacity, availability and delivery of {sup 123}I have to be improved to increase clinical access to this radionuclide, which is optimal for diagnostic imaging and which gives lower absorbed dose and therefore also less risk for thyroid stunning than {sup 131}I.

  1. Investigating an organ-targeting platform based on hydroxyapatite nanoparticles using a novel in situ method of radioactive {sup 125}Iodine labeling

    Energy Technology Data Exchange (ETDEWEB)

    Ignjatović, Nenad [Centre for Fine Particles Processing and Nanotechnologies, Institute of Technical Sciences of the Serbian Academy of Science and Arts, Knez Mihailova 35/4, 11000 Belgrade (Serbia); Vranješ Djurić, Sanja [Laboratory for Radioisotopes, Vinča Institute of Nuclear Sciences, University of Belgrade, PO Box 522, 11001 Belgrade (Serbia); Mitić, Žarko [Faculty of Medicine, Department of Pharmacy, University of Niš, Bulevar dr Zorana Đinđića 81, 18000 Niš (Serbia); Janković, Drina [Laboratory for Radioisotopes, Vinča Institute of Nuclear Sciences, University of Belgrade, PO Box 522, 11001 Belgrade (Serbia); Uskoković, Dragan, E-mail: dragan.uskokovic@itn.sanu.ac.rs [Centre for Fine Particles Processing and Nanotechnologies, Institute of Technical Sciences of the Serbian Academy of Science and Arts, Knez Mihailova 35/4, 11000 Belgrade (Serbia)

    2014-10-01

    In this study, we have investigated the synthesis of nanoparticles of hydroxyapatite (HAp) and hydroxyapatite coated with chitosan (HAp/Ch) and the chitosan-poly-D,L-lactide-co-glycolide polymer blend (HAp/Ch-PLGA) as an organ-targeting system. We have examined and defined the final destination, as well as the dynamics and the pathways of the synthesized particles following intravenous administration in vivo. The XRD, ZP, FT-IR and SEM analyses have confirmed that the hydroxyapatite nanoparticles with d{sub 50} = 72 nm are coated with polymers. Radioactive 125-Iodine ({sup 125}I), a low energy gamma emitter, was used to develop a novel in situ method for the radiolabeling of particles and investigation of their biodistribution. {sup 125}I-labeled particles exhibited high stability in saline and serum over the second day, which justified their use in the following in vivo studies. The biodistribution of {sup 125}I-labeled particles after intravenous injection in rats differed significantly: HAp particles mostly targeted the liver, HAp/Ch the spleen and the liver, while HAp/Ch-PLGA targeted the lungs. Twenty-four hours post injection, HAp particles were excreted completely, while both {sup 125}I-HAp/Ch and {sup 125}I-HAp/Ch-PLGA were retained in the body for a prolonged period of time with more than 20% of radioactivity still found in different organs. - Highlights: • An organ-targeting carrier based on nano-hydroxyapatite • In situ labeling • Biodistribution of {sup 125}I-labeled HAp particles.

  2. Iodine Deficiency

    NARCIS (Netherlands)

    Zimmermann, M.B.

    2009-01-01

    Iodine deficiency has multiple adverse effects in humans, termed iodine deficiency disorders, due to inadequate thyroid hormone production. Globally, it is estimated that 2 billion individuals have an insufficient iodine intake, and South Asia and sub-Saharan Africa are particularly affected.

  3. Radionuclide Basics: Iodine

    Science.gov (United States)

    ... Centers Radiation Protection Contact Us Share Radionuclide Basics: Iodine Iodine (chemical symbol I) is a chemical element. ... in the environment Iodine sources Iodine and health Iodine in the Environment All 37 isotopes of iodine ...

  4. Destruction of post-surgery thyroid remnants by 19 mCi (703 MBq) of iodine 131

    International Nuclear Information System (INIS)

    Tassy, D.; Lonchampt, M.F.; Minebois, A.; Antigny, J.F.

    1997-01-01

    The adjuvant treatment by iodine 131 in good prognostic forms of differentiated thyroid cancers (DTC) makes not the object of a general consensus. There is no study demonstrating the benefit from such a treatment. Administration of an elevated iodine 131 activity and the constraint of a supplementary hospitalization are in these conditions questionable. In 6 patients, presenting the criteria of good prognostic and in post-operation, ambulatory conditions, administration of 19 mCi (703 MBc) of iodine 131 was done without previous administration of tracing dosage, followed after 72 hours by a whole-body scintigraphy, in the usual pause conditions. This administration was repeated 6 to 12 months later and followed by a new scintigraphic examination. The cervical fixation of iodine 131 was established qualitatively and quantitatively (as compared with a control zone). Five/six patients presented initially a cervical intense fixation with the star-like usual image and 1/6 patient a moderated fixation. Beginning with the second administration no cervical fixation was noted in 4/6 patients and a very low fixation in 2/6 patients. The concomitantly measured thyroglobulin, under simulation by TSH endogenous, was 131 I after quasi-total thyroidectomy in good-prognostic forms of DTC, without administration of previous tracing dosage to avoid possible phenomena of thyroid tissue blocking, allows probably, in overwhelming majority of cases, both a full or quasi-full destruction of the thyroid remnants and a severe reduction in the thyroglobulin rate measured in the conditions of pause of hormone-therapy

  5. Effect of acupuncture for radioactive-iodine-induced anorexia in thyroid cancer patients: a randomized, double-blinded, sham-controlled pilot study.

    Science.gov (United States)

    Jeon, Ju-Hyun; Yoon, Jeungwon; Cho, Chong-Kwan; Jung, In-Chul; Kim, Sungchul; Lee, Suk-Hoon; Yoo, Hwa-Seung

    2015-05-01

    The aim of this study is to evaluate the efficacy and safety of acupuncture for radioactive iodine (RAI)-induced anorexia in thyroid cancer patients. Fourteen thyroid cancer patients with RAI-induced anorexia were randomized to a true acupuncture or sham acupuncture group. Both groups were given 6 true or sham acupuncture treatments in 2 weeks. Outcome measures included the change of the Functional Assessment of Anorexia and Cachexia Treatment (FAACT; Anorexia/Cachexia Subscale [ACS], Functional Assessment of Cancer Therapy-General [FACT-G]), Visual Analogue Scale (VAS), weight, body mass index (BMI), ACTH, and cortisol levels. The mean FAACT ACS scores of the true and sham acupuncture groups increased from baseline to exit in intention-to-treat (ITT) and per protocol (PP) analyses; the true acupuncture group showed higher increase but with no statistical significance. Between groups, from baseline to the last treatment, statistically significant differences were found in ITT analysis of the Table of Index (TOI) score (P = .034) and in PP analysis of the TOI (P = .016), FACT-G (P = .045), FAACT (P = .037) scores. There was no significant difference in VAS, weight, BMI, ACTH, and cortisol level changes between groups. Although the current study is based on a small sample of participants, our findings support the safety and potential use of acupuncture for RAI-induced anorexia and quality of life in thyroid cancer patients. © The Author(s) 2015.

  6. The use of a new radioactive-iodine labeled lipid marker to follow in vivo disposition of liposomes: comparison with an encapsulated aqueous space marker

    International Nuclear Information System (INIS)

    Abra, R.M.; Schreier, H.; Szoka, F.C.

    1982-01-01

    The in vivo disposition of multilamellar liposomes extruded at 0.6 micrometers (PC/DPPA/CH/ alpha-T . 4:1:5:0.1 molar ratio) when injected i.v. into mice has been examined utilizing a novel iodinatable phospholipid derivative as a lipid phase marker (p-hydroxybenzamidine phosphatidylethanolamine: 125 I-BPE) and compared to that using 14 C-inulin as an aqueous phase marker. At times up to 5 h post-dose the disposition of both markers was essentially identical with the exception of blood and intestine, where 125 I-BPE levels were consistently higher than 14 C-inulin levels. At time intervals from 5-72 h post-dose 125 I-BPE levels in all the organs examined were lower than those of 14 C-inulin. These differences in the behaviour of the two labels may be explained in terms of exchange of the iodinated lipids, excretion of released inulin and long term metabolism of the lipid marker. We conclude tha 125 I-BPE is a useful marker for following liposome disposition in short-term studies particularly in view of the easily quantifiable nature of gamma-radioactivity which obviates the need for sample preparation

  7. Hypothyroidism and hyponatremia: data from a series of patients with iatrogenic acute hypothyroidism undergoing radioactive iodine therapy after total thyroidectomy for thyroid cancer.

    Science.gov (United States)

    Vannucci, L; Parenti, G; Simontacchi, G; Rastrelli, G; Giuliani, C; Ognibene, A; Peri, A

    2017-01-01

    The aim of the present study was to evaluate the role of hypothyroidism as a cause of hyponatremia in a clinical model of iatrogenic acute hypothyroidism due to thyroid hormone withdrawal prior to ablative radioactive iodine (RAI) therapy after total thyroidectomy. The study group consisted of 101 differentiated thyroid cancer (DTC) patients (77 women and 24 men). Plasma concentration of thyroid-stimulating hormone ([TSH]) and sodium ([Na + ]) was evaluated before total thyroidectomy (pre[TSH] and pre[Na + ]) and on the day of RAI therapy (post[TSH] and post[Na + ]). The frequency of hypothyroidism-associated hyponatremia was 4 % (4/101). Pre[Na + ] was significantly higher than post[Na + ] (140.7 ± 1.6 vs 138.7 ± 2.3 mEq/L, p = 0.012). Moreover, a linear correlation was identified between pre[Na + ] and post[Na + ]. Iatrogenic acute hypothyroidism-related hyponatremia is uncommon. However, because of the significant reduction of [Na + ] in the transition from euthyroidism to iatrogenic hypothyroidism, the value of pre[Na + ] should be viewed as a parameter to be considered. Since it acts as an independent risk factor for the development of hyponatremia, patients with a pre[Na + ] close to the lower limit of normal range may deserve a closer monitoring of [Na + ].

  8. Evaluation of Salivary Gland Dysfunction Using Salivary Gland Scintigraphy in Sjoegren's Syndrome Patients and in Thyroid Cancer Patients after Radioactive Iodine Therapy

    Energy Technology Data Exchange (ETDEWEB)

    Kang, Ji Yeon; Jang, Su Jin; Lee, Won Woo; Jang, Sung June; Lee, Yun Jong; Kim, Sang Eun [Seoul National Univ., Seoul (Korea, Republic of)

    2011-09-15

    Salivary gland scintigraphy (SGS) provides an objective means of diagnosing salivary gland dysfunction in Sjogren's syndrome (SS) patients and in thyroid cancer patients after radioactive iodine (RAI) therapy. In the present study, SGS was performed in SS patients and in thyroid cancer patients post RAI, and scintigraphic parameters were compared. Twenty eight SS patients (males:females=1:27, age 53.3{+-}11.9 years), 28 controls (males:females=3.25, age 54.1{+-}10.1 years), and 92 thyroid cancer patients (males:females=28:64, age 46.2{+-}12.9) who had undergone a session of high dose RAI therapy (mean dose, 5.2{+-}1.5 GBq) were included. SGS was performed using Tc 99m pertechnetate (925MBq). Scintigraphic parameters (parotid uptake ratio PU, submandibular uptake ratio SU, percent age parotid excretion %PE, and percentage submandibular excretion %SE) were measured and compared for SS, thyroid cancer post RAI, and control patients. PU, SU, %SE, and %PE were all significantly lower in SS than in post RAI thyroid cancer of control patients (p<0.05), whereas only %PE was significantly lower in post RAI thyroid cancer patients than in controls (P<0.05). SU and %SE were found to be correlated with the unstimulated whole salivary flow rate. Scintigraphic parameters derived from SGS can play a crucial role in the detection of salivary gland dysfunction in SS patients and in post RAI thyroid cancer patients.

  9. Evaluation of Salivary Gland Dysfunction Using Salivary Gland Scintigraphy in Sjoegren's Syndrome Patients and in Thyroid Cancer Patients after Radioactive Iodine Therapy

    International Nuclear Information System (INIS)

    Kang, Ji Yeon; Jang, Su Jin; Lee, Won Woo; Jang, Sung June; Lee, Yun Jong; Kim, Sang Eun

    2011-01-01

    Salivary gland scintigraphy (SGS) provides an objective means of diagnosing salivary gland dysfunction in Sjogren's syndrome (SS) patients and in thyroid cancer patients after radioactive iodine (RAI) therapy. In the present study, SGS was performed in SS patients and in thyroid cancer patients post RAI, and scintigraphic parameters were compared. Twenty eight SS patients (males:females=1:27, age 53.3±11.9 years), 28 controls (males:females=3.25, age 54.1±10.1 years), and 92 thyroid cancer patients (males:females=28:64, age 46.2±12.9) who had undergone a session of high dose RAI therapy (mean dose, 5.2±1.5 GBq) were included. SGS was performed using Tc 99m pertechnetate (925MBq). Scintigraphic parameters (parotid uptake ratio PU, submandibular uptake ratio SU, percent age parotid excretion %PE, and percentage submandibular excretion %SE) were measured and compared for SS, thyroid cancer post RAI, and control patients. PU, SU, %SE, and %PE were all significantly lower in SS than in post RAI thyroid cancer of control patients (p<0.05), whereas only %PE was significantly lower in post RAI thyroid cancer patients than in controls (P<0.05). SU and %SE were found to be correlated with the unstimulated whole salivary flow rate. Scintigraphic parameters derived from SGS can play a crucial role in the detection of salivary gland dysfunction in SS patients and in post RAI thyroid cancer patients.

  10. A Randomized Controlled Trial for the Effectiveness of Aromatherapy in Decreasing Salivary Gland Damage following Radioactive Iodine Therapy for Differentiated Thyroid Cancer.

    Science.gov (United States)

    Nakayama, Michihiro; Okizaki, Atsutaka; Takahashi, Koji

    2016-01-01

    Objective. The aim of this study was to investigate effects of aromatherapy in decreasing salivary gland damage for patients undergoing radioactive iodine (RAI) therapy with differentiated thyroid cancer (DTC). Materials and Methods. The subjects were 71 patients with DTC. They were divided into aromatherapy group (group A, n = 35) and a control group (group B, n = 36). We blended 1.0 mL of lemon and 0.5 mL of ginger essential oils. The patients in the inhalation aromatherapy group inhaled this blend oil and those in the control group inhaled distilled water as placebo for 10 min during admission. We statistically compared salivary gland function before and after treatment between groups A and B. Results. In comparison with group B, the rate of change of the accumulation rate was significantly higher in the parotid glands and submandibular glands of group A ( P aromatherapy in the prevention of treatment-related salivary gland disorder. This trial is registered with UMIN Clinical Trial Registry: UMIN000013968.

  11. Clinical evolution of hyperthyroid patients treated with radioactive iodine and/or propylthiouracil, at Hospital Nacional de Geriatria y Gerontologia: January 2005 - August 2010

    International Nuclear Information System (INIS)

    Gutierrez Delgado, Alejandro

    2011-01-01

    The epidemiological and clinical characteristics of the elderly population with hyperthyroidism disorders are presented. The integral valuation was performed in the external consultation endocrinology of Hospital Nacional de Geriatria y Gerontologia. The approach to 81 patients with radioactive iodine and/or propylthiouracil is determined, its clinical evolution and possible side adverse effects to established treatment. An instrument was designed for the collection of data in the clinical records of the patients studied. The ANOVA analysis and Bonferroni Post Hoc test is performed to compare quantitative variables. The crossing of qualitative variables has used the Chi square with a confidence level of 95%. The toxic multinodular goiter has resulted the main etiology of the disease. The 24.7% of patients have presented cognitive impairment, 27.2% have showed suspicion of depressive disorders. Weight loss has been the most frequent suggestive clinical symptom and propylthiouracil the main antithyroid treatment. Better detection in such patients is obtained and has helped to establish in a timely manner the best available therapeutic. Likewise, morbidity is reduced [es

  12. A Randomized Controlled Trial for the Effectiveness of Aromatherapy in Decreasing Salivary Gland Damage following Radioactive Iodine Therapy for Differentiated Thyroid Cancer

    Directory of Open Access Journals (Sweden)

    Michihiro Nakayama

    2016-01-01

    Full Text Available Objective. The aim of this study was to investigate effects of aromatherapy in decreasing salivary gland damage for patients undergoing radioactive iodine (RAI therapy with differentiated thyroid cancer (DTC. Materials and Methods. The subjects were 71 patients with DTC. They were divided into aromatherapy group (group A, n=35 and a control group (group B, n=36. We blended 1.0 mL of lemon and 0.5 mL of ginger essential oils. The patients in the inhalation aromatherapy group inhaled this blend oil and those in the control group inhaled distilled water as placebo for 10 min during admission. We statistically compared salivary gland function before and after treatment between groups A and B. Results. In comparison with group B, the rate of change of the accumulation rate was significantly higher in the parotid glands and submandibular glands of group A (P<0.05. In comparison with group B, a significant increase in rate of secretion change before and after treatment was noted in the bilateral parotid glands in group A (P<0.05. Conclusion. Because an amelioration of salivary gland function was observed in the present study, our results suggest the efficacy of aromatherapy in the prevention of treatment-related salivary gland disorder. This trial is registered with UMIN Clinical Trial Registry: UMIN000013968.

  13. Separation of iodine-131 from water using isotopic exchange with iodine-starch compound

    International Nuclear Information System (INIS)

    Ignatov, V.P.; Kolomejtseva, I.V.

    1990-01-01

    Conditions of iodine isotopic exchange with iodine-starch compound (ISC) were studied with the aim of compound utilizatoin for radioactive iodine separation from solution. It is shown that in pH range from 2 to 7 the degree of iodine extraction and coefficient of its distribution practically do not depend on pH, at pH>7 ISC destruction (decolorizing) starts and iodine extraction decreases. Rapid method of iodine separation from solution is suggested. The method can be used in radiochemical techniques. The degree of extraction equals 80 %, a higher degree of extraction can not be achieved owing to ISC formation peculiarities

  14. Volatilization of iodine from vegetation

    Energy Technology Data Exchange (ETDEWEB)

    Amiro, B D; Johnston, F L [Atomic Energy of Canada Ltd., Pinawa, MB (Canada). Whiteshell Nuclear Research Establishment

    1989-01-01

    Gaseous emissions of iodine were measured from bean plant foliage. A gamma-emitting iodine tracer, Na {sup 125}I, was taken up by the plants from a hydroponic growth medium and released to a cuvette atmosphere. The dynamics of the flux were studied using a flow-through gamma detector. The relationship between leaf radioactive tracer activity and growth-medium activity was linear, as was the relationship between the iodine flux and both leaf and growth-medium activity. Iodine flux and leaf conductance to water responded similarly to changes in light levels, suggesting that the stomata may partially control the flux. The flux was inhibited by aeration of the hydroponic growth media, and we postulate that methylation causes the iodine flux. Iodine emissions from living vegetation probably contribute < 0.1% to the stable iodine concentration in the atmosphere above terrestrial areas. However, this pathway may be a direct route for radioactive iodine transport from contaminated soils to the atmosphere. (author).

  15. Studies in iodine metabolism. Progress report, April 1975-- March 1976

    International Nuclear Information System (INIS)

    Van Middlesworth, L.

    1976-01-01

    Investigations during the past twelve months have included the following subjects: factors which influence release of radioiodine from thyroid glands; contamination of commercially available low-iodine diets; effects of hypoxia on release of iodine from thyroid glands of rats and mice; development of practical tests for available iodine in low-iodine diets; reproduction and abnormal thyroglobulin of rats maintained on low-iodine diets; observations on radioactivity in animal thyroids; collaboration with other laboratories regarding radium in bovine thyroids

  16. Quantitative method for determination of body inorganic iodine

    International Nuclear Information System (INIS)

    Filatov, A.A.; Tatsievskij, V.A.

    1991-01-01

    An original method of quantitation of body inorganic iodine, based upon a simultaneous administration of a known dose of stable and radioactive iodine with subsequent radiometry of the thyroid was proposed. The calculation is based upon the principle of the dilution of radiactive iodine in human inorganic iodine space. The method permits quantitation of the amount of inorganic iodine with regard to individual features of inorganic space. The method is characterized by simplicity and is not invasive for a patient

  17. Method of removing iodine and compounds thereof from gaseous effluents

    International Nuclear Information System (INIS)

    Keener, R.L.; Kittle, P.A.

    1976-01-01

    Anion exchange resins including an acrylic backbone formed by the suspension polymerization of a mixture of an acrylic and a crosslinking monomer are useful in the removal of iodine and iodine compounds from gaseous effluents. Removal of radioactive iodine contaminants, particularly alkyl iodine compounds or hydrogen iodine, under extreme conditions, namely temperatures up to 180 0 C and humidities up to 100 percent, from effluents resulting from a major nuclear accident could probably be adsorbed by these resins described herein

  18. Transfer of gaseous iodine to Tradescantia

    International Nuclear Information System (INIS)

    Nakamura, Yuji; Ohmomo, Yoichiro.

    1984-01-01

    Transfer rates of gaseous elemental iodine and methyliodide from atmosphere to Tradescantia were investigated in relation to supposed genetic mutation due to radioactive iodine released from nuclear facilities. The estimated transfer rate of elemental iodine to the young buds of Tradescantia, which was given as the ratio of iodine uptake rate per unit weight of the plant to the concentration of the element in the air, was approximately 7 x 10 -2 cm 3 /g.sec, about 30 to 40 times higher than that of methyliodide. The contribution of direct deposition of elemental iodine was suggested to be significant, although methyliodide was mainly absorbed by respiration through stomata of the plant. (author)

  19. Radioactivity

    International Nuclear Information System (INIS)

    Chelet, Y.

    2006-01-01

    The beginning of this book explains the why and how of the radioactivity, with a presentation of the different modes of disintegration. Are tackled the reports between radioactivity and time before explaining how the mass-energy equivalence appears during disintegrations. Two chapters treat natural radioisotopes and artificial ones. This book makes an important part to the use of radioisotopes in medicine (scintigraphy, radiotherapy), in archaeology and earth sciences (dating) before giving an inventory of radioactive products that form in the nuclear power plants. (N.C.)

  20. Radioactivity

    International Nuclear Information System (INIS)

    2002-01-01

    This pedagogical document presents the origin, effects and uses of radioactivity: where does radioactivity comes from, effects on the body, measurement, protection against radiations, uses in the medical field, in the electric power industry, in the food (ionization, radio-mutagenesis, irradiations) and other industries (radiography, gauges, detectors, irradiations, tracers), and in research activities (dating, preservation of cultural objects). The document ends with some examples of irradiation levels (examples of natural radioactivity, distribution of the various sources of exposure in France). (J.S.)

  1. Is radioactive iodine-131 treatment related to the occurrence of non-synchronous second primary malignancy in patients with differentiated thyroid cancer?

    International Nuclear Information System (INIS)

    Souza, Marcelo Cruzick de; Momesso, Denise P.; Vieira Neto, Leonardo; Vaisman, Mario; Vaisman, Fernanda; Corbo, Rossana; Martins, Rosangela Aparecida Gomes

    2016-01-01

    Objective: Much controversy relates to the risk of non-synchronous second primary malignancies (NSSPM) after radioactive iodine treatment (RAI-131) in differentiated thyroid cancer (DTC) patients. This study evaluated the relationship between RAI-131 and NSSPM in DTC survivors with long-term follow-up. Materials and methods: Retrospective analysis of 413 DTC cases was performed; 252 received RAI-131 and 161 were treated with thyroidectomy alone. Exclusion criteria were: prior or synchronous non-thyroidal malignancies (within the first year), familial syndromes associated to multiple neoplasms, ionizing radiation exposure or second tumors with unknown histopathology. Results: During a mean follow-up of 11.0 ± 7.5 years, 17 (4.1%) patients developed solid NSSPM. Patients with NSSPM were older than those without (p = 0.02). RAI-131 and I-131 cumulative activity were similar in patients with and without NSSPM (p = 0.18 and p = 0.78, respectively). Incidence of NSSPM was 5.2% in patients with RAI-131 treatment and 2.5% in those without RAI-131 (p = 0.18). Using multivariate analysis, RAI-131 was not significantly associated with NSSPM occurrence (p = 0.35); age was the only independent predictor (p = 0.04). Under log rank statistical analysis, after 10 years of follow-up, it was observed a tendency of lower NSSPM-free survival among patients that received RAI-131 treatment (0.96 vs. 0.87; p = 0.06), what was not affected by age at DTC diagnosis. Conclusion: In our cohort of DTC survivors, with a long-term follow-up period, RAI-131 treatment and I-131 cumulative dose were not significantly associated with NSSPM occurrence. A tendency of premature NSSPM occurrence among patients treated with RAI-131 was observed, suggesting an anticipating oncogenic effect by interaction with other risk factors. (author)

  2. Is radioactive iodine-{sup 131} treatment related to the occurrence of non-synchronous second primary malignancy in patients with differentiated thyroid cancer?

    Energy Technology Data Exchange (ETDEWEB)

    Souza, Marcelo Cruzick de; Momesso, Denise P.; Vieira Neto, Leonardo; Vaisman, Mario, E-mail: dmomesso@terra.com.br [Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, (Brazil). Servico de Endocrinologia; Vaisman, Fernanda; Corbo, Rossana [Instituto Nacional do Cancer (INCA), Rio de Janeiro, RJ (Brazil). Servico de Endocrinologia; Martins, Rosangela Aparecida Gomes [Hospital Universitario Clementino Fraga Filho (HUCFF), Rio de Janeiro, RJ (Brazil). Divisao de Pesquisa

    2016-02-15

    Objective: Much controversy relates to the risk of non-synchronous second primary malignancies (NSSPM) after radioactive iodine treatment (RAI-131) in differentiated thyroid cancer (DTC) patients. This study evaluated the relationship between RAI-131 and NSSPM in DTC survivors with long-term follow-up. Materials and methods: Retrospective analysis of 413 DTC cases was performed; 252 received RAI-131 and 161 were treated with thyroidectomy alone. Exclusion criteria were: prior or synchronous non-thyroidal malignancies (within the first year), familial syndromes associated to multiple neoplasms, ionizing radiation exposure or second tumors with unknown histopathology. Results: During a mean follow-up of 11.0 ± 7.5 years, 17 (4.1%) patients developed solid NSSPM. Patients with NSSPM were older than those without (p = 0.02). RAI-131 and I-131 cumulative activity were similar in patients with and without NSSPM (p = 0.18 and p = 0.78, respectively). Incidence of NSSPM was 5.2% in patients with RAI-131 treatment and 2.5% in those without RAI-131 (p = 0.18). Using multivariate analysis, RAI-131 was not significantly associated with NSSPM occurrence (p = 0.35); age was the only independent predictor (p = 0.04). Under log rank statistical analysis, after 10 years of follow-up, it was observed a tendency of lower NSSPM-free survival among patients that received RAI-131 treatment (0.96 vs. 0.87; p = 0.06), what was not affected by age at DTC diagnosis. Conclusion: In our cohort of DTC survivors, with a long-term follow-up period, RAI-131 treatment and I-131 cumulative dose were not significantly associated with NSSPM occurrence. A tendency of premature NSSPM occurrence among patients treated with RAI-131 was observed, suggesting an anticipating oncogenic effect by interaction with other risk factors. (author)

  3. Clinical management and outcomes in patients with hyperfunctioning distant metastases from differentiated thyroid cancer after total thyroidectomy and radioactive iodine therapy.

    Science.gov (United States)

    Qiu, Zhong-Ling; Shen, Chen-Tian; Luo, Quan-Yong

    2015-02-01

    Hyperfunctioning distant metastasis (HFDM) from differentiated thyroid cancer (DTC) is a rare entity. This study aimed to assess the outcomes of DTC patients presenting with HFDM after total thyroidectomy and radioactive iodine therapy. A total of 5367 DTC patients treated with (131)I after total thyroidectomy were analyzed retrospectively from January 1991 to June 2013. Therapeutic efficacy was evaluated based on changes in serum thyroglobulin (Tg) and anatomical imaging changes in metastatic lesions. The relationships between survival time and several variables were assessed by univariate and multivariate analyses using the Kaplan-Meier method and Cox's proportional hazards model respectively. Thirty-eight patients with HFDM from DTC were diagnosed, including four with hyperthyroidism, four with subclinical hyperthyroidism, and three with subclinical hypothyroidism. The remaining 27 were euthyroid. Of 25 patients with lung metastases, 84% (21/25) showed disappearance or shrinkage of lung nodules; of 24 patients with bone metastases, 66.67% (16/24) exhibited no obvious imaging changes in metastatic bone lesions after (131)I therapy. Serum Tg decreased significantly in 81.58% (31/38) and increased in 18.42% (7/38) after (131)I therapy. The 10-year survival rate of DTC patients with HFDM was 65.79% (25/38). Multivariate analyses identified age at occurrence of distant metastases (thyroid cancer (PTC; p=0.032, NA, and 0.043) as independent predictors of survival. The response of hyperfunctioning lung metastases to (131)I treatment was better than that of non-hyperfunctioning lung metastases in DTC, while hyperfunctioning bone metastases responded similarly compared to non-hyperfunctioning bone metastases. Patients younger than 45 years at occurrence of distant metastases, those with only lung metastases, and patients with PTC had better prognoses.

  4. Volatility of ruthenium-106, technetium-99, and iodine-129, and the evolution of nitrogen oxide compounds during the calcination of high-level, radioactive nitric acid waste

    International Nuclear Information System (INIS)

    Rimshaw, S.J.; Case, F.N.; Tompkins, J.A.

    1980-02-01

    The nitrate anion is the predominant constituent in all high-level nuclear wastes. Formic acid reacts with the nitrate anion to yield noncondensable, inert gases (N 2 or N 2 O), which can be scrubbed free of 106 Ru, 129 I, and 99 Tc radioactivities prior to elimination from the plant by passing through HEPA filters. Treatment of a high-level authentic radioactive waste with two moles of formic acid per mole of nitrate anion leads to a low RuO 4 volatility of about 0.1%, which can be reduced to an even lower level of 0.007% on adding a 15% excess of formic acid. Without pretreatment of the nitrate waste with formic acid, a high RuO 4 volatility of approx. 35% is observed on calcining a 4.0 N HNO 3 solution in quartz equipment at 350 0 C. The RuO 4 volatility falls to approx. 1.0% on decreasing the initial HNO 3 concentration to 1.0 N or lower. It is postulated that thermal denitration of a highly nitrated ruthenium complex leads to the formation of volatile RuO 4 , while decarboxylation of a ruthenium-formate complex leads to the formation of nonvolatile RuO 2 . Wet scrubbing with water is used to remove RuO 4 from the off-gas stream. In all glass equipment, small amounts of particulate RuO 2 are formed in the gas phase by decomposition of RuO 4 . The 99 Tc volatility was found to vary from 0.2 to 1.4% on calcining HNO 3 and HCOOH (formic acid) solutions over the temperature range of 250 to 600 0 C. These unexpectedly low volatilities of 99 Tc are correlated to the high thermal stability limits of various metal pertechnetates and technetates. Iodine volatilities were high, varying from a low of 30% at 350 0 C to a high of 97% at 650 0 C. It is concluded that with a proper selection of pretreatment and operating conditions the 106 Ru and 99 Tc activities can be retained in the calcined solid with recycle of the wet scrubbing solution

  5. Iodine chemistry in a reactor regulation

    International Nuclear Information System (INIS)

    Powers, D.A.

    1996-01-01

    Radioactive iodine has always been an important consideration in the regulation of nuclear power reactors to assure the health and safety of the public. Regulators adopted conservatively bounding predictions of iodine behavior in the earliest days of the development of nuclear power because there was so little known about either accidents or the chemistry of iodine. Today there is a flood of new information and understanding of the chemistry of iodine under reactor accident conditions. This paper offers some thoughts on how the community of scientists engaged in the study of iodine chemistry can present the results of their work so that it is more immediately adopted by the regulator. It is suggested that the scientific community consider the concept of consensus standards so effectively used within the engineering community to define the status of the study of radioactive iodine chemistry for reactor safety. (author) 9 refs

  6. Iodine chemistry in a reactor regulation

    Energy Technology Data Exchange (ETDEWEB)

    Powers, D A [Nuclear Regulatory Commission, Washington, DC (United States). Advisory Committee on Reactor Safeguards

    1996-12-01

    Radioactive iodine has always been an important consideration in the regulation of nuclear power reactors to assure the health and safety of the public. Regulators adopted conservatively bounding predictions of iodine behavior in the earliest days of the development of nuclear power because there was so little known about either accidents or the chemistry of iodine. Today there is a flood of new information and understanding of the chemistry of iodine under reactor accident conditions. This paper offers some thoughts on how the community of scientists engaged in the study of iodine chemistry can present the results of their work so that it is more immediately adopted by the regulator. It is suggested that the scientific community consider the concept of consensus standards so effectively used within the engineering community to define the status of the study of radioactive iodine chemistry for reactor safety. (author) 9 refs.

  7. Study and development of methodology for radioactive iodine fixation in polymeric substrate for manufacturing sources used in brachytherapy; Estudo e desenvolvimento de metodologia para fixacao de iodo radioativo em substrato polimerico para confeccao de fontes utilizadas em braquiterapia

    Energy Technology Data Exchange (ETDEWEB)

    Rodrigues, Bruna T.; Souza, Carla D.; Benega, Marcos A.G. and others, E-mail: bteigarodrigues@gmail.com, E-mail: carladdsouza@yahoo.com.br, E-mail: marcosagbenega@gmail.com [Instituto de Pesquisas Energeticas e Nucleares (IPEN/CNEN-SP), Sao Paulo, SP (Brazil). Centro de Tecnologia das Radiacoes

    2014-07-01

    According global estimates of Globocan 2012 project of the International Agency for Research of Cancer, of the World Health Organization, there were 14,1 million new cases of cancer and a total of 8,2 million deaths from cancer. Also show that in 2030, the overall load will be 21,4 million new cases and 13,2 million cancer deaths. One of the prostate cancer therapy is brachytherapy, used in early and middle stages of the disease. It is made with the introduction of seeds with radioactive material within the tumor or in nearby regions, affecting the minimum surrounding tissues. The aim of this work is the study and developing the deposition of radioactive iodine on the polymeric substrate method, and an analysis relating the efficiency of the method to implementation in the laboratory of brachytherapy from IPEN. Iodine-125 is adsorbed on an epoxy resin solution. The objective of this study is to offer a new proposal for seeds. The results will give the data for the radiation protection and the procedures for radioactive waste management.

  8. Iodinated bleomycin

    International Nuclear Information System (INIS)

    Lunghi, F.; Riva, P.; Assone, F.; Villa, M.; Plassic, G.

    1978-01-01

    Bleomycin was labelled with iodine-131 by the iodine monochloride method. Iodination did not alter the chemical and chromatographic features and ''in vitro'' stability studies on freeze-dried 131 I-Bleomycin having a specific activity of 1 mCi/mg, stored at different temperatures, showed no appreciable variation of the free-iodine content. Tissue distribution of 131 I-Bleomycin has been evaluated in tumor bearing rats. Patients have been injected with 0.5-1.0 mCi of 131 I-Bleomycin corresponding to a maximum of 1.5 mg. No adverse reactions have been observed. Total body scans have been performed at 2, 6, 24 and 48 hours after injection. The iodinated Bleomycin was rapidly distributed and cleared from the body and showed an early uptake in the neoplastic tissue. A diagnostic accuracy of 90% has been observed in malignant deseases, while no false positive results have been, at the moment, recorded. (author)

  9. Experimental study of contamination by inhalation of radioactive iodine aerosols. Biological balance; Etude experimentale de la contamination par inhalation d'aerosols d'iode radioactif bilan biologique

    Energy Technology Data Exchange (ETDEWEB)

    Marble, G. [Commissariat a l' Energie Atomique, 92 - Fontenay-aux-Roses (France). Centre d' Etudes Nucleaires

    1968-07-01

    Several articles have been published concerning research into contamination produced by inhalation of radioactive iodine aerosols in monkeys. Results dealing with the biological balance of this contamination are presented and discussed in this report. (author) [French] L'etude experimentale de la contamination par inhalation d'aerosols d'iode radioactif effectuee chez le singe a fait l'objet de plusieurs publications. Les resultats concernant le bilan biologique de cette contamination sont presentes et discutes dans ce rapport. (auteur)

  10. The importance of prevention with iodine after nuclear accidents

    International Nuclear Information System (INIS)

    Mornealo, Elena; Chirca, Lucia

    2011-01-01

    Medical negative consequences of the disastrous accident from the Chernobyl are tangible till present and the thyroid pathology has a special place among them. It is caused by the actions of radioactive iodine and can be greatly minimized by the implementation of prophylaxis with stable iodine. The basic principles, benefits and risks of iodine prophylaxis are reported in this article. (authors)

  11. Embolization of an iodine-125 radioactive seed from the prostate gland into the right ventricle: An unusual pattern of seed migration

    International Nuclear Information System (INIS)

    Schild, Michael H.; Wong, William W.; Vora, Sujay A.; Ward, Lynn D.; Nguyen, Ba D.

    2009-01-01

    Transperineal permanent brachytherapy using iodine-125 or palladium-103 seeds is a standard treatment modality for localized prostate cancer. Migration of seeds to the lungs is a common phenomenon, whereas migration of seeds to the right ventricle is a rare event. We report a case of iodine-125 seed migration to the right ventricle as demonstrated by chest CT scan and add to the very few published reports on this finding. These rare patients did not suffer adverse effects from such event.

  12. Recovery of iodine as iodine-125 from biological materials prior to assay

    International Nuclear Information System (INIS)

    Jones, G.B.; Belling, G.B.; Buckley, R.A.

    1979-01-01

    In biological tissues iodine is usually present as iodoamino acids or iodoproteins. The organic material must be oxidised and the iodine converted into iodate prior to the final spectrophotometric determination. At parts per billion (10 9 ) levels, recoveries of added iodine are difficult to measure precisely as iodine can easily be lost from the sample and added inorganic iodine may not be recovered in the same proportions as the naturally occurring iodine. Iodine-125 provides a much more sensitive, specific and accurate means of testing the recovery of nanogram amounts of iodine from biological tissues and it can be incorporated into tissues in the naturally occurring compounds. Plants can be grown in a solution culture containing iodine-125 and animals can be injected with iodine-125 to provide tissues where naturally occurring iodine compounds are labelled with radioactive iodine. These tissues can be used to examine the recovery of iodine after oven drying, freeze drying, alkali ashing and acid digestion of the samples. Experimental details are given for spinach, tobacco, oats, cauliflower and thyroid. Results are given and discussed. (author)

  13. Comparison of fixed low dose versus high dose radioactive iodine for the treatment of hyperthyroidism: retrospective multifactorial analysis impacting the outcome of therapy

    International Nuclear Information System (INIS)

    Suresh Kumar, A.C.; Malhotra, G.; Basu, S.; Asopa, R.V.

    2010-01-01

    Full text: Radioactive iodine ( 131 I) as a fixed dose protocol is widely used for treatment of hyperthyroidism. However, there is no consensus on the best optimum dose for an individual patient. The objectives of this study were to observe the outcome of 131 I therapy in patients of primary hyperthyroidism in relation to fixed low dose versus high dose regimen, impact of antithyroid drugs and influence of thyroid gland size on therapy outcome. Materials and Methods: Study design: Retrospective analysis. Study group included 287 diagnosed patients of primary hyperthyroidism who had undergone 131 I therapy for the first time (68 M, 219 F; Mean age ± S.D.: 43.84 ± 12.53). All patients with low RAIU, thyrocardiac disease were excluded. Details of antithyroid (ATD) drug treatment were recorded. Analysis was done from 2002 till patients became euthyroid/hypothyroid or until January 2010. Each patient's response was evaluated initially at 6 weeks and thereafter every three months. Appropriate statistical tests were applied to compare treatment response between the groups. A P value<0.05 was considered significant. Results: Of 287 patients, 209 patients had been administered low dose (Mean ± S.D.: 4.68 ± 0.62 mCi) while 78 patients had received high dose (Mean ± S.D.: 9.15 ± 1.05 mCi) of radioiodine. 57.9% (121/ 209) patients in the low dose group responded as compared to 75.6% (59/78) in high dose group after a follow up of more than 36 months. Similarly, among patients with and without antithyroid drug treatment, grade II and above goiters the response rates were significantly higher for high dose group as compared to low dose group. Conclusion: We suggest that high dose radioiodine treatment with 8 to 10 mCi is effective in treating hyperthyroidism in patients with a better success rate than the low dose treatment with 3 to 5 mCi. This is also likely to be helpful in patients who have not received antithyroid drugs. It appears that clinically relevant

  14. Dry method for recycling iodine-loaded silver zeolite

    International Nuclear Information System (INIS)

    Thomas, T.R.; Staples, B.A.; Murphy, L.P.

    1978-01-01

    Fission product iodine is removed from a waste gas stream and stored by passing the gas stream through a bed of silver-exchanged zeolite until the zeolite is loaded with iodine, passing dry hydrogen gas through the bed to remove the iodine and regenerate the bed, and passing the hydrogen stream containing the hydrogen iodide thus formed through a lead-exchanged zeolite which absorbs the radioactive iodine from the gas stream and permanently storing the lead-exchanged zeolite loaded with radioactive iodine

  15. Iodine removing means

    International Nuclear Information System (INIS)

    Takeshima, Masaki.

    1975-01-01

    Object: To employ exhaust gas from an incinerator to effect regeneration of an adsorbent such as active carbon which has adsorbed a radioactive gas such as iodine contained in the ventilating system exhaust gas of a boiling water reactor power plant. Structure: Radioactive exhaust gas such as iodine, xenon and krypton is led to an active carbon adsorbing means for removal through adsorption. When the adsorbing function of the active carbon adsorption means is reduced, the exhaust gas discharged from the incinerator is cooled down to 300 0 C and then caused to flow into the active carbon layer, and after depriving it of sulfur dioxide gas, oxides of nitrogen, daughter nuclides resulting from attenuation of radioactive gas and so forth, these being adsorbed by the carbon active layer, it is led again to the incinerator, whereby the radioactivity accompanying the regenerated gas is sealed as ash within the incinerator. Further, similarly accompanying fine active carbon particles and the like are utilized as a heat source for the incinerator. (Kamimura, M.)

  16. Iodine-131 Releases from Radioactive Lanthanum Processing at the X-10 Site in Oak Ridge, Tennessee (1944-1956)- An Assessment of Quantities released, Off-Site Radiation Doses, and Potential Excess Risks of Thyroid Cancer, Volume 1

    International Nuclear Information System (INIS)

    Apostoaei, A.I.; Burns, R.E.; Hoffman, F.O.; Ijaz, T.; Lewis, C.J.; Nair, S.K.; Widner, T.E.

    1999-01-01

    In the early 1990s, concern about the Oak Ridge Reservation's past releases of contaminants to the environment prompted Tennessee's public health officials to pursue an in-depth study of potential off-site health effects at Oak Ridge. This study, the Oak Ridge dose reconstruction, was supported by an agreement between the U.S. Department of Energy (DOE) and the State of Tennessee, and was overseen by a 12-member panel appointed by Tennessee's Commissioner of Health. One of the major contaminants studied in the dose reconstruction was radioactive iodine, which was released to the air by X-10 (now called Oak Ridge National Laboratory) as it processed spent nuclear reactor fuel from 1944 through 1956. The process recovered radioactive lanthanum for use in weapons development. Iodine concentrates in the thyroid gland so health concerns include various diseases of the thyroid, such as thyroid cancer. The large report, ''Iodine-131 Releases from Radioactive Lanthanum Processing at the X-10 Site in Oak Ridge, Tennessee (1944-1956) - An Assessment of Quantities Released, Off-site Radiation Doses, and Potential Excess Risks of Thyroid Cancer,'' is in two volumes. Volume 1 is the main body of the report, and Volume 1A, which has the same title, consists of 22 supporting appendices. Together, these reports serve the following purposes: (1) describe the methodologies used to estimate the amount of iodine-131 (I-131) released; (2) evaluate I-131's pathway from air to vegetation to food to humans; (3) estimate doses received by human thyroids; (4) estimate excess risk of acquiring a thyroid cancer during ones lifetime; and (5) provide equations, examples of historical documents used, and tables of calculated values. Results indicate that females born in 1952 who consumed milk from a goat pastured a few miles east of X-10 received the highest doses from I-131 and would have had the highest risks of contracting thyroid cancer. Doses from cow's milk are considerably less . Detailed

  17. Iodine-131 Releases from Radioactive Lanthanum Processing at the X-10 Site in Oak Ridge, Tennessee (1944-1956)- An Assessment of Quantities released, Off-Site Radiation Doses, and Potential Excess Risks of Thyroid Cancer, Volume 1

    Energy Technology Data Exchange (ETDEWEB)

    Apostoaei, A.I.; Burns, R.E.; Hoffman, F.O.; Ijaz, T.; Lewis, C.J.; Nair, S.K.; Widner, T.E.

    1999-07-01

    In the early 1990s, concern about the Oak Ridge Reservation's past releases of contaminants to the environment prompted Tennessee's public health officials to pursue an in-depth study of potential off-site health effects at Oak Ridge. This study, the Oak Ridge dose reconstruction, was supported by an agreement between the U.S. Department of Energy (DOE) and the State of Tennessee, and was overseen by a 12-member panel appointed by Tennessee's Commissioner of Health. One of the major contaminants studied in the dose reconstruction was radioactive iodine, which was released to the air by X-10 (now called Oak Ridge National Laboratory) as it processed spent nuclear reactor fuel from 1944 through 1956. The process recovered radioactive lanthanum for use in weapons development. Iodine concentrates in the thyroid gland so health concerns include various diseases of the thyroid, such as thyroid cancer. The large report, ''Iodine-131 Releases from Radioactive Lanthanum Processing at the X-10 Site in Oak Ridge, Tennessee (1944-1956) - An Assessment of Quantities Released, Off-site Radiation Doses, and Potential Excess Risks of Thyroid Cancer,'' is in two volumes. Volume 1 is the main body of the report, and Volume 1A, which has the same title, consists of 22 supporting appendices. Together, these reports serve the following purposes: (1) describe the methodologies used to estimate the amount of iodine-131 (I-131) released; (2) evaluate I-131's pathway from air to vegetation to food to humans; (3) estimate doses received by human thyroids; (4) estimate excess risk of acquiring a thyroid cancer during ones lifetime; and (5) provide equations, examples of historical documents used, and tables of calculated values. Results indicate that females born in 1952 who consumed milk from a goat pastured a few miles east of X-10 received the highest doses from I-131 and would have had the highest risks of contracting thyroid cancer. Doses from cow

  18. Iodine poisoning

    Science.gov (United States)

    ... Iodine is also used during the production of methamphetamine. Note: This list may not be all inclusive. ... breathing machine (ventilator) Blood and urine tests Chest x-ray EKG (electrocardiogram, or heart tracing) Fluids through a ...

  19. Disposal of Iodine-129

    International Nuclear Information System (INIS)

    Morgan, M.T.; Moore, J.G.; Devaney, H.E.; Rogers, G.C.; Williams, C.; Newman, E.

    1978-01-01

    One of the problems to be solved in the nuclear waste management field is the disposal of radioactive iodine-129, which is one of the more volatile and long-lived fission products. Studies have shown that fission products can be fixed in concrete for permanent disposal. Current studies have demonstrated that practical cementitious grouts may contain up to 18% iodine as barium iodate. The waste disposal criterion is based on the fact that harmful effects to present or future generations can be avoided by isolation and/or dilution. Long-term isolation is effective in deep, dry repositories; however, since penetration by water is possible, although unlikely, release was calculated based on leach rates into water. Further considerations have indicated that sea disposal on or in the ocean floor may be a more acceptable alternative

  20. Iodine in diet

    Science.gov (United States)

    Diet - iodine ... Many months of iodine deficiency in a person's diet may cause goiter or hypothyroidism . Without enough iodine, ... and older children. Getting enough iodine in the diet may prevent a form of physical and intellectual ...

  1. Criteria for safe working with iodine-125

    International Nuclear Information System (INIS)

    Linsley, G.S.

    1977-01-01

    Radio-immunoassay and other saturation assay tests involving the use of iodine-125 are finding wide application for the determination of hormone concentrations in biological fluids. In such tests, iodinations involving concentrations of a milli-curie per micro-litre are common. Iodine-125 presents a problem from the monitoring standpoint because of its low energy photon emission (27 and 35 keV). Iodine is preferentially taken up by the thyroid gland and work involving moderate amounts of radio-iodine may give rise to a significant hazard in an accident situation. The general precautions which should be taken in work with unsealed radioactive substances are briefly summarized, working limits for iodine-125 are identified, and methods of personal protection and monitoring in an emergency situation described. (author)

  2. Long-term thyroid values after intake of radio-active iodine; Bilans thyroidiens de longue duree apres administration d'iode radioactif

    Energy Technology Data Exchange (ETDEWEB)

    Riviere, R [Institut National de la Sante et de la Recherche Medicale, 75 - Paris (France); Commissariat a l' Energie Atomique, Saclay (France). Centre d' Etudes Nucleaires

    1965-07-01

    In connection with a compartment theory, a kinetic study of thyroid metabolism in man requires the determination of the specific iodine activity at all accessible levels (plasma, urines, faeces), during periods of over a month; The basic methods required for such a study are therefore the use of iodine-125 as a tracer, the exact determination of iodine-127 using activation analysis and the setting-up of a daily diet of constant iodine content. The results are presented for each particular case and the main parameters of thyroid metabolism are calculated. The discussion includes some special considerations concerning the pathological condition of the subject or a break in the thyroid equilibrium. It shows in particular that constant disagreement exists between the experimental curves for the specific iodine activity and the corresponding theoretical curves for a conventional thyroid process based on 3 compartments; these discrepancies concern both the inorganic iodine and the organic iodine eliminated with the faeces. (author) [French] Dans le cadre d'une theorie a compartiments, l'etude cinetique du metabolisme thyroidien chez l'homme necessite la determination de l'activite specifique de l'iode a tous les niveaux accessibles (plasma, urines, feces), pendant des periodes depassant un mois. Les methodes de base indispensables pour une telle etude sont donc l'utilisation de l'iode 125 comme traceur, le dosage precis de l'iode 127 grace a l'analyse par activation et l'etablissement d'une diete journaliere constante en iode. Les resultats sont presentes pour chaque cas et les principaux parametres du metabolisme thyroidien calcules. La discussion fait part de considerations particulieres liees a l'etat pathologique du sujet ou a une rupture de l'equilibre thyroidien. Elle met surtout en lumiere des desaccords constants entre les courbes experimentales d'activite specifique de l'iode et les courbes theoriques correspondantes conformes au schema thyroidien classique a 3

  3. WHO's new recommendations about iodine prophylaxis at nuclear catastrophes

    International Nuclear Information System (INIS)

    Paile, Wendla

    1999-01-01

    WHO has prepared new advice about using stable iodine as protection against emission of radioactive iodine from nuclear catastrophes. The experiences from Chernobyl show that the risk for thyroid gland cancer after emission of radio-iodine is significant. The risk of serious side effects of stable iodine as single dose is stated to be minimal. Stable iodine is a safe, effective remedy for protecting the thyroid gland against radioactive iodine. It is recommended to adjust different criteria for iodine prophylaxis for new-born, children, young people and adults older than 40 years. For children of the age up to 18 years iodine prophylaxis should be considered at 10 mGy thyroid gland doses, and for young adults at 100 mGy. For adults of 40 years or more the cancer risk of radioactive iodine is very low and iodine prophylaxis is unnecessary provided that the expected does not exceed 5 Gy. The new information about risk and advantage must be considered in planning for distribution and storage of stable iodine. WHO also commends that everybody has the possibility to buy it in a pharmacy. (EHS)

  4. Iodine Satellite

    Science.gov (United States)

    Kamhawi, Hani; Dankanich, John; Martinez, Andres; Petro, Andrew

    2015-01-01

    The Iodine Satellite (iSat) spacecraft will be the first CubeSat to demonstrate high change in velocity from a primary propulsion system by using Hall thruster technology and iodine as a propellant. The mission will demonstrate CubeSat maneuverability, including plane change, altitude change and change in its closest approach to Earth to ensure atmospheric reentry in less than 90 days. The mission is planned for launch in fall 2017. Hall thruster technology is a type of electric propulsion. Electric propulsion uses electricity, typically from solar panels, to accelerate the propellant. Electric propulsion can accelerate propellant to 10 times higher velocities than traditional chemical propulsion systems, which significantly increases fuel efficiency. To enable the success of the propulsion subsystem, iSat will also demonstrate power management and thermal control capabilities well beyond the current state-of-the-art for spacecraft of its size. This technology is a viable primary propulsion system that can be used on small satellites ranging from about 22 pounds (10 kilograms) to more than 1,000 pounds (450 kilograms). iSat's fuel efficiency is ten times greater and its propulsion per volume is 100 times greater than current cold-gas systems and three times better than the same system operating on xenon. iSat's iodine propulsion system consists of a 200 watt (W) Hall thruster, a cathode, a tank to store solid iodine, a power processing unit (PPU) and the feed system to supply the iodine. This propulsion system is based on a 200 W Hall thruster developed by Busek Co. Inc., which was previously flown using xenon as the propellant. Several improvements have been made to the original system to include a compact PPU, targeting greater than 80 percent reduction in mass and volume of conventional PPU designs. The cathode technology is planned to enable heaterless cathode conditioning, significantly increasing total system efficiency. The feed system has been designed to

  5. Radiation exposure by radio-iodine release of the planned nuclear power plant Wyhl. Expert's opinion on thyroid exposure due to radioactive I-131

    Energy Technology Data Exchange (ETDEWEB)

    Bleck-Neuhaus, J

    1981-01-01

    The radioecology of iodine-131 in the off-air of a nuclear power plant is subject to investigation of the critical exposure pathway air - pasture ground - cow - milk. According to the findings on the factors influencing the radiation exposure of man presented in scientific publication we have to deviate today from static equilibrium models. Such models can no longer satisfy at the present state of the art. The viewing of the short-term time behaviour of the radioecological parameter that is imperative with iodine-131 shows that the conventional calculation, chiefly with mean values of many years, does not satisfy the requirements to replace the calculation of the radiation exposure at the most unfavourable points of exposure demanded by the Radiation Protection Ordinance. This report proves that in a number of possible events under normal operating conditions the radiation exposure is far more important and the limiting dose rates are unmistakably exceeded. If favourable conditions coincide it can in fact be expected that the radiation exposure by radio iodine remains below the limiting close rate.

  6. Iodine Prophylaxis and Nuclear Accidents

    International Nuclear Information System (INIS)

    Franic, Z.

    1998-01-01

    Iodine is a highly volatile element therefore being very mobile in the environment. It enters the metabolism of living organisms and is selectively taken up and concentrated in the thyroid gland. The plume (cloud-like formation) of radioactive material that might be released in the environment in the case of a serious nuclear accident, primarily consists of the radioactive isotopes of iodine. Among those, due to its decay properties, is the most important 131 I. The effective means of protecting the thyroid gland against exposure to radioactive iodine is an intake of stable iodine. Therefore, one of the central issues in the emergency planning is to determine whether and at which projected thyroid radiation dose stable iodine should be given to the population. The International Atomic Energy Agency (IAEA) set the generic optimized intervention value for iodine prophylaxis to 100 mGy of avertable committed dose to a thyroid.The prophylaxis is implemented by utilizing the pills of pills of potassium iodine (KI). The efficacy of KI in protecting the thyroid gland depends upon the time of intake relative to the start of exposure to radioactive iodine. The best results are obtained if KI is taken 1-2 hours before or immediately after the start of exposure. The recommended dosage, based upon the study performed by Il'in et.al. is 130 mg/day. KI should be taken at least three days after the acute exposure to radioiodine, to prevent accumulation in a thyroid gland of radioiodine excreted from the other compartments of the body. The largest epidemiological study on the effects of KI prophylaxis ever performed was the one in Poland after the Chernobyl accident. Stable iodine was given as single dose of KI solution to 10.5 million of children and 7 millions of adults. Among children no serious side effects were seen while only two adults (with previously recorded iodine sensitivity) had severe respiratory distresses. Polish experiences showed that rapid response to such

  7. Radiolabeling and biotinylation of internalizing monoclonal antibody chimeric BR96: Potential use of extracorporeal immunoadsorption with enhanced tumor radioactivity retention of Iodine, Indium and Rhenium

    International Nuclear Information System (INIS)

    Chen, JianQing.

    1997-01-01

    In this thesis, methodology of radiolabeling and simultaneous biotinylation for internalizing monoclonal antibody chimeric BR96 have been investigated by using three element groups of potential therapeutic radionuclides iodine, indium and rhenium, and their different labeling methods. The biodistribution and kinetics of biotinylated and radiolabeled chiBR96 have been studied in colon carcinoma isografted rats. The potential use of ECIA, based on the biotin-avidin concept, has been evaluated and compared with the approach of avidin 'chase' in the same animal tumor model with respect to an enhancement of tumor-to-normal tissue (T/N) activity ratio. 131 refs

  8. Radiolabeling and biotinylation of internalizing monoclonal antibody chimeric BR96: Potential use of extracorporeal immunoadsorption with enhanced tumor radioactivity retention of Iodine, Indium and Rhenium

    Energy Technology Data Exchange (ETDEWEB)

    Chen, JianQing

    1997-01-01

    In this thesis, methodology of radiolabeling and simultaneous biotinylation for internalizing monoclonal antibody chimeric BR96 have been investigated by using three element groups of potential therapeutic radionuclides iodine, indium and rhenium, and their different labeling methods. The biodistribution and kinetics of biotinylated and radiolabeled chiBR96 have been studied in colon carcinoma isografted rats. The potential use of ECIA, based on the biotin-avidin concept, has been evaluated and compared with the approach of avidin `chase` in the same animal tumor model with respect to an enhancement of tumor-to-normal tissue (T/N) activity ratio. 131 refs.

  9. False-positive radioactive iodine uptake mimicking miliary lung metastases in a patient affected by papillary thyroid cancer and IgA deficiency

    Energy Technology Data Exchange (ETDEWEB)

    Demidowich, Andrew Paul; Reynolds, James C. [National Institutes of Health, Bethesda (United States); Kundu, Amartya [Dept. of MedicineUniversity of Massachusetts Medical School, Worcester (United States); Celi, Francesco S. [Div. of Endocrinology and MetabolismVirginia Commonwealth UniversityRichmond (United States)

    2016-09-15

    A 42-year-old female with immunoglobulin A deficiency and recurrent sinopulmonary infections underwent thyroidectomy for papillary thyroid cancer (PTC). Follow-up {sup 123}I scintigraphy demonstrated diffuse pulmonary uptake, suggesting metastatic disease. However, subsequent pathologic, biochemical and radiographic testing proved that she was in fact disease free, and the initial {sup 123}I pulmonary uptake was identified as a false positive. Inflammatory conditions may rarely cause iodine uptake in non-thyroidal tissues due to local retention, organification, and/or immunologic utilization. To avoid exposing patients to unnecessary treatments, it is critical for clinicians to recognize that comorbid pulmonary conditions may mimic metastatic PTC on radioiodine scintigraphy.

  10. Production techniques and quality control of sealed radioactive sources of palladium-103, iodine-125, iridium-192 and ytterbium-169. Final report of a coordinated research project 2001-2005

    International Nuclear Information System (INIS)

    2006-06-01

    of sealed sources based on Iodine-125, Palladium-103, Iridium-192 and Ytterbium-169. Experienced scientist groups from Belarus, China, Hungary, India, the Islamic Republic of Iran, Kazakhstan, the Republic of Korea, Peru, Poland and the Russian Federation participated in the CRP under research contracts and agreements. The technology and experimental procedures described in this report are the result of the common collaborative research of all the participants in the CRP. Many of these procedures are innovative and yet simple to follow by anyone wishing to prepare radioactive sealed sources based on 125 I, 103 Pd, 169 Yb and 192 Ir

  11. New iodine filter pack design

    International Nuclear Information System (INIS)

    Blackbee, B.A.

    1977-10-01

    To enable Naval Emergency Monitoring Teams to fulfil their role in the field it was necessary to locate or design a replacement filter pack for the collection of radioactive iodine air samples. Collaboration with the Berkeley Laboratories of the Central Electricity Generating Board provided the necessary starting point for a suitable type of package. Further development by NGTE (West Drayton) yielded the improved filter pack which is the subject of this memorandum. (author)

  12. Iodine neutron capture therapy

    Science.gov (United States)

    Ahmed, Kazi Fariduddin

    A new technique, Iodine Neutron Capture Therapy (INCT) is proposed to treat hyperthyroidism in people. Present thyroid therapies, surgical removal and 131I treatment, result in hypothyroidism and, for 131I, involve protracted treatment times and excessive whole-body radiation doses. The new technique involves using a low energy neutron beam to convert a fraction of the natural iodine stored in the thyroid to radioactive 128I, which has a 24-minute half-life and decays by emitting 2.12-MeV beta particles. The beta particles are absorbed in and damage some thyroid tissue cells and consequently reduce the production and release of thyroid hormones to the blood stream. Treatment times and whole-body radiation doses are thus reduced substantially. This dissertation addresses the first of the several steps needed to obtain medical profession acceptance and regulatory approval to implement this therapy. As with other such programs, initial feasibility is established by performing experiments on suitable small mammals. Laboratory rats were used and their thyroids were exposed to the beta particles coming from small encapsulated amounts of 128I. Masses of 89.0 mg reagent-grade elemental iodine crystals have been activated in the ISU AGN-201 reactor to provide 0.033 mBq of 128I. This activity delivers 0.2 Gy to the thyroid gland of 300-g male rats having fresh thyroid tissue masses of ˜20 mg. Larger iodine masses are used to provide greater doses. The activated iodine is encapsulated to form a thin (0.16 cm 2/mg) patch that is then applied directly to the surgically exposed thyroid of an anesthetized rat. Direct neutron irradiation of a rat's thyroid was not possible due to its small size. Direct in-vivo exposure of the thyroid of the rat to the emitted radiation from 128I is allowed to continue for 2.5 hours (6 half-lives). Pre- and post-exposure blood samples are taken to quantify thyroid hormone levels. The serum T4 concentration is measured by radioimmunoassay at

  13. Mobile Iodine Mineralization Based on Malachite Transformation

    Energy Technology Data Exchange (ETDEWEB)

    Lee, Seung Yeop; Baik, Min Hoon [Korea Atomic Energy Research Institute, Daejeon (Korea, Republic of)

    2016-10-15

    Our new method that is proposed here, however, offer drastic cost cutting by using copper. Moreover, the selectivity of iodine in anion-rich water is advantage to lower the disposal cost by reducing the radioactive waste volume. Iodide (I{sup -}) is soluble and mobile in water, so it is very difficult to capture and precipitate it with common adsorbents. Until now, various exchanger and getter materials have been developed to capture radioactive iodine in wastewater. The materials developed generally showed a good performance under acidic conditions. However, the adsorption amounts were not relatively large in neutral and high pH conditions. Furthermore, the capacity to capture iodine is limited by their properties, such as the specific surface area and adsorbing affinity. Recently, Ag-coated materials have attracted attention as adsorbents. They have shown higher uptake for I- compared to other substances, but they are costly. Our new method that is proposed here, however, offer drastic cost cutting by using copper. Moreover, the selectivity of iodine in anion-rich water is advantage to lower the disposal cost by reducing the radioactive waste volume. Radioactive iodine isotopes are characterized as volatile and mobile species that are difficult to capture by adsorbents. In our study, we developed a new way to uptake and crystallize the mobile iodide as cuprous iodide (CuI). This method will be a promising way to simply stabilize iodide in a solid form with compacted volume.

  14. Radioactive substances

    International Nuclear Information System (INIS)

    Butler, G.C.; Hyslop, C.

    1980-01-01

    The purpose of this chapter is to show how to assess the detriment resulting from the release of radioactive materials to the environment. The minimum information required for the assessments is given for seven radionuclides of interest from the point of view of environmental contamination. The seven radionuclides are tritium, krypton-85, strontium-90, iodine-131, cesium-137, radium-226 and plutonium-239. Information is given on the radiation doses and the radiation effects on man due to these radioisotopes. (AN)

  15. Age dependency in the absorption of radioactive Iodine (131I) in the thyroid and total body of newborn, pubertal and adult fischer 344 rats

    International Nuclear Information System (INIS)

    Nitta, Yumiko; Endo, Satoru; Fujimoto, Nariaki; Kamiya, Kenji; Ohtaki, Megu; Hayakawa, Norihiko; Takada, Jun; Hoshi, Masaharu

    1998-01-01

    In this study, activities of 131 I in the thyroid, total body and blood were measured for rats of three different ages to estimate the movement of 131 I in the body, the absorbed doses were calculated in the thyroid and total body under the exposed condition of iodine deficiency and sufficiency, and the standard curves for the determination of absorbed doses in the thyroid and total body were obtained for rats of newborn, pubertal and adult. Authors used female rats of Fisher 344 strain in this experiment and set up twelve experimental group of different ages (1, 4 and 9 weeks old), and divided each age group into one standard diet (SD) group and three iodine deficient diet (IDD) groups. Rats were intravenously injected once with 131 I in 0.9% saline with the activity of 0.38, 1.03 and 9.42 kBq per g weight. In the thyroid and total body, the absorbed dose values increased in an injected activity-dependent manner, and those of 1-week-old rats were significantly higher than those of 4- and 9-weeks old rats. The absorbed dose values in IDD-treated groups were higher than those in the SD-treated groups. The speed of 131 I accumulation into the thyroid and that of 131 I excretion from the body was slow in 1-week-old groups. The data also showed that most of injected 131 I distributed in the thyroid and blood in 4- and 9-week-old groups but not in the 1-week-old group, indicating that 131 I is pooled in certain tissues or organs except the thyroid in rats of the 1-week-old group at which the development of the thyroid has not been completed. Standard curves were obtained for the estimation of absorbed doses in the thyroid and total body on the bases of injected activity of 131 I for each age group of rats. These standard curves are to be used in the carcinogenesis experiment which compare the effectiveness of internal with external irradiation under the condition of iodine deficiency or sufficiency in the rats of different ages. (K.H.)

  16. Age-dependent exposure to radioactive iodine (131I) in the thyroid and total body of newborn, pubertal and adult fischer 344 rats

    International Nuclear Information System (INIS)

    Nitta, Yumiko; Fujimoto, Nariaki; Kamiya, Kenji; Hoshi, Masaharu; Endo, Satoru

    2001-01-01

    Female rats of the Fischer 344 strain at ages of 1, 4 and 9 weeks were exposed to 131 I intraperitoneally with activities of 0.38, 1.03 and 3.42 kBq per gram of body weight under the condition of iodine deficiency. The absorbed doses in the thyroid increased linearly depending on the injected activities. Irradiation at 1 week old caused heavier exposure than those at 4 and 9 weeks old by 7.5 and 7.7 times, respectively; however, damage of the thyroid tissue was more obvious in the 4-week-old groups than in the 1-week-old groups. The absorbed doses in the total body were proportional to the square root of the injected activities. The one-week-old groups were exposed more heavily than the 4- and 9-week-old groups by 3.6 and 4.7 times, respectively, shown by the slow excretion of 131 I with the values of effective half-life of 131 I activity (T eff ). An IDD-treatment was not so effective to enhance the 131 I absorption in the total body, as in the thyroid. No matter how the iodine concentration in the blood changed, the 1-week-old groups could not react to normalize the level. We drew standard curves, which enabled us to estimate the absorbed doses in the thyroid and the total body in the case of the injected activities of 131 I for the newborn, pubertal and adult rats. (author)

  17. Global searches for microalgae and aquatic plants that can eliminate radioactive cesium, iodine and strontium from the radio-polluted aquatic environment: a bioremediation strategy.

    Science.gov (United States)

    Fukuda, Shin-Ya; Iwamoto, Koji; Atsumi, Mika; Yokoyama, Akiko; Nakayama, Takeshi; Ishida, Ken-Ichiro; Inouye, Isao; Shiraiwa, Yoshihiro

    2014-01-01

    The Fukushima 1 Nuclear Power Plant accident in March 2011 released an enormously high level of radionuclides into the environment, a total estimation of 6.3 × 10¹⁷ Bq represented by mainly radioactive Cs, Sr, and I. Because these radionuclides are biophilic, an urgent risk has arisen due to biological intake and subsequent food web contamination in the ecosystem. Thus, urgent elimination of radionuclides from the environment is necessary to prevent substantial radiopollution of organisms. In this study, we selected microalgae and aquatic plants that can efficiently eliminate these radionuclides from the environment. The ability of aquatic plants and algae was assessed by determining the elimination rate of radioactive Cs, Sr and I from culture medium and the accumulation capacity of radionuclides into single cells or whole bodies. Among 188 strains examined from microalgae, aquatic plants and unidentified algal species, we identified six, three and eight strains that can accumulate high levels of radioactive Cs, Sr and I from the medium, respectively. Notably, a novel eustigmatophycean unicellular algal strain, nak 9, showed the highest ability to eliminate radioactive Cs from the medium by cellular accumulation. Our results provide an important strategy for decreasing radiopollution in Fukushima area.

  18. Present status of iodine research at IPSN

    Energy Technology Data Exchange (ETDEWEB)

    Bardelay, J [IPSN/DPEA/SEAC (France)

    1996-12-01

    Since several years, IPSN has conducted an effort in order to evaluate the release of radioactive iodine in case of hypothetical severe accident in a realistic manner. This source-term evaluation is performed with IODE code which is a module of the EXCADRE system of codes. This code is validated against: -analytical experiments: in these experiments, IPSN studies radiolytic effects and chemical processes in the sump, organic formation, mass transfer, effect of spray (CARAIDAS experiment), - the CAIMAN semi global experiment; this experiment will allow to study the phenomena linked to iodine behavior under representative containment geometry in the presence of painted surfaces and global irradiation, - the PHEBUS FP program. The paper consists to describe succinctly the current status of IODE and the various experiments for its validation. In case of hypothetical severe accident iodine can induce important perturbations of human organism. The effects are principally radiological, in particular on the thyroid. At short term, radioactive iodine is the most important contributor for the sanitary risk. It represents 55% of effective dose and 92% of thyroid dose at 10 km in case of controlled rejects with current assumptions. This is the reason why it must be actively studied. In France, the safety evaluations are performed with mechanistic codes or lumped parameter codes like EXCADRE which contains a module devoted to iodine studies: IODINE. The objective of the French experimental program on iodine is to understand and quantify important phenomena in order to put kinetic parameters in IODE module. The experiments can be classified in analytical experiments, the semi-global experiment CAIMAN which takes into account different phenomena studied in analytical experiments and the global experiment PHEBUS PF, not only devoted to iodine behavior study. In the following text we will present the needs of IODINE code and these different experiments. (author).

  19. Present status of iodine research at IPSN

    International Nuclear Information System (INIS)

    Bardelay, J.

    1996-01-01

    Since several years, IPSN has conducted an effort in order to evaluate the release of radioactive iodine in case of hypothetical severe accident in a realistic manner. This source-term evaluation is performed with IODE code which is a module of the EXCADRE system of codes. This code is validated against: -analytical experiments: in these experiments, IPSN studies radiolytic effects and chemical processes in the sump, organic formation, mass transfer, effect of spray (CARAIDAS experiment), - the CAIMAN semi global experiment; this experiment will allow to study the phenomena linked to iodine behavior under representative containment geometry in the presence of painted surfaces and global irradiation, - the PHEBUS FP program. The paper consists to describe succinctly the current status of IODE and the various experiments for its validation. In case of hypothetical severe accident iodine can induce important perturbations of human organism. The effects are principally radiological, in particular on the thyroid. At short term, radioactive iodine is the most important contributor for the sanitary risk. It represents 55% of effective dose and 92% of thyroid dose at 10 km in case of controlled rejects with current assumptions. This is the reason why it must be actively studied. In France, the safety evaluations are performed with mechanistic codes or lumped parameter codes like EXCADRE which contains a module devoted to iodine studies: IODINE. The objective of the French experimental program on iodine is to understand and quantify important phenomena in order to put kinetic parameters in IODE module. The experiments can be classified in analytical experiments, the semi-global experiment CAIMAN which takes into account different phenomena studied in analytical experiments and the global experiment PHEBUS PF, not only devoted to iodine behavior study. In the following text we will present the needs of IODINE code and these different experiments. (author)

  20. Iodine behaviour in severe accidents

    Energy Technology Data Exchange (ETDEWEB)

    Dutton, L M.C.; Grindon, E; Handy, B J; Sutherland, L [NNC Ltd., Knutsford (United Kingdom); Bruns, W G; Sims, H E [AEA Technology, Harwell (United Kingdom); Dickinson, S [AEA Technology, Winfrith (United Kingdom); Hueber, C; Jacquemain, D [IPSN/CEA, Cadarache, Saint Paul-Lez-Durance (France)

    1996-12-01

    A description is given of analyses which identify which aspects of the modelling and data are most important in evaluating the release of radioactive iodine to the environment following a potential severe accident at a PWR and which identify the major uncertainties which affect that release. Three iodine codes are used namely INSPECT, IODE and IMPAIR, and their predictions are compared with those of the PSA code MAAP. INSPECT is a mechanistic code which models iodine behaviour in the aqueous aerosol, spray water and sump water, and the partitioning of volatile species between the aqueous phases and containment gas space. Organic iodine is not modelled. IODE and IMPAIR are semi-empirical codes which do not model iodine behaviour in the aqueous aerosol, but model organic iodine. The fault sequences addressed are based on analyses for the Sizewell `B` design. Two types of sequence have been analysed.: (a) those in which a major release of fission products from the primary circuit to the containment occur, e.g. a large LOCAS, (b) those where the release by-passes the containment, e.g. a leak into the auxiliary building. In the analysis of the LOCA sequences where the pH of the sump is controlled to be a value of 8 or greater, all three codes predict that the oxidation of iodine to produce gas phase species does not make a significant contribution to the source term due to leakage from the reactor building and that the latter is dominated by iodide in the aerosol. In the case where the pH of the sump is not controlled, it is found that the proportion of gas phase iodine increases significantly, although the cumulative leakage predicted by all three codes is not significantly different from that predicted by MAAP. The radiolytic production of nitric acid could be a major factor in determining the pH, and if the pH were reduced, the codes predict an increase in gas phase iodine species leaked from the containment. (author) 4 figs., 7 tabs., 13 refs.

  1. Experience in the patients management which received treatments with radioactive iodine ({sup 131}I). Measurements and dosimetry pertaining to the personnel related; Experiencia en el manejo de pacientes que recibieron tratamientos con yodo radiactivo ({sup 131}I). Mediciones reglamentarias y dosimetria del personal relacionado

    Energy Technology Data Exchange (ETDEWEB)

    Ruiz J, A [Instituto Nacional de la Nutricion Salvador Zubiran, Departamento de Medicina Nuclear, Tlalpan, 14000 Mexico D.F. (Mexico)

    1999-07-01

    In the INNSZ there are administering ablative doses of radioactive iodine to patients with problems of the thyroid gland from 40 years ago. Starting from 1992 was initiated the restlessness to inform to the patients verbally and in writing over the measurements of radiological safety that must be followed for the protection of their families. In this work it is commented, the benefits obtained with the patients and the teachings to give to the personnel what attend the patients which receive treatments with iodine-131 and must be hospitalized. It is commented too over the standardization standing of the patients discharged whom received radioactive material and lastly, it was make a dosimetric study of the nurses, radiotherapeutic and control area. (Author)

  2. Leak test method and test device for iodine filter

    International Nuclear Information System (INIS)

    Fukasawa, Tetsuo; Funabashi, Kiyomi; Miura, Noboru; Miura, Eiichi.

    1995-01-01

    An air introduction device which can change a humidity is disposed upstream of an iodine filter to be tested, and a humidity measuring device is disposed downstream of the iodine filter respectively. At first, dried air reduced with humidity is flown from the air introduction device to the iodine filter, to remove moisture content from an iodine adsorber in the iodine filter. Next, air at an increased humidity is supplied to the iodine filter. The difference between the time starting the supply of the highly humid air and the time detecting the high humidity at the humidity measuring device is measured. When the time difference is smaller than the time difference measured previously in a normal iodine filter, it shows the presence of leak in the iodine filter to be tested. With such procedures, leakage in the iodine filter which removes radioactive iodine from off-gases discharged from the radioactive material handling facilities can be detected easily by using water (steams), namely, a naturally present material. (I.N.)

  3. Pediatric endocrine surgery development

    Directory of Open Access Journals (Sweden)

    Ivan I. Dedov

    2017-12-01

    Full Text Available Department of pediatric surgery at the Endocrinology Research Centre has been around for nearly two years. During operation, surgical treatment has received more than 500 patients with various endocrine disorders. The article discusses modern diagnostic approaches and surgical options for diseases included in the new direction of pediatric surgery – endocrine surgery in children. There are discussions about options for radical treatment of Graves disease in children, positive and negative aspects of surgical and radioactive iodine treatment. Is own stats of postoperative hyperparathyroidism. Is proposed to optimize the algorithm of actions in identifying thyroid nodules in children. In primary hyperparathyroidism, the emphasis is on the complexity of the postoperative management of patients related to the feature of children’s age in determining the severity of the reactions on the water-electrolyte disorders. Separately reviewed the literature of the adrenal glands diseases in children, demonstrating their own clinical cases which required surgical intervention. The authors describe the possibilities of modern neurosurgical equipment in the Endocrinology Research Centre in operations on the pituitary gland in children. Patients of different age groups performed transnasal transsphenoidal removal of tumors of the chiasm-sellar region using endoscopic assistance. The article also cited research data of pancreas diseases and their surgical treatment. Much attention is paid to the gender section of endocrine surgery in children. Discusses the tactics in disorders of sex development, gonadal tumors in children, diseases of the breast. In conclusion outlines the prospects for the development of endocrine surgery in children.

  4. Management modes for iodine-129

    International Nuclear Information System (INIS)

    White, I.F.; Smith, G.M.

    1984-01-01

    This study completes a two-stage programme, supported by the Commission of the European Communities, on management modes for iodine-129. The models for the radiological assessment of iodine-129 management modes have been reviewed and, where necessary, revised, and a generic radiological assessment has been carried out using these models. Cost benefit analysis has been demonstrated for a variety of iodine-129 management modes; for a wide range of assumptions, the costs of abatement of atmospheric discharges would be outweighed by the radiological benefits. The cost benefit analysis thus complements and confirms the preliminary conclusion of the previous study: iodine-129 should be trapped to a large extent from the off-gases of a large reprocessing plant and disposed of by other suitable means, in order to ensure that all exposures from this radionuclide are as low as reasonably achievable. Once the major fraction of the iodine-129 throughput of a reprocessing plant has been trapped from the dissolver off-gases, there are unlikely to be strong radiation protection incentives either for further trapping from the dissolver off-gases or for trapping from the vessel off-gases. In a generic study it is not possible to state an optimum choice of process(es) for abatement of atmospheric discharges of iodine-129. This choice must be determined by assessments in the specific context of a particular reprocessing plant, its site, the waste disposal routes that are actually available, and also in the wider context of the management plans for all radioactive wastes at the plant in question

  5. Iodine and Pregnancy

    OpenAIRE

    Yarrington, Christina; Pearce, Elizabeth N.

    2011-01-01

    Iodine is a necessary element for the production of thyroid hormone. We will review the impact of dietary iodine status on thyroid function in pregnancy. We will discuss iodine metabolism, homeostasis, and nutritional recommendations for pregnancy. We will also discuss the possible effects of environmental contaminants on iodine utilization in pregnant women.

  6. Biodegradable radioactive implants for glaucoma filtering surgery produced by ion implantation

    Energy Technology Data Exchange (ETDEWEB)

    Assmann, W. [Department fuer Physik, Ludwig-Maximilians-Universitaet Muenchen, 85748 Garching (Germany)]. E-mail: walter.assmann@lmu.de; Schubert, M. [Department fuer Physik, Ludwig-Maximilians-Universitaet Muenchen, 85748 Garching (Germany); Held, A. [Augenklinik, Technische Universitaet Muenchen, 81675 Munich (Germany); Pichler, A. [Augenklinik, Technische Universitaet Muenchen, 81675 Muenchen (Germany); Chill, A. [Zentralinstitut fuer Medizintechnik, Technische Universitaet Muenchen, 85748 Garching (Germany); Kiermaier, S. [Zentralinstitut fuer Medizintechnik, Technische Universitaet Muenchen, 85748 Garching (Germany); Schloesser, K. [Forschungszentrum Karlsruhe, 76021 Karlsruhe (Germany); Busch, H. [NTTF GmbH, 53619 Rheinbreitbach (Germany); Schenk, K. [NTTF GmbH, 53619 Rheinbreitbach (Germany); Streufert, D. [Acri.Tec GmbH, 16761 Hennigsdorf (Germany); Lanzl, I. [Augenklinik, Technische Universitaet Muenchen, 81675 Munich (Germany)

    2007-04-15

    A biodegradable, {beta}-emitting implant has been developed and successfully tested which prevents fresh intraocular pressure increase after glaucoma filtering surgery. Ion implantation has been used to load the polymeric implants with the {beta}-emitter {sup 32}P. The influence of ion implantation and gamma sterilisation on degradation and {sup 32}P-fixation behavior has been studied by ion beam and chemical analysis. Irradiation effects due to the applied ion fluence (10{sup 15} ions/cm{sup 2}) and gamma dose (25 kGy) are found to be tolerable.

  7. Iodine intake in Denmark

    International Nuclear Information System (INIS)

    Pedersen, K.M.; Noehr, S.B.; Laurberg, P.

    1997-01-01

    Iodine deficiency with a high frequency of goitre and, in severely affected areas, cretinism is common in some areas of the world. In Denmark the iodine intake as evaluated by urinary iodine excretion has been at a stable low level for many years, except for the part of the population now taking iodine supplementation as part of vitamin/mineral preparations. The iodine intake is lowest in the western part to the country where an epidemiological study of elderly subjects has demonstrated a high frequency of goitre and hyperthyroidism in women. This supports the suggestion of a controlled moderate increase in iodine intake via an iodine supplementation program. (au) 40 refs

  8. Radioactive pollutions by iodine-131 in France, from November 1, 1961 to February 1, 1962; Les pollutions radioactives par l'iode 131 en France du 1er novembre 1961 au 1er fevrier 1962

    Energy Technology Data Exchange (ETDEWEB)

    Jeanmaire, L; Michon, G

    1962-07-01

    The report gives all the results of iodine-131 measurements on 450 milk samples, on 27 animal thyroids, and on 311 human thyroids between November 1, 1961 and February 1, 1962. All these results and their interpretation show that the iodine concentrations, even if they have not attained a critical level have nevertheless come close to it, and that if the Soviet series of explosions had continued it would perhaps have been necessary to take sanitary precautions. The discussion concerns the determination of the moment when such steps should be taken. (authors) [French] Le rapport fournit l'ensemble des dosages d'iode 131 effectues sur 450 echantillons de lait, sur 27 thyroides animales et sur 311 thyroides humaines entre le 1er novembre 1961 et le 1er fevrier 1962. L'ensemble des resultats et leur interpretation montrent que les teneurs en iode, si elles n'ont pas atteint les niveaux critiques, s'en sont toutefois approchees et que si la serie des explosions sovietiques s'etait poursuivie, la situation aurait pu necessiter la mise en place de mesures sanitaires. La discussion porte sur la determination du moment ou de telles mesures doivent etre prises. (auteurs)

  9. Studies in iodine metabolism. Progress report, April 1975 -- March 1976. [Rats, mice, cattle, /sup 125/I, /sup 131/I

    Energy Technology Data Exchange (ETDEWEB)

    Van Middlesworth, L.

    1976-01-01

    Investigations during the past twelve months have included the following subjects: factors which influence release of radioiodine from thyroid glands; contamination of commercially available low-iodine diets; effects of hypoxia on release of iodine from thyroid glands of rats and mice; development of practical tests for available iodine in low-iodine diets; reproduction and abnormal thyroglobulin of rats maintained on low-iodine diets; observations on radioactivity in animal thyroids; collaboration with other laboratories regarding radium in bovine thyroids.

  10. Prognostication of the radioactive contamination with iodine 131, strontium 90 and cesium 137 of the air and soil after commissioning the ''Kozloduj'' nuclear power plant

    Energy Technology Data Exchange (ETDEWEB)

    Khristova, M; Paskalev, Z [Nauchno-Izsledovatelski Inst. po Radiologiya i Radiatsionna Khigiena, Sofia (Bulgaria)

    1975-01-01

    The content of iodine 131, strontium 90 and cesium 137 in the air (curie/l) and soil (curie/m/sup 2/ sec) in the area of the Kozloduj atomic power station (at a distance from 3 to 75 km from the chimney-stack of the power station) was determined. The concentrations of these radionuclides are determined under different meteorologic conditions: air temperature from -20/sup 0/C to +20/sup 0/C and a wind speed from 2 m/sec to 30 m/sec. The data show that at -20/sup 0/C radionuclide concentrations in the air decrease with increasing distance from the chimney-stack, regardless of the speed of the wind. At +20/sup 0/C radionuclide concentrations in the air increase with the distance from the chimney-stack, peak at a definite distance and then decrease. At 2 m/sec and speed this maximum is at a distance of 50 km from station. As the speed of the air increases, the peak moves nearer and remains about 30 km from the power station. Results on ground surface concentrations show that a trend is observed toward persistent decrease with distance from the power station. In rainy weather they are almost four times higher than in dry weather. The radionuclide concentrations on the ground surface will be comparable to their global deposits.

  11. Estimation of the internal radiation dose received by the adult population of Graz due to the contamination with radioactive iodine and cesium

    International Nuclear Information System (INIS)

    Rabitsch, H.; Kahr, G.

    1991-07-01

    During the first months following the fallout we have measured the activities of J-131 in some human thyroids. To study the long-term variation of radiocesium with time, we have observed the activity level of Cs-134 and Cs-137 in human muscle tissues over a period of 4 years. Simultaneously we have determined the activities of the naturally occuring potassium-40 in all samples, which were taken at forensic autopsies of persons deceased in the area of Graz. Comparisons of iodine and radiocesium activities measured in the samples with data obtained by other studies after nuclear weapon tests are given. Average individual thyroid dose was calculated to be 556.1 μSv. The main part of this thyroid dose is caused by the inhalation pathway. Effective individual dose equivalents originated by the radiocesium body content were calculated by means of time-integrated activities and the method of absorbed fractions. Dose estimations based on data of the Standard Man and a distribution factor of 0.7 was assumed with regards to the amount of radiocesium and K-40 in muscle mass. From the measurements, we have estimated a mean individual effective dose equivalent of 252.2 μSv due to internal exposure to radiocesium during the 4 years following the fallout. Estimated dose values are compared with predictions and the exposure caused by K-40. (Authors, shortened by Quittner)

  12. Iodine tablets - many benefits and few disadvantages

    International Nuclear Information System (INIS)

    Paile, W.

    1996-01-01

    The number of thyroid cancers among children has increased steeply around Chernobyl after the nuclear catastrophe. An iodine tablet taken at the right time would have protected the thyroid from the effects of radioiodine. Nuclear fallout may contain large amounts of radioactive iodine. If this enters the body, either through inhalation or ingestion, most of it ends up in the thyroid. As a result, the thyroid may be exposed to a considerable radiation dose. High doses endanger the functioning of the thyroid, and even smaller doses may cause benign or malignant tumours in the thyroid. Sensitivity of the thyroid to radiation depends largely on the person's age. The younger the child, the higher the risk. Adults probably have a low risk. It has not been shown that people over 40 years of age would have any risk of contracting radiation-induced thyroid cancer. Iodine tablets are particularly important for children. Iodine has fewer side effects than had been thought previously. At least for children, the risk of side effects caused by one dose of iodine is so small that it can be ignored when considering whether iodine should be given in a fallout situation. The risk increases with age. It must unconditionally be left for the authorities to decide who should be given iodine tablets and when. (orig.)

  13. Simulation of ISTP-EPICUR Iodine Chemistry Tests with RAIM

    Energy Technology Data Exchange (ETDEWEB)

    Kim, Han-Chul; Cho, Yeong-Hun; Jang, Dong-Ju; Ryu, Myung-Hyun [Nuclear Korea Institute of Nuclear Safety, Daejeon (Korea, Republic of)

    2014-10-15

    The amount of iodine release largely depends on its volatility in the containment. Iodine has several chemical forms including aerosols, vapor, and gas. Among them gaseous iodine such as I{sub 2} and organic iodide are dominating due to their high volatility. Therefore, such iodine behavior has been extensively examined. Korea Institute of Nuclear Safety (KINS) has been joining the relevant international programs such as ISTP-EPICUR, OECD-BIP and OECD-STEM. In the course of this study, a simple iodine model, RAIM (Radio-Active Iodine chemistry Model) has been developed, based on the IMOD methodology and other previous studies. This model deals with chemical reactions associated with formation and destruction of iodine species in the containment atmosphere and the sump in a simple manner, as shown in Fig. 1. It also treats adsorption and desorption of volatile iodine on the paint surface. The iodine species modeled are inorganic volatile iodine, organic iodides of high volatility (HVRI) and low volatility (LVRI), non-volatiles, non-aqueous iodine, and iodine oxide aerosols (IO{sub x}). Many other material participating in the iodine reactions, e.g., air radiolysis products (ARP) such as ozone, are also modeled. This paper especially shows the analysis results after addition of gaseous reaction model to RAIM, which was further accompanied by adjustments of the existing reaction rate constants even for the aqueous reactions. After integration of iodine reaction models for gas and aqueous phase, RAIM was applied the S1-9 and S1-11 tests which were carried out in aqueous phase. In addition, re-analysis of the S2-6-5-2 test, for which iodine-loaded coupons were tested in gas phase, was also performed.

  14. Thyroid iodine uptake and serum triiodothyronine level in eldery subjects

    International Nuclear Information System (INIS)

    Paradowski, L.; Dolinska, G.; Knapik, Z.; Rynowiecka, M.

    1980-01-01

    Iodine uptake by the thyroid and serum triiodothyronine (T 3 ) level in subjects aged from 65 to 93 years were determined. Low T 3 level and normal uptake of inorganic iodine by the thyroid were found. In the light of these results it is suggested that normal accumulation of inorganic iodine and low production of T 3 are characteristic features of euthyroidism in elderly subjects. It is believed that the function of the thyroid is expressed better by determination of the serum levels of thyroid hormones than determination of the uptake of radioactive iodine. Elaboration of standard normal values which would take into account abnormalities encountered in old age is postulated. (author)

  15. A new concept for filtration units for trapping radioactive aerosols and iodine in the ventilation systems of nuclear power plants with WWER reactors

    International Nuclear Information System (INIS)

    Foerster, V.; Slanina, S.

    1985-01-01

    The paper describes a concept for new filtration units in the ventilation systems of nuclear power plants with WWER reactors. The new units are characterized by more stringent requirements on the efficiency of air purification (removal of radioactive contaminants) and various requirements for the quality of air purification in the ventilation systems. Work performed at the Scientific Research Institute for Air Technology has resulted in filtration units of a universal modular type, the structural design of which permits a high degree of variation in their component parts. A brief description is given of the filtration units, their basic technical characteristics and examples of their use in nuclear power plant ventilation systems. (author)

  16. RADIOACTIVE IODINE THERAPY WITHOUT RECENT ANTITHYROID DRUG PRETREATMENT FOR HYPERTHYROIDISM COMPLICATED BY SEVERE HYPERBILIRUBINEMIA DUE TO HEPATIC DYSFUNCTION: EXPERIENCE OF A CHINESE MEDICAL CENTER.

    Science.gov (United States)

    Ding, Yong; Xing, Jialiu; Qiu, Zewu; Wang, Yong; Zhang, Youren; Fang, Yi; Peng, Xiaobo; Long, Yahong; Deng, Pei

    2016-02-01

    The objective of this work is to report our experience with (131)I therapy without recent antithyroid drug (ATD) pretreatment for refractory severe hyperthyroidism complicated by hyperbilirubinemia due to hepatic dysfunction. Five patients with refractory severe hyperthyroidism were treated with (131)I at 90 to 120 μCi/g-thyroid (total activity, 6.2 to 10.1 mCi). The patients previously had received ATD treatment from 2 months to 12 years and discontinued ATDs from 2 months to 4 years before (131)I treatment due to treatment failure or severe jaundice. Prior to (131)I therapy, the patients were asked to take a low-iodine diet and were treated with bisoprolol fumarate, digoxin, furosemide, S-adenosylmethionine, polyene phosphatidylcholine, and plasma exchange as supportive treatment for related clinical conditions. Four of the patients also received lithium carbonate in conjunction with their (131)I treatment. The patients were followed for 4 to 9 years after (131)I therapy. After (131)I treatment, jaundice disappeared completely within 3 to 4 months in all patients, and liver function tests returned to normal. Concurrent atrial fibrillation and heart failure, leukopenia and thrombocytopenia, or thrombocytopenia and left cardiac enlargement improved remarkably in 3 patients during the follow-up period. Three to 45 months after (131)I treatment, hypothyroidism was noted in the patients and they were treated with L-thyroxine replacement therapy. (131)I therapy without recent ATD pretreatment for refractory severe hyperthyroidism complicated by serious jaundice appears to be safe and effective, with good long-term results. It may be the preferred therapy for such patients and should be used as early as possible.

  17. Handheld single photon emission computed tomography (handheld SPECT) navigated video-assisted thoracoscopic surgery of computer tomography-guided radioactively marked pulmonary lesions.

    Science.gov (United States)

    Müller, Joachim; Putora, Paul Martin; Schneider, Tino; Zeisel, Christoph; Brutsche, Martin; Baty, Florent; Markus, Alexander; Kick, Jochen

    2016-09-01

    Radioactive marking can be a valuable extension to minimally invasive surgery. The technique has been clinically applied in procedures involving sentinel lymph nodes, parathyroidectomy as well as interventions in thoracic surgery. Improvements in equipment and techniques allow one to improve the limits. Pulmonary nodules are frequently surgically removed for diagnostic or therapeutic reasons; here video-assisted thoracoscopic surgery (VATS) is the preferred technique. VATS might be impossible with nodules that are small or located deep in the lung. In this study, we examined the clinical application and safety of employing the newly developed handheld single photon emission tomography (handheld SPECT) device in combination with CT-guided radioactive marking of pulmonary nodules. In this pilot study, 10 subjects requiring surgical resection of a pulmonary nodule were included. The technique involved CT-guided marking of the target nodule with a 20-G needle, with subsequent injection of 25-30 MBq (effective: 7-14 MBq) Tc-99m MAA (Macro Albumin Aggregate). Quality control was made with conventional SPECT-CT to confirm the correct localization and exclude possible complications related to the puncture procedure. VATS was subsequently carried out using the handheld SPECT to localize the radioactivity intraoperatively and therefore the target nodule. A 3D virtual image was superimposed on the intraoperative visual image for surgical guidance. In 9 of the 10 subjects, the radioactive application was successfully placed directly in or in the immediate vicinity of the target nodule. The average size of the involved nodules was 9 mm (range 4-15). All successfully marked nodules were subsequently completely excised (R0) using VATS. The procedure was well tolerated. An asymptomatic clinically insignificant pneumothorax occurred in 5 subjects. Two subjects were found to have non-significant discrete haemorrhage in the infiltration canal of the needle. In a single subject, the

  18. Long-term migration of iodine in sedimentary rocks based on iodine speciation and 129I/127I ratio

    Science.gov (United States)

    Togo, Y.; Takahashi, Y.; Amano, Y.; Matsuzaki, H.; Suzuki, Y.; Muramatsu, Y.; Iwatsuki, T.

    2012-12-01

    [Introduction] 129I is one of the available indexes of long-term migration of groundwater solutes, because of its long half-life (15.7 million years) and low sorption characteristics. The Horonobe underground research center (Japan Atomic Energy Agency), at which are conducted research and development of fundamental techniques on geological disposal of high-level radioactive waste, is an appropriate site for natural analogue studies, because iodine concentration in groundwater is high in this area. To predict iodine behavior in natural systems, speciation of iodine is essential because of different mobility among each species. In this study, we determined iodine speciation and129I/127I isotope ratios of rock and groundwater samples to investigate long term migration of iodine. [Methods] All rock and groundwater samples were collected at Horonobe underground research center. The region is underlain mainly by Neogene to Quaternary marine sedimentary rocks, the Wakkanai Formation (Wk Fm, siliceous mudstones), and the overlying Koetoi Formation (Kt Fm, diatomaceous mudstones). Iodine species in rock samples were determined by iodine K-edge X-ray absorption near edge structure (SPring-8 BL01B1). Thin sections of rock samples were prepared, and iodine mapping were obtained by micro-XRF analysis (SPring-8 BL37XU). Iodine species (IO3-, I-, and organic I) in groundwater were separately detected by high performance liquid chromatography connected to ICP-MS. The 129I/127I ratios in groundwater and rock samples were measured by accelerator mass spectrometry (MALT, Univ. of Tokyo). Iodine in rock samples were separated by pyrohydrolysis and water extraction. [Results and discussion] Concentration of iodine in groundwater varied widely and was much higher than that of seawater showing a high correlation with that of chlorine (R2 = 0.90). Species of iodine in groundwater was mainly I-. Iodine in rock samples decreased near the boundary between Wk and Kt Fms. Iodine K-edge XANES

  19. Iodine and thyroid function

    Directory of Open Access Journals (Sweden)

    Hye Rim Chung

    2014-03-01

    Full Text Available Severe iodine deficiency causes hypothyroidism that results in impaired somatic growth and motor development in children. Mild and moderate iodine deficiencies cause multifocal autonomous growth of thyroid, which results in thyrotoxicosis. On the other hand, iodine excess is associated with the development of hypothyroidism and thyroid autoimmunity. In areas of iodine deficiency, a sudden increase in iodine intake is associated with transient hyperthyroidism. Recent studies demonstrated that long-term thyroid function of subjects who experienced both iodine deficiency and iodine excess during childhood tended to be abnormal despite optimization of their current iodine intake. Iodine status in the Korean Peninsula is very unique because people in the Republic of Korea have been shown to have predominantly excessive iodine levels, whereas the Democratic People's Republic of Korea is known to be an iodine-deficient area. Further research is warranted to verify the optimal ranges of iodine intake and to clarify the effects of iodine intake on thyroid disorders in the Korean Peninsula.

  20. Values of iodine metabolism biomarkers in assessing the iodine nutrition status in surgically treated patients with thyroid disease.

    Science.gov (United States)

    Han, Jian-hua; Wu, Lian; Yu, Song-lin; Fang, Hui-ling; Kamg, Wei-ming; Cheng, Xin-qi; Lu, Jie; Yu, Jian-chun; Qiu, Ling

    2015-04-01

    To assess the clinical application value of iodine metabolism biomarkers in assessing iodine nutrition status in surgically treated patients with thyroid disease. Blood,morning urine and 24-hour urine samples were collected in 31 healthy volunteers and in 30 surgically treated patients with thyroid disease before and after surgery. Iodine concentration was analyzed by inductively coupled plasma mass spectrometry. The iodine metabolism biomarkers including serum iodine (SI), morning urine iodine(UI), morning urine iodine/urine creatinine ratio (UI/UCr), 24-hour urine iodine (24 h UI), and 24-hour urine iodine excretion (24 h UIE) were evaluated in these two groups. In addition, the validation coincidence rate of iodine metabolism biomarkers in healthy volunteers to different reference ranges including World Health Organization, Mayo Clinic, and Quest Diagnostics were calculated. The UI/UCr ratio of pre-operative thyroid disease patients was significantly lower than that of healthy volunteers (P0.05) between these two groups. The SI, UI ,and 24 h UI in postoperative thyroid disease patients were significantly higher than those of the pre-operative patients (all Piodine metabolism biomarkers. The UI/UCr ratio may be used for iodine nutrition evaluation in surgically treated patients with thyroid disease.

  1. Efficacy of adjuvant therapy with 3.7 GBq radioactive iodine in intermediate-risk patients with 'higher risk features' and predictive value of postoperative nonstimulated thyroglobulin.

    Science.gov (United States)

    Rosario, Pedro W; Mourão, Gabriela F; Calsolari, Maria Regina

    2016-11-01

    This study evaluated the efficacy of adjuvant therapy with 3.7 GBq radioactive iodine (RAI) in patients with papillary thyroid carcinoma (PTC) of intermediate risk with higher risk features and determined the predictive value of postoperative nonstimulated thyroglobulin (Tg). This was a prospective study including 85 patients with PTC of intermediate risk and higher risk features: tumor greater than 1 cm and aggressive histological subtype or vascular invasion; and/or more than three positive lymph node (LN) or LN greater than 1.5 cm or showing macroscopic extracapsular extension; and/or a combination of tumor greater than 4 cm, microscopic extrathyroidal extension, aggressive histology, and LN metastases (cN1). After thyroidectomy, all patients had nonstimulated Tg of at least 0.3 ng/ml and ultrasonography showed no anomalies. When evaluated 12 months after RAI therapy, an excellent response to initial therapy was achieved in 61 patients (71.7%). Structural disease was detected in five patients (5.9%). During follow-up, 6/80 patients (7.5%) without structural disease 1 year after RAI developed relapse. In the last assessment, 80 patients (94.1%) had nonstimulated Tg less than 1 ng/ml and no evidence of structural disease. There was no case of death because of the tumor. Postoperative nonstimulated Tg was a predictive factor of the main outcome (structural disease 1 year after RAI or recurrence) and the best cut-off was 1.8 ng/ml (sensitivity: 72.7%, specificity: 83.4%, negative predictive value: 95.4%). In patients with PTC of intermediate risk with higher risk features treated with 3.7 GBq RAI, postoperative nonstimulated Tg up to 1.8 ng/ml was a predictor of low risk of structural disease 1 year after therapy or recurrence.

  2. Star-Shaped Intense Uptake of ¹³¹I on Whole Body Scans Can Reflect Good Therapeutic Effects of Low-Dose Radioactive Iodine Treatment of 1.1 GBq.

    Science.gov (United States)

    Kong, Sung Hye; Lim, Jung Ah; Song, Young Shin; Moon, Shinje; Kim, Ye An; Kim, Min Joo; Cho, Sun Wook; Moon, Jae Hoon; Yi, Ka Hee; Park, Do Joon; Cho, Bo Youn; Park, Young Joo

    2018-05-04

    After initial radioactive iodine (RAI) treatment in differentiated thyroid cancer patients, we sometimes observe a star-shaped region of intense uptake of ¹³¹I on whole body scans (WBSs), called a 'star artifact.' We evaluated the clinical implications of star artifacts on the success rate of remnant ablation and long-term prognosis. Total 636 patients who received ¹³¹I dose of 1.1 GBq for the initial RAI therapy and who did not show distant metastasis at the time of diagnosis were retrospectively evaluated. A negative second WBS was used for evaluating the ablation efficacy of the RAI therapy. Among them, 235 patients (36.9%) showed a star artifact on their first WBS. In patients with first stimulated thyroglobulin (sTg) levels ≤2 ng/mL, patients with star artifacts had a higher rate of negative second WBS compared with those without star artifacts (77.8% vs. 63.9%, P=0.044), and showed significantly higher recurrence-free survival (P=0.043) during the median 8.0 years (range, 1.0 to 10.0) of follow-up. The 5- and 10-year recurrence rates (5YRR, 10YRR) were also significantly lower in patients with star artifacts compared with those without (0% vs. 4.9%, respectively, P=0.006 for 5YRR; 0% vs. 6.4%, respectively, P=0.005 for 10YRR). However, ablation success rate or recurrence-free survival was not different among patients whose first sTg levels >2 ng/mL regardless of star artifacts. Therefore, star artifacts at initial RAI therapy imply a good ablation efficacy or a favorable long-term prognosis in patients with sTg levels ≤2 ng/mL. Copyright © 2018 Korean Endocrine Society.

  3. Inquiry about 131 Iodine use in Brazil

    International Nuclear Information System (INIS)

    Albino, Claudio Cordeiro; Takahashi, Mirian Hideko; Senhorini Junior, Sidney; Graf, Hans

    2001-01-01

    Radioactive iodine is an effective and widely accepted therapy for Graves disease (G D) and differentiated thyroid carcinoma (DTC), but there still are some controversies about the criteria for its use. To establish the present tendency for radioiodine indication, we have sent questionnaires for members of The Brazilian Society of Endocrinology and Latin American Thyroid Society, with 3 index cases: G D, toxic nodular goiter (TNG) and DTC. For each case, questions were proposed about diagnostic procedures and therapy with some clinical variants, which could modify the therapeutic choice. From the almost 2000 questionnaires sent only 82 replies (3.4%) were analyzed. Most of respondents defined themselves as general endocrinologists (85%), working in South and Southeast regions of Brazil (80%), with more than 20 years of professional activity and working mainly at University Hospitals (40%). In case index 1 (G D), 95% of the respondents used arrays of T 3, T 4 and TSH for the diagnosis and 25% added TRAb and thyroid scan. Antithyroid drugs (ATD) were the first choice for 72%, followed by radioiodine and surgery (26% and 1.3% respectively). None of clinical variants such as severe exophthalmos, older age or goiter size modified the therapy. In case 2 (TNG), radioiodine was the first therapy for 84% of professionals and the presence of compressive symptoms was the only variant that changed this tendency, when surgery was the main option. In case 3 (DTC), almost all indicated total thyroidectomy. Radioiodine for thyroid remnants was proposed by 45% of respondents, independent of residual uptake, while the remaining did so depending of different values of uptake, giving 30 to 100 mCI. These data show that radioiodine use is increasing for hyperthyroidism, but still less than observed in other countries and that we do not have uniformity for treatment of DTC. (author)

  4. Methods to determine iodine plate-out

    International Nuclear Information System (INIS)

    Hougaard, H.; Solgaard, P.; Zak, W.

    1986-03-01

    A literature study on iodines behaviour after release from irradiated fuel rods and a detailed dscription of the ventilation system in the hot cell facility form the basis of chosen conditions for some preliminary experiments using non-radioactive iodine. The conclusion states that the system is well suited for the purpose as is the method of sampling from the surface of the ventilation duct, while the releasing technique and the chemical analysis has to be further developed, neutron activation analysis being most promising. (author)

  5. Administering of steady iodine in the case of a nuclear accident

    International Nuclear Information System (INIS)

    2004-01-01

    In the case of serious accidents, some nuclear installations, especially the nuclear power plants, can release in atmosphere radioactive elements such radioactive iodine. this radioisotope, will contribute to the populations irradiation and can lead to a thyroid cancer. Consequently tablets of steady iodine are distributed in prevention to the populations living in the vicinity of nuclear power plant. In the case of an alert of radioactive release, the Prefect will order to take these tablets. (N.C.)

  6. Iodination of phenol

    International Nuclear Information System (INIS)

    Christiansen, J.V.; Feldthus, A.; Carlsen, L.

    1990-01-01

    Phenol is iodinated in aqueous solution at pH 5 (acetate buffer) by elemental iodine or, if the iodine is present as iodide, enzymatically controlled by peroxidases. Generally mono-, di- and triiodophenols are obtained, the overall product composition being virtually identical for the two iodination modes. However, there is a tendency to a higher para to ortho ratio for the enzymatically controlled reaction. The mutual ratios of the single iodophenols depends on the initial concentration ratio between phenol and the iodinating species. The first step in the iodination leads preferentially to substitution in the ortho position rather than in the para position in contract to e.g. the corresponding bromination. The relative rates of the competive reactions in the combined iodination scheme has been derived. (author) 2 tabs., 3 ills., 15 refs

  7. Radioguided Surgery for Localization of Nonpalpable Breast Lesions A Mini-Review

    DEFF Research Database (Denmark)

    Langhans, Linnea; Klausen, Thomas Levin; Tvedskov, Tove Filtenborg

    2016-01-01

    by ultrasound a small titanium seed containing typically 1-10 MBq of radioactive iodine-125 is placed in the centre of the nonpalpable breast lesion. During the operation the seed is located with a hand-held gamma probe. To date, only few cohort studies exist on the feasibility of RSL, and the method has only...... of patients with insufficient resection margin. These patients require a reoperation. New methods in the field of radioguided surgery (RGS) have been developed including radioguided occult lesion localization (ROLL) and radioactive seed localization (RSL). Especially RSL is a very promising technique. Guided...

  8. Assessment of risks associated to ionizing radiations: lung cancers after domestic radon exposure and thyroid cancers after accidental exposure to radioactive iodines

    International Nuclear Information System (INIS)

    Catelinois, O.

    2004-09-01

    Chernobyl nuclear power plant accident fallout, is based on the excess relative risk model published by E. Ron et al. in 1995. The target population is composed of all children younger than 15 years and living in the eastern part of France at the time of the accident (26 April 1986). The incidence rates between 1978 and 1997 are analysed and forecasted up to 2007 using age-period-cohort models. Thyroid doses are estimated from all available data about the contamination in France from the Chernobyl fallout/ The risks characterization is carried out by considering various scenarios on the projection of spontaneous incidence rates, the effectiveness of internal exposures compared to external ones and the levels of radioactive deposits. Uncertainties to the risk coefficient, the expected spontaneous incidence rates and the thyroid dose are considered. The estimated number of thyroid cancer cases in excess between 1991 and 2007 for the target population ranges from 5 (90% U.I.: 1-15) to 63 (90% U.I. 12-180). In comparison, depending on the scenario of spontaneous rate projection, the number of spontaneous cancer cases should range from 894 (90% U.I.: 869-920) to 1,716 (90% U.I.:1,691-1,741) between 1991 and 2007. The results show that the thyroid cancer incident rate increase observed in France during last 20 years cannot be explained by the Chernobyl fallout. The work provides an adaptation of the classical risk assessment method integrating each of its step such as a discussion about the choice of the dose-response relationship. The data analysis considers the interaction between ionizing radiation and other risk factors, a spontaneous incidence rate projection and a quantification of uncertainties. This work provides new results showing the importance of the choice of the dose-response relationship, of the consideration of the spontaneous incidence trend and of the quantification of uncertainties in risk assessment. In conclusion, this work provides new knowledge for public

  9. Iodine deficiency and iodine excess in Jiangsu Province, China

    NARCIS (Netherlands)

    Zhao, J.

    2001-01-01

    Keywords:
    iodine deficiency, iodine excess, endemic goiter, drinking water, iodine intake, thyroid function, thyroid size, iodized salt, iodized oil, IQ, physical development, hearing capacity, epidemiology, meta-analysis, IDD, randomized trial, intervention, USA, Bangladesh,

  10. Separation of iodine from mercury containing scrubbing solutions

    Science.gov (United States)

    Burger, Leland L.; Scheele, Randall D.

    1979-01-01

    Radioactive iodines can be recovered from a nitric acid scrub solution containing mercuric nitrate by passing a current through the scrub solution to react the iodine with the mercuric nitrate to form mercuric iodate which precipitates out. The mercuric iodate can then be reacted to recover the radioiodine for further processing into a form suitable for long-term storage and to recover the mercury for recycling.

  11. Ordinance on distribution of iodine tablets to the population

    International Nuclear Information System (INIS)

    1992-01-01

    This Ordinance provides for the organization of supplies of iodine tablets to the population. The tablets will be held in case of occurrences that might endanger the population following an accident provoking the emission of radioactive iodine. The Federal Health Ministry is responsible for organizing the supply to the appropriate bodies for distribution to the population. The Ordinance entered into force on 1 August 1992. (NEA)

  12. Iodine-125 seeds for cancer treatment

    Energy Technology Data Exchange (ETDEWEB)

    Rostelato, Maria E.C.M.; Zeituni, Carlos A.; Feher, Anselmo; Moura, Joao A.; Moura, Eduardo S.; Nagatomi, Helio R.; Manzoli, Jose E.; Souza, Carla D., E-mail: elisaros@ipen.b, E-mail: czeituni@pobox.co, E-mail: afeher@ipen.b, E-mail: jmoura31@yahoo.com.b, E-mail: esmoura@ipen.b, E-mail: hrnagato@ipen.b, E-mail: jemanzoli@ipen.b, E-mail: cdsouza@ipen.b [Instituto de Pesquisas Energeticas e Nucleares (IPEN/CNEN-SP), Sao Paulo, SP (Brazil); Karam, Dib, E-mail: dib.karan@usp.b [Universidade de Sao Paulo (USP), SP (Brazil). Escola de Artes, Ciencias e Humanidades

    2009-07-01

    In Brazil, cancer has become one of the major public health problems. An estimate by the Health Ministry showed that 466,430 people had the disease in the country in 2008. The prostate cancer is the second largest death cause among men. The National Institute of Cancer estimated the occurrence of 50,000 new cases for 2009. Some of these patients are treated with Brachytherapy, using Iodine-125 seeds. By this technique, small seeds with Iodine-125, a radioactive material, are implanted in the prostate. The advantages of radioactive seed implants are the preservation of healthy tissues and organs near the prostate, besides the low rate of impotence and urinary incontinence. The Energy and Nuclear Research Institute - IPEN, which belongs to the Nuclear Energy National Commission - CNEN, established a program for the development of the technique and production of Iodine-125 seeds in Brazil. The estimate for the 125-Iodine seeds demand is of 8,000 seeds/month and the laboratory to be implanted will need this production capacity. The purpose of this paper is to explain the project status and show some data about the seeds used in the country. The project will be divided in two phases: technological development of a prototype and a laboratory implementation for the seeds production. (author)

  13. Rationale and design of decision: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory, differentiated thyroid cancer

    International Nuclear Information System (INIS)

    Brose, Marcia S; Schlumberger, Martin; Nutting, Christopher M; Sherman, Steven I; Shong, Young Kee; Smit, Johannes WA; Reike, Gerhard; Chung, John; Kalmus, Joachim; Kappeler, Christian

    2011-01-01

    The incidence of thyroid cancer and the number of patients who die from this disease are increasing globally. Differentiated thyroid cancer (DTC) is the histologic subtype present in most patients and is primarily responsible for the increased overall incidence of thyroid cancer. Sorafenib is a multikinase inhibitor that targets several molecular signals believed to be involved in the pathogenesis of thyroid cancer, including those implicated in DTC. In phase II studies of patients with DTC, sorafenib treatment has yielded a median progression-free survival (PFS) of 58 to 84 weeks and disease control rates of 59% to 100%. The DECISION trial was designed to assess the ability of sorafenib to improve PFS in patients with locally advanced or metastatic, radioactive iodine (RAI)-refractory DTC. DECISION is a multicenter, double-blind, randomized, placebo-controlled phase III study in patients with locally advanced/metastatic RAI-refractory DTC. Study treatment will continue until radiographically documented disease progression, unacceptable toxicity, noncompliance, or withdrawal of consent. Efficacy will be evaluated every 56 days (2 cycles), whereas safety will be evaluated every 28 days (1 cycle) for the first 8 months and every 56 days thereafter. Following disease progression, patients may continue or start sorafenib, depending on whether they were randomized to receive sorafenib or placebo, at investigator discretion. Patients originally randomized to receive sorafenib will be followed up every 3 months for overall survival (OS); patients originally randomized to receive placebo will be followed up every month for 8 months after cross-over to sorafenib. The duration of the trial is expected to be 30 months from the time the first patient is randomized until the planned number of PFS events is attained. The primary endpoint is PFS; secondary endpoints include OS, time to disease progression, disease control rate, response rate, duration of response, safety, and

  14. [68Ga]DOTATATE PET/MRI and [18F]FDG PET/CT are complementary and superior to diffusion-weighted MR imaging for radioactive-iodine-refractory differentiated thyroid cancer

    International Nuclear Information System (INIS)

    Vrachimis, Alexis; Stegger, Lars; Wenning, Christian; Noto, Benjamin; Konnert, Julia Renate; Riemann, Burkhard; Weckesser, Matthias; Burg, Matthias Christian; Allkemper, Thomas; Heindel, Walter; Schaefers, Michael

    2016-01-01

    The purpose of this study was to determine whether [ 68 Ga]DOTATATE PET/MRI with diffusion-weighted imaging (DWI) can replace or complement [ 18 F]FDG PET/CT in patients with radioactive-iodine (RAI)-refractory differentiated thyroid cancer (DTC). The study population comprised 12 patients with elevated thyroglobulin and a negative RAI scan after thyroidectomy and RAI remnant ablation who underwent both [ 18 F]FDG PET/CT and [ 68 Ga]DOTATATE PET/MRI within 8 weeks of each other. The presence of recurrent cancer was evaluated on a per-patient, per-organ and per-lesion basis. Histology, and prior and follow-up examinations served as the standard of reference. Recurrent or metastatic tumour was confirmed in 11 of the 12 patients. [ 68 Ga]DOTATATE PET(/MRI) correctly identified the tumour burden in all 11 patients, whereas in one patient local relapse was missed by [ 18 F]FDG PET/CT. In the lesion-based analysis, overall lesion detection rates were 79/85 (93 %), 69/85 (81 %) and 27/82 (33 %) for [ 18 F]FDG PET/CT, [ 68 Ga]DOTATATE PET/MRI and DWI, respectively. [ 18 F]FDG PET(/CT) was superior to [ 68 Ga]DOTATATE PET(/MRI) in the overall evaluation and in the detection of pulmonary metastases. In the detection of extrapulmonary metastases, [ 68 Ga]DOTATATE PET(/MRI) showed a higher sensitivity than [ 18 F]FDG PET(/CT), at the cost of lower specificity. DWI achieved only poor sensitivity and was significantly inferior to [ 18 F]FDG PET in the lesion-based evaluation in the detection of both extrapulmonary and pulmonary metastases. [ 18 F]FDG PET/CT was more sensitive than [ 68 Ga]DOTATATE PET/MRI in the evaluation of RAI-refractory DTC, mostly because of its excellent ability to detect lung metastases. In the evaluation of extrapulmonary lesions, [ 68 Ga]DOTATATE PET(/MRI) was more sensitive and [ 18 F]FDG PET(/CT) more specific. Furthermore, DWI did not provide additional information and cannot replace [ 18 F]FDG PET for postoperative monitoring of patients with

  15. Iodine deficiency disorders

    Energy Technology Data Exchange (ETDEWEB)

    Ali, S M [Pakistan Council for Science and Technology, Islamabad (Pakistan)

    1994-12-31

    Iodine deficiency (IDD) is one of the common problem in the diet. Iodine deficiency as prevalence of goiter in population occurs in the mountainous areas. There is consensus that 800 million people are at risk of IDD from living in iodine deficient area and 190 million from goiter. Very high prevalence of IDD in different parts of the world are striking. It has generally observed that in iodine-deficient areas about 50% are affected with goiter, 1-5% from cretinsim and 20% from impaired mental and/or mortor function. (A.B.).

  16. Liquid dynamic in the retroperitoneum: study of albumin labelled with iodine-131

    International Nuclear Information System (INIS)

    Steinman, E.

    1990-01-01

    The retroperitoneal region in not very well-known, specially what concerns its behavior and dynamics, when there is presence of blood and other collections. Therefore, we decided to study the dissemination of the absorption of liquids, using for that a radioactive indicator deposited in different areas of the retroperitoneum. The chosen indicator was iodinated albumin (RIHSA). This study was performed in patients submitted to different types of surgical procedures, but in those who did not present retroperitoneum affections or previous surgeries. In all patients, the blood concentration rate of the indicator in determined times was determined and also the scintilografic image with 24, 48 and 72 hours after finished the surgical procedure was undertaken. It was observed that in the retroperitoneum, the indicator tend to be concentrated in the same place as it was injected at least up to 72 hours and that in the peritoneum the indicator migrates earlier to the abdominal cavity. Besides, the blood transference in retroperitoneum is performed on a slower manner when compared to the peritoneum, except for the anterior para renal area. Radioactive iodine injected in the retroperitoneum was earlier captured by the thyroid. The adopted technique is inocuous, simple, reproductible and quantified. (author)

  17. Radioactivity and food

    International Nuclear Information System (INIS)

    Olszyna-Marzys, A.E.

    1990-01-01

    Two topics relating to radioactivity and food are discussed: food irradiation for preservation purposes, and food contamination from radioactive substances. Food irradiation involves the use of electromagnetic energy (x and gamma rays) emitted by radioactive substances or produced by machine in order to destroy the insects and microorganisms present and prevent germination. The sanitary and economic advantages of treating food in this way are discussed. Numerous studies have confirmed that under strictly controlled conditions no undesirable changes take place in food that has been irradiated nor is radioactivity induced. Reference is made to the accident at the Chernobyl nuclear power station, which aroused public concern about irradiated food. The events surrounding the accident are reviewed, and its consequences with regard to contamination of different foods with radioactive substances, particularly iodine-131 and cesium-137, are described. Also discussed are the steps that have been taken by different international organizations to set limits on acceptable radioactivity in food.15 references

  18. Iodine-131 Releases from Radioactive Lanthanum Processing at the X-10 Site in Oak Ridge, Tennessee (1944-1956)- An Assessment of Quantities released, Off-Site Radiation Doses, and Potential Excess Risks of Thyroid Cancer- APPENDICES Appendices-Volume 1A

    International Nuclear Information System (INIS)

    Apostoaei, A.I.; Burns, R.E.; Hoffman, F.O.; Ijaz, T.; Lewis, C.J.; Nair, S.K.; Widner, T.E.

    1999-01-01

    This report consists of all the appendices for the report described below: In the early 1990s, concern about the Oak Ridge Reservation's past releases of contaminants to the environment prompted Tennessee's public health officials to pursue an in-depth study of potential off-site health effects at Oak Ridge. This study, the Oak Ridge dose reconstruction, was supported by an agreement between the U.S. Department of Energy (DOE) and the State of Tennessee, and was overseen by a 12-member panel appointed by Tennessee's Commissioner of Health. One of the major contaminants studied in the dose reconstruction was radioactive iodine, which was released to the air by X-10 (now called Oak Ridge National Laboratory) as it processed spent nuclear reactor fuel from 1944 through 1956. The process recovered radioactive lanthanum for use in weapons development. Iodine concentrates in the thyroid gland so health concerns include various diseases of the thyroid, such as thyroid cancer. The large report, ''Iodine-131 Releases from Radioactive Lanthanum Processing at the X-10 Site in Oak Ridge, Tennessee (1944-1956) - An Assessment of Quantities Released, Off-site Radiation Doses, and Potential Excess Risks of Thyroid Cancer,'' is in two volumes. Volume 1 is the main body of the report, and Volume 1A, which has the same title, consists of 22 supporting appendices. Together, these reports serve the following purposes: (1) describe the methodologies used to estimate the amount of iodine-131 (I-131) released; (2) evaluate I-131's pathway from air to vegetation to food to humans; (3) estimate doses received by human thyroids; (4) estimate excess risk of acquiring a thyroid cancer during ones lifetime; and (5) provide equations, examples of historical documents used, and tables of calculated values as appendices. Results indicate that females born in 1952 who consumed milk from a goat pastured a few miles east of X-10 received the highest doses from I-131 and would have had the highest

  19. Iodine-131 Releases from Radioactive Lanthanum Processing at the X-10 Site in Oak Ridge, Tennessee (1944-1956)- An Assessment of Quantities released, Off-Site Radiation Doses, and Potential Excess Risks of Thyroid Cancer- APPENDICES Appendices-Volume 1A

    Energy Technology Data Exchange (ETDEWEB)

    Apostoaei, A.I.; Burns, R.E.; Hoffman, F.O.; Ijaz, T.; Lewis, C.J.; Nair, S.K.; Widner, T.E.

    1999-07-01

    This report consists of all the appendices for the report described below: In the early 1990s, concern about the Oak Ridge Reservation's past releases of contaminants to the environment prompted Tennessee's public health officials to pursue an in-depth study of potential off-site health effects at Oak Ridge. This study, the Oak Ridge dose reconstruction, was supported by an agreement between the U.S. Department of Energy (DOE) and the State of Tennessee, and was overseen by a 12-member panel appointed by Tennessee's Commissioner of Health. One of the major contaminants studied in the dose reconstruction was radioactive iodine, which was released to the air by X-10 (now called Oak Ridge National Laboratory) as it processed spent nuclear reactor fuel from 1944 through 1956. The process recovered radioactive lanthanum for use in weapons development. Iodine concentrates in the thyroid gland so health concerns include various diseases of the thyroid, such as thyroid cancer. The large report, ''Iodine-131 Releases from Radioactive Lanthanum Processing at the X-10 Site in Oak Ridge, Tennessee (1944-1956) - An Assessment of Quantities Released, Off-site Radiation Doses, and Potential Excess Risks of Thyroid Cancer,'' is in two volumes. Volume 1 is the main body of the report, and Volume 1A, which has the same title, consists of 22 supporting appendices. Together, these reports serve the following purposes: (1) describe the methodologies used to estimate the amount of iodine-131 (I-131) released; (2) evaluate I-131's pathway from air to vegetation to food to humans; (3) estimate doses received by human thyroids; (4) estimate excess risk of acquiring a thyroid cancer during ones lifetime; and (5) provide equations, examples of historical documents used, and tables of calculated values as appendices. Results indicate that females born in 1952 who consumed milk from a goat pastured a few miles east of X-10 received the highest doses from

  20. Speciation of iodine (I-127 and I-129) in lake sediments

    DEFF Research Database (Denmark)

    Englund, E.; Aldahan, A.; Hou, Xiaolin

    2010-01-01

    Fallout of anthropogenic 129I at northern Europe has been occurring since the early 1950. Nevertheless, it is still unclear where and how this radioactive iodine is incorporated in the surface environment. In order to elucidate part of this problem, we here present an investigation of the occurre......Fallout of anthropogenic 129I at northern Europe has been occurring since the early 1950. Nevertheless, it is still unclear where and how this radioactive iodine is incorporated in the surface environment. In order to elucidate part of this problem, we here present an investigation...... the sediment. Organic bound iodine was the dominant form over other fractions, while iodine bound to metal oxides was negligible. The leachable part constituted 5–6% of the iodine. Diagenetic influence seems to exert a limited effect on distribution of iodine in the examined sediment section....

  1. Measurement of Iodine-129 concentration in environmental water samples around Fukushima area - Role of river system in the global iodine cycle

    Science.gov (United States)

    Matsuzaki, Hiroyuki; Tokuyama, Hironori; Miyake, Yasuto; Honda, Maki; Yamagata, Takeyasu; Muramatsu, Yasuyuki

    2013-04-01

    According to Fukushima Dai-ichi Nuclear Power Plant (FDNPP) accident, vast amount of radioactive nuclides including radioactive iodine were spilled out into the environment. There is no question about that detailed observation of distribution of radioactive nuclides and evaluation of the radiation exposure of residents is extremely important. On the other hand, from the view of an elemental dynamics in the environment, this event can be considered as a spike of the radioactive isotope. It is also the case for the iodine. A rare isotope Iodine-129 was widely distributed in a very short time by the FDNPP accident. Iodine-129 directly landing on the soil surface had been trapped in the upper layer of the soil and the depth profile should indicate the migration in and the interaction with the soil. If Iodine-129 was trapped in the woods, it seems to take rather longer time to landing on the ground. Either way, a certain portion of the Iodine-129 should be moving downward and finally washed out by the groundwater or river with a certain rate and transported into the sea. The concentration of Iodine-129 in environmental water samples taken from rivers and ponds are considered to reflect the iodine transportation process by the fluvial system. For the detailed discussion of the role of the fluvial system in the global iodine cycle, Iodine-129 concentration of various water samples collected from Fukushima area was measured by means of Accelerator Mass Spectrometry. The results ranged from 3E06 atoms/L to 3E09 atoms/L. Samples from Abukuma area (South West of FDNPP) showed lower concentration. On the other hand, samples collected from North West part (Iitate village and Minami Soma region) showed higher concentration (more than 1E8 atoms/L). Delayed enhancement of Iodine-129 concentration over a year in river systems surrounded by woods was also observed which is considered to correspond to the delayed release from the woods.

  2. Evaporation of iodine from nitric acid with the aid of peroxide

    International Nuclear Information System (INIS)

    Cathers, G.I.; Shipman, C.J.

    1975-01-01

    Traces of radioactive iodine with a concentration of 5 x 10 -4 M or less that remained in nitric acid solution after reprocessing of nuclear fuels can, without great apparatus effort, be distilled off as hydrogen iodide by continuous addition of hydrogen peroxide to the solution boiling at about 105 0 C to 1,15 0 C, and then be separated as elementary iodine. Starting from a 4 to 6 molecular nitric acid solution, the H 2 O 2 -concentration amounts to 0.012 percentage by weight and is kept at this level during the entire distillation process. The iodine concentration is also profitably kept at the level of the starting solution by adding non-radioactive iodine, since an isotopec exchange of radioactive iodine bound in organic impurities is advanced in that way. (UWI) [de

  3. Induction of hyperparathyroidism by radioactive iodine

    International Nuclear Information System (INIS)

    Rosen, I.B.; Palmer, J.A.; Rowen, J.; Luk, S.C.

    1984-01-01

    External irradiation to the head and neck has been associated with the emergence of hyperparathyroidism, due both to adenoma and hyperplasia since a single case report was published in 1975. A recent report indicates that there may be some association between hyperparathyroidism and radioiodine administered for thyroid disease. Eight patients are presented herein, all female and in middle age, who presented with hyperparathyroidism due to adenoma (six patients) or hyperplasia (one patient who had undergone radioiodine treatment). In three patients, the dose of radioiodine exceeded 30 mCi. The duration of latency ranged from 4 to 20 years. Associated thyroid disease included cancer, colloid nodules, and thyroiditis. All patients became eucalcemic and have remained so. Experimental results that have supported the influence of radioiodine on parathyroid hyperactivity do not appear completely applicable to the human model. It is believed that the low mitotic rate equivalent to low radiosensitivity may have protected the parathyroid gland somewhat from neoplastic change, although the association of thyroid carcinoma and parathyroid adenoma appears to be a significant expression of radiation exposure. It may be the lack of a pituitary-stimulating hormone and the absence of an abscopal mechanism, as illustrated by irradiation to the thyroid, that explains the relative immunity of parathyroid behavior in the face of radioiodine exposure. Regardless of the frequency and validity of the association, it is important to recognize the possibility of the association illustrated by our case reports and scrutinize appropriate patients by intermittent serum calcium sampling, both for confirmation and possible detection of occult hyperparathyroidism

  4. The iodine reactivity; La reactivite de l'iode

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    2003-07-01

    The iodine is an important element because it has long life isotopes (such as iodine 129) and a great mobility in natural media. Iodine presents a complex chemistry because of its volatility and its strong redox reactivity. The S.E.C.R. works to better understand the reactivity of this element in different natural, industrial or biological environments. It plays a part in thermochemical sites as a possible way of hydrogen formation. This seminar gives some aspects relative to the chemical reactivity of iodine, since its thermochemistry in the I/S cycles to produce hydrogen to its reactivity in the natural medium and its potential radiological impact. This document includes 4 presentations transparencies dealing with: the {sup 129}I cycle rejected in the low radioactive gaseous and liquid effluents of the La Hague reprocessing plant (C. Frechou); a bibliographic review of iodine retention in soils (F. Bazer-Bachi); the hydrogen production and the iodine/sulfur thermochemical cycle (role of iodine in the process); and the direct characterization by electro-spray ionization mass spectroscopy of iodine fixation by fulvic acids (P. Reiller, B. Amekraz, C. Moulin, V. Moulin)

  5. Hyperthyroidism treatment by iodine 131: about a study on 270 patients

    International Nuclear Information System (INIS)

    Leroux, M.A.

    2005-01-01

    This study constitutes a starting point for a thought about the use of iodine 131 in the treatment of hyperthyroidism. The therapies are different depending on the teams, for the iodine 131 activities to deliver and their calculation modes; The use of synthesis anti-thyroid drugs before therapy is discussed. The radiation protection is an important factor in the decision of a metabolic radiotherapy. The indications of the treatment by radioactive iodine are different in Europe and in Usa. (N.C.)

  6. Marine geochemistry of iodine

    International Nuclear Information System (INIS)

    Kennedy, H.; Elderfield, H.

    1985-01-01

    Iodine has long been classified as a biophilic element with analyses showing that iodine is strongly enriched, relative to seawater concentrations in both plankton and particulate matter and that the concentration of iodine found in surface sediments is still further enriched relative to that found in the sedimenting particulate matter. The extent of enrichment of iodine relative to carbon in deep sea surface sediments has been shown to depend on the carbon accumulation rate. Iodine decomposition rates have been calculated and are shown to vary with the sedimentation rate in the same manner as has been shown for organic carbon. Vertical profiles of total dissolved iodine, iodate and iodide in interstitial waters of sediments from the north east Atlantic are characterised by three zones of reaction as identified by changes in the concentration of iodate and iodide. These reaction zones represent (i) iodide production (ii) iodide oxidation and (iii) iodate reduction. Pore water and solid phase iodine profiles from cores containing turbidite units have shown that iodine, released to pore waters as iodide during the oxidation of the organic matter, has been scavenged after diffusing upwards into a less reducing region of the sediment. (author)

  7. Iodine-deficiency disorders

    NARCIS (Netherlands)

    Zimmermann, M.B.; Jooste, P.L.; Pandav, C.S.

    2008-01-01

    billion individuals worldwide have insufficient iodine intake, with those in south Asia and sub-Saharan Africa particularly affected. Iodine deficiency has many adverse effects on growth and development. These effects are due to inadequate production of thyroid hormone and are termed

  8. Immobilization of fission iodine by reaction with insoluble natural organic matter

    International Nuclear Information System (INIS)

    Steinberg, S.M.; Schmett, G.T.; Kimble, G.; Emerson, D.W.; Turner, M.F.; Rudin, M.

    2008-01-01

    Iodine-129 is a fission product and highly mobile in the environment. Along with other stable isotopes of iodine, 129 I is released during reprocessing of nuclear fuel and must be trapped to prevent the release of radioactivity to the environment. Past studies have provided evidence that iodine can become associated with natural organic matter (NOM). This research explores the use of NOM (sphagnum peat and humic acid) to sequester iodine from the vapor and aqueous phases. NOM-associated iodine may be stable for geological storage. NOM-sequestered iodine can be recovered by pyrolysis to prepare target materials for transmutation. The nature of the NOM-iodine association has been explored. (author)

  9. Iodine mineral waters

    Directory of Open Access Journals (Sweden)

    Iluta Alexandru

    2011-11-01

    Full Text Available Iodine mineral waters are found especially in sub-Carpathian region, also in regions with Salif deposits. Waters are currently used iodine in drinking cure for chaps and Basedow. Are also indicated in balneology. Iodine water containing at least 1 mg L, there is pure iodine is usually given the nature of other types of mineral waters further: sodium chlorinated water (Bazna (50-70 mg iodine / l, Baile Govora (50 - 70 mg / l, Bălţăteşti (4-5 mg / l, salted Monteoru (30 mg / l, mine water mixed alkaline chlorination, sulphate, which are indicated for crenoterapie (hypo or isotonic to the bathrooms Olăneşti or Călimăneşti-Căciulata.

  10. Iodine leaflets in chapter D5 'Distribution of iodine pills'

    International Nuclear Information System (INIS)

    1981-01-01

    Jodine leaflet A will be distributed together with iodine pills in a nuclear disaster. Iodine leaflet B is suitable for informing the public in advance. Iodine leaflet C informs physicians in a scientific way on the benefits and risk of iodine pills. (orig./HP) [de

  11. Iodine generator for reclaimed water purification

    Science.gov (United States)

    Wynveen, R. A.; Powell, J. D.; Schubert, F. H. (Inventor)

    1977-01-01

    The system disclosed is for controlling the iodine level in a water supply in a spacecraft. It includes an iodine accumulator which stores crystalline iodine, an electrochemical valve to control the input of iodine to the drinking water and an iodine dispenser. A pump dispenses fluid through the iodine dispenser and an iodine sensor to a potable water tank storage. The iodine sensor electronically detects the iodine level in the water, and through electronic means, produces a correction current control. The correction current control operates the electro-chemical iodine valve to release iodine from the iodine accumulator into the iodine dispenser.

  12. Preparation of directly iodinated steroid hormones and related directly halogenated compounds

    International Nuclear Information System (INIS)

    Sahadevan, V.

    1981-01-01

    The preparation of directly iodinated radioactive steroid hormones is described for use in radioimmunoassays or radiolocalization and treatment of human breast tumours. The radioactive iodinated steroid hormone is prepared by reacting a parent steroid hormone with an alkali metal iodide containing radioactive 123 I, 125 I, 130 I or 131 I in the presence of hydrogen peroxide or chloramine-T. The parent steroid hormones include the adrenal corticosteroids, the estrogens, the progestogens, the progestins and the diuretic and antidiuretic agents. The radioactive iodinated steroid hormone is prepared by iodinating the parent steroid hormone directly on the cyclopentanophenanthrene nucleus. The radioactive iodinated steroid hormones have the same antigenicity and receptor site specificity as the parent steroid hormone. The invention is illustrated by 1) the method of iodination of estradiol-17β, 2) results for the percentage labelling of several steroids and steroid hormones, 3) results for the radioimmunoassay of 125 I-estradiol and 4) results for the binding of directly iodinated estradiol-17β in an estrogen receptor assay of human breast cancer. (U.K.)

  13. Is placental iodine content related to dietary iodine intake?

    LENUS (Irish Health Repository)

    Burns, R

    2011-08-01

    Delivery of iodine to the foetus depends not only on maternal dietary iodine intake but also on the presence of a functioning placental transport system. A role for the placenta as an iodine storage organ has been suggested, and this study compares the iodine content of placentas from women giving birth at term in Ireland and Iran, areas with median urinary iodine of 79 and 206 μg\\/l respectively.

  14. Nuclear ventilation installations. Method of control of the scrubbing coefficient of iodine trap

    International Nuclear Information System (INIS)

    1982-12-01

    The present standard aims at defining a method to control the scrubbing coefficient of radioactive iodine trapping systems, used in nuclear ventilation installations. It applies to the installations where the trapping, efficiency of radioactive iodine has to be known, tested and compared to a reference value generally included in the safety reports. It applies to the installations where the absolute pressure of the air in the ventilation systems is above 1,4. 10 5 Pa (1,4 Bar) [fr

  15. Iodine removal in containment filtered venting system during nuclear accident

    International Nuclear Information System (INIS)

    Bera, Subrata; Deo, Anuj Kumar; Nagrale, D.B.; Paul, U.K.; Prasad, M.; Gaikwad, A.J.

    2015-01-01

    Post Fukushima nuclear accident, containment filtered venting system is being introduced in Indian nuclear power plant to strengthen the defense in depth safety barrier by depressurizing the containment building along with minimization of radioactivity release to environment during a severe accident. Radioactive iodine is one of the major contributors to radiation dose during early release phase of a severe accident. Physical and Chemical form of iodine and iodine bearing compounds includes particulates, elemental and organic. In the most efficient design of CFVS, wet scrubbing mechanism has been employed through use of venture scrubber. The Iodine removal process in wet scrubber involves two processes: chemical reaction in highly alkaline aqueous solution and impingement of particulates with water droplets produced in the venturi nozzle. In this paper, venturi has been modeled using the Calvert model. The variation of efficiency has been estimated for the different particle sizes. The impact of the shape parameter of log-normal distribution on the amount of scrubbed iodine has also been assessed. Release phase wise the scrubbed amount of iodine in the venturi based CFVS system has been estimated for a typical BWR. (author)

  16. Iodine in meat in Macedonia

    International Nuclear Information System (INIS)

    Bogdanov, Bogdan; Gonev, Mihajlo; Tadzher, Isak

    2000-01-01

    Iodine deficiency in Macedonia still persists in a mild form. In 1999 the iodination of salt rose to 20 m gr iodine in Kg salt. The consumption of salt diminished after the last war from 20-30 gr salt per day to 10-20 gr salt daily. This shows that the problem of the elimination of iodine deficiency is being vigorously tackled. Since 1956 the iodine in salt in Macedonia rose to 10 m gr KI/Kg salt. The content of iodine in the Macedonian diet seems to be important. The amount of iodine in milk, eggs and bread is low as found by the investigation of MANU. The content of iodine in meat is low, compared to British meat is 10 times lower. The average iodine content in Macedonian meat is 95.15 micro gr per Kg, whereas in British meat it is 850-1510 micro gr iodine per k gr meat. (Original)

  17. Controversies in urinary iodine determinations

    OpenAIRE

    Soldin, Offie Porat

    2002-01-01

    Iodine deficiency (ID) is associated with increased prevalence of goiter, increased risk for neurodevelopmental disorders, and is the world’s leading cause of intellectual deficits. Iodine nutritional status of a population is assessed by measurements of urinary iodine concentrations which are also used to define, indicate, survey and monitor iodine deficiency and consequently its treatment. Several methods are available for urinary iodine determination. Discussed here are some of the limitat...

  18. The Success Rate of Initial {sup 131I} Ablation in Differentiated Thyroid Cancer: Comparison Between Less strict and Very Strict Low Iodine Diets

    Energy Technology Data Exchange (ETDEWEB)

    Yoo, Ik Dong; Kim, Sung Hoon; Seo, Ye Young; Oh, Jin Kyoung; O, Joo Hyun; Chung, Soo Kyo [The Catholic Univ. of Korea, Seoul (Korea, Republic of)

    2012-03-15

    To decrease the risk of recurrence or metastasis in differentiated thyroid cancer (DTC), selected patients receive radioactive iodine ablation of remnant thyroid tissue or tumor. A low iodine diet can enhance uptake of radioactive iodine. We compared the success rates of radioactive iodine ablation therapy in patients who followed two different low iodine diets (LIDs). The success rates of postsurgical radioactive iodine ablation in DTC patients receiving empiric doses of 150 mCi were retrospectively reviewed. First-time radioactive iodine ablation therapy was done in 71 patients following less strict LID. Less strict LID restricted seafood, iodized salt, egg yolk, dairy products, processed meat, instant prepared meals, and multivitamins. Very strict LID additionally restricted rice, freshwater fish, spinach, and soybean products. Radioactive iodine ablation therapy was considered successful when follow up {sup 123I} whole body scan was negative and stimulated serum thyroglobulin level was less than 2.0 ng/mL. The success rate of patients following less strict LID was 80.3% and for very strict LID 75.6%. There was no statistically significant difference in the success rates between the two LID groups (P=0.48). Very strict LID may not contribute to improving the success rate of initial radioactive iodine ablation therapy at the cost of great inconvenience to the patient.

  19. The behavior of gaseous iodine in sand

    International Nuclear Information System (INIS)

    Takahashi, Kanji

    1974-01-01

    Radioactive iodine gas was passed through 10 different sands collected at rivers and hills. The relation between the amount of the loaded gas and the amount of adsorbed gas was determined at room temperature, 50 -- 60 0 C, and 90 -- 100 0 C under humidity of 2 sand. This amount was about 1 -- 3 times as much as that of monomolecular membrane adsorption, 0.2 -- 0.3 μg/cm 2 . The decrease of adsorption amount that accompanies the increase of humidity is attributable to the decrease of effective surface area of sand due to the presence of water. The transport of iodine in sand was studied by passing gaseous iodine through a glass tubing packed with sand. The distribution in the flow direction of iodine indicated that the ease of desorption depends upon the situation of adsorption. Easily desorbed case was named Henry type adsorption. Hardly desorbed case was named absorption type. Discussion is made on experimental results. (Fukutomi, T.)

  20. Study of Iodine Behavior in the Gas Phase during a Severe Accident

    International Nuclear Information System (INIS)

    Kim, Hanchul; Cho, Yeonghun; Ryu, Myunghyun

    2014-01-01

    Among the iodine species, the organic iodides produced from the reaction between iodine and organics such as paint, are not easily trapped by the filters during the containment venting following a severe accident. Korea Institute of Nuclear Safety (KINS) has been studying this issue, joining international research programs such as ISTP-EPICUR, OECDBIP and OECD-STEM. In the course of this study, a simple iodine model, RAIM (Radio-Active Iodine chemistry Model) has been developed (Oh et al., 2011), based on the IMOD methodology, and other previous studies. This paper deals with our recent activities on this study, including the development of the model for the iodine reactions in gas phase. Iodine reactions in gas phase were modeled and added to the RAIM code, taking into account several relevant reactions such as formation of ARP, iodine oxide, and organic iodides in gas phase. RAIM was then applied to analyze the S2-6-5-2 test for which iodine-loaded coupons were tested in gas phase. The analysis results show a reasonable estimation of volatile iodine concentration with the desorption rate constant of about 10 -6 s -1 , while those of the other iodine species overestimated for the whole period of the test. It reveals the need to determine appropriate values for the rate constants for formation of iodine oxides and organic iodides

  1. Some methods of detection of atmospheric contamination by iodine 131

    International Nuclear Information System (INIS)

    Billard, Francois; Chevalier, Gerard; Gaillard, Pierre; Pradel, Jacques

    1964-01-01

    Due to the extensive use of iodine, risks of contamination by iodine 131 are increasing. Moreover, the increase of reactor power requires venting installations equipped with efficient safety filters which must be tested. The authors thus report the study of iodine trapping in filters, and its atmospheric detection and measurement. They report studies and achievements in the field of measurement of atmospheric pollution, and tests performed on iodine trapping by activated coals. After having outlined key qualities of an apparatus for atmospheric control, the authors indicate the various sampling methods. They discuss the method and calibration for the measurement of radioactivity of filters and coal which have trapped iodine 131. They discuss measurement sensitivity. They report how the efficiency of coals has been checked. They describe the experimental installation, and report the tests of some detectors of atmospheric contamination: sampling cartridges full of activated coal, gas mask cartridge, continuous control apparatus ('coffee machine' type), and detector of gaseous iodine. Appendices indicate the calculation of error on a cartridge counting rate, iodine generation methods (discontinuous method, continuous method) [fr

  2. Electrochemistry of iodine

    Energy Technology Data Exchange (ETDEWEB)

    Yaraliev, Ya.A. (AN Azerbajdzhanskoj SSR, Baku. Inst. Neorganicheskoj i Fizicheskoj Khimii)

    1982-06-01

    The review is devoted to investigations into oxidation-reduction processes in different systems including iodine. The data on adsorption of iodine on metals are discussed; the connection between the nature of iodine adsorption and the mechanism of its electrode reactions is considered. The metals studied can be placed in the following series taking into account the degree of I sorption on them: Cd approximately Tl < Sn approximately Pb < Ga < Bi < Hg < Co approximately Ni < Fe < Ag approximately Rh approximately Pd approximately Ir < Pt. The data are given of standard and equilibrium potentials in iodine systems. Electric oxidation and electric reduction of iodide ions is investigated using the methods of Faraday impedance and rectification, methods of voltamperometry and oscillopolarography, rotating disc electrode, chronopotentiometry. Anode and cathode processes of oxidation-reduction reactions in I/sup -//IO/sub 3//sup -/, I/sub 2//IO/sub 3//sup -/ and I/sub 2//I/sup +/ systems are analyzed.

  3. Determination of ultra-low level 129I in vegetation using pyrolysis for iodine separation and accelerator mass spectrometry measurements

    DEFF Research Database (Denmark)

    Hou, Xiaolin; Wang, Yanyun

    2016-01-01

    Radioactive isotopes of iodine are the most common radiological toxins from nuclear accidents due to their high release and high enrichment in human thyroid. Among the radioactive isotopes, long-lived 129I can not only be used for the estimation of the radioactive risk of short-lived radioactive...... and ultra-low concentration in normal environmental and biological samples, it is important to efficiently separate iodine from the sample matrix and sensitively measure 129I. However, the complicated chemical properties of iodine and high organic content in biological samples make efficient separation...... of iodine very difficult using conventional acid digestion and alkaline ashing methods. By optimizing the key parameters related to the separation of iodine by pyrolysis using a tube furnace, including carbonization temperature, heating protocol, combustion assisting gas, iodine volatilization process...

  4. Placental transfer of iodine and iodine compounds

    International Nuclear Information System (INIS)

    Stieve, F.E.; Zemlin, G.; Griessl, I.

    1985-11-01

    The following topics are valid for man and mammalians with haemochorial placenta, which are examined up to now: Within several hours after injection of radioactive inorganic iodide-compounds activity can be realized in the fetus. The transfer occurs bidirectionally through the placenta. The concentration of radioactive iodide in the fetal serum exceeds that of the maternal one already a short time after application. Radioactive iodide accumulates in the fetus before its thyroid starts its function and is mainly concentrated in liver and intestine; after starting its function, the fetal thyroid, stores the radioactive iodide at a very high percent rate. During gestation the concentration of radioactive iodide in the fetal thyroid increases and at the end of gestation it can exceed by 3-10 fold that in the maternal thyroid. Single uptake of radioactive iodide leads to a higher activity than chronic uptake. No analogy can be found in the concentration of fetal and maternal radioactive thyroid hormon compounds. A placental permeability for T 4 and T 3 only exists to a very small extent. Resulting from radioactive iodide transfer examinations, good accordance can be found between the individual animal species and man, while data on the passage of radioactive thyroid hormones vary to a small extent between the animal species. (orig./MG) [de

  5. Iodine Hall Thruster

    Science.gov (United States)

    Szabo, James

    2015-01-01

    Iodine enables dramatic mass and cost savings for lunar and Mars cargo missions, including Earth escape and near-Earth space maneuvers. The demonstrated throttling ability of iodine is important for a singular thruster that might be called upon to propel a spacecraft from Earth to Mars or Venus. The ability to throttle efficiently is even more important for missions beyond Mars. In the Phase I project, Busek Company, Inc., tested an existing Hall thruster, the BHT-8000, on iodine propellant. The thruster was fed by a high-flow iodine feed system and supported by an existing Busek hollow cathode flowing xenon gas. The Phase I propellant feed system was evolved from a previously demonstrated laboratory feed system. Throttling of the thruster between 2 and 11 kW at 200 to 600 V was demonstrated. Testing showed that the efficiency of iodine fueled BHT-8000 is the same as with xenon, with iodine delivering a slightly higher thrust-to-power (T/P) ratio. In Phase II, a complete iodine-fueled system was developed, including the thruster, hollow cathode, and iodine propellant feed system. The nominal power of the Phase II system is 8 kW; however, it can be deeply throttled as well as clustered to much higher power levels. The technology also can be scaled to greater than 100 kW per thruster to support megawatt-class missions. The target thruster efficiency for the full-scale system is 65 percent at high specific impulse (Isp) (approximately 3,000 s) and 60 percent at high thrust (Isp approximately 2,000 s).

  6. Radio-iodination of a rabbit fibrinogen by the chloramine-T method

    Energy Technology Data Exchange (ETDEWEB)

    Moza, A K; Kumar, M; Belavalgidad, M I; Sapru, R P [Post-Graduate Inst. of Medical Education and Research, Chandigarh (India). Dept. of Experimental Medicine

    1974-01-01

    A method for radio-iodination of fibrinogen using chloramine-T has been described. Samples of greater than 90% clottable counts were obtained. Electrophoretic mobility and immunodiffusion showed that the entire radioactivity was present in the fibrinogen band. In vivo studies on the turnover of this labelled product in rabbits showed a half-life of 52.8 to 61.7 hrs in two batches of animals. The results compare very well with the reported results obtained from fibrinogen labelled with radioactive iodine by the iodine-monochloride method. The advantages of the new method have been pointed out.

  7. Iodine-125 safety procedures in a biochemical laboratory

    International Nuclear Information System (INIS)

    1989-01-01

    Radioactive isotopes of iodine are of considerable importance in biochemical research and this 14 minute videotape is designed to give workers an introduction to the radiation safety aspects of their use. It deals with I-125, which is now generally used in preference to I-131, but the principles of safe working practice are the same for both isotopes. (author)

  8. Enzymatic iodination of salivary proteins by the 125I-lactoperoxidase system

    International Nuclear Information System (INIS)

    Tenovuo, J.; Sarimo, S.S.

    1977-01-01

    Purified milk lactoperoxidase and endogenous human salivary peroxidase were used to label the proteins of whole mouth saliva with [ 125 I]iodide. The proteins were then analyzed by isoelectric focusing or they were subjected to one-dimensional polyacrylamide gel electrophoresis at pH 8.4. The radioactivity of the resolved protein fractions was determined. There were three to four major and four to five minor areas of radioactivity which were carried together with more or less distinctive fractions. Amylase and albumin were shown to be the most effective in binding [ 125 I]iodide. No significant differences were observed in the iodination patterns of salivary proteins iodinated in the presence of endogenous saliva peroxidase and those iodinated in the presence of added milk lactoperoxidase. Hydrogen peroxide was necessary for iodination to take place. The significance of iodoproteins and the role of salivary peroxidases in the nonthyroidal metabolism of iodine are discussed. (author)

  9. Iodine deficiency and thyroid disorders.

    Science.gov (United States)

    Zimmermann, Michael B; Boelaert, Kristien

    2015-04-01

    Iodine deficiency early in life impairs cognition and growth, but iodine status is also a key determinant of thyroid disorders in adults. Severe iodine deficiency causes goitre and hypothyroidism because, despite an increase in thyroid activity to maximise iodine uptake and recycling in this setting, iodine concentrations are still too low to enable production of thyroid hormone. In mild-to-moderate iodine deficiency, increased thyroid activity can compensate for low iodine intake and maintain euthyroidism in most individuals, but at a price: chronic thyroid stimulation results in an increase in the prevalence of toxic nodular goitre and hyperthyroidism in populations. This high prevalence of nodular autonomy usually results in a further increase in the prevalence of hyperthyroidism if iodine intake is subsequently increased by salt iodisation. However, this increase is transient because iodine sufficiency normalises thyroid activity which, in the long term, reduces nodular autonomy. Increased iodine intake in an iodine-deficient population is associated with a small increase in the prevalence of subclinical hypothyroidism and thyroid autoimmunity; whether these increases are also transient is unclear. Variations in population iodine intake do not affect risk for Graves' disease or thyroid cancer, but correction of iodine deficiency might shift thyroid cancer subtypes toward less malignant forms. Thus, optimisation of population iodine intake is an important component of preventive health care to reduce the prevalence of thyroid disorders. Copyright © 2015 Elsevier Ltd. All rights reserved.

  10. Physiological basis of iodine prophylaxis in case of a nuclear accident

    Energy Technology Data Exchange (ETDEWEB)

    Gembicki, M [University School of Medical Sciences, Poznan (Poland). Dept. of Endocrinology

    1996-08-01

    The uptake of radioactive iodine may be prevented in nearly 100% if the stable iodine will be in sufficiently large quantity before the release radioactive isotopes to the atmosphere. It may also, at least partially reduce the thyroid uptake of radioactive isotopes even if given later. The quantity of stable iodine recommended differs, however most of the data indicate that the doses of 100 mg given to the adult persons might nearly totally block the thyroid iodine uptake. The prophylactic action carried out in Poland after the Chernobyl disaster when about 12 million children and 6 million adults received the stable iodine allowed to collect well documented data in this matter. It was stated that 70 mg of stable iodine is blocking the thyroid uptake with the mean of 82% after 24 hours, 39% after 48 hours and only 26% after 72 hours. Therefore it seems that the blocking doses (which may be even less than 70 mg) should be given every 24 hours for a few days hoping that the most serious danger of contamination with radioactive iodine will pass. 14 refs, 4 figs.

  11. The determination of iodine in biological media using radioactivation analysis (1962)

    International Nuclear Information System (INIS)

    Comar, D.

    1962-06-01

    The object of this study is to show that the application of radioactivation analysis to the determination of iodine in biological media makes it possible to measure iodine concentrations of the order of 0.0001 μg. After a review of the chemical methods with a mention of the difficulties they present, the optimum conditions for the determination of iodine in biological liquids are given. Three methods are described: - the first consists of a chemical treatment which liberates the protein bound iodine in an inorganic form. After distillation this iodine is irradiated in a flux of thermal neutrons. The induced radioactivity is compared to that of a standard sample irradiated in the same conditions by γ spectrometry. - the second method which is of more general application consists in irradiating the sample and then extracting the iodine; its induced radio-activity is then measured by β-counting. - the third method measures the iodine directly in the thyroid tissue by anti-compton spectrometry. The sensitivity, the reproducibility and the accuracy are discussed. Some applications are described: determination of iodine in its various organic forms in serum, determination of iodine in urines, in food-stuffs, etc., in the thyroid tissue, etc. (author) [fr

  12. Survey of iodine metabolism in man illustrated by an iodide load investigation

    International Nuclear Information System (INIS)

    Bassoee, C.-F.; Langaasdalen, H.

    1977-12-01

    The first part of this report deals with the human metabolism of iodine, its sources, serum iodine, uptake in the thyroid, hormonal thyroid secretion and iodine excretion. The thyroid hormones are discussed as is the regulating of the iodine metabolism. The second part consists of a study performed on six healthy persons over two days. These were given 5mg iodine in aqueous solution rally and series of blood tests taken. Two persons were also given 100mg and 200mg respectively per day for 3weeks. The results are tabulated and discussed. In the third and final section the radiation hygiene aspects are treated. The basis is the uptake of large amounts of I - 131 from radioactive fallout. Carcinogenesis and hypothyroidism following this are discussed and therapy and iodine prophylaxis are described. (JIW)

  13. Introduction to Test Facility for Iodine Retention in Filtered Containment Venting System

    Energy Technology Data Exchange (ETDEWEB)

    Jung, Jaehoon; An, Sang Mo; Ha, Kwang Soon; Kim, Hwan Yeol [KAERI, Daejeon (Korea, Republic of)

    2015-05-15

    In many countries the implementation of FCVS's is under discussion to mitigate fission product release not only in the short-term but also in the long-term view. To verify the performance of FCVS, the large-scaled tests have been performed such as advanced containment experiments (ACE), the iodine and aerosol retention rate test facility (JAVA), etc. The elemental and organic iodides are the main gaseous iodine species in the containment atmosphere. For the iodine retention, experimental programs have confirmed the existence of gaseous organic iodine in some cases in higher concentrations than for gaseous molecular iodine (I{sub 2}). The Reaction of Methyl iodide (CH{sub 3}I) with surfaces and the removal by containment filters and scrubbers is less efficient in comparison to molecular iodine. In the recent years, an experimental and analytical work has been conducted at the Paul Scherrer Institute (PSI) to develop a process leading to a fast, comprehensive and reliable retention of volatile iodine species in aqueous solutions. New FCVS test facility to verify the performance of FCVS is designed and under construction. The iodine retention tests are planned with elemental iodine or with organic iodide loaded carrier gas consisting of pure non-condensable gas, pure steam and of typical mixtures of non-condensable gas/steam. This paper introduces the iodine generation and measurement system for the iodine retention test of FCVS. In severe accidents elemental and organic iodides are the main gaseous iodine species in the containment atmosphere. Release of the gaseous species in sufficient quantities from containment to environment generates a risk for public health. The filtered containment venting systems (FCVS) can considerably reduce the leakage of radioactive materials to the environment. New integral test facility is prepared to verify a performance of the FCVS. The test facility consists of a test vessel, thermal-hydraulic, and aerosol/iodine generation and

  14. Advance in radioactive decontamination

    International Nuclear Information System (INIS)

    Basteris M, J. A.; Farrera V, R.

    2010-09-01

    The objective of the present work was to determine if the application of the Na hypochlorite has some utility in the radioactive decontamination, in comparison with the water, detergent and alcohol. Several methods were compared for decontaminate the iodine 131 and technetium 99, the work table and the skin it was carried out an initial count with the Geiger Muller. Later on, in a single occasion, the areas were washed with abundant water, alcohol, clothes detergent and sodium hypochlorite (used commercially as domestic bleacher) without diluting. Observing that the percentage in the decrease of the counted radioactivity by the Geiger Muller, decreased in the following way: It was demonstrated that the Na hypochlorite presents the highest index of radioactive decontamination with 100% of effectiveness. The Na hypochlorite is an excellent substance that can be used with effectiveness and efficiency like decontamination element in the accident cases of radioactive contamination in the clinical laboratories of nuclear medicine. (Author)

  15. Use of 177Lu-dotatate in the treatment of iodine refractory thyroid carcinomas.

    Science.gov (United States)

    Oliván-Sasot, P; Falgás-Lacueva, M; García-Sánchez, J; Vera-Pinto, V; Olivas-Arroyo, C; Bello-Arques, P

    In a patient with a differentiated thyroid cancer the standard treatment protocol to be followed is surgery, ablation of thyroid remnants with 131 Iodine ( 131 I), and TSH suppression. However, the treatment with 131 I is not effective in some cases, and it no longer becomes a therapeutic option due to cell de-differentiation with loss of 131 I uptake. Systemic treatment can be used as other options, although patients are not always responsive; thus, the disease may progress and therapeutic options may run out. Endocrine tumours may express somatostatin receptors,and this characteristic has been used, not only for diagnosis, but also for their treatment through somatostatin analogue labelling with radioactive isotopes. This was the case of a patient suffering from iodine-refractory follicular thyroid carcinoma, with somatostatin receptors expression, treated with 177 Lu-DOTATATE, showing an excellent clinical and analytical response. Copyright © 2016 Elsevier España, S.L.U. y SEMNIM. All rights reserved.

  16. Raim – A model for iodine behavior in containment under severe accident condition

    Directory of Open Access Journals (Sweden)

    Han-Chul Kim

    2015-12-01

    Full Text Available Following a severe accident in a nuclear power plant, iodine is a major contributor to the potential health risks for the public. Because the amount of iodine released largely depends on its volatility, iodine's behavior in containment has been extensively studied in international programs such as International Source Term Programme-Experimental Program on Iodine Chemistry under Radiation (EPICUR, Organization for Economic Co-operation and Development (OECD-Behaviour of Iodine Project, and OECD-Source Term Evaluation and Mitigation. Korea Institute of Nuclear Safety (KINS has joined these programs and is developing a simplified, stand-alone iodine chemistry model, RAIM (Radio-Active Iodine chemistry Model, based on the IMOD methodology and other previous studies. This model deals with chemical reactions associated with the formation and destruction of iodine species and surface reactions in the containment atmosphere and the sump in a simple manner. RAIM was applied to a simulation of four EPICUR tests and one Radioiodine Test Facility test, which were carried out in aqueous or gaseous phases. After analysis, the results show a trend of underestimation of organic and molecular iodine for the gas-phase experiments, the opposite of that for the aqueous-phase ones, whereas the total amount of volatile iodine species agrees well between the experiment and the analysis result.

  17. Simulation of Iodine Behavior by Coupling of a Standalone Model with MELCOR

    Energy Technology Data Exchange (ETDEWEB)

    Kim, Han Chul; Cho, Song Won [Korea Institute of Nuclear Safety, Daejeon (Korea, Republic of)

    2012-05-15

    During a severe accident, a large fraction of iodine in the core can be released into the containment. Iodine is important in terms of its high activity in the early phase after a core-melt accident due to its short half-life isotopes and its serious effect on the public health, especially on the thyroid. Therefore, iodine behavior has been extensively studied through the international research programs. Major research areas are iodine chemistry, surface reactions, mass transfer, modeling of iodine chemistry and its applications to severe accident assessment, and accident management. Advanced tools for modeling these phenomena have been developed and validated by several experiments such as ISTP-EPICUR (International Source Term Program - Experimental Program on Iodine Chemistry under Radiation) and PARIS, and OECD-BIP (Behavior of Iodine Project) in which Korea Institute of Nuclear Safety (KINS) has been participating. As a result, a simple iodine model, RAIM (Radio-Active Iodine chemistry Model) was developed, based on the IMOD methodology in order to deal with organic iodides conveniently. RAIM has been also coupled with MELCOR, replacing the pool chemistry model (PCM). This coupling model, MELCOR-RAIM, will be used for an integrated severe accident assessment that takes into account the organic iodine behavior. This model is described herein, and representative simulation results of the model are presented

  18. RAIM-A model for iodine behavior in containment under severe accident condition

    Energy Technology Data Exchange (ETDEWEB)

    Kim, Han Chul; Cho, Yeong Hun [Korea Institute of Nuclear Safety, Daejeon (Korea, Republic of)

    2015-12-15

    Following a severe accident in a nuclear power plant, iodine is a major contributor to the potential health risks for the public. Because the amount of iodine released largely depends on its volatility, iodine's behavior in containment has been extensively studied in international programs such as International Source Term Programme-Experimental Program on Iodine Chemistry under Radiation (EPICUR), Organization for Economic Co-operation and Development (OECD)-Behaviour of Iodine Project, and OECD-Source Term Evaluation and Mitigation. Korea Institute of Nuclear Safety (KINS) has joined these programs and is developing a simplified, stand-alone iodine chemistry model, RAIM (Radio-Active Iodine chemistry Model), based on the IMOD methodology and other previous studies. This model deals with chemical reactions associated with the formation and destruction of iodine species and surface reactions in the containment atmosphere and the sump in a simple manner. RAIM was applied to a simulation of four EPICUR tests and one Radioiodine Test Facility test, which were carried out in aqueous or gaseous phases. After analysis, the results show a trend of underestimation of organic and molecular iodine for the gas-phase experiments, the opposite of that for the aqueous-phase ones, whereas the total amount of volatile iodine species agrees well between the experiment and the analysis result.

  19. New radioactive tracers can help find cause of jaundice

    International Nuclear Information System (INIS)

    Carrard, G.

    1987-01-01

    Radioactive tracers for the investigation of a condition known as persistent jaundice of the newborn, have been designed, prepared and tested at ANSTO. The tracers are chemical compounds of the radioactive elements gallium-67 and indium-111. They given lower radiation doses than the conventional radioactive tracer, iodine-131, used in these studies

  20. Iodine-131 monitoring in sewage plant outflow

    International Nuclear Information System (INIS)

    McGowan, D R; Crawley, M T; Pratt, B E; Hinton, P J; Peet, D J

    2014-01-01

    Three different hospital sites (Oxford, Sutton and Guildford) have performed sampling of their local sewage plant outflow to determine levels of radioactivity resulting from iodine-131 patients undergoing radionuclide therapies. It was found that a maximum of 20% of activity discharged from the hospitals was present in the sewage plant final effluent channel. This is significantly below the level predicted by mathematical models in current use. The results further show that abatement systems to reduce public exposure are unlikely to be warranted at hospital sites. (paper)

  1. Working rules for medical application of radioactive substances

    International Nuclear Information System (INIS)

    Gloebel, B.

    1982-01-01

    After incorporation of radioactive substances radiation exposure is detectable only in case of iodine 125 and iodine 131. Organizational measures should improve the protection of personnel. According to the experience gained decontamination successes are possible between 1 and 99%, however they evade forecasting. With iodine 131 it is necessary to make for accelerated discharge resp. prevent further penetration from the extrathydroidal space into the thyroid gland. (DG) [de

  2. Mock iodine-125 radiation source

    International Nuclear Information System (INIS)

    Coffey, D.L.

    1976-01-01

    An intimate mixture of americium-241 and iodine-129 provides an energy spectrum that reliably simulates the spectrum of iodine-125 in a well-type detector. As such, it may be used as a long-lived standard to calibrate instruments such as well scintillation spectrometers in which measurements are to be made involving iodine-125

  3. Enhanced thyroid iodine metabolism in patients with triiodothyronine-predominant Graves' disease

    International Nuclear Information System (INIS)

    Takamatsu, J.; Hosoya, T.; Naito, N.

    1988-01-01

    Some patients with hyperthyroid Graves' disease have increased serum T3 and normal or even low serum T4 levels during treatment with antithyroid drugs. These patients with elevated serum T3 to T4 ratios rarely have a remission of their hyperthyroidism. The aim of this study was to investigate thyroid iodine metabolism in such patients, whom we termed T3-predominant Graves' disease. Mean thyroid radioactive iodine uptake was 51.0 +/- 18.1% ( +/- SD) at 3 h, and it decreased to 38.9 +/- 20.1% at 24 h in 31 patients with T3-predominant Graves' disease during treatment. It was 20.0 +/- 11.4% at 3 h and increased to 31.9 +/- 16.0% at 24 h in 17 other patients with hyperthyroid Graves' disease who had normal serum T3 and T4 levels and a normal serum T3 to T4 ratio during treatment (control Graves' disease). The activity of serum TSH receptor antibodies was significantly higher in the patients with T3-predominant Graves' disease than in control Graves' disease patients. From in vitro studies of thyroid tissue obtained at surgery, both thyroglobulin content and iodine content in thyroglobulin were significantly lower in patients with T3-predominant Graves' disease than in the control Graves' disease patients. Thyroid peroxidase (TPO) activity determined by a guaiacol assay was 0.411 +/- 0.212 g.u./mg protein in the T3-predominant Graves' disease patients, significantly higher than that in the control Graves' disease patients. Serum TPO autoantibody levels determined by immunoprecipitation also were greater in T3-predominant Graves' disease patients than in control Graves' disease patients. Binding of this antibody to TPO slightly inhibited the enzyme activity of TPO, but this effect of the antibody was similar in the two groups of patients

  4. Stimulation of granulocytic cell iodination by pine cone antitumor substances

    International Nuclear Information System (INIS)

    Unten, S.; Sakagami, H.; Konno, K.

    1989-01-01

    Antitumor substances (Fractions VI and VII) prepared from the NaOH extract of pine cone significantly stimulated the iodination (incorporation of radioactive iodine into an acid-insoluble fraction) of human peripheral blood adherent mononuclear cells, polymorphonuclear cells (PMN), and human promyelocytic leukemic HL-60 cells. In contrast, these fractions did not significantly increase the iodination of nonadherent mononuclear cells, red blood cells, other human leukemic cell lines (U-937, THP-1, K-562), human diploid fibroblast (UT20Lu), or mouse cell lines (L-929, J774.1). Iodination of HL-60 cells, which were induced to differentiate by treatment with either retinoic acid or tumor necrosis factor, were stimulated less than untreated cells. The stimulation of iodination of both PMN and HL-60 cells required the continuous presence of these fractions and was almost completely abolished by the presence of myeloperoxidase inhibitors. The stimulation activity of these fractions was generally higher than that of various other immunopotentiators. Possible mechanisms of extract stimulation of myeloperoxidase-containing cell iodination are discussed

  5. Procedure for determination of the decontamination of piping in the production of iodine-125 seeds

    International Nuclear Information System (INIS)

    Moura, J.A.; Moura, E.S.; Sprenger, F.E.; Nagatomi, H.R.; Zeituni, C.A.; Feher, A.; Manzoli, J.E.; Souza, C.D.; Rostelato, M.E.C.M.

    2009-01-01

    Iodine-125 seeds are radioactive sources used in the prostate cancer treatment. This work objective was to determine the necessary conditions and procedures for decontamination of liquid transfer tubes when a radioactive material leakage occurs during the process of seed quality control

  6. Evaluation method of iodine re-evolution from an in-containment water pool after a loss of coolant accident, Part II: Evaluation of pH and iodine re-evolution

    International Nuclear Information System (INIS)

    Kim, Tae Hyeon; Jeong, Ji Hwan

    2016-01-01

    Highlights: • It is required to evaluate re-evolved iodine from sump water after LOCA. • Transport of iodine and chemicals influencing pH were analyzed using CFD. • Chemical conditions of the iodine-rich region suppress iodine re-evolution. • The current evaluation method for I 2 re-evolution is excessively conservative. - Abstract: Radioactive iodine that is released during a postulated loss of coolant accident is dissolved into the containment spray water and transported into the in-containment refueling water storage tank (IRWST). The re-evolution of iodine from the water is a safety concern. In this study, three-dimensional computational fluid dynamics (CFD) analyses are conducted in order to analyze the transport of chemical species including iodine in the IRWST and to calculate the amount of iodine that re-evolves from the IRWST water. The CFD analyses demonstrate that the pH of water is high where the iodine concentration is high. Considering that the creation rate of molecular iodine declines as the pH increases, it can be understood that the iodine re-evolution is not so strong in practical situations because the chemical conditions of the iodine-rich region suppress the re-evolution of the iodine. In addition, four different methods for evaluating the amount of re-evolved iodine are examined. The amount of re-evolved iodine calculated using the total-volume-average values, which are currently used for safety analyses, appear to be significantly higher than those determined using other methods. The amount of re-evolved iodine estimated using a realistic method with a conservative assumption of volatilization appears to be approximately one thousandth of that evaluated using the current method. This implies that the current method is very conservative.

  7. The tyrosyl residues in creatine kinase. Modification by iodine.

    Science.gov (United States)

    Fattoum, A; Kassab, R; Pradel, L A

    1975-10-20

    The effect of the iodination of tyrosyl residues in creatine kinase from rabbit muscle has been investigated at alkaline pH after reversible masking of the reactive thiol groups. The conversion of 4-5 tyrosyl residues to monoiodotyrosines as measured by spectrotitration and by radioactive iodine labelling resulted in almost total loss of enzymic activity. The modified enzyme was unable to bind its nucleotide substrates but no significant conformational change was revealed by optical rotatory dispersion or Stokes radius measurements. However, change in the reactivity of some non-essential thiol groups, presumably those located near the active thiol groups, was observed.

  8. Adsorption of iodine and cesium onto some cement materials

    Energy Technology Data Exchange (ETDEWEB)

    Mine, Tatsuya [Mitsui Shipbuilding and Engineering Co. Ltd., Tokyo (Japan); Mihara, Morihiro; Ito, Masaru [Power Reactor and Nuclear Fuel Development Corp., Tokai, Ibaraki (Japan). Tokai Works; Kato, Hiroshige [IDC, Tokai, Ibaraki (Japan)

    1997-06-01

    Cement materials, being expected to be used in structural materials in underground disposals of radioactive wastes, may adsorb nuclides resulting in retardation of their migration in environment. In this report adsorption behaviors of cement pastes toward iodine (as anion) and cesium (as cation) were studied. Adsorption of iodine was remarkable for OPC and MHP pastes that are known to have high molar ratio CaO/SiO{sub 2}, partition coefficient being 100 ml/g for initial tracer concentration of 10{sup -5} mol/l. Partition coefficient for cesium for PFA paste was found to be 5 ml/g on average. (S. Ohno)

  9. Adsorption of iodine and cesium onto some cement materials

    International Nuclear Information System (INIS)

    Mine, Tatsuya; Mihara, Morihiro; Ito, Masaru

    1997-06-01

    Cement materials, being expected to be used in structural materials in underground disposals of radioactive wastes, may adsorb nuclides resulting in retardation of their migration in environment. In this report adsorption behaviors of cement pastes toward iodine (as anion) and cesium (as cation) were studied. Adsorption of iodine was remarkable for OPC and MHP pastes that are known to have high molar ratio CaO/SiO 2 , partition coefficient being 100 ml/g for initial tracer concentration of 10 -5 mol/l. Partition coefficient for cesium for PFA paste was found to be 5 ml/g on average. (S. Ohno)

  10. Special syntheses of certain organic iodine compounds

    International Nuclear Information System (INIS)

    Henry, R.; Debuchy, D.; Junod, E.

    1960-01-01

    The technical difficulties encountered in working on radioactive products force us to choose the simplest methods of chemical synthesis possible. For iodine compounds, two special methods have been chosen: - by using fission recoil, we can prepare simple iodine compounds such as iodobenzene or methyl iodide in high yields and having a good degree of purity. The method consists in the irradiation of mixtures of uranium oxide and benzoic acid or ammonium acetate. The iodised product is separated by distillation, after dissolving the recoil medium in a solvent. - by isotopic exchange between the inorganic iodine of different valencies and complex molecules such as Bengal pink, and diodone, it is also possible to obtain satisfactory labelling yields. These reactions have been adapted so as to give a minimum time for isotopic exchange. In the case of Bengal pink, we have found a yield of 90 per cent after 60 minutes by exchange between Nal and the organic molecule in aqueous solution in presence of hydrogen peroxide. For diodone the method proposed by Liebster has been modified so as to reduce losses during purification. The analytical methods adopted for these different compounds are described. (author) [fr

  11. Investigation of alumino-phosphate glasses for iodine conditioning

    International Nuclear Information System (INIS)

    Lemesle, T.

    2013-01-01

    Iodine 129 is a long-lived intermediate level radioactive waste, which is currently managed by isotopic dilution. In view of an alternative management by geological disposal, we aimed at developing phosphate glasses of the AgI-Ag 2 O-P 2 O 5 -Al 2 O 3 system, elaborated at low temperature and without iodine volatilization. Alumina is expected to induce crosslinking of the phosphate network and thus to improve the thermal and chemical properties. To define a glass composition that meets the specifications, we varied the level of iodine, the Ag 2 O/P 2 O 5 ratio and alumina content. For 1 g.cm -3 of iodine, SEM-EDS observations indicate that alumina solubility is limited to 0.5% mol., independently of Ag 2 O/P 2 O 5 ratio. The structural study by 31 P, 27 Al and 109 Ag MAS NMR, shows that aluminum adopts an octahedral coordination that effectively contributes to the crosslinking of the glassy network and iodine is incorporated without clustering. 31 P- 27 Al NMR correlations confirmed the presence of an alumino-phosphate network, and 31 P- 31 P correlations indicate that iodine does not change the connectivity of the glass network. The glass composition 28,8AgI-44,2Ag 2 O-26,5P 2 O 5 -0,5Al 2 O 3 presents the best compromise between the level of incorporation of iodine and the chemical durability, has a glass transition temperature of 123 C and an initial alteration rate in pure water at 50 C of 6 g.m -2 .d -1 . The long-term behavior of this glass is controlled by a post-alteration structure based on pyrophosphate, which holds nearly 80% of the initial iodine. (author) [fr

  12. Iodine in soil

    International Nuclear Information System (INIS)

    Johanson, Karl Johan

    2000-12-01

    A literature study of the migration and the appearance of iodine isotopes in the bio-sphere particularly in soil is presented. Some important papers in the field of iodine appearance in soil and the appearance of 129 I in the surroundings of reprocessing plants are discussed. The most important conclusions are: 1. Iodine binds to organic matter in the soil and also to some oxides of aluminium and iron. 2. If the iodine is not bound to the soil a large fraction of added 129 I is volatilized after a rather short period. 3. The binding and also the volatilisation seems to be due to biological activity in the soil. It may take place within living microorganisms or by external enzymes excreted from microorganisms. 4. Due to variations in the composition of soil there may be a large variation in the distribution of 129 I in the vertical profile of soil - usually most of the 129 I in the upper layer - which also results in large variations in the 129 I uptake to plants

  13. Iodine in soil

    Energy Technology Data Exchange (ETDEWEB)

    Johanson, Karl Johan [Swedish Univ. of Agricultural Sciences, Uppsala (Sweden). Dept. of Forest Mycology and Pathology

    2000-12-01

    A literature study of the migration and the appearance of iodine isotopes in the bio-sphere particularly in soil is presented. Some important papers in the field of iodine appearance in soil and the appearance of {sup 129}I in the surroundings of reprocessing plants are discussed. The most important conclusions are: 1. Iodine binds to organic matter in the soil and also to some oxides of aluminium and iron. 2. If the iodine is not bound to the soil a large fraction of added {sup 129}I is volatilized after a rather short period. 3. The binding and also the volatilisation seems to be due to biological activity in the soil. It may take place within living microorganisms or by external enzymes excreted from microorganisms. 4. Due to variations in the composition of soil there may be a large variation in the distribution of {sup 129}I in the vertical profile of soil - usually most of the {sup 129}I in the upper layer - which also results in large variations in the {sup 129}I uptake to plants.

  14. Iodine filters in nuclear installations

    International Nuclear Information System (INIS)

    Wilhelm, J.G.

    1982-01-01

    The present report discusses the significance for environmental exposure of the iodine released with the gaseous effluents of nuclear power stations and reprocessing plants in relation to releases of other airborne radionuclides. Iodine filtration processes are described. The release pathways and the composition of airborne fission product iodine mixtures and their bearing on environmental exposure are discussed on the basis of measured fission product iodine emissions. The sorbents which can be used for iodine filtration, their removal efficiencies and range of applications are dealt with in detail. The particular conditions governing iodine removal, which are determined by the various gaseous iodine species, are illustrated on the basis of experimentally determined retention profiles. Particular attention is given to the limitations imposed by temperature, humidity, radiation and filter poisoning. The types of filter normally used are described, their advantages and drawbacks discussed, the principles underlying their design are outlined and the sources of error indicated. The methods normally applied to test the efficiency of various iodine sorbents are described and assessed. Operating experience with iodine filters, gathered from surveillance periods of many years, is supplemented by a large number of test results and the findings of extensive experiments. Possible ways of prolonging the permissible service lives of iodine filters are discussed and information is given on protective measures. The various iodine removal processes applied in reprocessing plants are described and compared with reference to efficiency and cost. The latest developments in filter technology in reprocessing plants are briefly outlined

  15. Thyroid iodide compartments and their implication in the rat thyroid iodine organification

    International Nuclear Information System (INIS)

    Bastiani, P.; Simon, C.

    1982-01-01

    To estimate the relative participation of transported and intrathyroidally generated iodide (internal iodide) in the iodination of newly synthesized and preexisting thyroglobulin (Tg) in the rat thyroid, the specific radioactivities (SRAs) of thyroid iodide, Tg, lysosomal iodine, and plasma hormones were followed for 92 h after radioactive iodide injection in intact or hypophysectomized rats. In control rats, the SRA of Tg and lysosomal iodine reached a maximum at 12 h. However, the SRA of lysosomal iodide was always smaller than that of Tg. In contrast, the SRA of hormonal iodide attained a maximum at 48 h. Thus, newly labeled iodine is endocytosed and mixed inside the lysosomes with older previously iodinated molecules; hormone secretion is mainly due to old labeled iodine (i.e. iodine with a high SRA from 48-96 h). These results are consistent with the presence of least two Tg compartments, with different turnover rates and hormone contents. On the other hand, in hypophysectomized rats, the SRA of Tg, lysosomes, and hormones showed only one maximum, at 24 h. Furthermore, the SRAs of Tg and lysosomes were similar at each time interval. It is inferred that in such rats, the old labeled iodine compartment is strongly reduced, and that inside the lysosomes, newly labeled iodine is predominant. Since in hypophysectomized rats, the recycling of iodide is abolished, it is concluded that in normal rats: 1) transported iodide is organified mainly by direct iodination of newly synthesized Tg, independently of TSH, and 2) internal iodide is organified mainly by delayed iodination of preexisting Tg, this process being TSH dependent

  16. Perchlorate, iodine supplements, iodized salt and breast milk iodine content

    Energy Technology Data Exchange (ETDEWEB)

    Kirk, Andrea B. [Department of Epidemiology, School of Public Health, University of North Texas Health Sciences Center, 3500 Camp Bowie Blvd., Fort Worth, TX 76107 (United States); Kroll, Martina; Dyke, Jason V.; Ohira, Shin-Ichi; Dias, Rukshan A.; Dasgupta, Purnendu K. [Department of Chemistry and Biochemistry, 700 Planetarium Place, University of Texas at Arlington, Arlington, TX 76019 (United States)

    2012-03-15

    This study was undertaken to determine if increasing maternal iodine intake through single dose tablets will decrease breast milk concentrations of the iodine-uptake inhibitor, perchlorate, through competitive inhibition. We also sought to determine if the timing of supplementation influences the fraction of iodine excreted in milk versus urine and to compare the effectiveness of iodized salt as a means of providing iodine to breastfed infants. Thirteen women who did not use supplements, seven of whom used iodized salt and six of whom used non-iodized salt, submitted four milk samples and a 24-h urine collection daily for three days. Women repeated the sampling protocol for three more days during which {approx} 150 {mu}g of iodine were taken in the evening and again for three days with morning supplementation. Samples were analyzed using isotope-dilution inductively-coupled plasma-mass spectrometry for iodine and isotope-dilution ion chromatography-tandem mass spectrometry for perchlorate. No statistically significant differences were observed in milk iodine or perchlorate concentrations during the two treatment periods. Estimated perchlorate intake was above the U.S. National Academy of Sciences suggested reference dose for most infants. Single daily dose iodine supplementation was not effective in decreasing milk perchlorate concentrations. Users of iodized salt had significantly higher iodine levels in milk than non-users. Iodized salt may be a more effective means of iodine supplementation than tablets. - Highlights: Black-Right-Pointing-Pointer Estimated infant exposures to perchlorate were, on a {mu}g/kg basis, {approx} 5 Multiplication-Sign higher than those of mothers. Black-Right-Pointing-Pointer Daily supplements are less effective than iodized salt in providing iodine to lactating women. Black-Right-Pointing-Pointer Low iodine and high perchlorate in milk may place infants at risk of iodine deficiency.

  17. Standard for administration of stable iodine pilulae. Standard of the nuclear safety commission, action for accident in TEPCO Fukushima-1 and recent European trends

    International Nuclear Information System (INIS)

    Ishihara, Hiroshi

    2011-01-01

    Preventive taking of stable-iodine tablets is effective to avoid thyroid gland disorder due to internal exposure to the radioactive iodine if radioactive iodine is released outside by any nuclear accident. In Japan, the Nuclear Safety Commission proposed the standard of the preventive taking in 2002, and, at the Fukushima Daiichi nuclear disaster, the head of the local task force instructed to take on the recommendation from the Commission. Author described the action principle of stable-iodine tablets, present concept for the preventive taking, recent change of the concept in Europe for the preventive taking, and some precepts which have shown in past Fukushima Daiichi nuclear disaster. (J.P.N.)

  18. Studies of iodine adsorption and desorption on HTGR coolant circuit materials

    International Nuclear Information System (INIS)

    Osborne, M.F.; Compere, E.L.; de Nordwall, H.J.

    1976-04-01

    Safety studies of the HTGR system indicate that radioactive iodine, released from the fuel to the helium coolant, may pose a problem of concern if no attenuation of the amount of iodine released occurs in the coolant circuit. Since information on iodine behavior in this system was incomplete, iodine adsorption on HTGR materials was studied in vacuum as a function of iodine pressure and of adsorber temperature. Iodine coverages on Fe 3 O 4 and Cr 2 O 3 approached maxima of about 2 x 10 14 and 1 x 10 14 atoms/cm 2 , respectively, whereas the iodine coverage on graphite under similar conditions was found to be less by a factor of about 100. Iodine desorption from the same materials into vacuum or flowing helium was investigated, on a limited basis, as a function of iodine coverage, of adsorber temperature, and of dry vs wet helium. The rate of vacuum desorption from Fe 3 O 4 was related to the spectrum of energies of the adsorption sites. A small amount of water vapor in the helium enhanced desorption from iron powder but appeared to have less effect on desorption from the metal oxides

  19. In-place testing of off-gas iodine filters

    International Nuclear Information System (INIS)

    Duce, S.W.; Tkachyk, J.W.; Motes, B.G.

    1980-01-01

    At the Idaho National Engineering Laboratory, both charcoal and silver zeolite (AgX) filters are used for radioactive iodine off-gas cleanup of reactor systems. These filters are used in facilities which are conducting research in the areas of reactor fuel failure, reactor fuel inspection, and loss of fluids from reactor vessels. Iodine retention efficiency testing of these filters is dictated by prudent safety practices and regulatory guidelines. A procedure for determining iodine off-gas filter efficiency in-place has been developed and tested on both AgX and charcoal filters. The procedure involves establishing sample points upstream and downstream of the filter to be tested. A step-by-step approach for filter efficiency testing is presented

  20. Project requirements for reconstruction of the RA reactor ventilation system, Task 2.8. Measurement of radioactive iodine and other isotopes contents in the gas system of the RA reactor, Annex of the task

    International Nuclear Information System (INIS)

    Vujisic, Lj. et al

    1981-01-01

    This report is a supplement to the task 2.8. When planning and constructing the ventilation system, it was found that it is necessary to perform additional experiments during RA reactor operation at 2 MW power level for a longer period. In addition to the helium system, the potential source of radioactive pollutants is the space below the upper water shielding of the reactor. All the experimental and fuel channels are ending in this space. During repair and fuel exchange radioactivity can be released in this space. For that reason this space is important when planing and designing the filtration system for incidental conditions or planned dehermetisation of the reactor. The third point where radioactive isotope identification was done, was the entrance into the chimney during steady state operation and planned dehermetisation of the reactor. The following samples were measured: gas system during reactor operation at 2 MW power; entrance into the chimney during last 48 hours of reactor operation at 2 MW power; sample on the platform under the upper water shield with the opened fuel channel after the reactor shutdown; and simultaneously with the latter, measurement at the entrance to the chimney. This annex contains the list of identified radioactive isotopes, volatile and gaseous as well as concentration of volatile 131 I on the adsorbents [sr

  1. Iodine Status in Pregnant & Breastfeeding Women

    DEFF Research Database (Denmark)

    Andersen, Stine Linding

    Iodine is required for the synthesis of thyroid hormones, which are crucial regulator of early brain development. The source of iodine in the fetus and the breastfed infant is maternal iodine, and adequate iodine intake in pregnant and breastfeeding is of major concern. Severe iodine deficiency can...... cause irreversible brain damage, whereas the consequences of mild to moderate iodine deficiency are less clear. Denmark was previously iodine deficient with regional differences (mild iodine deficiency in East Denmark and moderate iodine deficiency in West Denmark), and also pregnant and breastfeeding...... women suffered from iodine deficiency. A mandatory iodine fortification of household salt and salt used for commercial production of bread was introduced in Denmark in the year 2000. The PhD thesis investigates intake of iodine supplements and urinary iodine status in Danish pregnant and breastfeeding...

  2. Treatment with iodine pills - not only in Switzerland. Judgement for the assumption on costs; Jodtablettenverteilung auf dem Pruefstand - nicht nur in der Schweiz. Zum Urteil des Schweizer Bundesverwaltungsgerichts zur Kostentragung fuer die Jodtablettenverteilung

    Energy Technology Data Exchange (ETDEWEB)

    Feldmann, Ulrike

    2017-02-15

    During a severe accident in a nuclear power plant the release of radioactive iodine is possible. A precautionary measure to prevent man from the reception of radioactive iodine is an early and right taking of non-radioactive iodine pills. After the accident in Fukushima iodine tablets have been stored by authorities as an precautionary measures. In the case of an accident, a quick distribution should be possible. One question which arises are the costs bearers of such a storage. Are nuclear power plant operators responsible for such measures, carried out by the authorities?.

  3. The speciation of iodine in the environment

    International Nuclear Information System (INIS)

    Bulman, R.A.

    1986-01-01

    The speciation of iodine in the environment is discussed under the following topics: (i) sea surface to atmosphere, (ii) chemistry in bulk seawater, (iii) iodine in rocks, (iv) iodine in soils, (v) iodine in plants and (vi) iodine in solidified wastes. (author)

  4. [Thyroid cancer after Chernobyl: is iodine 131 the only culprit ? Impact on clinical practice].

    Science.gov (United States)

    Guiraud-Vitaux, Françoise; Elbast, Mouhamad; Colas-Linhart, Nicole; Hindie, Elif

    2008-02-01

    The large increase in the incidence of thyroid cancer among children who were mainly less than five years old at the time of the Chernobyl accident is still a major preoccupation for endocrinologists and nuclear physicians. Epidemiological studies have focused solely on iodine 131. However, past knowledge on thyroid irradiation (medical use of iodine 131, radioactive fallout on Marshall islands and the Nevada, and Hanford site releases) as well as number of recent works (about low-dose irradiation), raise question on the role of other factors. It is here shown that post-Chernobyl thyroid irradiation is complex and that all factors (iodine 131, but also short lived isotopes of iodine and external irradiation) should be considered. Finally, one need to think about some of the present medical uses of iodine 131, and especially to the treatment of hyperthyroidism in young subjects.

  5. Atomic iodine laser

    International Nuclear Information System (INIS)

    Fisk, G.A.; Gusinow, M.A.; Hays, A.K.; Padrick, T.D.; Palmer, R.E.; Rice, J.K.; Truby, F.K.; Riley, M.E.

    1978-05-01

    The atomic iodine photodissociation laser has been under intensive study for a number of years. The physics associated with this system is now well understood and it is possible to produce a 0.1 nsec (or longer) near-diffraction-limited laser pulse which can be amplified with negligible temporal distortion and little spatial deformation. The output of either a saturated or unsaturated amplifier consists of a high-fidelity near-diffraction-limited, energetic laser pulse. The report is divided into three chapters. Chapter 1 is a survey of the important areas affecting efficient laser operation and summarizes the findings of Chap. 2. Chapter 2 presents detailed discussions and evaluations pertinent to pumps, chemical regeneration, and other elements in the overall laser system. Chapter 3 briefly discusses those areas that require further work and the nature of the work required to complete the full-scale evaluation of the applicability of the iodine photodissociation laser to the inertial confinement program

  6. Iodine immobilization in apatites

    International Nuclear Information System (INIS)

    Audubert, F.; Lartigue, J.E.

    2000-01-01

    In the context of a scientific program on long-lived radionuclide conditioning, a matrix for iodine 129 immobilization has been studied. A lead vanado-phosphate apatite was prepared from the melt of lead vanado-phosphate Pb 3 (VO 4 ) 1.6 (PO 4 ) 0.4 and lead iodide PbI 2 in stoichiometric proportions by calcination at 700 deg. C during 3 hours. Natural sintering of this apatite is not possible because the product decomposition occurs at 400 deg. C. Reactive sintering is the solution. The principle depends on the coating of lead iodide with lead vanado-phosphate. Lead vanado-phosphate coating is used as iodo-apatite reactant and as dense covering to confine iodine during synthesis. So the best condition to immobilize iodine during iodo-apatite synthesis is a reactive sintering at 700 deg. C under 25 MPa. We obtained an iodo-apatite surrounded with dense lead vanadate. Leaching behaviour of the matrix synthesized by solid-solid reaction is under progress in order to determine chemical durability, basic mechanisms of the iodo-apatite alteration and kinetic rate law. Iodo-apatite dissolution rates were pH and temperature dependent. We obtained a rate of 2.5 10 -3 g.m -2 .d -1 at 90 deg. C in initially de-ionised water. (authors)

  7. Separation and retention of iodine

    International Nuclear Information System (INIS)

    Thomas, T.R.

    1976-01-01

    Caustic and mercuric nitrate scrubbers have been used for iodine recovery from process offgas, but they exhibit low decontamination factors for organic iodide removal and produce liquid wastes that are unsuitable for final storage. The Iodox process gives high decontamination factors for both organic iodides and elemental iodine. The liquid waste can be evaporated to a solid or concentrated and fixed in cement. Efficient separation and retention of gaseous iodine species can be obtained with silver-loaded adsorbents. The waste is a dry solid easily handled and stored. Adsorbents containing cheaper metals appear to have lower iodine-loading capacities and may be unsuitable for bulk iodine removal from process offgas because of the large amounts of solid waste that would be generated. A potential method for regenerationg and recycling silver-loaded adsorbents is being evaluated. In conjunction with the regeneration, lead-exchanged zeolite is used as a secondary adsorbent for the final fixation and storage of the iodine

  8. Studies of iodine concentration in steel and transition metals

    International Nuclear Information System (INIS)

    Kormann, C.; Kozlowski, W.; Oleksi-Frenzel, J.; Nachtigall, K.; Neste, A. van; Welsh, M.; Titze-Zaeske, B.; Plieth, W.

    1990-01-01

    Radioactive iodine which originates from nuclear fuel reprocessing plants as a fission product and consists mainly of the radioactive isotopes 129 I, 131 I, and of the inactive 127 I, must be quantitatively adsorbed at the end of the process for the purpose of safe waste disposal. Inspite of using high-alloy austenitic chrome nickel steels, major corrosion effects were observed at tubes and containers of the PASSAT dissolver waste gas purifier. This research project serves to clarify the question in which parts of the installation iodine concentration is to be expected under certain conditions. Furthermore it serves to identify the redox state of iodine in the various installation components. For this purpose steel (1.4306esu and 1.4563N), zirconium and titanium were studied in nitric iodic media. With the objective of calculating iodine adsorption isotherms, the following methods were used to obtain qualitative and quantitative data: FTIR, ellipsometry, 131 I radiotracer method, cyclo-voltametry, closed circuit potential measurements, ion chromatography. (orig./DG) [de

  9. Iodine deficiency disorders (IDD) in regions of Russia affected by Chernobyl

    International Nuclear Information System (INIS)

    Gerasimov, G.; Alexandrova, G.; Arbuzova, M.

    1996-01-01

    The present article provides an update on IDD in the Western regions of Russia (Bryansk, Kaluga, Tula and Orel) which were contaminated by radioactive fallout after the Chernobyl accident in 1986. These surveyed areas meet the criteria of ICCIDD/UNICEF/WHO for mild and moderate IDD. Higher iodine excretion and smaller goiter prevalence (mild level of IDD) were more typical for urban sites, while lower iodine levels and higher goiter endemicity (moderate level of IDD) were found in rural areas. IDD control programmes should be developed and implemented in Chernobyl areas and iodine excretion should be monitored continuously to minimize future thyroid abnormalities

  10. Physico-chemical aspects of the bovine growth hormone iodination by the electrolytic method

    International Nuclear Information System (INIS)

    Caro, R.A.; Ciscato, V.A.; Giacomini, S.M.V. de; Quiroga, S.; Kurcbart, H.; Radicella, R.

    1975-04-01

    With a view to studying the mechanism by which iodine is incorporated into the bovine somatotropin molecule, labelling was carried out by the electrolytic method (pH7.4, current 20 μA) as a function of time for various total iodine/protein ratios. In all cases the labelling yields were determined by paper electrophoresis. The corresponding degree of iodination was calculated on the basis of the values obtained and knowledge of the amount of reacting protein, values greater than 12 being obtained in many cases. Enzymatic hydrolysis was carried out on all the samples obtained and in the hydrolysates an increase in free iodide was observed which became more manifest as the iodide/protein molar ratio increased. The percentage of radioactivity from monoiodotyrosine and diiodotyrosine was determined for the various degrees of iodination from chromatograms of the hydrolysates. For an iodination value of 12, diiodotyrosine radioactivity of 70% was found. When the degree of relative iodination for each iodide/protein molar ratio is calculated from the hydrolysis data, it can be seen that only 75% of the total number of available places in the tyrosine residues accept the incorporation of iodine. This fact suggests that not all tyrosine residues are equally accessible. (author)

  11. Iodine prophylaxis around the Semipalatinsk Nuclear Testing Site, Republic of Kazakstan.

    Science.gov (United States)

    Hamada, Aiko; Zakupbekova, Mairash; Sagandikova, Sagadat; Espenbetova, Maira; Ohashi, Toshinori; Takamura, Noboru; Yamashita, Shunichi

    2003-12-01

    This study aimed to clarify the iodine deficiency status in the Semipalatinsk region that has been contaminated by radioactive fallout from nuclear testing during the period of the former USSR. Based on the Japan-Kazakstan joint project of adult cancer screening around the Semipalatinsk Nuclear Testing Site (SNTS), from May to October 2002 spot urine specimens were collected at random in each village. Separately, children aged 5-15 years from around the SNTS were chosen at random and spot urine specimens were collected from them. Area contaminated by radioactive fallout around the SNTS, Republic of Kazakstan. A total of 2609 adults aged >40 years from 16 settlements in three regions and one city, and 298 children aged 5-15 years from two regions and one city. Median urinary iodine concentrations of adults and children in all regions were in the range of 116.0-381.7 and 127.7-183.0 microg l(-1), respectively. The highest prevalence of values 100 microg l(-1). In agreement with our previous studies, the urinary iodine concentration data showed no clear evidence of iodine deficiency around the SNTS. Kazakstan is geographically and nutritionally at moderate risk of iodine deficiency disorders without fortification or iodine replacement by iodised salt. The socio-medical prophylaxis against iodine deficiency has been successfully maintained in East Kazakstan.

  12. The thyroid protection in case of nuclear accident by an iodine prophylaxis

    International Nuclear Information System (INIS)

    Carrera, F.

    2004-12-01

    The first part of the thesis describes the thyroid functional activity and the place of iodine in organisms, iodine is linked to the thyroid functioning. The second part of the thesis is interested in the ionizing radiation effect in general then on the thyroid. The external irradiation has been essentially studied from the data of the Hiroshima and Nagasaki explosions. The internal contamination of thyroid is known by the use of 131 iodine for medical or diagnostic uses. A mixed contamination is described with the example of the nuclear test in Marshall Islands. Follows a chapter devoted to the thyroid cancers, the most serious thyroid radioinduced pathology. The third part concerns the place of iodine in the nuclear power plants. The functioning of a nuclear power plant is described as well as its radioactive emission in normal operation and in accidental situation. The sanitary impact of a radioactive iodine emission is detailed from a bibliographic synthesis coming from the studies on the development of thyroid cancers appeared after the Chernobylsk disaster. The ingestion of steady iodine constitutes an preventive measure efficient against the arising of these cancers. Its efficiency and innocuousness are discussed. Then a last part summarizes the administrative measures taken in France so that the population can have at her disposal iodine tablets before and in case of accidents. (N.C.)

  13. Chemical generation of iodine atoms

    Energy Technology Data Exchange (ETDEWEB)

    Hewett, Kevin B. [Directed Energy Directorate, Air Force Research Laboratory, 3550 Aberdeen Avenue SE, Kirtland AFB, NM 87117-5776 (United States)]. E-mail: kevin.hewett@kirtland.af.mil; Hager, Gordon D. [Directed Energy Directorate, Air Force Research Laboratory, 3550 Aberdeen Avenue SE, Kirtland AFB, NM 87117-5776 (United States); Crowell, Peter G. [Northrup Grumman Information Technology, Science and Technology Operating Unit, Advanced Technology Division, P.O. Box 9377, Albuquerque, NM 87119-9377 (United States)

    2005-01-10

    The chemical generation of atomic iodine using a chemical combustor to generate the atomic fluorine intermediate, from the reaction of F{sub 2} + H{sub 2}, followed by the production of atomic iodine, from the reaction of F + HI, was investigated. The maximum conversion efficiency of HI into atomic iodine was observed to be approximately 75%, which is in good agreement with the theoretical model. The conversion efficiency is limited by the formation of iodine monofluoride at the walls of the combustor where the gas phase temperature is insufficient to dissociate the IF.

  14. [Metabolic therapy with iodine 131 in patients with chronic renal failure. Clinical case].

    Science.gov (United States)

    Vázquez-Rodríguez Barbero, Inmaculada; Espadas-Maeso, María José; Muñoz-Morales, Ana; Flores-Gómez, Pilar; Serrano-Carretero, María Belén; Castedo-Sal, Juan José; Sánchez Rey-Castro, Elena; Zamorano-Córdoba, Antonio

    2015-01-01

    62 year-old male with CKD stage 5 in dialysis program since 2012 who underwent surgery for papillary thyroid carcinoma with lymph node metastasis. Subsequently, the patient was admitted to the Unit of Metabolic Therapy at his reference hospital, where he is administered 80 millicuries of iodine-131 as a treatment associated with the surgery, unable to have his conventional dialysis, nursing interventions required in various stages of implementation of the continuous extrarenal clearance techniques (TCDE) were performed. The following care values were addressed targeted to patients undergoing treatment with I(131): specific equipment, personal protective measures and major diagnoses and nursing interventions. TCDE, despite being attributed to very critical patients, they can be extrapolated to other patients in a given time. TCDE allowed these patients to undergo dialysis in a safe environment for staff, ensuring proper disposal of contaminated liquids. TCDE were an effective treatment for the removal of I131, a single ssesion being necessary to normalize the levels of radioactivity. Coordination between services allewed ensure proper and effective treatment for the patient. Copyright © 2015 Elsevier España, S.L.U. All rights reserved.

  15. The Status of Iodine Nutrition and Iodine Deficiency Disorders ...

    African Journals Online (AJOL)

    Background: Iodine deficiency disorders are serious public health problems in Ethiopia. The aim of this study was to measure the prevalence and severity of iodine deficiency disorders among school children in Metekel Zone. Methods: A cross-sectional school based descriptive study was conducted between February 2011 ...

  16. Quality Assurance Procedure Development in Iodine-125 Seeds Production

    International Nuclear Information System (INIS)

    Moura, J.A.; Moura, E.S.; Sprenger, F.E.

    2009-01-01

    Brachytherapy using Iodine-125 seeds has been used in prostate cancer treatment. In the quality control routine during seed production, leak tests are made to detect any leakage of radioactive material from inside the titanium shield. Leak tests are made according to the International Standard Organization- Radiation protection - sealed radioactive sources - ISO 9978 standard, and require liquid transfer between recipients. If any leakage happens, there will be contamination of the liquid and tubing. This study aims to establish decontamination routines for tubing, allowing its repeated use, in the automated assay process

  17. A prospective study demonstrating the effect of 5% povidone-iodine application for anterior segment intraocular surgery in Paraguay Estudio prospectivo demostrando el efecto de la instilación de yodo povidona al 5% previo a cirugía de segmento anterior en Paraguay

    Directory of Open Access Journals (Sweden)

    Lorena P. Quiroga

    2010-04-01

    Full Text Available PURPOSE: To determine the conjunctival bacterial flora in cataract surgery patients and the effect of presurgical irrigation with 5% povidone-iodine solution. METHODS: Three samples from the inferior conjunctival fornix of the eye to be operated were obtained at baseline before washing (T0 with 10 ml 5% povidone-iodine solution, immediately after washing (T1, and upon completion of surgery (T2. Bacteria from the samples were inoculated in blood agar, chocolate agar, and thioglycolate broth. RESULTS: A total of 221 patients (n=224 eyes with a mean age of 67 ± 13 years were included in the study. Bacteria from the (T0 samples were successfully grown in 73.2% of the thioglycolate agars, 21.0% of the blood agars, and 19.2% of the chocolate agars. Compared with T1 samples, the use of povidone-iodine wash translated into a 60.8% reduction (from 73.2% to 12.5% in colonization of the conjunctiva (pOBJETIVO: Determinar la flora bacteriana de la conjuntiva en los pacientes a ser sometidos a cirugía de catarata y el efecto del lavado prequirúrgico con yodo povidona al 5% sobre dichos microorganismos. MÉTODOS: Se tomaron 3 muestras del fondo de saco conjuntival del ojo a ser operado de catarata antes (T0 de la irrigación de la conjuntiva con 10 ml de yodo povidona al 5%, como control, inmediatamente después (T1 y al término de la cirugía (T2. Se realizaron cultivos en agar sangre, agar chocolate y en caldo de tioglicolato. RESULTADOS: Se incluyeron en el estudio 221 pacientes (n=24 ojos con un promedio de edad de 67 ± 13 años. El porcentaje de crecimiento bacteriano en (T0 fue de 73,2% en tioglicolato, 21% en agar sangre y 19,2 % en agar chocolate. Al compararlo con (T1 el efecto de la yodo povidona se tradujo en una reducción del 60,8% (de 73,2% a 12,5% en la colonización conjuntival (p<0.001. Entre las muestras de los tiempos T1 y T2 no hubo diferencia significativa en cuanto al crecimiento bacteriano. CONCLUSIÓN: El lavado conjuntival con

  18. Adsorption and revaporisation studies on iodine oxide aerosols deposited on containment surface materials in LWR

    Energy Technology Data Exchange (ETDEWEB)

    Tietze, S.; Foreman, M.R.StJ.; Ekberg, C. [Chalmers Univ. of Technology, Goeteborg (Sweden); Kaerkelae, T.; Auvinen, A.; Tapper, U.; Lamminmaeki, S.; Jokiniemi, J. [VTT Technical Research Centre of Finland, Espoo (Finland)

    2012-12-15

    During a hypothetical severe nuclear accident, the radiation field will be very high in the nuclear reactor containment building. As a result gaseous radiolysis products will be formed. Elemental iodine can react in the gaseous phase with ozone to form solid iodine oxide aerosol particles (iodine oxide). Within the AIAS (Adsorption of Iodine oxide Aerosols on Surfaces) project the interactions of iodine oxide (IOx) aerosols with common containment surface materials were investigated. Common surface materials in Swedish and Finnish LWRs are Teknopox Aqua V A paint films and metal surfaces such as Cu, Zn, Al and SS, as well as Pt and Pd surfaces from hydrogen recombiners. Non-radioactive and {sup 131}I labelled iodine oxide aerosols were produced with the EXSI CONT facility from elemental iodine and ozone at VTT Technical Research Centre of Finland. The iodine oxide deposits were analysed with microscopic and spectroscopic measurement techniques to identify the kind of iodine oxide formed and if a chemical conversion on the different surface materials occurs. The revaporisation behaviour of the deposited iodine oxide aerosol particles from the different surface materials was studied under the influence of heat, humidity and gamma irradiation at Chalmers University of Technology, Sweden. Studies on the effects of humidity were performed using the FOMICAG facility, while heat and irradiation experiments were performed in a thermostated heating block and with a gammacell 22 having a dose rate of 14 kGy/h. The revaporisation losses were measured using a HPGe detector. The revaporisated {sup 131}I species from the surfaces were chemically tested for elemental iodine formation. The parameter dominating the degradation of the produced iodine oxide aerosols was humidity. Cu and Zn surfaces were found to react with iodine from the iodine oxide aerosols to form iodides, while no metal iodides were detected for Al and SS samples. Most of the iodine oxide aerosols are assumed to

  19. Adsorption and revaporisation studies on iodine oxide aerosols deposited on containment surface materials in LWR

    International Nuclear Information System (INIS)

    Tietze, S.; Foreman, M.R.StJ.; Ekberg, C.; Kaerkelae, T.; Auvinen, A.; Tapper, U.; Lamminmaeki, S.; Jokiniemi, J.

    2012-12-01

    During a hypothetical severe nuclear accident, the radiation field will be very high in the nuclear reactor containment building. As a result gaseous radiolysis products will be formed. Elemental iodine can react in the gaseous phase with ozone to form solid iodine oxide aerosol particles (iodine oxide). Within the AIAS (Adsorption of Iodine oxide Aerosols on Surfaces) project the interactions of iodine oxide (IOx) aerosols with common containment surface materials were investigated. Common surface materials in Swedish and Finnish LWRs are Teknopox Aqua V A paint films and metal surfaces such as Cu, Zn, Al and SS, as well as Pt and Pd surfaces from hydrogen recombiners. Non-radioactive and 131 I labelled iodine oxide aerosols were produced with the EXSI CONT facility from elemental iodine and ozone at VTT Technical Research Centre of Finland. The iodine oxide deposits were analysed with microscopic and spectroscopic measurement techniques to identify the kind of iodine oxide formed and if a chemical conversion on the different surface materials occurs. The revaporisation behaviour of the deposited iodine oxide aerosol particles from the different surface materials was studied under the influence of heat, humidity and gamma irradiation at Chalmers University of Technology, Sweden. Studies on the effects of humidity were performed using the FOMICAG facility, while heat and irradiation experiments were performed in a thermostated heating block and with a gammacell 22 having a dose rate of 14 kGy/h. The revaporisation losses were measured using a HPGe detector. The revaporisated 131 I species from the surfaces were chemically tested for elemental iodine formation. The parameter dominating the degradation of the produced iodine oxide aerosols was humidity. Cu and Zn surfaces were found to react with iodine from the iodine oxide aerosols to form iodides, while no metal iodides were detected for Al and SS samples. Most of the iodine oxide aerosols are assumed to be

  20. Modelling the chemistry of iodine

    International Nuclear Information System (INIS)

    Paquette, J.

    1989-01-01

    We have assembled a kinetic model, based on elementary chemical reactions, that describes the chemical behaviour of iodine in aqueous solution as a function of time and various parameters such as pH, concentration and radiation field. The model is conceptually divided into six section: aqueous iodine chemistry, aqueous organic iodide chemistry, water radiolysis, radiolysis of iodine solutions, radiolysis of organic iodide solutions and mass transfer. The model indicates that, in the absence of a radiation field, the rate of production of volatile iodine species is controlled by the rate of oxidation of the iodide ion. The volatile iodine species are dominated by organic iodides if organic impurities are present. The single most important parameter controlling iodine volatility is the pH of the solution; high pH values tend to minimize iodine volatility. In the presence of a radiation field, the volatility of iodine is controlled by the radiation-induced oxidation of the iodide ion. Again, iodine volatility is dominated by organic iodides if organic impurities are present. High pH values minimize iodine volatility. A sensitivity analysis has been performed on some sections of the model to identify reactions to which the volatility of iodine is most sensitive. In the absence of a radiation field, the volatility is most sensitive, first, to the rate of oxidation of the iodide ion, and, second, to the rate of mass transfer of volatile species between the aqueous and the gaseous phases. This approach should be useful in identifying reactions for which accurate rate constants are required and in decreasing the complexity of the model. 37 refs

  1. Adsorption of iodine from COIL waste gas on soaked coal-based activated carbon

    Science.gov (United States)

    Zhou, Junbo; Hao, Shan; Gao, Liping

    2014-04-01

    The chemical oxygen-iodine laser (COIL) has wide application prospects in military, industrial and medical treatment fields as a second generation gas chemical laser to follow the first HF/DF chemical laser. However, a COIL releases large amounts of gas, such as helium, oxygen, chlorine and iodine. Chlorides have a serious corrosive effect on the system, especially iodine vapor crystallization, which seriously endangers the normal use of vacuum systems, and radioactive methyl iodide, which is hazardous to operators and pollutes the environment. The use of soaked coal-based activated carbon as an adsorbent for removing methyl iodine is proposed, while it is proposed that coal-based activated carbon is an effective adsorbent for removing stable iodine. The research conducted in this work shows that iodine residues are less than 0.5 μg ml-1 after the adsorption treatment and the decontamination factor of the coal-based activated carbon for removing stable iodine is more than 1000. Using this method can achieve the purpose of removing harmful iodine, satisfy the requirements for engineering applications, and also be applied to other nuclear power plant flue gas treatments.

  2. Iodine metabolism and food needs

    International Nuclear Information System (INIS)

    Mornex, R.

    1992-01-01

    Iodine is an element that is necessary for the growth and mental development of a child and for the maintenance of the activity of all cells at all ages. In this article, the author recalls the iodine sources, its metabolism and the food needs and contributions

  3. Radioactive labelling of peptidic hormones

    International Nuclear Information System (INIS)

    Fromageot, P.; Pradelles, P.; Morgat, J.L.; Levine, H.

    1976-01-01

    The labelling of peptidic hormones requires stability, specificity and sensitivity of the label. Introduction of a radioactive atome is one way to satisfy these criteria. Several processes have been described to prepare radioactive TRF: synthesis of the peptide with labelled aminoacids or introduction of the label into the hormone. In that approach, tritium can be substituted in the imidazole ring, via precursors activating the proper carbon. Monoiodo TRF leads essentially to tritium labelling of the 5 positions whereas monoazo TRF allows the preparation of 3 H TRF labelled in the 2 positions. Di-substituted TRF leads to labelling into the 2 and 5 carbons. Labelled analogs of TRF can be prepared with labelled iodine; further developments of peptide labelling, will be presented. In particular, the homolytic scission of the C-iodine, bond by photochemical activation. The nascent carbon radical can be stabilized by a tritiated scavenger. This approach eliminates the use of heavy metal catalysts

  4. Uptake of Iodine-131 in mussel (Mytilus smaragdinns) and algae (caulerpa racemosa)

    International Nuclear Information System (INIS)

    Sombrito, E.Z.; Banzon, R.B.; de la Mines, A.S.; Bautista, E.Rb.

    1982-01-01

    The behavior of radionuclides in the environment has been the subject of research. Iodine-131, a beta emitter as one of the radionuclides has been studied. This study describes Iodine-131 uptake in mussel and algae. The bioaccumulation factor C was determined which gave the relationship between the concentration of radioactivity in biota relative to the water environment. Results of the experiments showed that the mussels steadily accumulated I-131 from radioactive medium. Much higher bioaccumulation factor was obtained in algae than in mussel. No attempt was made to measure activity in the soft parts. (ELC)

  5. Application of crown ethers to selective extraction and quantitative analysis of technetium 99, iodine 129 and cesium 135 in effluents

    International Nuclear Information System (INIS)

    Paviet, P.

    1992-01-01

    Properties of crown ethers are first recalled. Then extraction of technetium 99 is studied in actual radioactive effluents. Quantitative analysis is carried out by liquid scintillation and interference of tritium is corrected. Iodine 129 is extracted from radioactive effluents and determined by gamma spectrometry. Finally cesium 135 is extracted and determined by thermo ionization mass spectroscopy

  6. Breastfeeding and maternal and infant iodine nutrition.

    Science.gov (United States)

    Azizi, Fereidoun; Smyth, Peter

    2009-05-01

    The aim of this review is to explore information available regarding iodine secretion in milk, both mothers and infants iodine nutrition during breastfeeding and to make recommendations for appropriate iodine supplementation during lactation. MEDLINE was queried for studies between 1960 and 2007 that included lactation and breastfeeding with iodine and iodine deficiency. Studies were selected if they studied (i) Secretion of iodine in breast milk; (ii) breastfeeding and iodine nutrition; (iii) factors affecting maternal iodine metabolism and (iv) recommendations for iodine supplementation during breastfeeding. Thirty-six articles met the selection criteria. The iodine content of breast milk varies with dietary iodine intake, being lowest in areas of iodine deficiency with high prevalence of goitre. Milk iodine levels are correspondingly higher when programs of iodine prophylaxis such as salt iodization or administration of iodized oil have been introduced. The small iodine pool of the neonatal thyroid turns over very rapidly and is highly sensitive to variations in dietary iodine intake. Expression of the sodium iodide symporter is up-regulated in the lactating mammary gland which results in preferential uptake of iodide. In areas of iodine sufficiency breast milk iodine concentration should be in the range of 100-150 microg/dl. Studies from France, Germany, Belgium, Sweden, Spain, Italy, Denmark, Thailand and Zaire have shown breast milk concentrations of nutrition. The current WHO/ICCIDD/UNICEF recommendation for daily iodine intake (250 microg for lactating mothers) has been selected to ensure that iodine deficiency dose not occur in the postpartum period and that the iodine content of the milk is sufficient for the infant's iodine requirement.

  7. Pool scrubbing models for iodine components

    Energy Technology Data Exchange (ETDEWEB)

    Fischer, K [Battelle Ingenieurtechnik GmbH, Eschborn (Germany)

    1996-12-01

    Pool scrubbing is an important mechanism to retain radioactive fission products from being carried into the containment atmosphere or into the secondary piping system. A number of models and computer codes has been developed to predict the retention of aerosols and fission product vapours that are released from the core and injected into water pools of BWR and PWR type reactors during severe accidents. Important codes in this field are BUSCA, SPARC and SUPRA. The present paper summarizes the models for scrubbing of gaseous Iodine components in these codes, discusses the experimental validation, and gives an assessment of the state of knowledge reached and the open questions which persist. The retention of gaseous Iodine components is modelled by the various codes in a very heterogeneous manner. Differences show up in the chemical species considered, the treatment of mass transfer boundary layers on the gaseous and liquid sides, the gas-liquid interface geometry, calculation of equilibrium concentrations and numerical procedures. Especially important is the determination of the pool water pH value. This value is affected by basic aerosols deposited in the water, e.g. Cesium and Rubidium compounds. A consistent model requires a mass balance of these compounds in the pool, thus effectively coupling the pool scrubbing phenomena of aerosols and gaseous Iodine species. Since the water pool conditions are also affected by drainage flow of condensate water from different regions in the containment, and desorption of dissolved gases on the pool surface is determined by the gas concentrations above the pool, some basic limitations of specialized pool scrubbing codes are given. The paper draws conclusions about the necessity of coupling between containment thermal-hydraulics and pool scrubbing models, and proposes ways of further simulation model development in order to improve source term predictions. (author) 2 tabs., refs.

  8. Pool scrubbing models for iodine components

    International Nuclear Information System (INIS)

    Fischer, K.

    1996-01-01

    Pool scrubbing is an important mechanism to retain radioactive fission products from being carried into the containment atmosphere or into the secondary piping system. A number of models and computer codes has been developed to predict the retention of aerosols and fission product vapours that are released from the core and injected into water pools of BWR and PWR type reactors during severe accidents. Important codes in this field are BUSCA, SPARC and SUPRA. The present paper summarizes the models for scrubbing of gaseous Iodine components in these codes, discusses the experimental validation, and gives an assessment of the state of knowledge reached and the open questions which persist. The retention of gaseous Iodine components is modelled by the various codes in a very heterogeneous manner. Differences show up in the chemical species considered, the treatment of mass transfer boundary layers on the gaseous and liquid sides, the gas-liquid interface geometry, calculation of equilibrium concentrations and numerical procedures. Especially important is the determination of the pool water pH value. This value is affected by basic aerosols deposited in the water, e.g. Cesium and Rubidium compounds. A consistent model requires a mass balance of these compounds in the pool, thus effectively coupling the pool scrubbing phenomena of aerosols and gaseous Iodine species. Since the water pool conditions are also affected by drainage flow of condensate water from different regions in the containment, and desorption of dissolved gases on the pool surface is determined by the gas concentrations above the pool, some basic limitations of specialized pool scrubbing codes are given. The paper draws conclusions about the necessity of coupling between containment thermal-hydraulics and pool scrubbing models, and proposes ways of further simulation model development in order to improve source term predictions. (author) 2 tabs., refs

  9. The Safe Transportation of Radioactive Materials

    International Nuclear Information System (INIS)

    Megrahi, Abdulhafeed; Abu-Ali, Giuma; Enhaba; Ahmed

    2008-01-01

    In this paper, we present the essential conditions that should be required for transporting the radioactive materials. We demonstrate the procedure for transporting the radioactive iodine-131 from the Centre of Renewable Energies and Desalination of Water in Tajoura, Libya to Tripoli Medical Center. The safe measures were taken during the process of the transportation of the isotope produced in the centre including dosimetry analysis and the thickness of the container. (author)

  10. Iodine-131 distribution on the territory of the Republic of Belarus during the first period of the Chernobyl NPP catastrophe

    International Nuclear Information System (INIS)

    Germenchuk, M.G.; Zhukova, O.M.; Shagalova, E.D.; Matveenko, I.I.

    1998-01-01

    To reconstruct space distribution of iodine-131 on the territory of Belarus we used the following data: (i) contents of iodine-131 in soil measured by gamma spectrometry method in May-July, 1986; (ii) contents of iodine-131 in samples of radioactive atmospheric fall-outs measured by gamma spectrometry method in May, 1986; (iii) daily measurements of exposure dose power levels on the territory of Belarus obtained in April-July, 1986; (iv) results of aerial gamma radiation mapping, obtained in May, 1986; (v) daily measurements of radioactive contamination of milk on the territory of Belarus obtained in May-July, 1986; (vi) measurements of iodine-131 content in links of biological chain 'soil-grass-milk' sampled from 15 reference farms; (vii) maps of specific activity of natural hayfields grass on the territory of Belarus (for every district) obtained on June 2 and 5, on July 3, 1986. Dose commitments on thyroid gland caused by iodine isotopes were formed mainly during the first 2.5 months after the accident. Local irradiation of this organ was stipulated by high accumulation factor of iodine isotopes in thyroid gland that caused increasing of malignant thyroid tumors incidences, including children, on all over the territory of Belarus. Comparison of iodine-131 distribution map and malignant thyroid gland tumor incidences among children on the territory of Belarus map shows that the more level of iodine contamination the more malignant thyroid gland tumor incidence

  11. Contamination with iodine-131 in metabolic therapy

    International Nuclear Information System (INIS)

    Garcia, R.; Luis, J.; Gomez, A.; Gonzalez, V.; Herrador, M.; Rogriguez, J.R.

    1997-01-01

    High-dose radioactive iodine therapy using 131 I is the treatment of choice for patients with thyroid cancer following thyroidectomy. Because of the large amount of activity which is excreted during hospitalization, contamination harzard from 131 I excretion via perspiration, saliva, breath and urine may arise. In twelve patients treated with doses of 131 I ranging from 1.85-7.4GBq activity levels were measured in room surface, the toilet, patients saliva and skin. Removable activity from skin reached a maximum at 24h post-therapy. Removable activity from room surfaces exceed the level of contamination which requires clean-up in a public area during patient's hospitalization. The relatively high activities present in the saliva and skin of these patients emphasizes the need for all individuals coming in contact with these patients to be made aware of the contamination hazard present. (author)

  12. Iodine-129 and Iodine-127 speciation in groundwater at the Hanford Site, U.S.: iodate incorporation into calcite

    International Nuclear Information System (INIS)

    Zhang, Saijin; Yeager, Chris; Wellman, Dawn M.; Santschi, Peter H.

    2013-01-01

    The Hanford Site, the most contaminated nuclear site in the United States, has large radioactive waste plumes containing high 129I levels. The geochemical transport and fate of radioiodine depends largely on its chemical speciation that is greatly affected by environmental factors. This study reports, for the first time, the speciation of stable and radioactive iodine in the groundwater from the Hanford Site. Iodate was the dominant species and accounts for up to 84%, followed by organo-iodine and minimal levels of iodide. The relatively high pH and oxidizing environment may have prevented iodate reduction. Our results identified that calcite precipitation caused by degassing of CO2 during deep groundwater sampling incorporated between 7 to 40% of dissolved iodine (including 127I and 129I) that was originally in the groundwater, transforming dissolved to particulate iodate during sampling. In order to understand the mechanisms underlying iodine incorporation by calcite, laboratory experiments were carried out to replicate this iodine sequestering processes. Two methods were utilized in this study, 1) addition of sodium carbonate; 2) addition of calcium chloride followed by sodium carbonate where the pH was well controlled at ~8.2, which is close to the average pH of Hanford Site groundwater. It was demonstrated that iodate was the main species incorporated into calcite and this incorporation process could be impeded by elevated pH and decreasing ionic strength in groundwater. This study provides critical information for predicting the long-term fate and transport of 129I at the Hanford Site and reveals a potential means for improved remediation strategies of 129I

  13. Radio-iodine therapy and Helicobacter pylori infection

    International Nuclear Information System (INIS)

    Gholamrezanezhad, A.; Mirpour, S.; Saghari, M.; Abdollahzadeh, J.; Pourmoslemi, A.; Yarmand, S.

    2008-01-01

    Helicobacter pylori is the most important cause of gastritis and related morbidities. Following consumption, radioactive iodine accumulates considerably in the stomach. On the basis of this observation, we decided to determine whether the high radiation induced by radio-iodine in the stomach is effective in the eradication of this infection. All consecutive patients with differentiated thyroid carcinoma, who were referred for radio-iodine therapy [dose 117.1±24.4 mCi (4.3±0.9 GBq), range 100-200 mCi (3.7-7.4 GBq)], were enrolled. To detect H. pylori infection, the urease breath test (UBT) was performed 1-2 h before radio-iodine consumption and the test was repeated 2 months later. Of 88 patients, 71 had pre-treatment positive UBT. Of these, 23 patients had negative post-treatment result, which means a significant reduction (26.1%, 95% confidence interval (CI) 16.8-35.5%) in the number of positive UBT results in our treated population (32.4% of UBT-positive cases became UBT-negative). Considering the high prevalence of reinfection in developing countries, the therapeutic benefit would have been more considerable if the second UBT had been done with a lag time of less than 2 months. Although radio-iodine therapy is not a logical method for the treatment of patients suffering from H. pylori, our finding provides indirect evidence about the radiosensitivity of bacteria, the future clinical applications of which need to be further evaluated. Also this finding can be useful for the food industry, where radiation is used widely to sterilize food. Regarding the possibility of H. pylori suppression, we recommend not using UBT for screening for the infection for at least within 2 months following radio-iodine therapy. (author)

  14. Effectiveness and risks of stable iodine prophylaxis

    International Nuclear Information System (INIS)

    Waight, P.J.

    1995-01-01

    The factors upon which the efficacy of stable iodine prophylaxis depends are reviewed, with particular reference to the dose of stable iodine, the timing of the dose, the influence of dietary iodine and the impact of the other prospective actions. The risks of stable iodine ingestion are estimated, and their application to the principle of Justification in outlined. (Author)

  15. Effects of natural radioactivity on food radioactivity measurement

    International Nuclear Information System (INIS)

    Ennyu, Atsuhito

    2012-01-01

    Since the accident of the Fukushima Daiichi Nuclear Power Station of Tokyo Electric Company, groups and individuals including local governments, food manufacturers, distribution circles, retail circles, and citizens are eager to measure the radioactivity of food, in order to confirm the safety of food from the concerns about radioactive contamination. The measurement of radioactivity of food is done by quantitatively determining gamma rays due to radioactive cesium that was incorporated into the biosphere cycle after having been released into the environment. As for the radioactivity measurement of food using gamma-ray spectrometry with a potassium iodide scintillation detector, which is very commonly used, this paper describes the handling method of obtained data, the principle of erroneous detection of radioactive cesium and iodine interrupted by natural radionuclides, and countermeasures for it. Major natural radioactivity sources are uranium series and thorium series. This paper explains gamma rays, which are characteristic in the decay process of uranium series and often affect the measurement of radioactive cesium in food and water. (O.A.)

  16. Iodine and selenium migration through argillaceous rocks

    International Nuclear Information System (INIS)

    Frasca, Benjamin

    2011-01-01

    Deep argillaceous formations are considered as potential host rock for high-level radioactive waste repository. Based on safety assessment calculations, active selenium ( 79 Se) and iodine ( 129 I) from high level radioactive waste might be ones of the major dose contributors due to their longevity and their anionic character. However, because of their high sensitivity to redox condition, a special attention to the oxidation state of these elements is required. A comparative study on the diffusion properties of selenium and iodine through argillaceous rocks was realized with the aim to determine the effects of both the redox conditions and the mineralogy on the migration of these two elements. For these purposes, we have studied two argillaceous rocks: Toarcian argillite from Tournemire (France) and Opalinus clay (OPA) from the Mont-Terri (Switzerland). The study of the iodide migration allowed to confirm the control on the iodide retention of both oxidized pyrite and natural organic matter. A kinetic control of the iodide sorption is also suspected. We focus the selenium study on the more oxidized species, Se(IV) and Se(VI). The Se(IV) migration is strongly dependant from oxido-reduction processes. Indeed, the Se(IV) diffusion experiments through Tournemire argillite and OPA indicated a significant reduction associated to Fe(II). The Se(VI) study evidenced a behavior dependant from the initial concentration: at the highest concentration, no significant retention was observed while the retention is significant at the lowest concentration. Furthermore, spectroscopic analyses tend to show a low Se(VI) reduction at the Fe contact. However, biotic origin cannot be excluded. (author)

  17. Iodine in the environment revisited

    International Nuclear Information System (INIS)

    Christiansen, J.V.; Carlsen, L.

    1989-05-01

    The report gives an overview of the environmental cycle of iodine, especially focusing on the possible reactions being responsible for the retention of iodine in the terrestrial environment. During the last two decades evidence for the presence of iodine in soil as organically bound has been presented. The major part of inorganic iodine in the terrestrial environment will, under physical and chemical conditions normally prevailing, exist as iodide. No evidence for a direct reaction between iodide and organic material has been presented, whereas strong support for the engagement of microbial activity in the formation of organic iodine compounds in soil has been obtained. Incorporation of iodine in humic substances as a result of enzymatic catalysis, involving an enzyme of the perozidase group apperas reasonable. It is concluded that microbiological activity involving extracellular enzymes most probably is responsible for the possible retention of iodine in the terrestrial environment. It is suggested that these reactions in detail should be studied experimentally. (author) 3 tabs., 2 ills., 51 refs

  18. Model of iodine transport and reaction kinetics in a nuclear fuel reprocessing plant

    International Nuclear Information System (INIS)

    Davis, W. Jr.

    1977-05-01

    A model is presented to describe the time-dependent flow and retention of stable iodine isotopes and the decay of 131 I in a nuclear fuel reprocessing plant. The plant consists of 16 units of equipment such as a voloxidizer or graphite burner, fuel dissolver, solvent extractors, storage tanks, vaporizers, primary iodine sorbers, and silver zeolite. The rate of accumulation of bulk and radioactive iodine in these units and in the environment is described using 19 differential equations. Reasonable time-dependence of iodine retention factors (RFs) by the plant were calculated. RFs for a new plant in excess of 10 6 for stable iodine and 129 I decrease to the range of 10 3 to 10 2 as plant operating times exceed 50 to 100 days. The RFs for 131 I also decrease initially, for a period of approximately 10 days, but then increase by several orders of magnitude due to radioactive decay and isotopic exchange. Generally, the RFs for 131 I exceed those for stable iodine by factors of 10 4 or more. 19 references, 13 figures, 2 tables

  19. Iodine deficiency and nutrition in Scandinavia

    DEFF Research Database (Denmark)

    Manousou, Sofia; Dahl, Lisbeth; Heinsbaek Thuesen, Betina

    2017-01-01

    Iodine nutrition is a result of geological conditions, iodine fortification and monitoring strategies within a country together with the dietary habits of the population. This review summarizes the basis for the current iodine situation in the Scandinavian countries in order to identify gaps...... strategies have been used in Scandinavia to improve iodine nutrition. The major source of iodine is iodized salt in Sweden and from milk and dairy products in Norway. In Denmark, drinking water, milk, dairy products and iodized salt used in commercial production of bread are the important sources of iodine....... The current iodine status in Scandinavia is not optimal and action is ongoing to increase iodination in Denmark, where there is mild iodine deficiency in the general population. Data from all three countries indicate insufficient iodine nutrition during pregnancy and there is a need for data from children...

  20. Iodine excretion in school children in Copenhagen

    DEFF Research Database (Denmark)

    Rasmussen, Lone B.; Kirkegaard-Klitbo, Ditte Marie; Laurberg, Peter

    2016-01-01

    INTRODUCTION: Studies of dietary habits show a high iodine intake in children in Denmark. Iodine excretion in children has not previously been assessed. Iodine excretion in adults is below the recommended threshold, and it is therefore being discussed to increase the fortification level. The main...... objective of this study was to assess iodine excretion in children living in Copenhagen to establish whether a moderate increase in iodine fortification would lead to excess iodine intake in this group. METHODS: Children in first and fifth grade were recruited through schools in Copenhagen. In total, 244...... children de-ivered a urine sample. Urine samples were analysed for iodine and creatinine, and the results were expressed as urinary iodine concentration (UIC) and as estimated 24-h iodine excretion. Iodine excretion in children was also compared with that of adults living in the same area, investigated...

  1. Iodination of the humic samples from Hupa project

    International Nuclear Information System (INIS)

    Reiller, P.; Mercier-Bion, F.; Barre, N.; Gimenez, N.; Miserque, F.

    2005-01-01

    Full text of publication follows: Iodine radioactive isotopes, such as 129 I, are important radionuclides due to their significant impact in geological disposal: in the conditions of natural reducing groundwaters, iodine would essentially be present in the form of highly mobile iodide anion. But in shallow waters the presence of molecular iodine is to be taken into account. The interaction of iodine with natural organic matter in general and with humic substances (HS) in particular, has been the subject of numerous studies. It has been shown that in some cases, organically bound iodine can dominate the speciation either as methyl iodide or bound to humic substances [1, 2]. It is now also clear that this reactivity is closely related to the occurrence of molecular iodine I 2 (aq). The reaction scheme can be viewed as an electrophilic substitution of a hydrogen atom by an iodine atom on a phenolic ring. Nevertheless, in some of the latter studies, the characterization of the final reaction products did not satisfy the authors completely as total separation from I - produced during the iodination could not be achieved. Thus, further studies were led using samples from the CCE HUPA project: natural humic and fulvic extract from Gorleben [3] and synthetic samples obtained from FZ Rossendorf [4]. Dialysis procedures were envisaged to improve the incomplete separation between the colloidal humic matter and the iodide ions either unreacted or produced by the reaction [2]. The iodination of these samples were monitored using UV-Visible spectrophotometry. As in previous studies [2], the kinetics could not be linearized in simple order but the trends were conform to simple phenolic patterns. The apparent rates could nevertheless be correlated to the aromaticity (H/C ratio) of the samples. After dialysis, the iodine humic/fulvic interaction was characterised to occur as a carbon-iodine covalent bonding by X-ray photoelectron spectroscopy (XPS) [5]. Electro-spray ionisation

  2. Deep Bed Iodine Sorbent Testing FY 2011 Report

    International Nuclear Information System (INIS)

    Soelberg, Nick; Watson, Tony

    2011-01-01

    Nuclear fission results in the production of fission products (FPs) and activation products that increasingly interfere with the fission process as their concentrations increase. Some of these fission and activation products tend to evolve in gaseous species during used nuclear fuel reprocessing. Analyses have shown that I129, due to its radioactivity, high potential mobility in the environment, and high longevity (half life of 15.7 million years), can require control efficiencies of up to 1,000x or higher to meet regulatory emission limits. Deep-bed iodine sorption testing has been done to evaluate the performance of solid sorbents for capturing iodine in off-gas streams from nuclear fuel reprocessing plants. The objectives of the FY 2011 deep bed iodine sorbent testing are: (1) Evaluate sorbents for iodine capture under various conditions of gas compositions and operating temperature (determine sorption efficiencies, capacities, and mass transfer zone depths); and (2) Generate data for dynamic iodine sorption modeling. Three tests performed this fiscal year on silver zeolite light phase (AgZ-LP) sorbent are reported here. Additional tests are still in progress and can be reported in a revision of this report or a future report. Testing was somewhat delayed and limited this year due to initial activities to address some questions of prior testing, and due to a period of maintenance for the on-line GC. Each test consisted of (a) flowing a synthetic blend of gases designed to be similar to an aqueous dissolver off-gas stream over the sorbent contained in three separate bed segments in series, (b) measuring each bed inlet and outlet gas concentrations of iodine and methyl iodide (the two surrogates of iodine gas species considered most representative of iodine species expected in dissolver off-gas), (c) operating for a long enough time to achieve breakthrough of the iodine species from at least one (preferably the first two) bed segments, and (d) post-test purging

  3. Radiochemistry of iodine

    Energy Technology Data Exchange (ETDEWEB)

    Kahn, M.; Kleinberg, J.

    1977-09-01

    The preparation of isotopes of the element, with selected procedures for its determination in or separation from various media is described along with the separating of iodine species from each other. Each part of the introductory section is referenced separately from the remainder of the monograph. For the preparative and analytical sections there is an extensive, indexed bibliography which was developed from the indexes of Volumes 19 to 30 inclusive (1965-1974) of Nuclear Science Abstracts (NSA). From these indexes the NSA abstracts of possible pertinent references were selected for examination and a choice was made of those references which were to be included in the bibliography. The bibliography has both primary and secondary references. Although the monograph does not cover hot atom chemistry, the kinetics of exchange reactions, decay schemes, or physiological applications, papers in these areas were examined as possible sources of useful preparative and analytical procedures. (JRD)

  4. Radiochemistry of iodine

    International Nuclear Information System (INIS)

    Kahn, M.; Kleinberg, J.

    1977-09-01

    The preparation of isotopes of the element, with selected procedures for its determination in or separation from various media is described along with the separating of iodine species from each other. Each part of the introductory section is referenced separately from the remainder of the monograph. For the preparative and analytical sections there is an extensive, indexed bibliography which was developed from the indexes of Volumes 19 to 30 inclusive (1965-1974) of Nuclear Science Abstracts (NSA). From these indexes the NSA abstracts of possible pertinent references were selected for examination and a choice was made of those references which were to be included in the bibliography. The bibliography has both primary and secondary references. Although the monograph does not cover hot atom chemistry, the kinetics of exchange reactions, decay schemes, or physiological applications, papers in these areas were examined as possible sources of useful preparative and analytical procedures

  5. Current iodinated contrast media

    International Nuclear Information System (INIS)

    Stacul, F.

    2001-01-01

    The number of scientific papers on iodinated contrast media is declining. Indeed, comparative trials between high-osmolality and low-osmolality agents largely showed the higher safety and tolerability of the latter, and this is no longer a matter of discussion. Only financial constraints could prevent a total conversion to low-osmolality agents. Research comparing low-osmolality (nonionic monomers, ionic dimer) and iso-osmolality contrast media (nonionic dimers) are still ongoing. Both classes of nonionic compounds proved safer than the ionic dimer. The relative merits of nonionic monomers and nonionic dimers are a matter for debate, and criteria for a selective use of different agents for different procedures could be discussed. (orig.)

  6. The Danish investigation on iodine intake and thyroid disease, DanThyr: status and perspectives.

    Science.gov (United States)

    Laurberg, Peter; Jørgensen, Torben; Perrild, Hans; Ovesen, Lars; Knudsen, Nils; Pedersen, Inge Bülow; Rasmussen, Lone B; Carlé, Allan; Vejbjerg, Pernille

    2006-08-01

    Denmark was an area of iodine deficiency, and mandatory iodine fortification of table salt and salt in bread (13 p.p.m. iodine) was initiated in 2000/2001. The Danish investigation on iodine intake and thyroid disease (DanThyr) is the monitoring of the iodine fortification program. DanThyr consists of three main parts: a study of population cohorts initialized before (n=4649) and after (n=3570) iodization of salt, a prospective identification of incident cases of overt hyper- and hypothyroidism in a population of around 550,000 people since 1997, and compilation of data from the national registers on the use of thyroid medication, thyroid surgery, and radioiodine therapy. Studies were carried-out in parallel in subcohorts living in areas with differences in iodine content of ground water. The study showed profound effects of even small differences in iodine intake level on the prevalence of goiter, nodules, and thyroid dysfunction. Mild and moderate iodine deficiency was associated with a decrease in serum TSH with age. Other environmental factors were also important for goiter development (increase in risk, smoking and pregnancy; decrease in risk, oral contraception and alcohol consumption), and the individual risk depended on the genetic background. Environmental factors had only a minor influence on the prevalence of thyroid autoantibodies in the population. There were more cases of overt hypothyroidism in mild than in moderate iodine deficiency caused by a 53% higher incidence of spontaneous (presumably autoimmune) hypothyroidism. On the other hand, there were 49% more cases of overt hyperthyroidism in the area with moderate iodine deficiency. The cautious iodine fortification program, aiming at an average increase in iodine intake of 50 mug/day has been associated with a 50% increase in incidence of hyperthyroidism in the area with the most severe iodine deficiency. The incidence is expected to decrease in the future, but there may be more cases of Graves

  7. Radioactive Decay

    Science.gov (United States)

    Radioactive decay is the emission of energy in the form of ionizing radiation. Example decay chains illustrate how radioactive atoms can go through many transformations as they become stable and no longer radioactive.

  8. Radio-iodination of plasma membranes of toad bladder epithelium

    Energy Technology Data Exchange (ETDEWEB)

    Rodriguez, H J; Edelman, I S [California Univ., San Francisco (USA). Cardiovascular Research Inst.; California Univ., San Francisco (USA). Dept. of Medicine; California Univ., San Francisco (USA). Dept. of Biochemistry and Biophysics)

    1979-01-01

    The present report describes high yield enzymatic radio-iodination of the apical and basal-lateral plasma membranes of toad bladder epithelium with /sup 125/I-Na, by a procedure that does not breach the functional integrity of the epithelium, as assessed by the basal and vasopressin-sensitive short-circuit current (SCC). Iodination of basal-lateral plasma membranes, at a yield comparable to that obtained with apical labelling, was attained after about 30 min of exposure of the intact bladder to the labelling solutions. Approximately 25% of the basal-lateral labeling was lost when the epithelial cells were harvested after collagenase treatment, implying that some iodination of the basement membrane had taken place. Less than 10% of iodination of the apical or basal-lateral surfaces was accounted for by lipid-labeling. Analysis of the labeled apical and basal-lateral species by enzymatic digestion and thin layer chromatography disclosed that virtually all the radioactivity was present as mono-iodotyrosine (MIT). (orig./AJ).

  9. Low Iodine in the Follicular Lumen Caused by Cytoplasm Mis-localization of Sodium Iodide Symporter may Induce Nodular Goiter.

    Science.gov (United States)

    Huang, Huibin; Shi, Yaxiong; Liang, Bo; Cai, Huiyao; Cai, Qingyan

    2017-10-01

    Iodine is a key ingredient in the synthesis of thyroid hormones and also a major factor in the regulation of thyroid function. A local reduction of iodine content in follicular lumen leads to overexpression of local thyroid-stimulating hormone receptor (TSHr), which in turn excessively stimulates the regional thyroid tissue, and result in the formation of nodular goiter. In this study, we investigated the relationship between iodine content and sodium iodide symporter (NIS) expression by using the clinical specimens from patients with nodular goiter and explored the pathogenesis triggered by iodine deficiency in nodular goiter. In total, 28 patients were clinically histopathologically confirmed to have nodular goiter and the corresponding adjacent normal thyroid specimens were harvested simultaneously. Western blot and immunohistochemistry were performed to assay NIS expression and localization in thyrocytes of both nodular goiter and adjacent normal thyroid tissues. NIS expression mediated by iodine in follicular lumen was confirmed by follicular model in vitro. Meanwhile, radioscan with iodine-131were conducted on both nodular goiter and adjacent normal thyroid. Our data showed that NIS expression in nodular goiter was significantly higher than that in adjacent normal tissues, which was associated with low iodine in the follicular lumen. Abnormal localization of NIS and lower amount of radioactive iodine-131 were also found in nodular goiter. Our data implied that low iodine in the follicular lumen caused by cytoplasm mis-localization of NIS may induce nodular goiter.

  10. Milk Iodine Content in Slovakia

    Directory of Open Access Journals (Sweden)

    I. Paulíková

    2008-01-01

    Full Text Available The aim of this work was to map actual iodine status and its seasonal differences in raw milk of dairy cows, sheep, and goats in various regions of Slovakia. Iodine concentrations were determined in 457 samples of raw milk from dairy cows, 78 samples of sheep, and 16 samples of goat milk collected in various regions of Slovakia from 2002 to 2007. Among all the 457 samples of bovine milk, iodine content below 50 μg l-1 was recorded in 114 samples (24.94%; 294 samples (64.33% ranged between 50 and 200 μg l-1; 19 samples (4.16% from 200 to 500 μg l-1; 17 samples (3.72% between 500 and 1 000 μg l-1, and 13 samples (2.85% showed iodine concentrations over 1 000 μg l-1. regional concentrations showed the highest values in the Western, then Middle and Eastern Slovakia, and the lowest values in Northern Slovakia (p p -1 in 49 sheep (62.8% and in 6 goats below 60 μg l-1 (37.5%, which are indicative of iodine deficiency. When comparing seasonal differences, sheep and goat milk had higher iodine content during the winter feeding period, however, in dairy cows we recorded the opposite ratio. Except for goat milk (p < 0.01 the seasonal differences were not significant.

  11. Clinical applications of gamma-detection probes - radioguided surgery

    International Nuclear Information System (INIS)

    Schneebaum, S.; Stadler, J.; Skornick, Y.

    1999-01-01

    Radioguided surgery (RGS) is a surgical technique that enables the surgeon to identify tissue ''marked'' by a radionuclide before surgery, based on the tissue characteristics, the radioactive tracer and its carrying molecule, or the affinity of both. Thus, yet another tool has been added to the inspection and palpation traditionally used by the surgeon. Current clinical applications of radioguided surgery are: radioimmunoguided surgery (RIGS) for colon cancer, sentinel-node mapping for malignant melanoma (which has become state-of-the-art), sentinel-node mapping for breast, vulvar and penile cancer, and detection of parathyroid adenoma and bone tumour (such as osteid osteoma). Although the same gamma-detecting probe (GDP) may be used for all these applications, the carrier substance and the radionuclide differ. MoAb and peptides are used for RIGS, sulphur colloid for sentinel-node mapping, iodine-125 for RIGS, technetium-99m for sentinel node, parathyroid and bone. The mode of injection also differs, but there are some common principles of gamma-guided surgery. RIGS enables the surgeon to corroborate tumour existence, find occult metastases, and assess the margins of resection; this may result in a change on the surgical plan. Sentinel lymph-node (SLN) scintigraphy for melanoma guides the surgeon to find the involved lymph nodes for lymph-node dissection. SLN for breast cancer is being investigated with promising results. This procedure has also changed the outlook of lymph-node pathology by giving the pathologist designated tissue samples for more comprehensive examination. Gamma-guided surgery will result in more accurate and less unnecessary surgery, better pathology and, hopefully, in better patient survival. (orig.)

  12. Iodine Status of School-children (8-10 years) and Associated ...

    African Journals Online (AJOL)

    From a sub-sample oj 50 households, 50 salt samples used in the homes were coliectedJor ... to reduce the uptake of radioactive iodine by human ..... soils such that crops grown on would also lack .... Trace elements in. Human and Animal ...

  13. Iodine-129 in Seawater Offshore Fukushima: distribution, inorganic speciation, sources, and budget

    DEFF Research Database (Denmark)

    Hou, Xiaolin; Povinec, Pavel P.; Zhang, Luyuan

    2013-01-01

    The Fukushima nuclear accident in March 2011 has released a large amount of radioactive pollutants to the environment. Of the pollutants, iodine-129 is a long-lived radionuclide and will remain in the environment for millions of years. This work first report levels and inorganic speciation of 129...

  14. Arguments and experience feed back for the distribution of iodine tablets in the vicinity of nuclear plants

    International Nuclear Information System (INIS)

    Le Guen, B.; Gonin, M.; Hemidy, P.Y.; Bailloeuil, C.; Van Boxsom, D.; Renier, S.; Garcier, Y.

    2001-01-01

    Arguments and experience feed back for the distribution of iodine tablets in the vicinity of nuclear power plants. In the event of a nuclear accident, radioactive isotopes of iodine including 131 I can be released into the atmosphere. In 1997, as a safety measure, the French government decided to begin the distribution of stable iodine tablets (KI) to those living in the vicinity of nuclear power plants, to avoid having to do so in an emergency. The tablets were previously stored by Electricite de France (EDF) which held them at the disposal of the government authorities. Since the tablets distributed in 1997 are approaching their use-by date, EDF has started a new distribution campaign within a ten-kilometer radius of its twenty sites with a total of 58 nuclear reactors. During the public information meetings, the discussion focused on the effectiveness of this protective measure and the nature and frequency of the possible side effects while measuring the duration of its action under the conditions in which it was administered. A bibliographic study of the kinetics of iodine in the human body has enabled the indications and the means of use to be determined. The degree of effectiveness with which incorporation of radioactive iodine into the thyroid is prevented and the onset of thyroid dysfunction depend on both external and individual factors: uptake of iodine from food, functional condition of the thyroid, age, etc. In cases of prolonged exposure to radioactive iodine over several days, consideration needs to be given to taking stable iodine a second time, to maintain maximum protection. This presentation covers the impact of the 1997 and 2000 information campaigns, the effect of making stable iodine available to the public, the extent to which the public feels involved, and the reactions of health professionals. (author)

  15. Iodine filters in nuclear power stations

    International Nuclear Information System (INIS)

    Wilhelm, J.G.

    1977-04-01

    On the basis of calculated and recorded release rates of nuclear power plants, the significance of iodine releases in the invironmental impact relative to other nuclides is discussed. The release pathways for iodine in LWR-type reactors and the efficiency of various methods to lower the activity release are given. The airborne species of iodine are discussed with regard to their removal in iodine sorption filters and environmental impact. The technical status of iodine removal by means of iodine sorption filters is studied for normal operation and accident conditions in nuclear power stations on the basis of the data given in the relevant literature for the efficiency of a number of iodine sorption materials. The applicability of concepts for ventilation and containment and their influence on iodine filter systems are discussed. Design, structure, and testing of iodine sorption filters are treated in detail; recommendations for design are given, and failure sources are mentioned. (orig.) [de

  16. Iodine status in neonates in Denmark

    DEFF Research Database (Denmark)

    Nøhr, S B; Laurberg, Peter; Børlum, K G

    1994-01-01

    Iodine status of 147 neonates born in five different regions of Denmark was evaluated in relation to the iodine content of breast milk and iodine supplementation taken by the mother. Approximately two-thirds of the women had not received iodine supplementation. They had low iodine concentrations...... in breast milk and urinary iodine concentrations of the neonates at day 5 were low. The median values (milk/urine) were 33.6/31.7 micrograms/l (Randers 22/26, Ringkøbing 29/16, Aalborg 36/31. Arhus 54/41 and Copenhagen 55/59 micrograms/l). Higher values were found in the group where tablets containing...... iodine had been taken (milk/urine: 57.0/61.0 micrograms/l). In general, the values are low compared with internationally recommended levels. We suggest that mothers without autoimmune thyroid disease should receive iodine supplementation in the form of vitamin/mineral tablets containing iodine (150...

  17. Iodine-129 in the environment

    International Nuclear Information System (INIS)

    Tikhomirov, F.A.; Moiseev, I.T.

    1987-01-01

    The quantitative ratio of aerial and soil entries of 129 I into plants, parameters of its migration in the system of atmosphere-soil-plants-river water, dynamics of transformation and biological availability of 129 I in soil for plants were studied on the basis of field observations and experiments using the radioactive tracers. The doses of human thyroid gland irradiation by 129 I under atmospheric and soil pathways of its transport into diet are estimated. 129 I content in soil due to its systematic, for 50 years, releases into atmosphere is shown to be negligible, agricultural production contamination by 129 I resulting mainly from its fallout onto overground phytomass. The period, needed to achieve 129 I concentration equilibrium in the atmosphere-soil system under constant average 129 I content in the air, varies depending on the soil type from several hundred years (for podzolic soils) up to several thousand years (for chernozem). The 129 I half-accumulation period is equal to 150 years for soddy-podzolic soil and to 700 years for chernozem. In case of 129 I fallout lasting for 100 years the annual increase of its content in overground phytomass due to the transport from soil will account for 0,3% of its atmospheric entry way for soddy-podzolic soil and for 0,1% for chernozem, respectively. For a number of sierozem, yellow soil and calcareous chernozem types this addition is higher (up to 1%). Under constant iodine-129 concentration in air (1 Bq/m3) the absorbed dose for one-year child's thyroid gland in continental area is approximately equal to 2 (Gy/y)/(Bq/m3). The absorbed dose from globally dissipated 129 I under 99% efficiency of gas purification will not exceed 2·10 -7 Gy/y. The input of globally dissipated 129 I, originating from deep underground disposal of nuclear wastes can account for not more than 10 -9 Gy/y. In total, 129 I releases for the coming century is not going to produce limitations for nuclear energetics development. (author)

  18. Enhanced thyroid iodine metabolism in patients with triiodothyronine-predominant Graves' disease

    Energy Technology Data Exchange (ETDEWEB)

    Takamatsu, J.; Hosoya, T.; Naito, N.; Yoshimura, H.; Kohno, Y.; Tarutani, O.; Kuma, K.; Sakane, S.; Takeda, K.; Mozai, T.

    1988-01-01

    Some patients with hyperthyroid Graves' disease have increased serum T3 and normal or even low serum T4 levels during treatment with antithyroid drugs. These patients with elevated serum T3 to T4 ratios rarely have a remission of their hyperthyroidism. The aim of this study was to investigate thyroid iodine metabolism in such patients, whom we termed T3-predominant Graves' disease. Mean thyroid radioactive iodine uptake was 51.0 +/- 18.1% ( +/- SD) at 3 h, and it decreased to 38.9 +/- 20.1% at 24 h in 31 patients with T3-predominant Graves' disease during treatment. It was 20.0 +/- 11.4% at 3 h and increased to 31.9 +/- 16.0% at 24 h in 17 other patients with hyperthyroid Graves' disease who had normal serum T3 and T4 levels and a normal serum T3 to T4 ratio during treatment (control Graves' disease). The activity of serum TSH receptor antibodies was significantly higher in the patients with T3-predominant Graves' disease than in control Graves' disease patients. From in vitro studies of thyroid tissue obtained at surgery, both thyroglobulin content and iodine content in thyroglobulin were significantly lower in patients with T3-predominant Graves' disease than in the control Graves' disease patients. Thyroid peroxidase (TPO) activity determined by a guaiacol assay was 0.411 +/- 0.212 g.u./mg protein in the T3-predominant Graves' disease patients, significantly higher than that in the control Graves' disease patients. Serum TPO autoantibody levels determined by immunoprecipitation also were greater in T3-predominant Graves' disease patients than in control Graves' disease patients. Binding of this antibody to TPO slightly inhibited the enzyme activity of TPO, but this effect of the antibody was similar in the two groups of patients.

  19. Process for the impromptu preparation of a radio-iodine-labelled injectable fatty acid and the preparation of iodinated derivatives suitable for the application of this process

    International Nuclear Information System (INIS)

    Bardy, Andre; Comet, Michel; Coornaert, Sabine; Mathieu, J.P.; Riche, Francoise; Vidal, Michel.

    1983-01-01

    The radioiodine-labelled fatty acid is prepared by reaction of a fatty acid, bromated or iodinated in the #betta# position, with an aqueous solution of radioactive iodide at pH 7 in the presence of carrier iodide. The labelled product obtained is suspended in a buffer solution at pH 9 then dissolved in human serum albumin for injection purposes. The iodinated derivatives used as starting products may be obtained by condensation of a bromated fatty acid and an acetylene alcohol [fr

  20. Using radioactivity

    International Nuclear Information System (INIS)

    1982-10-01

    The leaflet discusses the following: radioactivity; radioisotopes; uses of ionising radiations; radioactivity from (a) naturally occurring radioactive elements, and (b) artificially produced radioisotopes; uses of radioactivity in medicine, (a) clinical diagnostic, (b) therapeutic (c) sterilization of medical equipment and materials; environmental uses as tracers; industrial applications, e.g. tracers and radiography; ensuring safety. (U.K.)

  1. Radioactive aerosols

    International Nuclear Information System (INIS)

    Chamberlain, A.C.

    1991-01-01

    Radon. Fission product aerosols. Radioiodine. Tritium. Plutonium. Mass transfer of radioactive vapours and aerosols. Studies with radioactive particles and human subjects. Index. This paper explores the environmental and health aspects of radioactive aerosols. Covers radioactive nuclides of potential concern to public health and applications to the study of boundary layer transport. Contains bibliographic references. Suitable for environmental chemistry collections in academic and research libraries

  2. Effect of iodination on human growth hormone and prolactin: characterized by bioassay, radioimmunoassay, radioreceptor assay, and electrophoresis

    International Nuclear Information System (INIS)

    Hughes, J.P.; Tanaka, T.; Gout, P.W.; Beer, C.T.; Noble, R.L.; Friesen, H.G.

    1982-01-01

    Human GH (hGH) and PRL (hPRL) were iodinated using lactoperoxidase. The iodinated hormones were characterized by RIA, radioreceptor assay (RRA), and bioassay (BA) using the Nb2 Node lymphoma cell line. The proportion of tracer that could bind to rat liver membranes or rabbit antibodies was determined, and the distribution of iodinated hormones was examined using polyacrylamide gel electrophoresis. Excess antibody was capable of precipitating 87.9% of the radioactivity associated with the hGH tracer and 86.0% of the hPRL tracer. The maximal specific binding to a liver membrane preparation averaged 67.3% of the [ 125 I]iodo-hGH radioactivity and 48.8% of the [ 125 I]iodo-hPRL radioactivity. The respective BA and RRA activity estimates for [ 125 ]iodo-hGH averaged 90% and 114% of the activity measured by the RIA. For [ 125 I]iodo-hPRL, the values were 75% by BA and 68% by RRA. The bioactivity profiles of iodinated hGH and hPRL shifted anodally on polyacrylamide gel electrophoresis in comparison to the bioactivity distribution of the respective uniodinated hormones. Iodine incorporation rather than oxidation appeared to be responsible for the shift. After electrophoresis, all eluates which contained significant radioactivity were active in the BA and RIA. Furthermore, specific activities calculated from the bioactive hormone and radioactivity in each electrophoretic segment agreed well with the average specific activity estimated from the amount of iodine incorporated into the protein peak upon gel filtration. These data suggest that hGH and hPRL to a major degree retain biological integrity after iodination

  3. Small organic molecules modulating iodine uptake in thyroid

    International Nuclear Information System (INIS)

    Ambroise, Y.

    2006-01-01

    The thyroid gland accumulates large quantities of iodine. This uptake is needed for the production of iodinated hormones (T3 and T4). The first step in the iodine accumulation is a basolateral transport of iodide ions by the cloned 'Natrium Iodide Sym-porter' also called NIS. Using high-throughput screening techniques, we have identified a series of inhibitors of the iodide uptake in thyrocytes. These compounds are of medical significance in case of thyroid deregulation and can also offer solutions for radio-iodine detoxification in case of emergency situations (nuclear industry...). In addition, these small organic molecules can be important tools for the understanding of NIS structure and functions In parallel, we have identified and characterized a single compound capable to strongly enhance the amount of intra-cellular iodide in rat thyrocytes (FRTL5) as well as in HEK293 cells transfected with hNIS (Natrium/Iodide Sym-porter). Preliminary studies show that this effect is NIS dependant, and is induced by alternative and unknown mechanisms. Future work will consist in unraveling the mode of action of this molecule. These informations will help us not only to better understand the iodide pathways in the thyroid, but also to design more active analogues. We will use photo-labelling techniques to identify new proteins involved in the iodide transfer and retention. In addition, preliminary experiments are underway to validate our compound as an anti-cancer agent. Targeted NIS gene delivery into tumors plus radio-iodide injection leads to tumor size regression. Unfortunately, doses of radioactivity are to high for safe treatment. Our compound may lead to enhanced radio-iodide entrapment, thus necessitating lower doses of radioactivity for tumor regression. (author)

  4. Study of Iodine Prophylaxis Following Nuclear Accidents

    International Nuclear Information System (INIS)

    Sri Widayati; Tedjasari, R. S.; Elfida

    2007-01-01

    Study of iodine prophylaxis following nuclear accidents has been done. Giving stable iodine to a population exposed by I-131 is one of preventive action from internal radiation to the thyroid gland. Stable iodine could be given as Kl tablet in a range of dose of 30 mg/day to 130 mg/day. Improper giving of stable iodine could cause side effect to health, so then some factors should be considered i. e. dose estimation, age, dose of stable iodine to be given, duration of stable iodine prophylaxis and risk of health. (author)

  5. Combination of ozone feed and wet electrostatic precipitator. Experimental study of an innovative system to filter gaseous iodine and iodine containing particles

    International Nuclear Information System (INIS)

    Gouëllo, Mélany; Hokkinen, Jouni; Kärkelä, Teemu; Auvinen, Ari

    2017-01-01

    Efficient mitigation systems capable of reducing as much as possible the radioactive discharge to the environment in a severe Nuclear Power Plant (NPP) accident are a necessity. Nuclear Power Plants are equipped with filtration systems which have been characterized for aerosol retention in a short term, but to a far lesser extent for the retention of volatile iodine or for the long-term behaviour of the system. After the Fukushima accident, one of the main concerns of the nuclear industry has been to verify the ability of filtration systems to mitigate the possible source term to the environment. Radiotoxic iodine has a significant contribution to a possible source term in a severe NPP accident. An innovative system has been developed at VTT Technical Research Centre of Finland Ltd. to filter gaseous iodine and iodine containing particles (e.g. I x O y ). The system consists of a combination of an ozone feed and a modern wet electrostatic precipitator (WESP). The electrostatic precipitation (ESP) technique is widely used in the industry to filter out impurities (i.e. particles) in gases. The advantage of a WESP is that the impurities are removed from the system with a solution. They can thus directly be transported to a water container, such as the sump in a nuclear power plant. The addition of ozone feed at the inlet of the WESP allows the oxidation of gaseous iodine into particles. The efficiency of the system for the filtration of gaseous molecular iodine and methyl iodine has been tested and the subsequent observations are further discussed in this paper. The results showed that the combination of WESP together with ozone feed results in a good filtering efficiency against molecular iodine under air atmosphere and air/steam atmosphere. (author)

  6. The radiotoxicology of iodine

    International Nuclear Information System (INIS)

    Taylor, D.M.

    1981-01-01

    Thirty radioisotopes of iodine are known but only those with mass numbers from 123 to 135 are of major radiotoxicological interest. Exposure of animals or man to inorganic 131 I or 125 I may result in the induction of benign or malignant thyroid tumors or depression of thyroid function; Bq for Bq 125 I is less toxic than 131 I. However, the shorter lived radioiodines 132 I, 133 I, and 135 I appear to be 10 to 100 times more toxic than 131 I alone. Little information is available about the toxicity of radioiodine containing organic compounds. The DNA precursor, iododeoxyuridine when labelled with 125 I becomes incorporated into the cell nucleus and produces severe and often irreparable damage due to the emission of Auger electrons. The risk estimate for the induction of thyroid carcinoma or adenoma by inorganic 131 I is considered to be 10 to 20x10 -6 persons Gy -1 y -1 , but may be up to 100 times larger for persons exposed to mixtures of short-lived radioiodines. (author)

  7. X-ray fluorescence analysis (XRF) and secondary ion mass spectrometry (SIMS) for analysis of iodine concentration in vitro in benign and malignant thyroid tissue

    International Nuclear Information System (INIS)

    Hansson, Marie; Berg, Gertrud; Ericsson, Lars; Grunditz, Torsten; Isaksson, Mats; Jansson, Svante; Nystrom, Ernst; Sodervall, Ulf

    2005-01-01

    Full text: The thyroid ability to store and concentrate iodine is of importance for radioiodine therapy in thyroid cancer. It is known that a normal thyroid contains 2-20 mg iodine while the information regarding malignant thyroid tissue is scarce. The purpose of this study was to investigate the iodine concentration in benign compared to malignant tissue. Methods: Thyroid tissue samples from healthy patients and from patients with papillary cancer were collected and frozen in connection with surgery. For the thyroid cancer patients, tissue was taken from both benign and malignant tissue. The iodine concentration was analysed with an XRF system consisting of a 241-Am source and an HPGe detector. When irradiating iodine containing tissue, characteristic X-rays are emitted. That radiation is detected with the strength of the detected signal being proportional to the amount of iodine in the sample. SIMS was used on glutaraldehyde fixed tissue as a histological tool for quantification and localization of iodine by sputtering and analysis of secondary ions. Results: The iodine concentration in benign tissue is considerably higher than in malignant samples. XRF measurements showed a medium iodine concentration in healthy thyroid tissue of 0.5 mg/mL. For the cancer patients, the iodine concentration was 0.3 mg/mL in benign tissue while no iodine could be detected in the malignant samples. These findings were consistent with the results from the SIMS investigation that gave a 100 times lower iodine concentration in malignant than in benign tissue. SIMS also showed that the iodine in benign tissue was predominantly located in the follicle lumen, while in the cancer cells low iodine concentration was found intra cellular as well as in the lumen. Conclusion: Iodine concentration in tissue from papillary cancer can be 100 times lower than in normal thyroid tissue. This is in accordance with the empirical knowledge that thyroid cancer should need about 100 times higher activity

  8. Iodine radiotherapy without water contamination: A contribution to environmental protection

    International Nuclear Information System (INIS)

    Benes, I.; Heinzel, F.; Mueller-Duysing, W.

    1976-01-01

    Radiotherapy with 131 I and in some instances with 125 I has been used in thyroid disease. Several millicuries up to hundreds of millicuries are administered as single dose or fractionated doses. A considerable amount (50-90%) of the administered radioiodide is excreted in the urine during the first 2-3 days, depending on the retention of iodine in the thyroidal or metastatic tissue. High doses therefore present the problem of very active urine accumulation and disposal. Only few hospitals have ''ideal'' conditions with a special canalisation for radioactive waste into storage tanks. Usually, the excreted radioactivity is stored in individual containers in a specified storage room for at least 10 half-lives. This can present contamination problems of both personnel and rooms, and tedious collection of excreted material. A semi-automated system has been installed for this unpleasant and hazardous job: separation of highly active urine from fairly inactive feces by an adapter to the toilet seat. Radioiodide is precipitated as the silver salt and separated by a filtration unit as a very small volume. More than 99.5% of the iodine radioactivity were separated out. The inactive urine can then be directed into the public canalisation

  9. Radio-guided occult lesion localisation using iodine-125 seeds ('ROLLIS') for removal of impalpable breast lesions: first Australian experience

    International Nuclear Information System (INIS)

    Taylor, Donna B.; Bourke, Anita G.; Westcott, Eliza

    2015-01-01

    Approximately one-third of breast cancers are impalpable and require pre-operative image-guided localisation. Hook-wire localisation (HWL) is commonly used but has several disadvantages. Use of a low-activity radioactive iodine-125 seed is a promising alternative technique used in the USA and the Netherlands. This pilot study describes the first use of this in Australia. In this prospective pilot study, 21 participants with biopsy-proven breast cancer underwent radio guided occult lesion localisation using iodine-125 seed(s) (ROLLIS) with insertion of a hook-wire for back up. Sentinel node biopsy was performed where indicated. Ease of hook-wire and seed insertion, duration of the procedure, dependence on the seed versus hook-wire during surgery, lesion location within the specimen, histopathology including size of radial margins, the ease of seed retrieval in pathology, and safe return of seeds for disposal were documented. Radiation dosimetry of staff was performed. All seeds were placed within 3.5 mm of the lesion. All lesions and seeds were removed. One participant needed re-excision for involved margins. Radiologists and surgeons both preferred ROLLIS. Surgeons were able to depend on the seed for localisation in all but one case. Sentinel node biopsy was successfully performed when required. Pathologists found seed retrieval quick and easy, with no detrimental effect on tissue processing. No radiation doses measurably above background were received by staff. ROLLIS is an easily learnt, safe and effective alternative technique to standard HWL.

  10. Spatial distribution of Iodine-129 in surface soil around the Fukushima Daiichi Nuclear Power Plant

    International Nuclear Information System (INIS)

    Miyake, Yasuto; Tagi, Kazuhiro; Matsuzaki, Hiroyuki; Fujiwara, Takeshi; Saito, Takumi; Yamagata, Takeyasu; Tsuchiya, Yoko; Nakano, Chuichiro; Honda, Maki

    2011-01-01

    Due to the accident at the Fukushima Daiichi nuclear power plant, which was caused by the Great East Japan Earthquake, a lot of radioactive materials were released into the environment. Among them, Iodine-131, which has a short half-life of 8 days, is thought to be hardly detected after the accident is concluded. It is very important to research how leaked out Iodine-131 was diffused in order to estimate the health impact of radiation at the time of the accident. On the other hand, Iodine-129, which was leaked out and was thought to act chemically-identically as Iodine-131, has an extremely long half-life of 15.7 million years and we are able to measure it equally after the accident. By following the trail of Iodine-129, it is considered to estimate the distribution of Iodine-131. To do this, at first, it is essential to measure simultaneously Iodine-131 and Iodine-129 in the same sample picked from near-the Fukushima Daiichi nuclear power plant and examine the relation between them (for example, the isotopic ratio of Iodine derived from the nuclear power plant (I-129/I-131)). At this study, we measured Iodine-129 in surface soil within 60 kilometers of the Fukushima Daiichi nuclear power plant, which was picked by research team of Nuclear Engineering Research Laboratory, Faculty of Engineering, the University of Tokyo. We discuss Iodine-129 derived from the nuclear power plant by considering the concentration range, the relation of a distance or a direction from the nuclear power plant, and the relation between I-129 and other radioactive nuclides (Cs-134, Cs-137, I-131). Since Iodine-129, which had been leaked out from the nuclear fuel reprocessing plant in Europe, was already transferred to Japan by way of the atmospheric transportation before the accident, it is important to distinguish between Iodine-129 from this accident and from the reprocessing plant. Then, we want to obtain the I-129/I-131 ratio originating in the accident precisely and discuss the

  11. [Assessment of dietary iodine intake of population in non-high-iodine areas in China].

    Science.gov (United States)

    Song, Xiaoyu; Li, Fengqin; Liu, Zhaoping; He, Yuna; Sui, Haixia; Mao, Weifeng; Liu, Sana; Yan, Weixing; Li, Ning; Chen, Junshi

    2011-03-01

    To assess the potential risk of dietary iodine insufficiency of population in non-high-iodine areas (water iodine China. The dietary iodine intake of 13 age-sex population groups were estimated by combining the data of iodine intake from food, table salt and drinking water. Two conditions were considered: consuming iodized salt or non-iodized salt. The data of food and table salt consumption were derived from the Chinese National Nutrition and Health Survey in 2002. Water consumption was calculated as the recommended water intake. Iodine contents of food, table salt and water were calculated from China Food Composition Table and iodine surveillance data. Under the condition of consuming iodized salt, the average iodine intake of all population groups was higher than the Recommended Nutrient Intake (RNI), while the iodine intakes of individuals above Upper Limits (UL) and below RNI were 5.8% and 13.4% respectively, and the iodine intake of individuals lower than the Estimated Average Requirement (EAR) was 9.4% in adults above 18 years of age (including pregnant and lactating women). If non-iodized salt was consumed, the average iodine intake of most sex-age population groups was higher than RNI, but the iodine intake of 97.6% of individuals would be lower than RNI, while the iodine intake of 97.4% of adults would be lower than EAR. The contribution of iodine from table salt was much higher than that from drinking water and food in the condition of consuming iodized salt, while food was the predominant contributor of dietary iodine in the condition of consuming non-iodized salt. The health risk of iodine deficiency was higher than that of iodine excess in areas where water iodine was China, and the risk of iodine insufficiency was much higher if non-iodized salt was consumed. Iodized salt should be the main sources of dietary iodine intake for population in areas where water iodine was China.

  12. Urinary Iodine Concentrations Indicate Iodine Deficiency in Pregnant Thai Women but Iodine Sufficiency in Their School-Aged Children

    NARCIS (Netherlands)

    Gowachirapant, S.; Winichagoon, P.; Wyss, L.; Tong, B.; Baumgartner, J.; Boonstra, A.; Zimmermann, M.B.

    2009-01-01

    The median urinary iodine concentration (UI) in school-aged children is recommended for assessment of iodine nutrition in populations. If the median UI is adequate in school-aged children, it is usually assumed iodine intakes are also adequate in the remaining population, including pregnant women.

  13. Iodinated contrast media nephrotoxicity

    International Nuclear Information System (INIS)

    Meyrier, A.

    1994-01-01

    In the late seventies, iodinated contrast agents (ICA) were considered to be a major cause of acute iatrogenic renal failure. Over the last decade new contrast agents have been synthesized, nonionic and less hyperosmolar. The incidence of acute renal failure due to ICAs, varies from 3.7 to 70% of cases according to the series, with an average figure of 10.2%. The pathophysiology of ICA nephrotoxicity was mainly studied in laboratory animal models. Three main factors are involved in an inducing ICA-mediated decrease in glomerular filtration rate: reduction of the renal plasma flow, a direct cytotoxic effect on renal tubular cells and erythrocyte alteration leading to intra-renal sludge. Excluding dysglobulinemias with urinary excretion of immunoglobulin light chains, which represent a special case of maximum nephrotoxicity, 4 main risk factors of renal toxicity have been identified in nondiabetic subjects: previous renal failure with serum creatinine levels greater than 140 μmol per liter, extracellular dehydration, age over 60 and use of high doses of ICA and/or repeated ICA injections before serum creatinine levels return to baseline. Preventive measures for avoiding ICA nephrotoxicity are threefold: maintain or restore adequate hydration with saline infusion, stop NSAID treatment several days before ICA administration, and allow a 5 day interval before repeating contrast media injections. New, nonionic and moderately hyperosmolar contrast agents appear to be much less nephrotoxic than conventional ICAs in laboratory animals and in high-risk patients. It is advisable to select such contrast media for investigating high-risk patients. This approach was recently substantiated in well designed, randomized clinical studies which included more than 2 000 patients. (author)

  14. Radiolytic oxidation of iodine in the containment at high temperature and dose rate

    International Nuclear Information System (INIS)

    Guilbert, S.; Bosland, L.; Jacquemain, D.; Clement, B.; Andreo, F.; Ducros, G.; Dickinson, S.; Herranz, L.; Ball, J.

    2007-01-01

    -line measurements of iodine volatilisation during irradiation at elevated temperatures and dose rates. This paper presents a description of the EPICUR facility and an overview of the experiments carried out so far to investigate radiolytic oxidation under those conditions in which data are to date insufficient. Experiments were performed using iodide solutions labelled with radioactive iodine ( 131 I). Gamma spectrometers were used to measure the rate of iodine volatilization on-line at 80 and 120 O C at a dose rate of 1.5 kGy.h -1 . The impact of dissolved oxygen and pH on the production of molecular iodine was also investigated. Tests indicate that iodine volatilization rates increased with decreasing temperature and in the absence of oxygen. On the other hand, the iodine volatility decreases strongly with increasing pH. A comparison with existing experimental data in the field is provided together with perspectives for the modelling work. (author)

  15. Experimental reproduction of iodine deficiency in cattle.

    Science.gov (United States)

    McCoy, M A; Smyth, J A; Ellis, W A; Arthur, J R; Kennedy, D G

    1997-11-22

    The role of iodine deficiency in stillbirth/perinatal weak calf syndrome was investigated in pregnant heifers. Five heifers were fed an iodine deficient diet (mean [sd] iodine concentration 0.06 [0.01] mg/kg dry matter [DM]) and six received an iodine sufficient diet (mean [sd] iodine concentration 1.45 [0.27] mg/kg DM). The diets consisted of wheat and soyabean meal with added minerals and vitamins (with or without iodine) and were fed to the heifers over the final four to five months of pregnancy. The iodine deficient diet produced clinicopathological changes and pathological changes in the thyroid glands of both the heifers and their offspring. However, all the calves in the iodine deficient group were born clinically normal.

  16. Thyroid disorders in mild iodine deficiency

    DEFF Research Database (Denmark)

    Laurberg, P; Nøhr, S B; Pedersen, K M

    2000-01-01

    Comparative epidemiologic studies in areas with low and high iodine intake and controlled studies of iodine supplementation have demonstrated that the major consequence of mild-to-moderate iodine deficiency for the health of the population is an extraordinarily high occurrence of hyperthyroidism...... endangered but the consequences of severe iodine deficiency for brain development are grave and a considerable safety margin is advisable. Moreover, a shift toward less malignant types of thyroid cancer and a lower radiation dose to the thyroid in case of nuclear fallout support that mild-to-moderate iodine...... deficiency should be corrected. However, there is evidence that a high iodine intake may be associated with more autoimmune hypothyroidism, and that Graves' disease may manifest at a younger age and be more difficult to treat. Hence, the iodine intake should be brought to a level at which iodine deficiency...

  17. Effect of iodine solutions on polyaniline films

    International Nuclear Information System (INIS)

    Ayad, M.M.; Amer, W.A.; Stejskal, J.

    2009-01-01

    Polyaniline (PANI) emeraldine-base films have been exposed to iodine solutions. The interaction between the films and the iodine solution was studied using the quartz-crystal microbalance (QCM) technique and the UV-visible absorption spectroscopy. The iodine-treated film of emeraldine base was subjected to dedoping process using 0.1 M ammonia solution. The resulting film was exposed again to the previously used iodine solution. Iodine was found to play multiple roles: the ring-iodination of PANI film, the oxidation of PANI to pernigraniline base, and iodine doping to PANI salt. A sensor based on PANI-coated electrode of QCM was developed to monitor the presence of iodine in solution.

  18. Hyperthyroidism treatment by iodine 131: about a study on 270 patients; Traitement de l'hyperthyroidie par l'iode 131: a propos d'une etude sur 270 patients

    Energy Technology Data Exchange (ETDEWEB)

    Leroux, M.A

    2005-07-01

    This study constitutes a starting point for a thought about the use of iodine 131 in the treatment of hyperthyroidism. The therapies are different depending on the teams, for the iodine 131 activities to deliver and their calculation modes; The use of synthesis anti-thyroid drugs before therapy is discussed. The radiation protection is an important factor in the decision of a metabolic radiotherapy. The indications of the treatment by radioactive iodine are different in Europe and in Usa. (N.C.)

  19. Contrast induced hyperthyroidism due to iodine excess

    OpenAIRE

    Mushtaq, Usman; Price, Timothy; Laddipeerla, Narsing; Townsend, Amanda; Broadbridge, Vy

    2009-01-01

    Iodine induced hyperthyroidism is a thyrotoxic condition caused by exposure to excessive iodine. Historically this type of hyperthyroidism has been described in areas of iodine deficiency. With advances in medicine, iodine induced hyperthyroidism has been observed following the use of drugs containing iodine—for example, amiodarone, and contrast agents used in radiological imaging. In elderly patients it is frequently difficult to diagnose and control contrast related hyperthyroidism, as most...

  20. Formation and behaviour of organic iodine

    International Nuclear Information System (INIS)

    Zilliacus, R.; Koukkar, P.; Karjunen, T.; Sjoevall, H.

    2002-01-01

    The report presents experimental studies on the formation of organic iodine in severe reactor accidents. The analyses were performed to evaluate the amount of alkaline chemical needed for effective pH control of containment water during the accidents. The formation of organic iodine in solutions used in the filtered venting system and the absorption of iodine compounds in the solutions were studied. Experiments for the formation of organic iodine on painted surfaces were also performed. (au)

  1. Mineral resource of the month: iodine

    Science.gov (United States)

    Polyak, Désirée E.

    2009-01-01

    The article focuses on iodine, its benefits and adverse effects, and its production and consumption. It states that iodine is essential to humans for it produces thyroid hormones to nourish thyroid glands but excessive intake could cause goiter, hyperthyroidism or hypothyroidism. U.S. laws require salt iodization to help prevent diseases. Chile and Japan are the world's leading iodine producer while in the U.S. iodine is mined from deep well brines in northern Oklahoma.

  2. The importance of iodine nutrition during pregnancy.

    Science.gov (United States)

    Glinoer, Daniel

    2007-12-01

    To examine the importance of iodine nutrition during pregnancy. Review of existing literature of iodine in pregnancy. Population surveys and metabolic studies. Pregnant women. The main changes in thyroid function associated with pregnancy are due to an increase in hormone requirements that begin in the first trimester of gestation. This increase can only be met by a proportional increase in hormone production, something that depends directly upon the availability of iodine. When dietary iodine is lacking, an adequate physiological adaptation is difficult to achieve and is progressively replaced by pathological alterations that occur in parallel with the degree and duration of iodine deprivation. Iodine prophylaxis should be given systematically to women during pregnancy. In most public health programmes dealing with the correction of iodine deficiency disorders, iodised salt has been used as the preferred means to deliver iodine to households. Iodised salt, however, is not the ideal means of delivering iodine in the specific instances of pregnancy, breast-feeding and complementary feeding because of the need to limit salt intake during these periods. In European countries, presently it is proposed that iodine is given to pregnant women and breast-feeding mothers by systematically administering multivitamin tablets containing iodine in order to reach the recommended dietary allowance of 250 microg iodine day-1.

  3. Iodine in Enteral and Parenteral Nutrition

    NARCIS (Netherlands)

    Zimmermann, M.B.; Crill, C.M.

    2010-01-01

    Iodine deficiency (ID) has multiple adverse effects on growth and development due to inadequate thyroid hormone production. Methods for assessment of iodine nutrition in individuals include the urinary iodine concentration (UI), thyroid size and thyroid function tests. The UI measured in several

  4. Industrial system for producing iodine-123

    International Nuclear Information System (INIS)

    Brantley, J.C.

    1985-01-01

    An industrial system to produce iodine-123 required a complex set of steps involving new approaches by the Food and Drug Administration, difficult distribution procedures, and evidence from potential users that either very pure iodine-123 or inexpensive iodine-123 is needed. Industry has shown its willingness to invest in new radionuclides but needs strong evidence as to product potential to justify those investments

  5. Iodine excretion in school children in Copenhagen

    DEFF Research Database (Denmark)

    Rasmussen, Lone B; Kirkegaard-Klitbo, Ditte Marie; Laurberg, Peter

    2016-01-01

    INTRODUCTION: Studies of dietary habits show a high iodine intake in children in Denmark. Iodine excretion in children has not previously been assessed. Iodine excretion in adults is below the recommended threshold, and it is therefore being discussed to increase the fortification level. The main...

  6. MARGINAL IODINE DEFICIENCY EXACERBATES PERCHLORATE THYROID TOXICITY.

    Science.gov (United States)

    The environmental contaminant perchlorate disrupts thyroid homeostasis via inhibition of iodine uptake into the thyroid. This work tested whether iodine deficiency exacerbates the effects of perchlorate. Female 27 day-old LE rats were fed a custom iodine deficient diet with 0, 50...

  7. Chemical species of iodine in some seaweeds. Pt. 2. Iodine-bound biological macromolecules

    International Nuclear Information System (INIS)

    Xiaolin Hou; Chifang Chai; Xiaojun Yan

    2000-01-01

    The distribution of iodine in various biological macromolecules in Sargassum kjellmanianum was studied using neutron activation analysis combined with chemical and biochemical separation techniques. The results indicate that iodine is mainly bound with protein, part of iodine with pigment and polyphenol, and little with polysaccharides, such as algin, fucoidan and cellulose. This result is significant for the mechanism of enriching iodine of algae and utilization of alga iodine. (author)

  8. Determination of iodine in biological samples by neutron activation analysis (NAA)

    International Nuclear Information System (INIS)

    Geetha, P.V.; Karunakara, N.; Prabhu, Ujwal; Yashodhara, I.; Ravi, P.M.; Sudhakar, J.; Ajith, Nicy; Swain, K.K.; Verma, R.; Reddy, A.V.R.; Acharya, R.

    2010-01-01

    During normal operating conditions of a nuclear reactor, the release of radionuclides to the environment will be extremely low and well within the limits. Radioiodine ( 131 I) is one of the radionuclides likely to get released into the atmosphere in case of a reactor accident. During the short initial phase of release of radioactivity, 131 I is rapidly transferred to milk, leading to significant thyroid dose to those consuming milk, especially infant and children. Hence, studies on Iodine transfer through grass-cow-milk is very important. Extensive studies on transfer for 131 I through grass-cow-milk pathway after Chernobyl accident has been reported. But, under normal operational conditions of the power reactor, 131 I is not present in measurable concentration in environmental matrices of a nuclear power generating station. Stable iodine is present in all environmental samples and from the concentration of stable iodine in grass and milk, one can estimate the transfer factor. The measurement of stable iodine in environmental sample is very challenging because of its extremely low concentration. Neutron activation analysis can be used for estimation of stable iodine in the environment after suitably optimizing the condition to minimize interferences. A method has been developed based on thermal neutron activation analysis (NAA) to estimate the iodine concentration present in grass and cow milk

  9. Regeneration of the iodine isotope-exchange efficiency for nuclear-grade activated carbons

    International Nuclear Information System (INIS)

    Deitz, V.R.

    1985-01-01

    The removal of radioactive iodine from air flows passing through impregnated activated carbons depends on a minimum of three distinguishable reactions: (1) adsorption on the carbon networks of the activated carbons, (2) iodine isotope exchange with impregnated iodine-127, and (3) chemical combination with impregnated tertiary amines when present. When a carbon is new, all three mechanisms are at peak performance and it is not possible to distinguish among the three reactions by a single measurement; the retention of methyl iodide-127 is usually equal to the retention of methyl iodide-131. After the carbon is placed in service, the three mechanisms of iodine removal are degraded by the contaminants of the air at different rates; the adsorption process degrades faster than the other two. This behavior will be shown by comparisons of methyl iodide-127 and methyl iodide-131 penetration tests. It was found possible to regenerate the iodine isotope-exchange efficiency by reaction with airborne chemical reducing agents with little or no improvement in methyl iodine-127 retention. Examples will be given of the chemical regeneration of carbons after exhaustion with known contaminants as well as for many carbons removed from nuclear power operations. The depth profile of methyl iodide-131 penetration was determined in 2-inch deep layers before and after chemical treatments

  10. The use of 125iodine-labeled RNA for detection of the RNA binding to ribosomes

    International Nuclear Information System (INIS)

    Mori, Tomohiko; Fukuda, Mitsuru

    1975-01-01

    The in vitro labeling of RNA with radioactive iodine is the efficient method to obtain the RNA with high specific activity. The present paper reports on the application of this technique to the production of iodine-labeled RNA for use in the experiment of binding RNA to ribosomes. Tobacco mosaic virus (TMV) RNA was used as natural mRNA, and E. coli S-30 preparation was used as a source of ribosomes. The TMV-RNA was prepared by bentonite-phenol extraction from TMV, and the method used for the iodation of RNA was based on the procedure described by Getz et al. The iodine-labeled RNA was incubated in a cell-free protein synthesizing system (S-30) prepared from E. coli K-12. After the incubation, the reaction mixture was layered onto sucrose gradient, centrifuged, and fractionated into 18 fractions. Optical density at 260 nm was measured, and radioactivity was counted, for each fraction. The binding of mRNA to ribosomes occurred even at 0 deg C, and the occurrence of the nonspecific binding was also shown. Consequently, the specific binding, i.e. the formation of the initiation complex being involved in amino acid incorporation, may be estimated by subtracting the radioactivity associated with monosomes in the presence of both rRNA and ATA from that in the presence of rRNA only. It was shown that the iodine-labeled RNA can be used for the studies of binding RNA to ribosomes. (Kako, I.)

  11. Comparison of iodine behavior in a containment's sump water and in a FCVS's pool

    Energy Technology Data Exchange (ETDEWEB)

    Shim, Sojin; Lee, Jaeyoung [Handong Global Univ., Pohang (Korea, Republic of); Park, Sanggil [ACT Co., Daejeon (Korea, Republic of)

    2016-10-15

    This source term could severely affect the environment with a severe radioactive potentially, which has a high radioactivity and a high volatility in a high temperature. Difficultly caught and considered to give sustained damage on thyroid, the iodine source term is protected from releasing to the environment. Especially in the over-high temperature and pressure out of the limit of containment design during a sever accident, the research and experiments to improve the retention efficiency of iodine species in a containment and a FCVS(Filtered Containment Venting System) which vents containment atmosphere in order to stabilize the temperature and the pressure have been conducted. Iodine is produced in and released from fuel rod and converted to other species in a sump water bottom of the containment, which pass thorough a pool in a FCVS during venting. In this paper, studies of phase and species conversion of iodine have been reviewed in order to fine the efficient retention conditions in a containment and a FCVS. In a sump water, high pH decreases the iodine's volatility and the nuclide's emission into the atmosphere. In a high temperature, the iodine volatility significantly decreases, but still it is required to assess the dependence of hydrolysis equilibrium reaction constant on the temperature. Molecular iodine that converted from an iodine ion species is reduced more easily when it is in the I- solution, so the reaction has the higher rate constant. Organic materials affect iodine volatility by the radiolysis into carboxylic acid and carbon dioxide that decrease the sump water's pH. It is considerable to use buffer solutions into the sump water to remain the pH high, but there is an uncertainty about the pH of the sump water which decide the utility of alkaline buffer.

  12. Inquiry about 131 Iodine use in Brazil; Inquerito sobre o uso do Iodo-131 no Brasil

    Energy Technology Data Exchange (ETDEWEB)

    Albino, Claudio Cordeiro; Takahashi, Mirian Hideko; Senhorini Junior, Sidney; Graf, Hans [Parana Univ., Curitiba, PR (Brazil); Inst. de Diabetes e Endocrinologia de Maringa, PR (Brazil)]. E-mail: ccalbino@uol.com.br

    2001-12-01

    Radioactive iodine is an effective and widely accepted therapy for Graves disease (G D) and differentiated thyroid carcinoma (DTC), but there still are some controversies about the criteria for its use. To establish the present tendency for radioiodine indication, we have sent questionnaires for members of The Brazilian Society of Endocrinology and Latin American Thyroid Society, with 3 index cases: G D, toxic nodular goiter (TNG) and DTC. For each case, questions were proposed about diagnostic procedures and therapy with some clinical variants, which could modify the therapeutic choice. From the almost 2000 questionnaires sent only 82 replies (3.4%) were analyzed. Most of respondents defined themselves as general endocrinologists (85%), working in South and Southeast regions of Brazil (80%), with more than 20 years of professional activity and working mainly at University Hospitals (40%). In case index 1 (G D), 95% of the respondents used arrays of T 3, T 4 and TSH for the diagnosis and 25% added TRAb and thyroid scan. Antithyroid drugs (ATD) were the first choice for 72%, followed by radioiodine and surgery (26% and 1.3% respectively). None of clinical variants such as severe exophthalmos, older age or goiter size modified the therapy. In case 2 (TNG), radioiodine was the first therapy for 84% of professionals and the presence of compressive symptoms was the only variant that changed this tendency, when surgery was the main option. In case 3 (DTC), almost all indicated total thyroidectomy. Radioiodine for thyroid remnants was proposed by 45% of respondents, independent of residual uptake, while the remaining did so depending of different values of uptake, giving 30 to 100 mCI. These data show that radioiodine use is increasing for hyperthyroidism, but still less than observed in other countries and that we do not have uniformity for treatment of DTC. (author)

  13. Studies of dynamic and static leaching of cemented and uncemented sorption material loaded with iodine-129

    International Nuclear Information System (INIS)

    Furrer, J.

    1989-05-01

    Leaching tests with water and brines were conducted on AC 6120 iodine sorption material (12 wt.% Ag) in order to improve the assessment of the behaviour of radioactive waste stored in a repository mine (salt or iron ore). As a result of the dynamic and static leaching tests, the leached fraction of I-129 in the uncemented material was found to be -1 %, while that of the cemented iodine sorption material was found to be -2 %. After ordinary steel had been added to the cemented sorption material, the leached fractions found were identical to those measured in uncemented material. The addition of stainless steel had only little influence on the leached fraction. (author)

  14. Radioactive source

    International Nuclear Information System (INIS)

    Drabkina, L.E.; Mazurek, V.; Myascedov, D.N.; Prokhorov, P.; Kachalov, V.A.; Ziv, D.M.

    1976-01-01

    A radioactive layer in a radioactive source is sealed by the application of a sealing layer on the radioactive layer. The sealing layer can consist of a film of oxide of titanium, tin, zirconium, aluminum, or chromium. Preferably, the sealing layer is pure titanium dioxide. The radioactive layer is embedded in a finish enamel which, in turn, is on a priming enamel which surrounds a substrate

  15. Iodine concentration calculated by dual-energy computed tomography (DECT) as a functional parameter to evaluate thyroid metabolism in patients with hyperthyroidism.

    Science.gov (United States)

    Binh, Duong Duc; Nakajima, Takahito; Otake, Hidenori; Higuchi, Tetsuya; Tsushima, Yoshito

    2017-07-19

    Thyroid function in patients with Grave's disease is usually evaluated by thyroid scintigraphy with radioactive iodine. Recently, dual-energy computed tomography (DECT) with two different energy X-rays can calculate iodine concentrations and can be applied for iodine measurements in thyroid glands. This study aimed to assess the potential use of DECT for the functional assessment of the thyroid gland. Thirteen patients with Grave's disease treated at our hospital from May to September 2015 were included in this retrospective study. Before treatments, all subjects had undergone both iodine scintigraphy [three and 24 h after oral administration of 123 I (20 μCi)] and non-enhanced DECT. The region of interests (ROIs) were placed in both lobes of the thyroid glands, and CT values (HU: Hounsfield unit) and iodine concentrations (mg/mL) calculated from DECT images were measured. The correlation between CT values and iodine concentrations from DECT in the thyroid gland was evaluated and then the iodine concentrations were compared with radioactive iodine uptake ratios by thyroid scintigraphy. Mean (±SD) 123 I uptake increased from 46.3 (±22.2) % (range, 11.1-80.1) at 3 h, to 66.5 (±15.2) % (range, 40.0-86.1) at 24 h (p hyperthyroid patients.

  16. Radioactivity metrology

    International Nuclear Information System (INIS)

    Legrand, J.

    1979-01-01

    Some aspects of the radioactivity metrology are reviewed. Radioactivity primary references; absolute methods of radioactivity measurements used in the Laboratoire de Metrologie des Rayonnements Ionisants; relative measurement methods; traceability through international comparisons and interlaboratory tests; production and distribution of secondary standards [fr

  17. Radioactive wastes

    International Nuclear Information System (INIS)

    Teillac, J.

    1988-01-01

    This study of general interest is an evaluation of the safety of radioactive waste management and consequently the preservation of the environment for the protection of man against ionizing radiations. The following topics were developed: radiation effects on man; radioactive waste inventory; radioactive waste processing, disposal and storage; the present state and future prospects [fr

  18. Incorporation of iodine into calcium phosphates with apatitic structure

    International Nuclear Information System (INIS)

    Coulon, Antoine

    2014-01-01

    In order to avoid the release of 129 I (long-lived intermediate-level waste) in the environment, we describe a novel material incorporating iodine under the form of iodate in a calcium phosphate based hydroxyapatite. This material is prepared by two synthetic processes: a wet precipitation route followed by a spark plasma sintering and a cementitious route. A high iodine content (with a maximum incorporation rate of 10 wt.%) is reached for both processes, by incorporation of the iodate in the apatitic structure. A monolith with relative density of 88.6% was obtained after shaping of the precipitated powders by spark plasma sintering. This material reveals satisfactory leaching properties, with an initial leaching rate in pure water at 50 C of 10 -2 g.m -2 .j -1 , and a residual leaching rate at 50 C of 10 -5 g.m -2 .j -1 in underground water of potential geological repositories. All in all, this material is a potential candidate for the conditioning of radioactive iodine. (author) [fr

  19. Thyroid disorders and radio iodine therapy: dental perspectives

    International Nuclear Information System (INIS)

    Batra, Arika; Krishnan, Manu; Tiwari, Brijesh; Singh, Sanjana; Sharma, Anu

    2014-01-01

    Thyroid disorders; hyper/hypothyroidism/thyroiditis/neoplasms are widely prevalent endocrine disorders. Oral manifestations of hyperthyroidism are increased susceptibility to caries, periodontal disease, maxillary/mandibular osteoporosis, premature shedding of deciduous teeth and early eruption of permanent teeth, sjogren and burning mouth syndromes. Undiagnosed/untreated hyperthyroidism often precipitates as 'Thyroid storm' during a stressful episode of surgical intervention/trauma. Hypothyroidism shows macroglossia, micrognathia, dysgeusia, thick lips, d